data_1dx8_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1dx8 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.159 0.504 . . . . 0.0 109.723 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.588 ' CE2' ' CD1' ' A' ' 34' ' ' PHE . 4.3 m-85 -100.4 147.05 26.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.13 -0.981 . . . . 0.0 109.908 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -117.71 128.15 54.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.234 -0.916 . . . . 0.0 110.222 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.9 t -69.86 112.04 6.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 110.178 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -11.54 59.54 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.135 -0.978 . . . . 0.0 109.592 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.422 ' HB1' ' NE2' ' A' ' 52' ' ' GLN . . . -85.19 -39.61 17.63 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.29 -0.881 . . . . 0.0 111.76 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.436 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 12.6 p -125.61 -32.99 2.82 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.672 -1.268 . . . . 0.0 111.752 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.83 21.61 5.97 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -83.09 156.03 23.53 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.229 -1.16 . . . . 0.0 109.565 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.467 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 2.7 mp -120.57 109.88 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 110.262 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.513 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 64.5 t80 -75.75 126.63 31.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.321 -0.862 . . . . 0.0 109.659 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.409 ' HB3' ' CB ' ' A' ' 21' ' ' LYS . 24.2 mt-10 -102.48 111.21 64.41 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.345 -0.847 . . . . 0.0 109.666 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.77 -70.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.487 1.256 . . . . 0.0 110.939 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.403 ' O ' ' CB ' ' A' ' 30' ' ' PRO . 66.4 tt0 -47.45 -26.18 1.29 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.448 -0.783 . . . . 0.0 110.567 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.409 ' CB ' ' HB3' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -93.58 -33.75 13.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.241 -0.912 . . . . 0.0 110.196 179.833 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.91 157.03 32.27 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -85.04 61.34 6.81 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.479 -1.013 . . . . 0.0 109.854 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -46.54 -26.67 0.93 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.454 -0.779 . . . . 0.0 110.679 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -80.77 -25.28 38.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.265 -0.897 . . . . 0.0 110.125 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -97.82 -30.41 12.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.209 -0.932 . . . . 0.0 110.157 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 127.39 4.17 5.92 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.959 -1.115 . . . . 0.0 110.536 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.5 mt -98.19 129.04 31.65 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.824 -1.398 . . . . 0.0 110.162 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 47.0 Cg_endo -74.31 173.14 14.71 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 O-C-N 123.505 1.266 . . . . 0.0 110.557 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 49.9 Cg_endo -70.9 -163.38 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.623 1.328 . . . . 0.0 110.262 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 50.21 40.58 37.39 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 99.7 m -147.28 115.46 4.26 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.183 -1.187 . . . . 0.0 110.253 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.98 151.55 56.35 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.514 1.27 . . . . 0.0 110.584 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.588 ' CD1' ' CE2' ' A' ' 8' ' ' TYR . 12.6 t80 -54.6 -32.5 58.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.328 -0.858 . . . . 0.0 110.066 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.4 m -63.56 -13.47 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.355 -0.841 . . . . 0.0 110.623 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -102.57 4.38 38.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.027 -1.045 . . . . 0.0 111.053 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.408 ' CB ' ' HD2' ' A' ' 50' ' ' LYS . 22.4 mt -56.61 178.97 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.832 -1.167 . . . . 0.0 110.044 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.8 m -69.18 164.96 21.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.215 -0.928 . . . . 0.0 110.324 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -63.93 -20.79 66.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.207 -0.933 . . . . 0.0 110.218 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.3 m -138.89 54.91 1.73 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.163 -0.961 . . . . 0.0 110.356 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.449 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 18.4 t80 -70.69 140.98 51.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.147 -0.971 . . . . 0.0 109.831 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.9 mtt -116.4 143.9 44.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.289 -0.882 . . . . 0.0 109.644 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 11.6 t -60.16 132.84 90.17 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.195 -0.941 . . . . 0.0 110.498 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.92 -9.22 20.79 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.569 1.3 . . . . 0.0 110.314 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -106.15 -40.04 5.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.078 -1.014 . . . . 0.0 110.707 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.436 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 1.3 p -122.72 5.1 9.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.133 -0.98 . . . . 0.0 111.113 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 4.2 mtm105 57.65 18.17 4.53 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.185 -0.947 . . . . 0.0 112.816 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.6 m -72.32 163.34 68.19 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 120.66 -1.275 . . . . 0.0 109.704 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -70.52 143.74 48.04 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.639 1.336 . . . . 0.0 110.235 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.488 ' HG2' ' CZ ' ' A' ' 34' ' ' PHE . 19.4 tttt -49.94 -24.63 2.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.208 -0.933 . . . . 0.0 110.549 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -66.17 -14.14 61.36 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.096 -1.002 . . . . 0.0 109.977 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.422 ' NE2' ' HB1' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -83.93 -5.56 59.24 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.141 -0.974 . . . . 0.0 109.999 179.218 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.523 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 12.7 m-85 -85.11 149.46 25.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.018 -1.051 . . . . 0.0 110.285 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.66 132.66 26.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.352 -0.842 . . . . 0.0 109.878 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.516 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 5.8 p -61.83 172.62 1.25 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.166 -0.959 . . . . 0.0 110.917 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.2 tt . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.733 -0.605 . . . . 0.0 109.718 179.476 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.423 ' O ' ' CG2' ' A' ' 56' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.237 0.542 . . . . 0.0 109.936 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.564 ' CE2' ' CD2' ' A' ' 34' ' ' PHE . 7.4 m-85 -109.59 141.93 41.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.168 -0.957 . . . . 0.0 109.878 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -106.18 129.88 54.16 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.162 -0.961 . . . . 0.0 110.275 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.9 t -71.42 116.17 11.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 110.339 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.73 -11.47 60.96 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.091 -1.006 . . . . 0.0 109.585 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.15 -41.37 15.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.309 -0.87 . . . . 0.0 111.653 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.453 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 14.3 p -123.12 -32.62 3.43 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.758 -1.214 . . . . 0.0 111.406 -179.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.0 24.0 5.92 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.46 ' CD2' ' N ' ' A' ' 16' ' ' ILE . 40.9 t80 -84.13 168.96 15.33 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.365 -1.079 . . . . 0.0 109.343 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.46 ' N ' ' CD2' ' A' ' 15' ' ' TYR . 33.9 mm -129.41 117.59 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.27 -0.894 . . . . 0.0 110.309 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.5 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 56.1 t80 -80.54 129.17 34.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.429 -0.794 . . . . 0.0 109.912 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -104.91 110.73 64.87 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.488 -0.758 . . . . 0.0 109.546 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.426 ' CB ' ' HA ' ' A' ' 33' ' ' PRO . 37.5 Cg_endo -68.58 -76.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.591 1.311 . . . . 0.0 111.464 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -46.02 -26.58 0.75 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.285 -0.885 . . . . 0.0 111.037 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.5 tttp -87.95 -36.09 17.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 110.522 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.46 145.63 17.81 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.41 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 2.9 t0 -85.11 62.07 7.27 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.3 -1.118 . . . . 0.0 109.876 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.39 -26.5 2.1 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.249 -0.907 . . . . 0.0 110.416 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -74.51 -20.41 59.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.303 -0.873 . . . . 0.0 109.921 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.41 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -106.99 -33.28 7.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.929 . . . . 0.0 109.969 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.94 32.97 0.66 Allowed Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.948 -1.12 . . . . 0.0 110.309 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.417 HD12 ' CD2' ' A' ' 37' ' ' LEU . 3.1 mt -124.1 130.39 24.4 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 120.876 -1.367 . . . . 0.0 109.753 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.46 173.21 13.57 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 O-C-N 123.601 1.316 . . . . 0.0 110.394 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -72.19 -164.87 0.19 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.629 1.331 . . . . 0.0 110.186 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 49.76 27.87 10.18 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.9 m -127.94 112.08 20.28 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.099 -1.236 . . . . 0.0 110.228 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.426 ' HA ' ' CB ' ' A' ' 19' ' ' PRO . 44.3 Cg_endo -70.87 153.08 64.0 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.554 1.292 . . . . 0.0 110.478 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.564 ' CD2' ' CE2' ' A' ' 8' ' ' TYR . 27.5 t80 -55.48 -28.36 54.04 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.234 -0.916 . . . . 0.0 110.106 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.405 HG21 ' N ' ' A' ' 36' ' ' ASP . 33.8 m -64.79 -20.16 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.207 -0.933 . . . . 0.0 110.077 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.405 ' N ' HG21 ' A' ' 35' ' ' VAL . 7.8 m-20 -90.54 -11.11 41.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.13 -0.981 . . . . 0.0 110.69 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.417 ' CD2' HD12 ' A' ' 28' ' ' ILE . 25.5 mt -52.54 157.65 1.47 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.974 -1.079 . . . . 0.0 110.322 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.34 139.34 58.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.307 -0.871 . . . . 0.0 109.99 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -51.17 -24.86 4.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.26 -0.9 . . . . 0.0 110.348 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.95 26.19 10.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.87 . . . . 0.0 110.177 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.454 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 18.3 t80 -56.04 131.96 48.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 109.844 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.1 mtt -113.3 147.46 37.55 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.265 -0.897 . . . . 0.0 109.545 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 7.9 t -58.72 134.25 86.39 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.0 110.44 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -77.83 1.09 9.21 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.533 1.281 . . . . 0.0 110.29 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -120.97 -34.96 3.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.027 -1.045 . . . . 0.0 110.923 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.453 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.7 OUTLIER -126.16 4.07 7.14 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.937 -1.102 . . . . 0.0 111.345 -179.668 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.78 17.75 10.13 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.085 -1.009 . . . . 0.0 112.142 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.406 ' CB ' ' SG ' ' A' ' 46' ' ' CYS . 5.0 t -70.44 153.39 95.11 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.822 -1.174 . . . . 0.0 109.707 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.16 145.33 43.89 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.587 1.309 . . . . 0.0 110.558 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.46 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 24.7 tttm -52.37 -32.03 36.6 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.175 -0.953 . . . . 0.0 110.186 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.15 -15.66 47.39 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.122 -0.987 . . . . 0.0 109.745 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.1 3.77 53.92 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.24 -0.912 . . . . 0.0 110.159 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -92.84 128.16 38.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.896 -1.127 . . . . 0.0 110.209 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.86 135.73 50.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.301 -0.874 . . . . 0.0 109.737 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 77.9 p -68.15 -178.44 1.04 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 110.908 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.43 ' O ' ' CG2' ' A' ' 56' ' ' ILE . 7.2 tp . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.466 0.65 . . . . 0.0 109.691 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.424 ' O ' ' CG2' ' A' ' 56' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.219 0.533 . . . . 0.0 109.879 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.505 ' CE2' ' HB3' ' A' ' 55' ' ' SER . 8.9 m-85 -118.1 135.88 53.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.153 -0.967 . . . . 0.0 109.635 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -101.53 135.76 42.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.048 -1.033 . . . . 0.0 110.55 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.9 t -77.49 113.95 15.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.194 -0.941 . . . . 0.0 110.248 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.01 -10.26 59.45 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.004 -1.06 . . . . 0.0 109.572 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.05 -39.48 17.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.43 -0.794 . . . . 0.0 111.584 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.459 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 13.8 p -125.5 -35.24 2.58 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.652 -1.28 . . . . 0.0 111.531 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.02 22.8 4.81 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.466 ' CG ' ' N ' ' A' ' 16' ' ' ILE . 59.2 t80 -83.66 170.22 14.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.351 -1.088 . . . . 0.0 109.871 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.466 ' N ' ' CG ' ' A' ' 15' ' ' TYR . 37.2 mm -132.24 115.03 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 110.255 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.499 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 68.4 t80 -78.17 135.94 37.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.331 -0.856 . . . . 0.0 110.136 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.415 ' O ' ' N ' ' A' ' 22' ' ' GLY . 5.8 mt-10 -115.28 110.09 45.75 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.516 -0.74 . . . . 0.0 109.461 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.99 -72.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.395 0 O-C-N 123.52 1.274 . . . . 0.0 111.237 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -44.81 -27.27 0.49 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.544 -0.722 . . . . 0.0 111.032 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -98.13 -24.02 15.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.207 -0.933 . . . . 0.0 110.147 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 18' ' ' GLU . . . 80.04 153.36 8.49 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.93 61.2 6.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.361 -1.081 . . . . 0.0 109.595 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.45 -27.78 0.78 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.57 -0.706 . . . . 0.0 110.965 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.85 -28.08 60.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.187 -0.946 . . . . 0.0 109.899 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -96.54 -28.22 14.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.291 -0.88 . . . . 0.0 110.073 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.8 24.63 2.27 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.413 HD12 ' CD1' ' A' ' 41' ' ' PHE . 7.6 mt -113.98 128.86 25.32 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.959 -1.318 . . . . 0.0 109.684 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.33 170.45 19.87 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.598 1.315 . . . . 0.0 110.665 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.01 -163.59 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.674 1.355 . . . . 0.0 110.144 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 48.99 34.38 15.79 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 90.2 m -138.7 115.08 8.79 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.259 -1.142 . . . . 0.0 110.271 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -72.08 148.8 51.3 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.568 1.299 . . . . 0.0 110.507 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.499 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 19.1 t80 -51.59 -27.85 12.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.42 -0.8 . . . . 0.0 110.272 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.1 m -71.0 -19.59 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.936 . . . . 0.0 110.52 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.27 -2.26 55.21 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.186 -0.946 . . . . 0.0 110.924 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.426 ' CD1' ' HD2' ' A' ' 50' ' ' LYS . 25.2 mt -53.19 -179.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.971 -1.08 . . . . 0.0 110.372 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.15 156.48 38.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.381 -0.825 . . . . 0.0 110.232 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -53.11 -26.31 16.13 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.268 -0.895 . . . . 0.0 110.424 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.32 60.43 1.67 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.143 -0.973 . . . . 0.0 110.42 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.452 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 10.0 t80 -71.64 128.49 35.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.164 -0.96 . . . . 0.0 109.685 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.4 ' HA ' ' O ' ' A' ' 48' ' ' SER . 18.1 mmt -103.0 145.83 29.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -0.925 . . . . 0.0 109.795 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 8.3 t -58.36 138.12 85.11 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.403 -0.811 . . . . 0.0 110.67 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -77.68 -0.57 10.77 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.686 1.361 . . . . 0.0 110.394 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -122.41 -34.15 3.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.032 -1.042 . . . . 0.0 111.022 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.459 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.8 OUTLIER -125.03 8.01 7.99 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.933 -1.105 . . . . 0.0 111.298 -179.655 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.69 21.41 4.59 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.122 -0.987 . . . . 0.0 112.432 178.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.413 ' CB ' ' SG ' ' A' ' 46' ' ' CYS . 10.9 t -77.23 153.25 82.11 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 120.666 -1.271 . . . . 0.0 109.627 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.26 142.06 49.04 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.584 1.307 . . . . 0.0 110.548 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.484 ' HG2' ' CZ ' ' A' ' 34' ' ' PHE . 4.4 ttpm? -48.4 -29.44 4.01 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.445 -0.784 . . . . 0.0 110.937 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -62.77 -14.79 49.13 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.986 -1.071 . . . . 0.0 109.967 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.09 1.1 56.08 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.125 -0.985 . . . . 0.0 110.03 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.449 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 16.6 m-85 -89.63 137.43 32.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.116 -0.99 . . . . 0.0 110.307 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -115.9 131.63 56.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.285 -0.885 . . . . 0.0 109.64 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.505 ' HB3' ' CE2' ' A' ' 8' ' ' TYR . 79.3 p -63.68 179.67 0.46 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.048 -1.032 . . . . 0.0 111.054 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.424 ' CG2' ' O ' ' A' ' 7' ' ' LYS . 1.2 tp . . . . . 0 C--N 1.297 -1.677 0 CA-C-O 121.405 0.622 . . . . 0.0 109.561 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.508 ' CE2' ' HB2' ' A' ' 55' ' ' SER . 22.2 m-85 -129.3 150.39 50.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.017 -1.052 . . . . 0.0 110.864 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.431 ' CB ' HD12 ' A' ' 16' ' ' ILE . 13.8 pt-20 -120.56 140.66 51.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.323 -0.861 . . . . 0.0 109.863 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 t -80.05 113.86 18.53 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.176 -0.953 . . . . 0.0 110.434 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.63 -11.71 61.11 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.115 -0.99 . . . . 0.0 109.613 178.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.08 -41.3 15.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 111.726 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.4 p -122.08 -32.85 3.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.726 -1.234 . . . . 0.0 111.551 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.14 21.12 6.03 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.507 ' CD2' ' N ' ' A' ' 16' ' ' ILE . 60.5 t80 -81.6 168.92 17.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.265 -1.138 . . . . 0.0 109.92 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.507 ' N ' ' CD2' ' A' ' 15' ' ' TYR . 34.8 mm -135.11 116.25 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.246 -0.908 . . . . 0.0 110.201 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.477 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 63.5 t80 -80.57 132.86 35.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -0.874 . . . . 0.0 110.109 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -113.93 113.86 46.78 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.561 -0.712 . . . . 0.0 109.655 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.406 ' CB ' ' O ' ' A' ' 32' ' ' THR . 38.5 Cg_endo -71.72 -65.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.474 1.25 . . . . 0.0 110.892 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -45.38 -27.33 0.67 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.715 -0.616 . . . . 0.0 110.776 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.12 -35.57 10.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.282 -0.886 . . . . 0.0 110.0 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.64 149.54 10.69 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -85.14 62.42 7.49 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.457 -1.025 . . . . 0.0 109.725 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -44.91 -27.5 0.54 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.629 -0.669 . . . . 0.0 110.916 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.45 -26.44 60.05 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.315 -0.865 . . . . 0.0 110.26 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -100.72 -25.68 14.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.223 -0.923 . . . . 0.0 110.335 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.92 19.1 3.39 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.893 -1.146 . . . . 0.0 110.244 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.2 mt -111.19 116.59 51.1 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 120.897 -1.355 . . . . 0.0 109.717 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.35 172.18 13.7 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.503 1.265 . . . . 0.0 110.611 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.54 -164.14 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.724 1.381 . . . . 0.0 110.145 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 47.61 27.33 4.36 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.406 ' O ' ' CB ' ' A' ' 19' ' ' PRO . 89.9 m -128.73 119.53 20.21 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.12 -1.223 . . . . 0.0 110.245 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -73.78 159.47 45.29 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 O-C-N 123.525 1.276 . . . . 0.0 110.878 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.479 ' CZ ' ' HE2' ' A' ' 50' ' ' LYS . 44.2 t80 -65.79 -28.93 69.37 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.448 -0.783 . . . . 0.0 110.157 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.2 m -69.45 -9.83 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -0.904 . . . . 0.0 110.809 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.67 -1.96 23.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.965 -1.085 . . . . 0.0 110.892 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.9 mt -52.07 162.57 0.45 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.883 -1.136 . . . . 0.0 110.27 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.7 t -49.57 164.86 0.08 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.31 -0.869 . . . . 0.0 110.44 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.46 -26.0 68.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.916 . . . . 0.0 110.233 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.9 p -131.65 52.73 2.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.271 -0.893 . . . . 0.0 110.46 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.47 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 26.9 t80 -63.46 132.17 50.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.216 -0.927 . . . . 0.0 109.785 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -110.17 143.97 39.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.878 . . . . 0.0 109.663 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.449 ' HB3' ' N ' ' A' ' 47' ' ' ARG . 8.7 t -55.49 137.45 69.56 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 110.741 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -77.6 -1.68 11.85 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.58 1.305 . . . . 0.0 110.287 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -120.56 -39.81 2.72 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.146 -0.971 . . . . 0.0 110.533 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.417 ' SG ' ' CB ' ' A' ' 48' ' ' SER . 0.6 OUTLIER -121.82 10.42 10.24 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.087 -1.008 . . . . 0.0 110.836 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.449 ' N ' ' HB3' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 52.95 17.73 0.94 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.29 -0.881 . . . . 0.0 112.655 178.557 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.417 ' CB ' ' SG ' ' A' ' 46' ' ' CYS . 4.1 t -67.7 156.2 89.6 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.598 -1.313 . . . . 0.0 109.715 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.86 143.48 45.65 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 123.684 1.36 . . . . 0.0 110.486 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.484 ' HA ' ' CD1' ' A' ' 53' ' ' PHE . 22.1 tttm -50.32 -25.26 3.6 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.325 -0.86 . . . . 0.0 110.517 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 -67.24 -11.61 57.92 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.202 -0.936 . . . . 0.0 110.146 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.52 0.7 57.46 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.053 -1.029 . . . . 0.0 110.104 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.484 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 39.6 m-85 -89.99 125.67 35.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.951 -1.093 . . . . 0.0 110.428 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -100.75 131.54 46.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.391 -0.818 . . . . 0.0 109.579 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.508 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 2.5 t -60.89 179.34 0.18 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.124 -0.985 . . . . 0.0 110.316 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.447 ' CG2' ' O ' ' A' ' 55' ' ' SER . 7.9 pt . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.782 -0.573 . . . . 0.0 109.509 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.437 ' O ' ' CG2' ' A' ' 56' ' ' ILE . 6.5 mttt . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.503 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 6.6 m-85 -111.93 132.19 54.91 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.055 -1.028 . . . . 0.0 110.354 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 17.3 tt0 -95.23 135.49 36.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.262 -0.899 . . . . 0.0 109.982 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.4 t -76.95 114.45 15.75 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.191 -0.943 . . . . 0.0 110.309 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -69.34 -11.47 60.84 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.192 -0.942 . . . . 0.0 109.722 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.2 -40.79 16.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.906 . . . . 0.0 111.819 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.454 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 14.0 p -124.53 -35.35 2.76 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.738 -1.226 . . . . 0.0 111.802 -178.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 116.94 20.5 4.87 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.616 -1.278 . . . . 0.0 109.988 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.453 ' CG ' ' N ' ' A' ' 16' ' ' ILE . 73.7 t80 -83.73 169.99 14.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -1.124 . . . . 0.0 109.51 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.453 ' N ' ' CG ' ' A' ' 15' ' ' TYR . 3.4 mp -132.7 110.23 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.119 -0.988 . . . . 0.0 110.064 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.501 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 73.3 t80 -70.06 140.28 52.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.265 -0.897 . . . . 0.0 110.109 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.403 ' HG2' ' HE2' ' A' ' 7' ' ' LYS . 14.6 mt-10 -115.26 108.21 48.26 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.545 -0.722 . . . . 0.0 109.857 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.81 -74.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.427 1.224 . . . . 0.0 111.042 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -46.85 -25.76 0.83 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.4 -0.812 . . . . 0.0 110.914 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.99 -38.2 11.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.13 -0.981 . . . . 0.0 110.44 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.37 148.52 24.1 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.09 61.99 7.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.399 -1.06 . . . . 0.0 110.07 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.18 -26.82 0.84 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.523 -0.735 . . . . 0.0 110.915 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -77.5 -23.0 50.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.173 -0.954 . . . . 0.0 110.333 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -102.69 -28.67 11.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.204 -0.935 . . . . 0.0 110.143 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.66 30.94 1.19 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.6 mt -122.89 122.39 27.09 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.123 -1.222 . . . . 0.0 109.783 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -70.71 173.06 12.38 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 O-C-N 123.516 1.272 . . . . 0.0 110.529 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -70.84 -163.54 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.788 1.415 . . . . 0.0 110.137 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 49.15 25.69 5.75 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 93.0 m -127.39 114.74 21.36 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.102 -1.234 . . . . 0.0 110.04 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -73.72 149.88 43.91 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.501 1.263 . . . . 0.0 110.78 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.501 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 55.0 t80 -53.9 -26.88 27.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.361 -0.837 . . . . 0.0 110.151 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.4 m -69.09 -16.11 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.172 -0.955 . . . . 0.0 110.632 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.19 -2.48 49.62 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.045 -1.034 . . . . 0.0 110.927 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.478 HD11 ' CD1' ' A' ' 34' ' ' PHE . 58.4 mt -59.0 158.56 8.31 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.919 -1.113 . . . . 0.0 110.155 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.0 t -54.55 166.84 0.4 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.302 -0.874 . . . . 0.0 110.227 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -72.3 -11.68 60.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.206 -0.934 . . . . 0.0 110.635 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 54.3 p -137.37 34.02 2.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.966 -1.084 . . . . 0.0 110.322 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.474 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 22.9 t80 -54.25 144.23 20.79 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.257 -0.902 . . . . 0.0 109.59 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.07 138.31 51.7 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.2 -0.938 . . . . 0.0 110.32 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 39.2 t -57.33 131.8 81.15 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.453 -0.779 . . . . 0.0 110.182 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.61 -3.26 13.6 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.489 1.257 . . . . 0.0 110.673 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -111.12 -30.19 7.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.004 -1.06 . . . . 0.0 110.686 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.454 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 1.5 p -135.17 7.94 3.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.995 -1.065 . . . . 0.0 111.313 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.3 16.32 3.06 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.207 -0.933 . . . . 0.0 112.897 178.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.4 p -72.66 156.93 89.65 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 120.626 -1.296 . . . . 0.0 109.884 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.0 140.67 46.16 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.551 1.29 . . . . 0.0 110.306 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.48 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 41.0 tttt -47.29 -30.42 3.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.31 -0.869 . . . . 0.0 111.481 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 29.6 p30 -63.18 -14.03 44.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.888 -1.133 . . . . 0.0 110.048 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.97 -2.83 58.66 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.101 -0.999 . . . . 0.0 110.146 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -81.95 168.04 18.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.958 -1.089 . . . . 0.0 110.21 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -147.28 132.79 18.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.376 -0.827 . . . . 0.0 109.471 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.503 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 64.5 p -65.52 174.82 2.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.973 -1.08 . . . . 0.0 110.91 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.437 ' CG2' ' O ' ' A' ' 7' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.418 0.628 . . . . 0.0 110.207 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.424 ' O ' ' CG1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.535 ' CE2' ' CD1' ' A' ' 34' ' ' PHE . 4.2 m-85 -104.41 166.68 10.24 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.113 -0.992 . . . . 0.0 110.565 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -131.12 134.33 46.47 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.344 -0.847 . . . . 0.0 110.279 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.9 t -74.85 112.42 11.04 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.204 -0.935 . . . . 0.0 109.991 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.61 -10.84 59.84 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.28 -0.968 . . . . 0.0 109.65 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.07 -39.93 17.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 111.767 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.437 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 13.0 p -124.54 -36.54 2.61 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.713 -1.242 . . . . 0.0 111.521 -178.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.27 21.16 4.15 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.407 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 37.5 t80 -81.19 160.62 24.29 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.206 -1.173 . . . . 0.0 109.756 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.444 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 2.8 mp -127.04 120.93 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.169 -0.957 . . . . 0.0 110.185 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.503 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 58.5 t80 -86.7 138.17 31.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.22 -0.925 . . . . 0.0 110.194 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -116.15 112.95 41.7 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.565 -0.709 . . . . 0.0 109.857 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -72.02 -66.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.58 1.305 . . . . 0.0 111.026 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.402 ' O ' ' CB ' ' A' ' 30' ' ' PRO . 1.4 tt0 -45.26 -27.04 0.58 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.698 -0.626 . . . . 0.0 110.97 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.1 tptt -99.86 -30.65 11.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 110.332 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.62 148.38 8.35 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -85.03 63.16 7.95 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.451 -1.029 . . . . 0.0 109.599 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -45.34 -29.29 1.01 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.606 -0.684 . . . . 0.0 110.899 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -68.69 -26.46 65.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.314 -0.866 . . . . 0.0 109.89 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -100.67 -28.89 12.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.335 -0.853 . . . . 0.0 109.995 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.05 15.71 3.76 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.955 -1.117 . . . . 0.0 110.462 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.9 mt -105.64 121.68 45.19 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.776 -1.426 . . . . 0.0 109.78 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -70.86 171.82 14.92 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.504 1.265 . . . . 0.0 110.691 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.402 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 49.6 Cg_endo -71.42 -163.83 0.14 Allowed 'Trans proline' 0 C--N 1.314 -1.285 0 O-C-N 123.771 1.406 . . . . 0.0 110.201 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 47.98 33.43 10.11 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 85.0 m -137.27 121.63 12.24 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.194 -1.18 . . . . 0.0 110.191 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -73.07 155.16 52.61 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.505 1.266 . . . . 0.0 110.745 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.535 ' CD1' ' CE2' ' A' ' 8' ' ' TYR . 24.5 t80 -58.04 -30.06 65.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.32 -0.862 . . . . 0.0 109.809 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.4 m -63.66 -14.84 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.321 -0.862 . . . . 0.0 110.691 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.64 0.94 45.77 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.053 -1.03 . . . . 0.0 111.001 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.521 ' CD1' ' CD2' ' A' ' 34' ' ' PHE . 21.3 mt -53.64 169.58 0.14 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.888 -1.133 . . . . 0.0 110.209 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.5 t -61.08 153.65 24.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.218 -0.927 . . . . 0.0 110.392 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -54.13 -39.3 66.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.262 -0.899 . . . . 0.0 110.445 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 96.7 p -120.04 43.85 2.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 110.489 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.439 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 40.7 t80 -63.26 137.01 58.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.202 -0.936 . . . . 0.0 109.971 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 45.2 mmm -111.47 164.43 12.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.206 -0.934 . . . . 0.0 109.575 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.3 t -76.63 133.27 70.7 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.291 -0.881 . . . . 0.0 110.3 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -75.09 -1.96 11.92 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.525 1.276 . . . . 0.0 110.287 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.96 -33.62 4.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.961 -1.087 . . . . 0.0 110.712 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.437 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.8 OUTLIER -129.38 7.12 5.34 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.995 -1.066 . . . . 0.0 111.188 -179.91 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.66 17.6 4.16 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.102 -0.999 . . . . 0.0 112.566 178.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.42 ' CB ' ' SG ' ' A' ' 46' ' ' CYS . 6.6 t -72.44 155.94 90.78 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 120.675 -1.266 . . . . 0.0 109.846 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.96 140.54 50.52 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.615 1.324 . . . . 0.0 110.377 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.447 ' HG2' ' CZ ' ' A' ' 34' ' ' PHE . 21.6 tttt -50.23 -25.41 3.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.238 -0.913 . . . . 0.0 110.735 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -66.6 -12.91 60.13 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.056 -1.028 . . . . 0.0 109.963 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.79 -2.88 58.91 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.07 -1.019 . . . . 0.0 110.08 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.471 ' HB2' ' CZ ' ' A' ' 34' ' ' PHE . 23.9 m-85 -86.41 134.33 33.71 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.956 -1.09 . . . . 0.0 110.072 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.68 139.11 52.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.203 -0.935 . . . . 0.0 109.612 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.519 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 35.5 p -63.83 176.91 0.83 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.935 . . . . 0.0 111.034 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.433 ' CG2' ' O ' ' A' ' 55' ' ' SER . 8.1 pt . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.261 0.553 . . . . 0.0 109.639 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.6 mtmt . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.537 ' CE2' ' CD2' ' A' ' 34' ' ' PHE . 14.9 m-85 -125.76 135.58 52.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.131 -0.981 . . . . 0.0 110.688 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -103.91 138.99 39.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.384 -0.822 . . . . 0.0 110.063 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.7 t -79.66 112.53 17.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.191 -0.943 . . . . 0.0 110.331 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.97 -11.18 60.49 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.147 -0.97 . . . . 0.0 109.658 178.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.03 -41.07 16.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.298 -0.876 . . . . 0.0 111.598 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.445 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 14.2 p -123.12 -35.51 2.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.699 -1.25 . . . . 0.0 111.428 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 116.65 20.62 4.94 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 119.677 -1.249 . . . . 0.0 110.071 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.476 ' CD2' ' N ' ' A' ' 16' ' ' ILE . 67.4 t80 -84.84 169.11 14.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.108 -1.231 . . . . 0.0 109.828 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.476 ' N ' ' CD2' ' A' ' 15' ' ' TYR . 3.3 mp -133.39 115.2 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.218 -0.926 . . . . 0.0 110.154 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.492 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 58.3 t80 -75.47 136.63 40.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.913 . . . . 0.0 110.086 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -113.5 112.3 48.81 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.549 -0.72 . . . . 0.0 109.632 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.06 -74.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.456 1.24 . . . . 0.0 111.554 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.411 ' O ' ' CB ' ' A' ' 30' ' ' PRO . 3.6 mm-40 -43.38 -27.3 0.25 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.525 -0.734 . . . . 0.0 111.398 -179.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 mmmt -93.65 -36.03 12.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.079 -1.013 . . . . 0.0 110.501 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.33 145.17 14.14 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -85.08 62.93 7.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.378 -1.072 . . . . 0.0 109.707 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -44.57 -27.17 0.44 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.595 -0.691 . . . . 0.0 111.251 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -74.6 -26.71 60.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.028 -1.045 . . . . 0.0 110.074 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -98.71 -27.93 13.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.219 -0.925 . . . . 0.0 109.983 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.05 30.72 1.42 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.477 HD12 ' CD1' ' A' ' 41' ' ' PHE . 11.4 mt -121.63 119.24 29.28 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.12 -1.224 . . . . 0.0 109.904 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.26 173.13 10.97 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.459 1.242 . . . . 0.0 110.359 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.411 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 47.1 Cg_endo -70.05 -163.85 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.68 1.358 . . . . 0.0 110.224 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 48.49 39.91 23.11 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.7 m -142.26 115.56 6.45 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.176 -1.191 . . . . 0.0 110.446 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -74.18 153.29 46.05 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.474 1.25 . . . . 0.0 110.51 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.537 ' CD2' ' CE2' ' A' ' 8' ' ' TYR . 43.3 t80 -61.74 -28.15 69.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.34 -0.85 . . . . 0.0 110.236 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.6 m -67.96 -9.73 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -0.933 . . . . 0.0 110.875 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -110.13 0.25 18.21 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.96 -1.087 . . . . 0.0 110.989 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.487 HD11 ' CD1' ' A' ' 34' ' ' PHE . 28.2 mt -51.02 164.09 0.17 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.997 -1.064 . . . . 0.0 110.285 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.4 m -50.18 157.59 0.65 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.189 -0.944 . . . . 0.0 110.446 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.18 -15.48 46.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.0 110.398 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.2 51.74 1.58 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.071 -1.018 . . . . 0.0 110.43 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.477 ' CD1' HD12 ' A' ' 28' ' ' ILE . 32.1 t80 -68.96 142.84 54.58 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.213 -0.929 . . . . 0.0 110.022 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 7.7 mtt -120.11 150.67 40.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.327 -0.858 . . . . 0.0 109.57 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.43 ' HB3' ' N ' ' A' ' 47' ' ' ARG . 7.3 t -58.13 135.92 84.37 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.223 -0.923 . . . . 0.0 110.26 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.78 -2.89 12.86 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.596 1.314 . . . . 0.0 110.437 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -121.66 -50.42 2.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.91 -1.119 . . . . 0.0 110.918 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.445 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -105.38 5.54 31.84 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.03 -1.044 . . . . 0.0 111.304 -179.345 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.43 ' N ' ' HB3' ' A' ' 43' ' ' CYS . 12.3 ttm-85 56.92 20.48 5.34 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.061 -1.024 . . . . 0.0 112.272 178.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.418 ' CB ' ' SG ' ' A' ' 46' ' ' CYS . 2.8 t -70.41 155.95 92.64 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 120.798 -1.188 . . . . 0.0 109.676 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.91 142.56 43.15 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.588 1.31 . . . . 0.0 110.266 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.484 ' HE2' ' CE2' ' A' ' 34' ' ' PHE . 22.4 tttt -51.77 -25.27 7.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.157 -0.964 . . . . 0.0 110.329 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.5 t30 -68.2 -11.95 60.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.136 -0.977 . . . . 0.0 109.826 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.83 1.36 57.22 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.162 -0.961 . . . . 0.0 110.077 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.458 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 34.6 m-85 -90.78 129.09 36.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.018 -1.051 . . . . 0.0 110.628 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.93 134.31 49.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.368 -0.832 . . . . 0.0 109.603 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.497 ' HB3' ' CE2' ' A' ' 8' ' ' TYR . 86.4 p -64.25 -179.94 0.5 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.074 -1.016 . . . . 0.0 110.984 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.7 tt . . . . . 0 N--CA 1.493 1.701 0 O-C-N 121.787 -0.57 . . . . 0.0 110.267 179.841 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.417 ' HG2' ' CG2' ' A' ' 16' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.575 ' CE2' ' CD1' ' A' ' 34' ' ' PHE . 4.4 m-85 -95.47 133.93 38.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 110.555 -179.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -101.54 132.06 47.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.42 -0.8 . . . . 0.0 110.281 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.1 t -74.39 119.45 18.61 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.2 -0.938 . . . . 0.0 110.169 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.3 -11.69 60.34 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.087 -1.008 . . . . 0.0 109.654 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.414 ' HB1' ' NE2' ' A' ' 52' ' ' GLN . . . -85.07 -37.85 19.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.241 -0.912 . . . . 0.0 111.699 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.447 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 13.7 p -126.63 -34.56 2.42 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.717 -1.24 . . . . 0.0 111.645 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.74 22.4 5.39 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -84.41 159.2 20.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.373 -1.074 . . . . 0.0 109.762 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.467 HG22 HD11 ' A' ' 16' ' ' ILE . 39.4 mm -123.6 111.0 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 0.0 110.655 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.432 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 53.1 t80 -75.75 130.65 38.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.41 -0.806 . . . . 0.0 110.175 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -108.38 113.25 60.49 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.434 -0.791 . . . . 0.0 109.406 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.405 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 38.3 Cg_endo -71.95 -64.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.495 1.261 . . . . 0.0 110.963 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -45.35 -26.82 0.58 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.702 -0.624 . . . . 0.0 111.12 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -97.07 -30.36 13.09 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.04 -1.037 . . . . 0.0 110.236 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.66 153.51 23.63 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.409 ' O ' ' N ' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -85.12 61.9 7.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.39 -1.064 . . . . 0.0 109.795 179.657 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.71 -28.51 0.63 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.513 -0.742 . . . . 0.0 110.953 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.8 -24.76 44.37 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.226 -0.921 . . . . 0.0 110.42 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -97.69 -27.48 14.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.154 -0.966 . . . . 0.0 110.213 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 119.48 27.57 2.14 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.5 mt -120.13 126.07 27.01 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.097 -1.237 . . . . 0.0 109.975 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.3 173.28 12.55 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.54 1.284 . . . . 0.0 110.289 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.76 -163.73 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.683 1.36 . . . . 0.0 110.088 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 47.71 26.79 4.2 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 91.8 m -124.22 111.34 28.52 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.138 -1.213 . . . . 0.0 110.292 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.405 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 47.3 Cg_endo -73.11 148.99 45.51 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.492 1.259 . . . . 0.0 110.614 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.575 ' CD1' ' CE2' ' A' ' 8' ' ' TYR . 12.7 t80 -52.46 -30.88 32.03 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.308 -0.87 . . . . 0.0 110.506 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.6 m -65.27 -17.49 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.23 -0.919 . . . . 0.0 110.841 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -99.73 -0.01 40.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.072 -1.017 . . . . 0.0 110.887 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.475 HD13 ' CD2' ' A' ' 34' ' ' PHE . 15.5 mt -53.66 170.68 0.11 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.853 -1.155 . . . . 0.0 110.248 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.8 m -57.82 166.2 1.51 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.207 -0.933 . . . . 0.0 110.412 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.44 -22.28 66.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.301 -0.874 . . . . 0.0 110.245 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.7 m -139.0 53.05 1.76 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.267 -0.896 . . . . 0.0 110.075 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.446 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 11.3 t80 -65.3 141.16 58.7 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.365 -0.834 . . . . 0.0 110.184 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 8.9 mtt -114.33 147.97 38.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.354 -0.841 . . . . 0.0 109.348 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 23.9 t -60.48 138.36 92.45 Favored Pre-proline 0 C--N 1.3 -1.552 0 O-C-N 121.278 -0.889 . . . . 0.0 110.582 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -78.79 3.14 7.59 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.643 1.338 . . . . 0.0 110.661 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -124.57 -35.83 2.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.913 -1.117 . . . . 0.0 110.782 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.447 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 1.2 p -124.66 4.62 8.21 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.989 -1.069 . . . . 0.0 111.334 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.44 18.87 7.24 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.163 -0.961 . . . . 0.0 112.478 178.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.3 p -71.51 162.0 75.36 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 120.573 -1.329 . . . . 0.0 109.507 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.4 144.86 51.81 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.596 1.314 . . . . 0.0 110.625 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.484 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 3.8 tttm -51.48 -31.23 22.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.219 -0.925 . . . . 0.0 110.496 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -65.25 -13.11 57.56 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.05 -1.032 . . . . 0.0 109.783 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.414 ' NE2' ' HB1' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -84.79 -5.22 59.32 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.12 -0.988 . . . . 0.0 109.762 178.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.429 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 21.5 m-85 -84.25 152.78 23.98 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.255 -0.903 . . . . 0.0 109.582 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.7 ttpp -142.57 131.55 23.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.175 -0.953 . . . . 0.0 110.034 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.505 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 9.1 p -59.88 172.42 0.75 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.158 -0.964 . . . . 0.0 110.444 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.432 ' O ' ' CG2' ' A' ' 56' ' ' ILE . 2.6 tt . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.572 0.701 . . . . 0.0 109.898 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.2 mttt . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.108 0.48 . . . . 0.0 109.828 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.509 ' CE2' ' HB2' ' A' ' 55' ' ' SER . 27.1 m-85 -130.31 143.66 50.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.029 -1.044 . . . . 0.0 110.473 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.441 ' CG ' HD12 ' A' ' 16' ' ' ILE . 2.8 tm-20 -111.78 134.54 53.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.383 -0.823 . . . . 0.0 109.8 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.2 t -77.61 113.64 15.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.227 -0.921 . . . . 0.0 110.446 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -70.44 -11.23 60.78 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.182 -0.949 . . . . 0.0 109.556 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.99 -40.42 16.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.894 . . . . 0.0 111.579 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.452 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 12.5 p -124.18 -32.07 3.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.728 -1.232 . . . . 0.0 111.553 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.13 22.03 6.38 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.516 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 56.7 t80 -83.18 169.02 16.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.282 -1.128 . . . . 0.0 109.871 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.516 ' N ' ' CD1' ' A' ' 15' ' ' TYR . 40.9 mm -134.06 115.32 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.058 -1.026 . . . . 0.0 110.68 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.504 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 69.5 t80 -78.88 136.8 37.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.335 -0.853 . . . . 0.0 109.898 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -117.75 112.61 38.59 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.482 -0.761 . . . . 0.0 109.801 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -69.82 -63.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.442 1.233 . . . . 0.0 110.558 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -47.46 -25.47 1.08 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.691 -0.631 . . . . 0.0 110.635 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.56 -42.24 7.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 0.0 110.675 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.55 153.31 29.59 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.425 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 0.9 OUTLIER -85.12 60.44 6.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.369 -1.077 . . . . 0.0 109.975 179.762 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.99 -25.81 0.88 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.443 -0.786 . . . . 0.0 110.948 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.83 -20.95 41.3 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.179 -0.951 . . . . 0.0 110.318 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -104.39 -29.82 10.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.119 -0.988 . . . . 0.0 110.295 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 124.52 34.07 0.73 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.425 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 4.6 mt -128.73 125.65 23.09 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.162 -1.199 . . . . 0.0 109.712 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.86 173.26 14.3 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.468 1.246 . . . . 0.0 110.575 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.66 -163.79 0.13 Allowed 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.77 1.405 . . . . 0.0 109.913 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 48.72 25.72 5.01 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.5 m -125.84 115.68 24.43 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.295 -1.121 . . . . 0.0 109.979 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -72.64 149.71 49.5 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.448 1.236 . . . . 0.0 110.894 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.504 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 60.4 t80 -54.97 -25.88 32.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.425 -0.797 . . . . 0.0 110.342 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.0 m -70.13 -24.23 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.11 -0.993 . . . . 0.0 110.304 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -87.5 -6.12 58.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.181 -0.949 . . . . 0.0 110.758 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.485 HD11 ' CD1' ' A' ' 34' ' ' PHE . 20.3 mt -52.19 160.54 0.76 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.043 -1.036 . . . . 0.0 110.282 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.87 150.78 19.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -0.897 . . . . 0.0 109.981 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -56.04 -25.39 44.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.254 -0.904 . . . . 0.0 110.313 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.34 38.34 4.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.122 -0.986 . . . . 0.0 110.709 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.452 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 36.4 t80 -59.34 133.45 56.1 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.043 -1.036 . . . . 0.0 109.793 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 13.8 mtp -109.98 155.79 21.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.367 -0.833 . . . . 0.0 109.5 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 30.6 t -71.78 131.8 85.62 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.15 -0.969 . . . . 0.0 110.213 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -75.41 -2.18 12.24 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.585 1.308 . . . . 0.0 110.513 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -112.91 -32.5 6.37 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.055 -1.028 . . . . 0.0 110.403 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.452 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 1.3 p -133.61 7.78 3.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.075 -1.016 . . . . 0.0 111.178 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 58.75 13.65 2.79 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.175 -0.953 . . . . 0.0 112.935 177.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.9 m -68.37 163.12 55.87 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 120.604 -1.31 . . . . 0.0 110.052 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.6 143.59 38.33 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.699 1.368 . . . . 0.0 110.431 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.488 ' HE2' ' CE2' ' A' ' 34' ' ' PHE . 9.8 tttm -49.97 -26.39 4.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.039 -1.038 . . . . 0.0 110.666 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -66.64 -12.07 56.49 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.124 -0.985 . . . . 0.0 110.006 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.27 -4.56 59.19 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.169 -0.957 . . . . 0.0 110.174 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.412 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 44.1 m-85 -84.25 144.44 28.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.945 -1.097 . . . . 0.0 110.44 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.0 ttmm -124.56 119.19 28.37 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.365 -0.834 . . . . 0.0 109.535 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.509 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 3.7 t -50.95 177.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.058 -1.026 . . . . 0.0 110.573 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.1 pt . . . . . 0 C--N 1.297 -1.681 0 O-C-N 121.653 -0.654 . . . . 0.0 110.012 179.721 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.1 tttp . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.529 ' CE2' ' CD2' ' A' ' 34' ' ' PHE . 11.5 m-85 -112.28 155.27 24.34 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.981 -1.074 . . . . 0.0 110.602 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -122.29 130.74 53.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.462 -0.774 . . . . 0.0 109.827 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 t -73.35 114.67 11.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.096 -1.002 . . . . 0.0 110.373 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.71 -12.68 61.71 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.371 -0.931 . . . . 0.0 109.36 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.407 ' N ' ' NE2' ' A' ' 52' ' ' GLN . . . -85.03 -41.01 16.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.343 -0.848 . . . . 0.0 111.758 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.422 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 11.4 p -123.53 -28.58 3.89 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.583 -1.323 . . . . 0.0 111.795 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.71 20.06 8.76 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.226 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -83.0 159.54 22.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.135 -1.215 . . . . 0.0 109.867 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.487 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 2.9 mp -121.82 120.36 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.91 . . . . 0.0 109.835 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.488 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 61.4 t80 -84.12 138.0 33.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.908 . . . . 0.0 110.376 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.97 110.62 45.88 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.738 -0.601 . . . . 0.0 109.911 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -72.89 -65.06 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.494 1.26 . . . . 0.0 111.088 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.426 ' O ' ' CB ' ' A' ' 30' ' ' PRO . 3.3 tt0 -45.48 -25.44 0.43 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.692 -0.63 . . . . 0.0 111.374 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.54 -41.84 7.57 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.094 -1.004 . . . . 0.0 110.65 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.26 145.96 19.75 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -85.09 63.23 7.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.335 -1.097 . . . . 0.0 109.676 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -43.64 -27.64 0.32 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.725 -0.61 . . . . 0.0 111.254 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -71.85 -29.1 64.04 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.154 -0.966 . . . . 0.0 109.924 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -96.82 -27.53 14.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.411 -0.805 . . . . 0.0 110.048 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.26 25.86 2.84 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.8 mt -114.6 120.27 38.08 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.074 -1.251 . . . . 0.0 110.001 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.409 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 45.4 Cg_endo -70.74 174.01 10.99 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.534 1.281 . . . . 0.0 110.509 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.426 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 47.6 Cg_endo -70.95 -163.28 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.715 1.376 . . . . 0.0 110.112 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 50.3 24.88 7.53 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 91.9 m -126.0 113.32 24.27 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.092 -1.24 . . . . 0.0 110.295 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.1 149.68 52.72 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 O-C-N 123.532 1.28 . . . . 0.0 110.619 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.529 ' CD2' ' CE2' ' A' ' 8' ' ' TYR . 27.3 t80 -52.38 -28.67 20.58 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.371 -0.831 . . . . 0.0 109.957 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.8 m -70.23 -15.41 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.285 -0.884 . . . . 0.0 110.557 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -98.32 -6.43 30.91 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.025 -1.047 . . . . 0.0 110.752 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.444 HD23 ' CE1' ' A' ' 17' ' ' TYR . 27.2 mt -51.25 162.28 0.34 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.956 -1.09 . . . . 0.0 110.461 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.3 m -50.31 154.8 1.14 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.347 -0.846 . . . . 0.0 110.508 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.19 -24.03 66.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.286 -0.884 . . . . 0.0 110.1 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.2 t -127.91 38.41 4.03 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.236 -0.915 . . . . 0.0 110.205 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.447 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 45.7 t80 -54.98 138.03 44.62 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.297 -0.877 . . . . 0.0 110.263 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.3 mmt -113.74 135.82 53.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.291 -0.881 . . . . 0.0 109.74 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 24.4 t -53.79 133.03 56.82 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.249 -0.907 . . . . 0.0 110.585 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -75.06 -3.69 14.29 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.447 1.235 . . . . 0.0 110.506 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -112.17 -35.65 5.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.033 -1.042 . . . . 0.0 110.559 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.422 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 1.5 p -128.57 6.51 5.69 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.087 -1.008 . . . . 0.0 111.01 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 54.46 20.07 2.63 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.209 -0.932 . . . . 0.0 112.714 178.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.0 m -74.27 165.68 51.33 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 120.617 -1.302 . . . . 0.0 109.658 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.51 136.06 30.11 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.638 1.336 . . . . 0.0 110.177 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.448 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 14.5 tttm -48.32 -26.01 1.83 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.2 -0.938 . . . . 0.0 110.697 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -63.69 -15.07 57.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.167 -0.958 . . . . 0.0 109.822 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.407 ' NE2' ' N ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -85.13 -2.97 58.62 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.255 -0.903 . . . . 0.0 110.136 179.381 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 34' ' ' PHE . 11.3 m-85 -82.75 133.16 35.15 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.95 -1.094 . . . . 0.0 110.478 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.91 120.33 38.12 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.197 -0.939 . . . . 0.0 109.527 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.499 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 3.0 t -52.0 -178.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.338 -0.851 . . . . 0.0 110.625 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.434 ' N ' ' OG ' ' A' ' 55' ' ' SER . 3.0 tt . . . . . 0 C--N 1.3 -1.575 0 O-C-N 121.531 -0.731 . . . . 0.0 109.691 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.409 ' O ' ' CG1' ' A' ' 56' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.152 0.501 . . . . 0.0 109.951 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.493 ' CE2' ' HB2' ' A' ' 55' ' ' SER . 22.9 m-85 -117.0 149.1 40.8 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.148 -0.97 . . . . 0.0 110.381 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -119.16 130.06 55.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 0.0 110.323 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.6 t -73.62 114.72 12.2 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.274 -0.891 . . . . 0.0 110.25 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -70.4 -11.39 60.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.071 -1.018 . . . . 0.0 109.624 178.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.09 -42.29 14.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.397 -0.814 . . . . 0.0 111.579 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.448 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 13.8 p -121.88 -31.04 4.0 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.709 -1.245 . . . . 0.0 111.418 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.65 23.0 6.73 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -82.31 159.25 23.15 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.34 -1.094 . . . . 0.0 109.517 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.3 mm -123.77 115.77 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.205 -0.934 . . . . 0.0 110.041 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.532 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 81.1 t80 -81.44 135.81 35.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.3 -0.875 . . . . 0.0 110.321 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -114.94 114.33 43.92 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.529 -0.732 . . . . 0.0 109.603 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -69.44 -67.04 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.531 1.28 . . . . 0.0 111.559 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -43.04 -28.0 0.24 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.739 -0.601 . . . . 0.0 111.225 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.4 tptt -96.8 -27.13 14.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.159 -0.963 . . . . 0.0 110.271 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.62 159.58 30.52 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.448 ' OD2' ' CZ ' ' A' ' 41' ' ' PHE . 1.0 OUTLIER -85.05 59.86 5.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.339 -1.095 . . . . 0.0 109.81 179.799 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -46.51 -26.51 0.89 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.406 -0.809 . . . . 0.0 110.613 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -76.01 -28.01 57.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 110.061 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -97.71 -27.45 14.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.304 -0.872 . . . . 0.0 110.192 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.16 22.67 2.58 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.43 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 5.0 mt -112.18 130.01 23.72 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 120.975 -1.309 . . . . 0.0 109.595 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.404 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 49.1 Cg_endo -74.38 173.48 14.17 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.483 1.254 . . . . 0.0 110.393 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.404 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 49.9 Cg_endo -71.68 -163.54 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.65 1.342 . . . . 0.0 110.065 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 51.17 32.98 29.68 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.794 -1.323 . . . . 0.0 109.794 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 93.8 m -137.63 122.03 12.1 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.209 -1.171 . . . . 0.0 110.064 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.32 151.84 34.19 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.547 1.288 . . . . 0.0 110.697 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.532 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 20.7 t80 -52.26 -33.25 40.86 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.305 -0.872 . . . . 0.0 109.84 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.3 m -64.69 -15.11 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.921 . . . . 0.0 110.506 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.53 -18.29 33.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.15 -0.968 . . . . 0.0 110.559 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 71.0 mt -51.81 146.45 8.13 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.046 -1.034 . . . . 0.0 110.29 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.93 160.0 0.36 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.194 -0.942 . . . . 0.0 110.519 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -66.83 -13.88 62.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -0.897 . . . . 0.0 110.624 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.6 t -122.11 25.5 9.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.023 -1.048 . . . . 0.0 110.365 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.461 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 25.4 t80 -54.81 135.22 47.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.131 -0.981 . . . . 0.0 109.871 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -109.42 150.66 27.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.369 -0.832 . . . . 0.0 109.58 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 18.1 t -66.38 134.76 94.62 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.113 -0.992 . . . . 0.0 110.347 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.71 -7.85 18.82 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.667 1.351 . . . . 0.0 110.185 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -110.19 -31.92 7.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.172 -0.955 . . . . 0.0 110.844 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.448 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.8 OUTLIER -134.49 7.31 3.57 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.021 -1.049 . . . . 0.0 111.353 -179.681 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 58.49 14.56 3.07 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.098 -1.001 . . . . 0.0 112.837 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.5 m -65.45 165.93 16.32 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 120.619 -1.301 . . . . 0.0 110.087 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.99 141.34 26.56 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.666 1.35 . . . . 0.0 110.152 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 41' ' ' PHE . 8.6 tttm -51.87 -26.21 9.61 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.215 -0.928 . . . . 0.0 110.261 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -68.53 -11.17 59.52 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.185 -0.947 . . . . 0.0 109.89 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.88 -2.35 58.55 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.175 -0.953 . . . . 0.0 110.076 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 17.9 m-85 -86.25 140.01 30.51 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.999 -1.063 . . . . 0.0 110.226 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.61 124.89 46.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.2 -0.938 . . . . 0.0 109.801 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.493 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 3.0 t -57.28 178.34 0.07 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.237 -0.914 . . . . 0.0 110.809 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.426 ' CG2' ' O ' ' A' ' 55' ' ' SER . 1.1 pt . . . . . 0 N--CA 1.494 1.747 0 O-C-N 121.828 -0.545 . . . . 0.0 109.832 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.411 ' O ' ' CG1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.499 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 7.8 m-85 -115.77 156.42 26.04 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.075 -1.015 . . . . 0.0 110.566 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.403 ' HG2' ' CG2' ' A' ' 56' ' ' ILE . 2.5 pp20? -126.43 136.26 52.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.367 -0.833 . . . . 0.0 110.168 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.0 t -78.25 111.84 14.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.945 . . . . 0.0 110.242 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.69 -10.83 59.82 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.204 -0.998 . . . . 0.0 109.426 178.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.429 ' HB1' ' NE2' ' A' ' 52' ' ' GLN . . . -84.68 -43.01 14.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.352 -0.843 . . . . 0.0 111.383 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.443 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 12.7 p -120.5 -31.66 4.26 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.632 -1.292 . . . . 0.0 111.273 -179.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.6 21.5 6.8 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.684 -1.246 . . . . 0.0 110.132 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.525 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 52.2 t80 -83.18 167.38 17.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.109 -1.23 . . . . 0.0 109.907 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.525 ' N ' ' CD1' ' A' ' 15' ' ' TYR . 36.5 mm -131.11 117.67 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.137 -0.977 . . . . 0.0 110.334 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.505 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 72.7 t80 -81.04 135.31 35.82 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.436 -0.79 . . . . 0.0 110.422 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -112.38 113.7 50.98 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.612 -0.68 . . . . 0.0 109.761 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -72.26 -68.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.414 1.218 . . . . 0.0 111.144 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -45.16 -26.63 0.5 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.581 -0.699 . . . . 0.0 111.2 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.99 -37.57 11.07 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.079 -1.013 . . . . 0.0 110.49 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.63 152.09 28.84 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' A' ' 26' ' ' ALA . 4.2 t0 -85.11 62.9 7.8 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.4 -1.059 . . . . 0.0 109.674 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.43 -27.37 0.44 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.647 -0.658 . . . . 0.0 111.03 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -77.22 -27.86 53.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.184 -0.947 . . . . 0.0 110.206 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -95.85 -28.83 14.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.251 -0.906 . . . . 0.0 110.362 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.08 11.55 5.21 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.815 -1.183 . . . . 0.0 110.296 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.6 mt -103.08 124.61 37.84 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 120.938 -1.33 . . . . 0.0 110.012 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.412 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 45.3 Cg_endo -71.91 173.74 12.31 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.468 1.246 . . . . 0.0 110.222 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.412 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 48.6 Cg_endo -70.19 -163.77 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.613 1.323 . . . . 0.0 110.252 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 49.94 27.17 9.52 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.4 m -128.12 116.51 20.33 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.333 -1.098 . . . . 0.0 110.279 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -73.55 150.33 45.58 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.53 1.279 . . . . 0.0 110.617 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.505 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 12.7 t80 -53.49 -29.53 36.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.413 -0.804 . . . . 0.0 109.979 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.3 m -67.22 -13.2 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 110.608 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.6 -4.03 38.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.069 -1.02 . . . . 0.0 110.93 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.405 ' CB ' ' HD2' ' A' ' 50' ' ' LYS . 28.1 mt -53.13 165.61 0.31 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.872 -1.142 . . . . 0.0 110.14 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.0 m -59.36 162.48 4.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.889 . . . . 0.0 110.279 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.36 -27.42 69.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.311 -0.868 . . . . 0.0 110.2 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.65 46.31 2.5 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.263 -0.898 . . . . 0.0 110.042 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.436 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 23.9 t80 -62.58 140.2 58.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.334 -0.854 . . . . 0.0 110.159 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 36.5 mtt -112.61 151.08 30.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.358 -0.839 . . . . 0.0 109.468 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 29.4 t -65.69 135.46 95.6 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.178 -0.951 . . . . 0.0 110.268 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -75.87 -0.02 9.76 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.503 1.265 . . . . 0.0 110.594 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -119.39 -38.77 2.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.01 -1.056 . . . . 0.0 110.825 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.443 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 1.4 p -123.12 8.16 9.2 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.025 -1.047 . . . . 0.0 111.13 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 27.3 mtt85 54.5 18.84 2.12 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.332 -0.855 . . . . 0.0 112.79 178.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.5 m -72.52 166.3 43.43 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 120.577 -1.327 . . . . 0.0 109.732 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.98 139.9 33.84 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.668 1.352 . . . . 0.0 110.387 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.492 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 9.6 tttm -48.98 -26.33 2.46 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.162 -0.961 . . . . 0.0 110.822 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -63.65 -14.9 56.22 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.127 -0.983 . . . . 0.0 109.862 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.429 ' NE2' ' HB1' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -83.87 -4.2 58.49 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.157 -0.965 . . . . 0.0 110.151 179.277 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -86.23 131.81 34.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.977 -1.077 . . . . 0.0 110.348 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.99 131.74 56.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.272 -0.893 . . . . 0.0 109.544 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.499 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 79.7 p -60.82 176.86 0.36 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.156 -0.965 . . . . 0.0 110.893 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.442 ' CG2' ' O ' ' A' ' 55' ' ' SER . 9.9 pt . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 121.362 0.601 . . . . 0.0 109.699 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.431 ' O ' ' CG1' ' A' ' 56' ' ' ILE . 4.3 mmtt . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.587 ' CE2' ' CD2' ' A' ' 34' ' ' PHE . 7.5 m-85 -112.26 145.11 40.55 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.156 -0.965 . . . . 0.0 110.625 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -115.12 135.74 53.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.404 -0.81 . . . . 0.0 109.995 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.9 t -75.24 113.46 12.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.23 -0.919 . . . . 0.0 110.573 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -11.28 60.79 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.449 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.442 ' N ' ' NE2' ' A' ' 52' ' ' GLN . . . -85.14 -40.26 16.94 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.312 -0.867 . . . . 0.0 111.484 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.441 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 12.6 p -123.95 -32.51 3.26 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.683 -1.26 . . . . 0.0 111.484 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.55 21.71 6.37 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -83.56 162.3 20.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -1.123 . . . . 0.0 109.74 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.429 ' N ' ' CD1' ' A' ' 16' ' ' ILE . 2.1 mp -123.51 116.39 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 0.0 109.939 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.49 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 78.3 t80 -82.86 127.87 33.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.164 -0.96 . . . . 0.0 110.15 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -106.4 111.08 64.25 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.698 -0.626 . . . . 0.0 109.614 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -70.28 -63.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.525 1.276 . . . . 0.0 110.806 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -46.8 -26.05 0.88 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.73 -0.606 . . . . 0.0 110.558 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -95.29 -31.16 13.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -0.924 . . . . 0.0 110.041 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.69 153.59 21.68 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -85.19 60.85 6.5 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.395 -1.062 . . . . 0.0 109.431 179.473 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -46.84 -26.76 1.04 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.536 -0.727 . . . . 0.0 110.682 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -81.14 -22.49 38.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.175 -0.953 . . . . 0.0 110.207 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -100.08 -27.61 13.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.229 -0.919 . . . . 0.0 110.012 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.51 28.98 1.36 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.4 mt -125.14 123.58 25.34 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.013 -1.286 . . . . 0.0 109.707 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.409 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 44.0 Cg_endo -70.0 173.47 11.14 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.525 1.276 . . . . 0.0 110.238 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 47.2 Cg_endo -69.99 -163.72 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.674 1.355 . . . . 0.0 110.233 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 49.04 26.0 5.7 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.6 m -125.34 121.11 24.97 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.272 -1.134 . . . . 0.0 110.257 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -76.41 158.16 36.69 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.477 1.251 . . . . 0.0 110.651 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.587 ' CD2' ' CE2' ' A' ' 8' ' ' TYR . 13.6 t80 -61.04 -34.18 74.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.349 -0.844 . . . . 0.0 109.945 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.8 m -65.51 -12.93 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.908 . . . . 0.0 110.529 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.57 -9.17 36.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.025 -1.047 . . . . 0.0 110.817 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 49.8 mt -53.85 156.07 3.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.0 -1.063 . . . . 0.0 110.185 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.9 t -52.56 147.78 7.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.168 -0.958 . . . . 0.0 110.255 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.64 -23.14 10.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 110.214 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 72.3 p -123.71 47.5 2.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.908 . . . . 0.0 110.487 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.464 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 27.7 t80 -70.56 145.63 50.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.164 -0.96 . . . . 0.0 109.835 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 28.3 mtm -121.11 138.02 54.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.293 -0.88 . . . . 0.0 109.994 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 27.5 t -54.68 133.81 64.8 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.368 -0.832 . . . . 0.0 110.235 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -76.33 -0.68 10.64 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.485 1.255 . . . . 0.0 110.627 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.72 -42.56 3.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.98 -1.075 . . . . 0.0 110.473 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.441 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 1.7 p -119.75 5.63 10.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.106 -0.996 . . . . 0.0 111.121 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 54.57 24.82 5.7 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.256 -0.902 . . . . 0.0 112.64 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.8 m -79.29 166.02 44.56 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 120.578 -1.327 . . . . 0.0 109.599 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.37 140.89 41.4 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.567 1.299 . . . . 0.0 110.75 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.476 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 23.8 tttt -50.58 -24.66 3.4 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.21 -0.931 . . . . 0.0 110.55 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -66.01 -13.41 59.83 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.08 -1.013 . . . . 0.0 109.933 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.442 ' NE2' ' N ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -85.05 -4.34 59.12 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.203 -0.936 . . . . 0.0 110.006 179.347 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -85.5 137.31 32.98 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.956 -1.09 . . . . 0.0 110.526 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.8 tttm -123.48 133.51 54.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.625 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.513 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 68.6 p -62.11 175.56 0.69 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.177 -0.952 . . . . 0.0 110.888 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.448 ' CG2' ' O ' ' A' ' 55' ' ' SER . 7.4 pt . . . . . 0 N--CA 1.497 1.89 0 CA-C-O 121.334 0.588 . . . . 0.0 110.079 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.405 ' O ' ' CG1' ' A' ' 56' ' ' ILE . 20.1 mttt . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.501 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 9.1 m-85 -112.26 150.09 31.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.115 -0.991 . . . . 0.0 110.432 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.408 ' HA ' HD12 ' A' ' 16' ' ' ILE . 43.7 tt0 -120.35 138.49 53.7 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.337 -0.852 . . . . 0.0 110.564 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.1 t -77.23 111.06 12.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.321 -0.862 . . . . 0.0 110.3 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -68.02 -11.23 58.53 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.36 -0.936 . . . . 0.0 109.568 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.36 -42.06 16.11 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.296 -0.878 . . . . 0.0 111.52 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.438 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 14.5 p -121.86 -34.75 3.31 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.707 -1.246 . . . . 0.0 111.498 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.06 22.08 5.06 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.442 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 29.5 t80 -84.27 158.82 21.1 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.308 -1.113 . . . . 0.0 109.804 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.442 ' N ' ' CD1' ' A' ' 15' ' ' TYR . 29.3 mm -122.5 120.04 59.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.318 -0.864 . . . . 0.0 110.267 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.502 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 80.6 t80 -83.25 130.03 35.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.909 . . . . 0.0 109.97 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -109.95 114.76 55.95 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.583 -0.698 . . . . 0.0 109.484 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.95 -68.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.529 1.279 . . . . 0.0 111.225 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -46.27 -25.48 0.63 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.476 -0.765 . . . . 0.0 111.175 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.66 -39.22 11.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.113 -0.992 . . . . 0.0 110.882 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.41 145.68 15.56 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -85.09 61.54 6.94 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.345 -1.091 . . . . 0.0 109.937 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.94 -25.92 1.54 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.397 -0.814 . . . . 0.0 110.461 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -75.49 -21.66 57.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.907 . . . . 0.0 110.092 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -105.56 -34.4 7.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.288 -0.883 . . . . 0.0 109.887 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 131.18 34.11 0.43 Allowed Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.892 -1.147 . . . . 0.0 110.361 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.2 mt -129.85 121.65 20.05 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 120.807 -1.408 . . . . 0.0 109.988 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.404 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 45.0 Cg_endo -70.13 173.93 10.58 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 O-C-N 123.613 1.323 . . . . 0.0 110.265 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.404 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 45.4 Cg_endo -68.59 -163.78 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.616 1.324 . . . . 0.0 110.176 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 47.76 27.79 4.91 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.4 m -125.75 113.9 24.81 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.218 -1.166 . . . . 0.0 110.344 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.31 146.92 41.02 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 123.472 1.248 . . . . 0.0 110.738 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.502 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 22.7 t80 -51.41 -34.02 32.94 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.433 -0.792 . . . . 0.0 110.561 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.0 m -65.75 -14.04 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.202 -0.936 . . . . 0.0 110.723 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -98.32 -1.61 41.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.998 -1.063 . . . . 0.0 110.996 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.458 HD23 ' CE1' ' A' ' 17' ' ' TYR . 26.0 mt -54.38 176.37 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.903 -1.123 . . . . 0.0 110.17 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.9 m -69.36 152.98 44.3 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.235 -0.916 . . . . 0.0 110.123 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.65 -23.28 40.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.161 -0.962 . . . . 0.0 110.216 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.4 m -129.28 43.52 3.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.167 -0.958 . . . . 0.0 110.27 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.46 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 20.0 t80 -62.89 132.65 52.83 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.377 -0.827 . . . . 0.0 109.85 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 7.0 mtt -111.33 148.19 33.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.376 -0.827 . . . . 0.0 109.668 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.428 ' HB3' ' N ' ' A' ' 47' ' ' ARG . 10.0 t -57.99 135.23 83.83 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.897 . . . . 0.0 110.422 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -76.12 -0.34 10.21 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 123.628 1.331 . . . . 0.0 110.578 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -122.88 -38.97 2.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.943 -1.098 . . . . 0.0 110.859 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.438 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -121.24 8.03 10.27 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.038 -1.039 . . . . 0.0 111.202 -179.62 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.428 ' N ' ' HB3' ' A' ' 43' ' ' CYS . 2.5 ttt180 58.37 13.84 2.62 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.183 -0.948 . . . . 0.0 112.786 178.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 m -63.63 156.81 69.9 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 120.594 -1.316 . . . . 0.0 109.714 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.77 146.54 43.07 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.665 1.35 . . . . 0.0 110.183 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.46 ' HB2' ' HB3' ' A' ' 41' ' ' PHE . 19.5 tttm -53.74 -27.19 26.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.022 -1.049 . . . . 0.0 110.235 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -67.98 -11.29 58.57 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.176 -0.952 . . . . 0.0 109.827 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.65 -2.67 58.72 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.21 -0.931 . . . . 0.0 110.016 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -89.9 126.06 35.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.012 -1.055 . . . . 0.0 110.348 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.2 tptt -108.8 134.13 51.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.209 -0.932 . . . . 0.0 109.739 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.501 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 80.0 p -63.72 179.46 0.49 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.121 -0.987 . . . . 0.0 110.761 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.405 ' CG1' ' O ' ' A' ' 7' ' ' LYS . 1.1 pt . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.271 0.557 . . . . 0.0 110.157 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.416 ' CB ' HG12 ' A' ' 56' ' ' ILE . 29.2 mttt . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.506 ' CE2' ' CD2' ' A' ' 34' ' ' PHE . 13.4 m-85 -122.7 148.04 45.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.037 -1.039 . . . . 0.0 110.628 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.421 ' CG ' HD12 ' A' ' 16' ' ' ILE . 5.1 tm-20 -120.02 128.08 53.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.414 -0.804 . . . . 0.0 109.906 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.4 t -65.31 110.07 2.48 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.161 -0.962 . . . . 0.0 110.059 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.91 -11.92 57.77 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.206 -0.934 . . . . 0.0 109.612 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.01 -40.46 16.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.327 -0.858 . . . . 0.0 111.782 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 11.7 p -123.95 -32.71 3.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.647 -1.283 . . . . 0.0 111.523 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.09 18.9 6.57 Favored Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.713 -1.232 . . . . 0.0 110.256 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.529 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 42.7 t80 -76.28 167.98 20.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -1.175 . . . . 0.0 109.516 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.529 ' N ' ' CD1' ' A' ' 15' ' ' TYR . 35.1 mm -130.82 120.26 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 110.424 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.48 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 51.5 t80 -89.36 142.5 27.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.325 -0.86 . . . . 0.0 109.966 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -123.69 112.49 29.11 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.544 -0.723 . . . . 0.0 109.829 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.437 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 40.4 Cg_endo -72.2 -67.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.516 1.272 . . . . 0.0 111.284 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -44.22 -28.0 0.47 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.794 -0.566 . . . . 0.0 110.922 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.7 mttp -96.15 -40.06 9.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 0.0 110.24 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.29 147.85 22.53 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 26' ' ' ALA . 2.8 t0 -84.94 61.11 6.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.465 -1.021 . . . . 0.0 109.65 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -45.49 -27.08 0.67 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.444 -0.785 . . . . 0.0 110.955 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -74.69 -27.43 60.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.115 -0.99 . . . . 0.0 109.975 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -98.48 -22.83 15.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.346 -0.846 . . . . 0.0 109.9 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.12 23.23 3.94 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.4 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 9.2 mt -115.26 114.57 43.07 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.117 -1.225 . . . . 0.0 109.907 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.91 173.9 9.54 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 O-C-N 123.597 1.314 . . . . 0.0 110.294 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -67.89 -164.43 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.57 1.3 . . . . 0.0 110.024 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 48.19 34.02 11.83 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 m -134.48 109.35 11.24 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.121 -1.223 . . . . 0.0 110.52 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.437 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 44.6 Cg_endo -71.8 148.72 52.81 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.455 1.24 . . . . 0.0 110.344 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.506 ' CD2' ' CE2' ' A' ' 8' ' ' TYR . 38.8 t80 -52.92 -24.23 8.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.204 -0.935 . . . . 0.0 109.861 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.433 ' CG2' ' HB2' ' A' ' 33' ' ' PRO . 32.1 m -72.27 -17.49 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.169 -0.957 . . . . 0.0 110.201 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.68 0.6 47.4 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.183 -0.948 . . . . 0.0 110.708 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.473 HD11 ' CD1' ' A' ' 34' ' ' PHE . 21.8 mt -52.23 167.33 0.13 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.947 -1.095 . . . . 0.0 110.182 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.3 m -56.53 173.31 0.19 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 110.257 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.05 -27.62 65.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.33 -0.856 . . . . 0.0 110.211 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 65.9 p -134.13 45.79 2.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 110.345 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.466 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 27.2 t80 -54.26 130.97 40.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.932 . . . . 0.0 109.932 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -108.34 150.01 27.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.427 -0.796 . . . . 0.0 109.43 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.429 ' HB3' ' N ' ' A' ' 47' ' ' ARG . 12.8 t -63.55 135.82 96.43 Favored Pre-proline 0 C--N 1.3 -1.551 0 O-C-N 121.16 -0.963 . . . . 0.0 110.539 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.76 -1.52 11.47 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.589 1.31 . . . . 0.0 110.382 178.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -118.72 -41.57 2.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.052 -1.03 . . . . 0.0 110.867 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -119.81 2.91 11.11 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.121 -0.987 . . . . 0.0 111.141 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.429 ' N ' ' HB3' ' A' ' 43' ' ' CYS . 1.1 ttt-85 58.28 23.36 10.31 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.146 -0.971 . . . . 0.0 112.515 178.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.3 m -75.01 164.94 58.01 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 120.566 -1.333 . . . . 0.0 109.676 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.06 138.98 29.07 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.632 1.333 . . . . 0.0 110.434 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.482 ' HA ' ' CD1' ' A' ' 53' ' ' PHE . 15.9 tttm -48.93 -29.18 4.46 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.271 -0.893 . . . . 0.0 110.821 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -63.09 -14.54 49.66 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.113 -0.992 . . . . 0.0 109.967 179.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.21 -1.39 57.87 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.086 -1.009 . . . . 0.0 110.169 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.482 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 32.6 m-85 -88.17 127.84 35.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.906 -1.121 . . . . 0.0 110.425 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.18 128.11 55.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 109.587 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 89.0 p -54.14 -174.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 110.814 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.416 HG12 ' CB ' ' A' ' 7' ' ' LYS . 1.3 pp . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.679 -0.638 . . . . 0.0 109.875 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.416 ' CB ' HG12 ' A' ' 56' ' ' ILE . 29.2 mttt . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.506 ' CE2' ' CD2' ' A' ' 34' ' ' PHE . 13.4 m-85 -122.7 148.04 45.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.037 -1.039 . . . . 0.0 110.628 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.421 ' CG ' HD12 ' A' ' 16' ' ' ILE . 5.1 tm-20 -120.02 128.08 53.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.414 -0.804 . . . . 0.0 109.906 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.4 t -65.31 110.07 2.48 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.161 -0.962 . . . . 0.0 110.059 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.91 -11.92 57.77 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.206 -0.934 . . . . 0.0 109.612 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.01 -40.46 16.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.327 -0.858 . . . . 0.0 111.782 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 11.7 p -123.95 -32.71 3.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.647 -1.283 . . . . 0.0 111.523 -179.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.09 18.9 6.57 Favored Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.713 -1.232 . . . . 0.0 110.256 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.529 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 42.7 t80 -76.28 167.98 20.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -1.175 . . . . 0.0 109.516 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.529 ' N ' ' CD1' ' A' ' 15' ' ' TYR . 35.1 mm -130.82 120.26 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 110.424 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.48 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 51.5 t80 -89.36 142.5 27.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.325 -0.86 . . . . 0.0 109.966 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -123.69 112.49 29.11 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.544 -0.723 . . . . 0.0 109.829 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.437 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 40.4 Cg_endo -72.2 -67.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.516 1.272 . . . . 0.0 111.284 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -44.22 -28.0 0.47 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.794 -0.566 . . . . 0.0 110.922 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.7 mttp -96.15 -40.06 9.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 0.0 110.24 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.29 147.85 22.53 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 26' ' ' ALA . 2.8 t0 -84.94 61.11 6.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.465 -1.021 . . . . 0.0 109.65 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -45.49 -27.08 0.67 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.444 -0.785 . . . . 0.0 110.955 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -74.69 -27.43 60.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.115 -0.99 . . . . 0.0 109.975 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -98.48 -22.83 15.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.346 -0.846 . . . . 0.0 109.9 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.12 23.23 3.94 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.4 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 9.2 mt -115.26 114.57 43.07 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.117 -1.225 . . . . 0.0 109.907 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.91 173.9 9.54 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 O-C-N 123.597 1.314 . . . . 0.0 110.294 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -67.89 -164.43 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.57 1.3 . . . . 0.0 110.024 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 48.19 34.02 11.83 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 m -134.48 109.35 11.24 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.121 -1.223 . . . . 0.0 110.52 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.437 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 44.6 Cg_endo -71.8 148.72 52.81 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.455 1.24 . . . . 0.0 110.344 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.506 ' CD2' ' CE2' ' A' ' 8' ' ' TYR . 38.8 t80 -52.92 -24.23 8.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.204 -0.935 . . . . 0.0 109.861 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.433 ' CG2' ' HB2' ' A' ' 33' ' ' PRO . 32.1 m -72.27 -17.49 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.169 -0.957 . . . . 0.0 110.201 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.68 0.6 47.4 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.183 -0.948 . . . . 0.0 110.708 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.473 HD11 ' CD1' ' A' ' 34' ' ' PHE . 21.8 mt -52.23 167.33 0.13 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.947 -1.095 . . . . 0.0 110.182 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.3 m -56.53 173.31 0.19 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 110.257 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.05 -27.62 65.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.33 -0.856 . . . . 0.0 110.211 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 65.9 p -134.13 45.79 2.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 110.345 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.466 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 27.2 t80 -54.26 130.97 40.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.932 . . . . 0.0 109.932 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -108.34 150.01 27.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.427 -0.796 . . . . 0.0 109.43 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.429 ' HB3' ' N ' ' A' ' 47' ' ' ARG . 12.8 t -63.55 135.82 96.43 Favored Pre-proline 0 C--N 1.3 -1.551 0 O-C-N 121.16 -0.963 . . . . 0.0 110.539 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.76 -1.52 11.47 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.589 1.31 . . . . 0.0 110.382 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -118.72 -41.57 2.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.052 -1.03 . . . . 0.0 110.867 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -119.81 2.91 11.11 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.121 -0.987 . . . . 0.0 111.141 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.429 ' N ' ' HB3' ' A' ' 43' ' ' CYS . 1.1 ttt-85 58.28 23.36 10.31 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.146 -0.971 . . . . 0.0 112.515 178.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.3 m -75.01 164.94 58.01 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 120.566 -1.333 . . . . 0.0 109.676 179.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.06 138.98 29.07 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.632 1.333 . . . . 0.0 110.434 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.482 ' HA ' ' CD1' ' A' ' 53' ' ' PHE . 15.9 tttm -48.93 -29.18 4.46 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.271 -0.893 . . . . 0.0 110.821 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -63.09 -14.54 49.66 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.113 -0.992 . . . . 0.0 109.967 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.21 -1.39 57.87 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.086 -1.009 . . . . 0.0 110.169 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.482 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 32.6 m-85 -88.17 127.84 35.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.906 -1.121 . . . . 0.0 110.425 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.18 128.11 55.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 109.587 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 89.0 p -54.14 -174.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 110.814 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.416 HG12 ' CB ' ' A' ' 7' ' ' LYS . 1.3 pp . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.679 -0.638 . . . . 0.0 109.875 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.4 mtpt . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.53 ' CE2' ' CB ' ' A' ' 55' ' ' SER . 30.2 m-85 -115.78 139.26 50.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.034 -1.041 . . . . 0.0 110.789 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -105.56 132.83 51.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.309 -0.87 . . . . 0.0 110.241 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.7 t -75.56 110.33 9.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 0.0 110.121 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.71 -11.92 56.37 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.203 -0.936 . . . . 0.0 109.866 178.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.03 -41.19 16.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -0.92 . . . . 0.0 111.717 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.453 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 13.8 p -122.85 -34.47 3.19 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.604 -1.31 . . . . 0.0 111.454 -179.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.76 21.72 5.29 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 24.5 t80 -84.57 158.19 20.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.365 -1.079 . . . . 0.0 109.706 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.477 ' N ' ' CD1' ' A' ' 16' ' ' ILE . 3.2 mp -123.97 120.17 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.216 -0.928 . . . . 0.0 110.15 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.503 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 66.5 t80 -83.05 137.56 34.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.312 -0.868 . . . . 0.0 110.025 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -116.28 110.87 42.72 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.592 -0.693 . . . . 0.0 109.411 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.42 -71.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.507 1.267 . . . . 0.0 111.151 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.414 ' O ' ' CB ' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -47.4 -24.73 0.85 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.335 -0.853 . . . . 0.0 111.04 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.52 -39.27 10.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.973 -1.079 . . . . 0.0 110.48 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.16 137.93 9.29 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -85.07 63.73 8.28 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.392 -1.064 . . . . 0.0 109.679 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.96 -28.35 0.25 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.778 -0.576 . . . . 0.0 111.117 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -67.17 -33.62 75.8 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.202 -0.936 . . . . 0.0 109.795 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.94 -25.53 15.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.303 -0.873 . . . . 0.0 110.09 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.16 25.31 3.28 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.7 mt -112.15 118.74 45.48 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.071 -1.252 . . . . 0.0 110.079 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.419 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 45.4 Cg_endo -71.95 174.49 11.16 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 O-C-N 123.541 1.285 . . . . 0.0 110.219 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 46.8 Cg_endo -69.27 -164.72 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.582 1.306 . . . . 0.0 109.933 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 47.73 26.19 3.88 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 47.9 m -127.45 111.4 21.07 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.136 -1.214 . . . . 0.0 110.038 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.426 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 45.0 Cg_endo -71.76 147.56 50.76 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.604 1.318 . . . . 0.0 110.77 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.503 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 47.3 t80 -54.42 -25.74 26.59 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.542 -0.723 . . . . 0.0 110.275 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.426 ' CG2' ' HB2' ' A' ' 33' ' ' PRO . 34.2 m -71.06 -13.59 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.272 -0.893 . . . . 0.0 110.647 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.56 -4.5 41.17 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.091 -1.005 . . . . 0.0 110.891 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.479 HD13 ' CD2' ' A' ' 34' ' ' PHE . 51.3 mt -51.0 164.53 0.15 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.91 -1.119 . . . . 0.0 110.428 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.03 173.31 1.44 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.324 -0.86 . . . . 0.0 110.244 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -74.17 -19.33 60.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.367 -0.833 . . . . 0.0 110.293 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.9 m -128.79 36.05 4.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.0 110.534 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.474 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 31.5 t80 -56.18 123.3 14.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.144 -0.973 . . . . 0.0 109.464 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 7.3 mtt -106.72 142.4 36.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 0.0 109.682 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.43 ' HB3' ' N ' ' A' ' 47' ' ' ARG . 5.4 t -52.58 136.41 43.36 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.27 -0.894 . . . . 0.0 110.426 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.66 -1.52 11.21 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.574 1.302 . . . . 0.0 110.673 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -123.9 -42.5 2.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.91 -1.119 . . . . 0.0 110.811 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.453 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -114.15 5.11 15.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.065 -1.022 . . . . 0.0 111.122 -179.703 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.43 ' N ' ' HB3' ' A' ' 43' ' ' CYS . 27.3 mtt180 54.43 25.65 6.3 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.171 -0.956 . . . . 0.0 112.408 178.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.417 ' CB ' ' SG ' ' A' ' 46' ' ' CYS . 2.5 t -75.6 157.68 83.98 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 120.702 -1.249 . . . . 0.0 109.779 178.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.16 139.45 35.49 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.675 1.355 . . . . 0.0 110.362 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.484 ' HA ' ' CD1' ' A' ' 53' ' ' PHE . 56.0 tttt -48.49 -28.26 3.22 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.184 -0.947 . . . . 0.0 110.901 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -67.14 -10.85 54.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.1 -1.0 . . . . 0.0 110.096 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.66 -2.38 58.28 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.191 -0.943 . . . . 0.0 110.193 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.484 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 33.1 m-85 -88.74 125.48 34.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.845 -1.159 . . . . 0.0 110.083 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -97.1 139.57 32.9 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.246 -0.909 . . . . 0.0 109.935 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.53 ' CB ' ' CE2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -80.12 153.99 28.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.426 -0.796 . . . . 0.0 110.187 -179.519 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.428 ' O ' ' CG2' ' A' ' 56' ' ' ILE . 1.2 tp . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.289 -0.882 . . . . 0.0 110.236 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.0 mttt . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.158 0.504 . . . . 0.0 109.707 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.506 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 13.3 m-85 -108.34 152.08 25.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.055 -1.028 . . . . 0.0 110.561 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -119.91 122.99 42.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.442 -0.786 . . . . 0.0 109.814 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.4 t -64.39 111.16 2.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.109 -0.994 . . . . 0.0 110.515 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -67.51 -12.17 59.69 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.229 -0.919 . . . . 0.0 109.501 178.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.04 -39.98 17.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.285 -0.884 . . . . 0.0 111.647 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.433 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 11.9 p -125.07 -29.66 3.3 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.62 -1.3 . . . . 0.0 111.433 -179.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.08 18.93 8.85 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.585 -1.293 . . . . 0.0 110.421 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 48.1 t80 -78.87 167.12 21.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.126 -1.22 . . . . 0.0 109.547 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.52 ' N ' ' CD1' ' A' ' 15' ' ' TYR . 35.3 mm -129.06 115.54 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.17 -0.956 . . . . 0.0 110.454 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.517 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 73.1 t80 -82.17 136.31 35.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.436 -0.79 . . . . 0.0 110.378 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 22' ' ' GLY . 5.6 mt-10 -115.84 109.65 45.02 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.599 -0.688 . . . . 0.0 109.468 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.41 ' CB ' ' HA ' ' A' ' 33' ' ' PRO . 37.9 Cg_endo -68.77 -70.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.573 1.302 . . . . 0.0 111.467 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -44.75 -27.09 0.46 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.551 -0.718 . . . . 0.0 111.034 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.41 -22.56 15.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.165 -0.959 . . . . 0.0 110.078 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 18' ' ' GLU . . . 79.93 147.22 4.44 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.414 ' HB2' ' CE1' ' A' ' 17' ' ' TYR . 15.2 t0 -85.04 62.32 7.43 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.356 -1.085 . . . . 0.0 109.69 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.56 -28.8 0.41 Allowed 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 121.465 0.65 . . . . 0.0 110.827 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.85 -32.12 73.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.298 -0.876 . . . . 0.0 110.005 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -99.03 -28.0 13.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.263 -0.898 . . . . 0.0 110.368 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.81 25.13 2.17 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.488 HD12 ' CD1' ' A' ' 41' ' ' PHE . 9.8 mt -110.71 123.98 34.22 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 120.955 -1.32 . . . . 0.0 109.597 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -70.9 170.09 18.77 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.49 1.258 . . . . 0.0 110.588 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -71.85 -163.39 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.694 1.365 . . . . 0.0 110.296 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 49.14 31.52 11.67 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 84.3 m -136.88 116.69 10.65 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.163 -1.198 . . . . 0.0 110.289 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.41 ' HA ' ' CB ' ' A' ' 19' ' ' PRO . 47.2 Cg_endo -72.15 148.21 49.76 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 123.582 1.306 . . . . 0.0 110.345 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.517 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 5.5 t80 -51.08 -36.37 39.76 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.238 -0.914 . . . . 0.0 110.018 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.14 -13.79 12.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.408 -0.807 . . . . 0.0 110.748 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -98.58 -0.25 43.53 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.028 -1.045 . . . . 0.0 110.691 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.403 ' CB ' ' HD2' ' A' ' 50' ' ' LYS . 36.9 mt -55.82 163.59 1.39 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.913 -1.117 . . . . 0.0 110.248 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.9 m -53.73 168.38 0.19 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.323 -0.86 . . . . 0.0 110.367 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.98 -35.18 79.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.275 -0.891 . . . . 0.0 110.29 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.2 t -124.32 51.6 1.57 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.179 -0.95 . . . . 0.0 110.369 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.488 ' CD1' HD12 ' A' ' 28' ' ' ILE . 18.1 t80 -64.76 126.93 29.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.171 -0.956 . . . . 0.0 109.915 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 10.9 mtt -97.95 145.36 26.55 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.23 -0.919 . . . . 0.0 109.588 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 25.1 t -63.01 136.34 96.64 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.214 -0.929 . . . . 0.0 110.375 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -75.93 -3.27 13.63 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.581 1.306 . . . . 0.0 110.571 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -115.23 -37.9 3.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.038 -1.039 . . . . 0.0 110.823 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.433 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 1.6 p -124.72 7.07 8.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.045 -1.035 . . . . 0.0 111.152 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 57.2 17.16 3.4 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.195 -0.941 . . . . 0.0 112.804 178.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.6 m -74.7 163.09 70.63 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 120.589 -1.319 . . . . 0.0 109.899 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.23 141.78 36.43 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.666 1.35 . . . . 0.0 110.699 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.48 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 24.5 tttm -48.34 -27.85 2.81 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.327 -0.858 . . . . 0.0 110.833 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -62.07 -15.29 43.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.075 -1.016 . . . . 0.0 109.971 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.45 -1.93 58.01 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.106 -0.996 . . . . 0.0 110.276 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.47 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 20.9 m-85 -85.09 134.34 34.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.833 -1.167 . . . . 0.0 110.494 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.99 119.99 35.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.385 -0.822 . . . . 0.0 109.768 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.506 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 3.4 t -52.89 178.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 110.58 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.426 ' O ' ' CG2' ' A' ' 56' ' ' ILE . 2.7 tt . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.664 -0.647 . . . . 0.0 109.952 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.414 ' O ' ' CG2' ' A' ' 56' ' ' ILE . 4.0 mttt . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.508 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 6.8 m-85 -109.55 150.23 28.48 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.073 -1.017 . . . . 0.0 110.784 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.437 ' CG ' HD12 ' A' ' 16' ' ' ILE . 17.9 tt0 -119.46 132.57 55.82 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.433 -0.792 . . . . 0.0 109.555 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.9 t -72.91 114.6 11.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.103 -0.998 . . . . 0.0 110.591 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -70.84 -11.66 61.09 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.379 -0.928 . . . . 0.0 109.548 178.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.428 ' N ' ' NE2' ' A' ' 52' ' ' GLN . . . -85.07 -40.55 16.69 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.312 -0.867 . . . . 0.0 111.759 -179.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.438 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 12.6 p -123.53 -33.65 3.19 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.65 -1.281 . . . . 0.0 111.413 -178.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.23 21.45 5.89 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.129 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.524 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 49.9 t80 -84.45 168.67 15.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.296 -1.12 . . . . 0.0 109.812 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.524 ' N ' ' CD1' ' A' ' 15' ' ' TYR . 40.9 mm -131.47 117.54 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.185 -0.947 . . . . 0.0 110.621 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.517 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 61.3 t80 -83.64 128.76 34.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.408 -0.808 . . . . 0.0 110.133 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -106.51 111.9 63.91 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.361 -0.837 . . . . 0.0 109.749 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.78 -65.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.489 1.257 . . . . 0.0 111.085 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -45.64 -29.43 1.23 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.648 -0.658 . . . . 0.0 110.865 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.6 mttp -94.82 -38.05 10.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 0.0 110.173 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.29 150.65 26.34 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -85.08 63.86 8.35 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.438 -1.036 . . . . 0.0 109.653 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -46.39 -27.27 1.02 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.525 -0.735 . . . . 0.0 110.796 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -74.77 -23.15 58.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.22 -0.925 . . . . 0.0 109.985 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -100.99 -31.28 11.19 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.377 -0.827 . . . . 0.0 109.92 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.34 28.29 1.35 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.7 mt -118.84 123.7 28.85 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.906 -1.349 . . . . 0.0 109.774 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.94 173.41 11.17 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.486 1.256 . . . . 0.0 110.431 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -72.39 -164.09 0.17 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.564 1.297 . . . . 0.0 110.216 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 48.5 30.98 8.85 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.6 m -131.01 116.85 16.95 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.118 -1.225 . . . . 0.0 110.362 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -74.49 150.31 40.64 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.408 1.215 . . . . 0.0 110.469 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.517 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 11.8 t80 -56.94 -23.45 45.38 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.231 -0.918 . . . . 0.0 109.907 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.3 m -70.22 -15.61 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.288 -0.883 . . . . 0.0 110.718 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.12 -0.99 35.16 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.174 -0.954 . . . . 0.0 110.893 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.0 mt -54.28 161.27 1.39 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.826 -1.171 . . . . 0.0 110.159 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.7 m -52.68 177.67 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.216 -0.928 . . . . 0.0 110.187 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.7 -18.03 49.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.248 -0.907 . . . . 0.0 110.458 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.6 p -133.2 37.4 3.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.105 -0.997 . . . . 0.0 110.541 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.455 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 14.5 t80 -56.61 133.87 54.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.138 -0.976 . . . . 0.0 109.774 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 5.1 mtt -106.99 143.9 34.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 109.854 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 35.9 t -56.64 138.96 76.6 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.879 . . . . 0.0 110.472 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -77.8 2.79 7.52 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.523 1.275 . . . . 0.0 110.873 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -124.61 -38.23 2.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.961 -1.087 . . . . 0.0 110.873 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.438 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 1.6 p -121.59 6.17 10.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.091 -1.006 . . . . 0.0 111.43 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.36 17.73 4.99 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.033 -1.042 . . . . 0.0 112.622 178.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.4 m -72.81 163.06 71.13 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 120.56 -1.338 . . . . 0.0 109.628 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.38 145.74 54.44 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.667 1.351 . . . . 0.0 110.334 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.483 ' HG2' ' CZ ' ' A' ' 34' ' ' PHE . 31.1 tttt -51.6 -24.74 5.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.3 -0.875 . . . . 0.0 110.255 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -66.12 -13.95 60.99 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.248 -0.907 . . . . 0.0 109.773 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.428 ' NE2' ' N ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -85.73 -3.73 58.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.238 -0.914 . . . . 0.0 110.043 179.193 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.45 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 17.1 m-85 -84.77 134.75 34.31 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.039 -1.038 . . . . 0.0 110.437 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.47 130.36 55.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.307 -0.87 . . . . 0.0 109.736 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.508 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 74.7 p -63.7 179.54 0.48 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 111.188 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.414 ' CG2' ' O ' ' A' ' 7' ' ' LYS . 4.8 tp . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.348 0.594 . . . . 0.0 109.546 179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.432 ' O ' ' CG2' ' A' ' 56' ' ' ILE . 1.3 mttt . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.193 0.521 . . . . 0.0 109.961 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.586 ' CE2' ' CD1' ' A' ' 34' ' ' PHE . 8.0 m-85 -113.95 125.54 54.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.131 -0.981 . . . . 0.0 109.931 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -88.85 128.78 35.67 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.239 -0.913 . . . . 0.0 110.168 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.6 t -72.35 115.16 11.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.195 -0.941 . . . . 0.0 110.242 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -70.37 -12.8 61.83 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.146 -0.971 . . . . 0.0 109.537 178.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.408 ' N ' ' NE2' ' A' ' 52' ' ' GLN . . . -85.08 -42.75 14.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.324 -0.86 . . . . 0.0 111.657 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.444 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 12.9 p -120.85 -27.29 5.05 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.72 -1.238 . . . . 0.0 111.382 -178.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.72 22.01 9.28 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.447 ' CG ' ' N ' ' A' ' 16' ' ' ILE . 60.7 t80 -81.88 168.35 18.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -1.117 . . . . 0.0 109.545 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.475 HG22 HD11 ' A' ' 16' ' ' ILE . 25.7 mm -127.58 102.65 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.238 -0.914 . . . . 0.0 109.935 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.516 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 76.4 t80 -66.91 134.82 52.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 109.693 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -114.4 110.6 47.47 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.475 -0.766 . . . . 0.0 110.01 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.4 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 39.2 Cg_endo -71.04 -62.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.506 1.266 . . . . 0.0 110.641 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -45.1 -26.45 0.46 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.825 -0.547 . . . . 0.0 111.054 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.5 mtpp -103.16 -29.51 11.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.083 -1.01 . . . . 0.0 110.364 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.75 151.36 21.57 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.407 ' CB ' HD11 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -85.1 63.42 8.1 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.399 -1.06 . . . . 0.0 109.533 179.754 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.69 -26.6 0.96 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.517 -0.74 . . . . 0.0 110.79 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -78.88 -19.77 51.11 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.189 -0.944 . . . . 0.0 110.254 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -104.1 -32.36 9.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.259 -0.9 . . . . 0.0 109.965 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 125.09 32.3 0.8 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.416 HD12 ' CD1' ' A' ' 41' ' ' PHE . 3.3 mt -126.82 123.51 23.75 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.037 -1.272 . . . . 0.0 109.875 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -71.2 173.09 12.76 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.543 1.286 . . . . 0.0 110.596 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -72.45 -163.4 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.759 1.399 . . . . 0.0 110.255 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 49.77 26.43 8.05 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.3 m -132.75 117.94 15.37 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.161 -1.2 . . . . 0.0 110.3 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.4 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 48.4 Cg_endo -74.38 151.77 43.22 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.492 1.259 . . . . 0.0 110.755 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.586 ' CD1' ' CE2' ' A' ' 8' ' ' TYR . 9.2 t80 -55.47 -24.42 30.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.365 -0.834 . . . . 0.0 110.104 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.9 m -71.07 -17.21 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 0.0 110.532 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -100.24 3.54 43.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.051 -1.031 . . . . 0.0 110.859 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.487 HD13 ' CD2' ' A' ' 34' ' ' PHE . 40.9 mt -54.64 169.67 0.2 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.975 -1.078 . . . . 0.0 110.265 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.25 162.05 12.72 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.184 -0.947 . . . . 0.0 110.253 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.3 -19.36 61.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.274 -0.891 . . . . 0.0 110.339 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -132.76 54.1 1.97 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.219 -0.926 . . . . 0.0 110.136 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.459 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 30.7 t80 -70.19 129.5 39.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.298 -0.876 . . . . 0.0 109.98 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 6.8 mtp -112.0 141.06 46.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.231 -0.918 . . . . 0.0 109.605 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 17.7 t -55.45 133.42 70.61 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 0.0 110.527 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.72 -1.91 11.75 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.615 1.324 . . . . 0.0 110.458 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.84 -35.92 4.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.976 -1.077 . . . . 0.0 110.914 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.444 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.9 OUTLIER -127.15 16.4 7.24 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.989 -1.069 . . . . 0.0 110.943 -179.694 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 56.4 mtt85 45.48 23.56 0.14 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.371 -0.831 . . . . 0.0 112.611 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.417 ' CB ' ' SG ' ' A' ' 46' ' ' CYS . 7.3 t -75.66 156.03 85.02 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 120.61 -1.307 . . . . 0.0 109.872 179.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.44 141.18 50.22 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.604 1.318 . . . . 0.0 110.41 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.51 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 12.5 tttm -49.16 -26.92 3.13 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.33 -0.856 . . . . 0.0 110.789 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.71 -14.56 53.43 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.066 -1.021 . . . . 0.0 109.952 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.408 ' NE2' ' N ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -89.2 1.45 55.66 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.227 -0.921 . . . . 0.0 110.271 179.303 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -89.54 148.47 23.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.896 -1.127 . . . . 0.0 111.012 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.5 133.95 47.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.564 -0.71 . . . . 0.0 109.152 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 75.7 p -70.52 176.81 3.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.989 -1.069 . . . . 0.0 111.301 -179.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.432 ' CG2' ' O ' ' A' ' 7' ' ' LYS . 1.6 tt . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.361 0.601 . . . . 0.0 109.912 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.6 mttm . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.489 ' CE2' ' HB2' ' A' ' 55' ' ' SER . 22.3 m-85 -122.64 139.56 53.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -0.906 . . . . 0.0 110.858 -179.385 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -110.13 141.15 43.41 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.361 -0.837 . . . . 0.0 109.836 179.409 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.7 t -81.01 114.1 19.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.068 -1.02 . . . . 0.0 110.37 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.27 -11.51 60.95 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.174 -0.954 . . . . 0.0 109.633 178.874 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.04 -42.22 15.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.369 -0.832 . . . . 0.0 111.759 -179.252 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.433 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 13.6 p -121.42 -34.71 3.4 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.668 -1.27 . . . . 0.0 111.424 -178.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.49 20.48 5.44 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 119.673 -1.251 . . . . 0.0 110.211 179.419 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 55.9 t80 -84.58 162.49 19.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.206 -1.173 . . . . 0.0 109.856 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.471 ' N ' ' CD1' ' A' ' 16' ' ' ILE . 3.3 mp -128.29 115.13 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.125 -0.984 . . . . 0.0 110.018 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.503 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 71.2 t80 -77.44 131.18 37.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.316 -0.865 . . . . 0.0 110.187 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -109.5 115.71 55.65 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.427 -0.795 . . . . 0.0 109.415 179.371 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -71.0 -65.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.465 1.245 . . . . 0.0 111.041 -179.484 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' A' ' 30' ' ' PRO . 0.5 OUTLIER -47.86 -24.04 0.9 Allowed 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.552 -0.717 . . . . 0.0 111.023 -179.835 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.2 tttp -99.13 -40.06 8.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.923 -1.11 . . . . 0.0 110.732 -179.724 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.74 147.85 22.72 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -85.11 61.34 6.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.447 -1.031 . . . . 0.0 109.985 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -44.72 -27.31 0.48 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.622 -0.674 . . . . 0.0 111.039 -179.724 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -69.26 -28.33 66.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.118 -0.989 . . . . 0.0 109.88 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -100.88 -28.33 12.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.343 -0.848 . . . . 0.0 109.983 179.661 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.54 28.54 1.43 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 179.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.402 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 8.8 mt -116.87 119.82 34.82 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.046 -1.267 . . . . 0.0 109.739 179.647 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -71.81 172.95 13.47 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.496 1.261 . . . . 0.0 110.553 -179.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.425 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 49.1 Cg_endo -70.64 -163.37 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.741 1.39 . . . . 0.0 110.28 179.813 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 50.22 27.83 12.03 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 63.3 m -131.71 115.91 15.87 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.198 -1.178 . . . . 0.0 110.341 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.83 148.61 46.4 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.466 1.245 . . . . 0.0 110.586 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.503 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 30.1 t80 -53.06 -30.27 34.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.36 -0.838 . . . . 0.0 109.968 179.823 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.9 m -66.75 -11.78 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.844 . . . . 0.0 110.716 -179.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -103.2 -2.42 27.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.012 -1.055 . . . . 0.0 110.92 -179.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.451 HD11 ' CD2' ' A' ' 34' ' ' PHE . 19.7 mt -52.1 172.81 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.926 -1.109 . . . . 0.0 110.312 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.8 m -64.36 150.9 45.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.219 -0.926 . . . . 0.0 110.23 -179.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -57.65 -22.18 44.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 0.0 110.234 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.4 p -129.61 38.51 3.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 0.0 109.911 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.461 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 30.8 t80 -60.46 135.66 57.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 110.345 -179.784 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.81 149.55 29.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.336 -0.853 . . . . 0.0 109.558 179.214 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 18.1 t -61.1 137.0 94.05 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.104 -0.997 . . . . 0.0 110.52 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.11 -3.37 13.75 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.602 1.317 . . . . 0.0 110.353 179.383 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.97 -39.28 3.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.07 -1.019 . . . . 0.0 110.632 -179.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.433 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.9 OUTLIER -124.24 9.17 8.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.164 -0.96 . . . . 0.0 110.954 -179.801 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 54.39 15.98 1.14 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.31 -0.869 . . . . 0.0 112.964 178.147 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.4 m -67.25 165.38 28.73 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 120.621 -1.299 . . . . 0.0 109.746 179.293 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.439 ' HB2' ' ND2' ' A' ' 51' ' ' ASN . 43.5 Cg_endo -69.85 144.29 53.08 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.677 1.356 . . . . 0.0 110.492 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.488 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 37.4 tttt -53.57 -32.16 49.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.174 -0.954 . . . . 0.0 110.608 -179.679 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.439 ' ND2' ' HB2' ' A' ' 49' ' ' PRO . 24.5 p30 -63.29 -14.45 49.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.054 -1.029 . . . . 0.0 109.738 179.258 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.62 -7.66 59.35 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.069 -1.019 . . . . 0.0 109.755 178.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -82.56 124.62 30.3 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.107 -0.996 . . . . 0.0 109.678 179.375 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -104.03 123.78 47.83 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.142 -0.974 . . . . 0.0 109.545 179.52 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.489 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 2.2 t -52.12 -179.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.103 -0.998 . . . . 0.0 110.241 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.414 ' N ' ' OG ' ' A' ' 55' ' ' SER . 4.5 tt . . . . . 0 N--CA 1.493 1.716 0 O-C-N 121.457 -0.777 . . . . 0.0 110.046 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.206 0.527 . . . . 0.0 110.19 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.84 103.13 5.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.282 -0.886 . . . . 0.0 110.097 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.448 HG22 HD12 ' A' ' 3' ' ' ILE . 51.2 mt -137.98 166.45 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.148 -0.97 . . . . 0.0 110.328 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER 174.02 -24.88 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.271 -0.893 . . . . 0.0 111.046 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.68 61.44 0.16 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.06 -1.025 . . . . 0.0 110.74 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 48.6 25.52 4.71 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.12 117.36 17.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.096 -1.238 . . . . 0.0 109.723 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.588 ' CE2' ' CD1' ' A' ' 34' ' ' PHE . 4.3 m-85 -100.4 147.05 26.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.13 -0.981 . . . . 0.0 109.908 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -117.71 128.15 54.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.234 -0.916 . . . . 0.0 110.222 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.9 t -69.86 112.04 6.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 110.178 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -11.54 59.54 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.135 -0.978 . . . . 0.0 109.592 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.422 ' HB1' ' NE2' ' A' ' 52' ' ' GLN . . . -85.19 -39.61 17.63 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.29 -0.881 . . . . 0.0 111.76 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.436 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 12.6 p -125.61 -32.99 2.82 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.672 -1.268 . . . . 0.0 111.752 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.83 21.61 5.97 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -83.09 156.03 23.53 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.229 -1.16 . . . . 0.0 109.565 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.467 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 2.7 mp -120.57 109.88 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 110.262 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.513 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 64.5 t80 -75.75 126.63 31.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.321 -0.862 . . . . 0.0 109.659 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.409 ' HB3' ' CB ' ' A' ' 21' ' ' LYS . 24.2 mt-10 -102.48 111.21 64.41 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.345 -0.847 . . . . 0.0 109.666 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.77 -70.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.487 1.256 . . . . 0.0 110.939 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.403 ' O ' ' CB ' ' A' ' 30' ' ' PRO . 66.4 tt0 -47.45 -26.18 1.29 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.448 -0.783 . . . . 0.0 110.567 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.409 ' CB ' ' HB3' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -93.58 -33.75 13.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.241 -0.912 . . . . 0.0 110.196 179.833 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.91 157.03 32.27 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -85.04 61.34 6.81 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.479 -1.013 . . . . 0.0 109.854 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -46.54 -26.67 0.93 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.454 -0.779 . . . . 0.0 110.679 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -80.77 -25.28 38.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.265 -0.897 . . . . 0.0 110.125 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -97.82 -30.41 12.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.209 -0.932 . . . . 0.0 110.157 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 127.39 4.17 5.92 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.959 -1.115 . . . . 0.0 110.536 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.5 mt -98.19 129.04 31.65 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.824 -1.398 . . . . 0.0 110.162 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 47.0 Cg_endo -74.31 173.14 14.71 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 O-C-N 123.505 1.266 . . . . 0.0 110.557 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 49.9 Cg_endo -70.9 -163.38 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.623 1.328 . . . . 0.0 110.262 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 50.21 40.58 37.39 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 99.7 m -147.28 115.46 4.26 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.183 -1.187 . . . . 0.0 110.253 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.98 151.55 56.35 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.514 1.27 . . . . 0.0 110.584 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.588 ' CD1' ' CE2' ' A' ' 8' ' ' TYR . 12.6 t80 -54.6 -32.5 58.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.328 -0.858 . . . . 0.0 110.066 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.4 m -63.56 -13.47 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.355 -0.841 . . . . 0.0 110.623 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -102.57 4.38 38.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.027 -1.045 . . . . 0.0 111.053 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.408 ' CB ' ' HD2' ' A' ' 50' ' ' LYS . 22.4 mt -56.61 178.97 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.832 -1.167 . . . . 0.0 110.044 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.8 m -69.18 164.96 21.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.215 -0.928 . . . . 0.0 110.324 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -63.93 -20.79 66.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.207 -0.933 . . . . 0.0 110.218 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.3 m -138.89 54.91 1.73 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.163 -0.961 . . . . 0.0 110.356 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.449 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 18.4 t80 -70.69 140.98 51.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.147 -0.971 . . . . 0.0 109.831 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.9 mtt -116.4 143.9 44.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.289 -0.882 . . . . 0.0 109.644 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 11.6 t -60.16 132.84 90.17 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.195 -0.941 . . . . 0.0 110.498 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.92 -9.22 20.79 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.569 1.3 . . . . 0.0 110.314 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -106.15 -40.04 5.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.078 -1.014 . . . . 0.0 110.707 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.436 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 1.3 p -122.72 5.1 9.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.133 -0.98 . . . . 0.0 111.113 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 4.2 mtm105 57.65 18.17 4.53 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.185 -0.947 . . . . 0.0 112.816 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.6 m -72.32 163.34 68.19 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 120.66 -1.275 . . . . 0.0 109.704 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -70.52 143.74 48.04 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.639 1.336 . . . . 0.0 110.235 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.488 ' HG2' ' CZ ' ' A' ' 34' ' ' PHE . 19.4 tttt -49.94 -24.63 2.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.208 -0.933 . . . . 0.0 110.549 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -66.17 -14.14 61.36 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.096 -1.002 . . . . 0.0 109.977 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.422 ' NE2' ' HB1' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -83.93 -5.56 59.24 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.141 -0.974 . . . . 0.0 109.999 179.218 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.523 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 12.7 m-85 -85.11 149.46 25.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.018 -1.051 . . . . 0.0 110.285 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.66 132.66 26.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.352 -0.842 . . . . 0.0 109.878 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.516 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 5.8 p -61.83 172.62 1.25 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.166 -0.959 . . . . 0.0 110.917 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.2 tt -159.99 77.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.733 -0.605 . . . . 0.0 109.718 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 4' ' ' ASP . 0.5 OUTLIER -100.71 65.76 1.17 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.299 -0.876 . . . . 0.0 109.975 -179.877 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.49 153.15 50.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.5 -0.75 . . . . 0.0 110.131 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 98.8 t -125.4 113.2 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.24 -0.913 . . . . 0.0 110.16 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 mp -126.1 120.58 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.158 -0.963 . . . . 0.0 110.29 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -176.2 127.16 0.21 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.34 -0.85 . . . . 0.0 109.913 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -176.85 104.96 0.19 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -118.76 -27.22 5.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.209 -1.171 . . . . 0.0 110.377 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -141.97 145.27 34.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 110.322 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -154.36 79.01 1.1 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.302 -0.874 . . . . 0.0 110.146 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 m-20 -90.74 53.16 2.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.164 -0.96 . . . . 0.0 110.406 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -157.43 -177.38 6.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.192 -0.942 . . . . 0.0 110.296 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.38 30.29 3.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 110.203 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.2 t80 53.58 68.38 0.85 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.191 -0.943 . . . . 0.0 110.255 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 CA-C-O 118.03 -1.428 . . . . 0.0 109.584 179.933 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.424 ' N ' ' OE1' ' A' ' 9' ' ' GLU . 6.4 ttt . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.222 0.534 . . . . 0.0 110.057 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.422 ' O ' ' CD1' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -61.88 96.38 0.07 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 110.158 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.422 ' CD1' ' O ' ' A' ' 2' ' ' GLU . 29.8 mm -140.91 165.68 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.248 -0.908 . . . . 0.0 109.649 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 29.7 t70 -138.48 5.17 2.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.104 -0.997 . . . . 0.0 111.178 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.57 -148.47 0.2 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.956 -1.09 . . . . 0.0 109.858 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.11 30.67 6.9 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.423 ' O ' ' CG2' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -80.24 130.39 35.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -1.152 . . . . 0.0 109.936 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.564 ' CE2' ' CD2' ' A' ' 34' ' ' PHE . 7.4 m-85 -109.59 141.93 41.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.168 -0.957 . . . . 0.0 109.878 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.424 ' OE1' ' N ' ' A' ' 1' ' ' MET . 4.8 tt0 -106.18 129.88 54.16 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.162 -0.961 . . . . 0.0 110.275 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.9 t -71.42 116.17 11.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 110.339 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.73 -11.47 60.96 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.091 -1.006 . . . . 0.0 109.585 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.15 -41.37 15.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.309 -0.87 . . . . 0.0 111.653 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.453 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 14.3 p -123.12 -32.62 3.43 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.758 -1.214 . . . . 0.0 111.406 -179.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.0 24.0 5.92 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.46 ' CD2' ' N ' ' A' ' 16' ' ' ILE . 40.9 t80 -84.13 168.96 15.33 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.365 -1.079 . . . . 0.0 109.343 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.46 ' N ' ' CD2' ' A' ' 15' ' ' TYR . 33.9 mm -129.41 117.59 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.27 -0.894 . . . . 0.0 110.309 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.5 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 56.1 t80 -80.54 129.17 34.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.429 -0.794 . . . . 0.0 109.912 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -104.91 110.73 64.87 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.488 -0.758 . . . . 0.0 109.546 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.426 ' CB ' ' HA ' ' A' ' 33' ' ' PRO . 37.5 Cg_endo -68.58 -76.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.591 1.311 . . . . 0.0 111.464 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -46.02 -26.58 0.75 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.285 -0.885 . . . . 0.0 111.037 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.5 tttp -87.95 -36.09 17.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 110.522 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.46 145.63 17.81 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.41 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 2.9 t0 -85.11 62.07 7.27 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.3 -1.118 . . . . 0.0 109.876 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.39 -26.5 2.1 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.249 -0.907 . . . . 0.0 110.416 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -74.51 -20.41 59.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.303 -0.873 . . . . 0.0 109.921 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.41 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -106.99 -33.28 7.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.929 . . . . 0.0 109.969 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.94 32.97 0.66 Allowed Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.948 -1.12 . . . . 0.0 110.309 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.417 HD12 ' CD2' ' A' ' 37' ' ' LEU . 3.1 mt -124.1 130.39 24.4 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 120.876 -1.367 . . . . 0.0 109.753 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.46 173.21 13.57 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 O-C-N 123.601 1.316 . . . . 0.0 110.394 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -72.19 -164.87 0.19 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.629 1.331 . . . . 0.0 110.186 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 49.76 27.87 10.18 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.9 m -127.94 112.08 20.28 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.099 -1.236 . . . . 0.0 110.228 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.426 ' HA ' ' CB ' ' A' ' 19' ' ' PRO . 44.3 Cg_endo -70.87 153.08 64.0 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.554 1.292 . . . . 0.0 110.478 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.564 ' CD2' ' CE2' ' A' ' 8' ' ' TYR . 27.5 t80 -55.48 -28.36 54.04 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.234 -0.916 . . . . 0.0 110.106 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.405 HG21 ' N ' ' A' ' 36' ' ' ASP . 33.8 m -64.79 -20.16 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.207 -0.933 . . . . 0.0 110.077 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.405 ' N ' HG21 ' A' ' 35' ' ' VAL . 7.8 m-20 -90.54 -11.11 41.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.13 -0.981 . . . . 0.0 110.69 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.417 ' CD2' HD12 ' A' ' 28' ' ' ILE . 25.5 mt -52.54 157.65 1.47 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.974 -1.079 . . . . 0.0 110.322 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.34 139.34 58.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.307 -0.871 . . . . 0.0 109.99 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -51.17 -24.86 4.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.26 -0.9 . . . . 0.0 110.348 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.95 26.19 10.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.87 . . . . 0.0 110.177 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.454 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 18.3 t80 -56.04 131.96 48.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 109.844 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.1 mtt -113.3 147.46 37.55 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.265 -0.897 . . . . 0.0 109.545 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 7.9 t -58.72 134.25 86.39 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.0 110.44 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -77.83 1.09 9.21 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.533 1.281 . . . . 0.0 110.29 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -120.97 -34.96 3.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.027 -1.045 . . . . 0.0 110.923 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.453 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.7 OUTLIER -126.16 4.07 7.14 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.937 -1.102 . . . . 0.0 111.345 -179.668 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.78 17.75 10.13 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.085 -1.009 . . . . 0.0 112.142 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.406 ' CB ' ' SG ' ' A' ' 46' ' ' CYS . 5.0 t -70.44 153.39 95.11 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.822 -1.174 . . . . 0.0 109.707 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.16 145.33 43.89 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.587 1.309 . . . . 0.0 110.558 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.46 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 24.7 tttm -52.37 -32.03 36.6 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.175 -0.953 . . . . 0.0 110.186 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.15 -15.66 47.39 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.122 -0.987 . . . . 0.0 109.745 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.1 3.77 53.92 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.24 -0.912 . . . . 0.0 110.159 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -92.84 128.16 38.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.896 -1.127 . . . . 0.0 110.209 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.86 135.73 50.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.301 -0.874 . . . . 0.0 109.737 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 77.9 p -68.15 -178.44 1.04 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 110.908 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.43 ' O ' ' CG2' ' A' ' 56' ' ' ILE . 7.2 tp -160.0 88.12 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 121.466 0.65 . . . . 0.0 109.691 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 4' ' ' ASP . 6.0 ptmt -101.66 64.55 0.99 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.136 -0.978 . . . . 0.0 110.533 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -174.62 156.75 2.44 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.172 -0.955 . . . . 0.0 110.487 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.2 m -103.48 178.31 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 0.0 110.275 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.404 HD11 HG22 ' A' ' 60' ' ' ILE . 48.5 mm -112.4 -65.09 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.29 -0.881 . . . . 0.0 110.223 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.83 62.92 6.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.227 -0.921 . . . . 0.0 110.268 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -101.07 110.27 3.85 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -89.83 61.22 5.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -1.144 . . . . 0.0 110.438 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.3 -20.39 40.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 110.142 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.22 -33.49 11.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.295 -0.878 . . . . 0.0 110.291 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -88.16 121.98 31.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.278 -0.889 . . . . 0.0 110.264 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -103.54 62.89 0.78 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.205 -0.934 . . . . 0.0 110.177 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 20.2 tttm -109.86 -42.62 4.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.284 -0.885 . . . . 0.0 110.08 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.62 109.39 9.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -0.915 . . . . 0.0 110.099 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 CA-C-O 117.965 -1.464 . . . . 0.0 109.453 -179.878 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.151 0.5 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.0 65.16 1.34 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.166 -0.959 . . . . 0.0 110.691 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.415 ' O ' ' N ' ' A' ' 58' ' ' LYS . 4.2 mp -128.72 169.31 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.187 -0.946 . . . . 0.0 109.478 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.425 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 29.4 t70 -141.42 4.53 1.79 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.003 -1.061 . . . . 0.0 111.62 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -91.38 -146.95 0.21 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.809 -1.182 . . . . 0.0 109.662 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.74 33.58 5.11 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.424 ' O ' ' CG2' ' A' ' 56' ' ' ILE . 0.2 OUTLIER -80.19 133.65 36.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.334 -1.098 . . . . 0.0 109.879 179.875 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.505 ' CE2' ' HB3' ' A' ' 55' ' ' SER . 8.9 m-85 -118.1 135.88 53.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.153 -0.967 . . . . 0.0 109.635 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -101.53 135.76 42.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.048 -1.033 . . . . 0.0 110.55 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.9 t -77.49 113.95 15.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.194 -0.941 . . . . 0.0 110.248 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.01 -10.26 59.45 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.004 -1.06 . . . . 0.0 109.572 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.05 -39.48 17.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.43 -0.794 . . . . 0.0 111.584 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.459 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 13.8 p -125.5 -35.24 2.58 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.652 -1.28 . . . . 0.0 111.531 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.02 22.8 4.81 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.466 ' CG ' ' N ' ' A' ' 16' ' ' ILE . 59.2 t80 -83.66 170.22 14.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.351 -1.088 . . . . 0.0 109.871 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.466 ' N ' ' CG ' ' A' ' 15' ' ' TYR . 37.2 mm -132.24 115.03 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 110.255 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.499 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 68.4 t80 -78.17 135.94 37.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.331 -0.856 . . . . 0.0 110.136 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.415 ' O ' ' N ' ' A' ' 22' ' ' GLY . 5.8 mt-10 -115.28 110.09 45.75 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.516 -0.74 . . . . 0.0 109.461 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.99 -72.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.395 0 O-C-N 123.52 1.274 . . . . 0.0 111.237 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -44.81 -27.27 0.49 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.544 -0.722 . . . . 0.0 111.032 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -98.13 -24.02 15.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.207 -0.933 . . . . 0.0 110.147 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 18' ' ' GLU . . . 80.04 153.36 8.49 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.93 61.2 6.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.361 -1.081 . . . . 0.0 109.595 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.45 -27.78 0.78 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.57 -0.706 . . . . 0.0 110.965 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.85 -28.08 60.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.187 -0.946 . . . . 0.0 109.899 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -96.54 -28.22 14.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.291 -0.88 . . . . 0.0 110.073 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.8 24.63 2.27 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.413 HD12 ' CD1' ' A' ' 41' ' ' PHE . 7.6 mt -113.98 128.86 25.32 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.959 -1.318 . . . . 0.0 109.684 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.33 170.45 19.87 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.598 1.315 . . . . 0.0 110.665 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.01 -163.59 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.674 1.355 . . . . 0.0 110.144 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 48.99 34.38 15.79 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 90.2 m -138.7 115.08 8.79 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.259 -1.142 . . . . 0.0 110.271 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -72.08 148.8 51.3 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.568 1.299 . . . . 0.0 110.507 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.499 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 19.1 t80 -51.59 -27.85 12.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.42 -0.8 . . . . 0.0 110.272 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.1 m -71.0 -19.59 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.936 . . . . 0.0 110.52 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.27 -2.26 55.21 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.186 -0.946 . . . . 0.0 110.924 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.426 ' CD1' ' HD2' ' A' ' 50' ' ' LYS . 25.2 mt -53.19 -179.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.971 -1.08 . . . . 0.0 110.372 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.15 156.48 38.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.381 -0.825 . . . . 0.0 110.232 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -53.11 -26.31 16.13 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.268 -0.895 . . . . 0.0 110.424 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.32 60.43 1.67 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.143 -0.973 . . . . 0.0 110.42 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.452 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 10.0 t80 -71.64 128.49 35.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.164 -0.96 . . . . 0.0 109.685 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.4 ' HA ' ' O ' ' A' ' 48' ' ' SER . 18.1 mmt -103.0 145.83 29.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -0.925 . . . . 0.0 109.795 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 8.3 t -58.36 138.12 85.11 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.403 -0.811 . . . . 0.0 110.67 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -77.68 -0.57 10.77 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.686 1.361 . . . . 0.0 110.394 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -122.41 -34.15 3.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.032 -1.042 . . . . 0.0 111.022 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.459 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.8 OUTLIER -125.03 8.01 7.99 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.933 -1.105 . . . . 0.0 111.298 -179.655 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.69 21.41 4.59 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.122 -0.987 . . . . 0.0 112.432 178.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.413 ' CB ' ' SG ' ' A' ' 46' ' ' CYS . 10.9 t -77.23 153.25 82.11 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 120.666 -1.271 . . . . 0.0 109.627 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.26 142.06 49.04 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.584 1.307 . . . . 0.0 110.548 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.484 ' HG2' ' CZ ' ' A' ' 34' ' ' PHE . 4.4 ttpm? -48.4 -29.44 4.01 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.445 -0.784 . . . . 0.0 110.937 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -62.77 -14.79 49.13 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.986 -1.071 . . . . 0.0 109.967 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.09 1.1 56.08 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.125 -0.985 . . . . 0.0 110.03 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.449 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 16.6 m-85 -89.63 137.43 32.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.116 -0.99 . . . . 0.0 110.307 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -115.9 131.63 56.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.285 -0.885 . . . . 0.0 109.64 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.505 ' HB3' ' CE2' ' A' ' 8' ' ' TYR . 79.3 p -63.68 179.67 0.46 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.048 -1.032 . . . . 0.0 111.054 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.424 ' CG2' ' O ' ' A' ' 7' ' ' LYS . 1.2 tp -157.6 69.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-O 121.405 0.622 . . . . 0.0 109.561 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 4' ' ' ASP . 39.5 mttt -91.12 65.61 5.56 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.438 -0.788 . . . . 0.0 109.717 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -170.47 148.59 3.15 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.474 -0.766 . . . . 0.0 110.474 -179.72 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.2 t -123.88 122.54 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.249 -0.907 . . . . 0.0 110.217 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.411 HG13 ' N ' ' A' ' 61' ' ' ALA . 5.6 tp -125.72 154.07 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.305 -0.872 . . . . 0.0 110.21 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.411 ' N ' HG13 ' A' ' 60' ' ' ILE . . . -153.36 23.23 0.54 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.197 -0.939 . . . . 0.0 110.147 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -144.07 103.22 0.3 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.1 128.7 55.21 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.255 -1.144 . . . . 0.0 110.248 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -100.77 -40.32 7.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.209 -0.932 . . . . 0.0 110.219 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 53.46 79.38 0.13 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.905 . . . . 0.0 110.275 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -146.92 46.38 1.17 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.224 -0.923 . . . . 0.0 110.329 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -70.83 -25.78 62.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 0.0 109.955 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.3 mttt 52.06 43.15 30.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.284 -0.885 . . . . 0.0 110.333 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -141.53 64.33 1.41 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.221 -0.924 . . . . 0.0 110.374 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.944 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 ttm . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.313 0.578 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -84.65 90.29 7.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 0.0 110.231 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.432 ' O ' ' HB2' ' A' ' 4' ' ' ASP . 13.1 pt -134.88 126.17 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.229 -0.92 . . . . 0.0 110.204 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.432 ' HB2' ' O ' ' A' ' 3' ' ' ILE . 12.6 t0 178.06 -32.02 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.62 -0.675 . . . . 0.0 110.18 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.413 ' O ' ' CG ' ' A' ' 19' ' ' PRO . 25.6 mt-10 -66.66 78.03 0.11 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 110.104 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 55.06 22.46 28.5 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.53 131.7 35.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.211 -1.17 . . . . 0.0 109.468 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.508 ' CE2' ' HB2' ' A' ' 55' ' ' SER . 22.2 m-85 -129.3 150.39 50.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.017 -1.052 . . . . 0.0 110.864 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.431 ' CB ' HD12 ' A' ' 16' ' ' ILE . 13.8 pt-20 -120.56 140.66 51.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.323 -0.861 . . . . 0.0 109.863 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 t -80.05 113.86 18.53 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.176 -0.953 . . . . 0.0 110.434 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.63 -11.71 61.11 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.115 -0.99 . . . . 0.0 109.613 178.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.08 -41.3 15.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 111.726 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.4 p -122.08 -32.85 3.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.726 -1.234 . . . . 0.0 111.551 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.14 21.12 6.03 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.507 ' CD2' ' N ' ' A' ' 16' ' ' ILE . 60.5 t80 -81.6 168.92 17.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.265 -1.138 . . . . 0.0 109.92 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.507 ' N ' ' CD2' ' A' ' 15' ' ' TYR . 34.8 mm -135.11 116.25 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.246 -0.908 . . . . 0.0 110.201 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.477 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 63.5 t80 -80.57 132.86 35.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -0.874 . . . . 0.0 110.109 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -113.93 113.86 46.78 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.561 -0.712 . . . . 0.0 109.655 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.413 ' CG ' ' O ' ' A' ' 5' ' ' GLU . 38.5 Cg_endo -71.72 -65.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.474 1.25 . . . . 0.0 110.892 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -45.38 -27.33 0.67 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.715 -0.616 . . . . 0.0 110.776 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.12 -35.57 10.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.282 -0.886 . . . . 0.0 110.0 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.64 149.54 10.69 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -85.14 62.42 7.49 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.457 -1.025 . . . . 0.0 109.725 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -44.91 -27.5 0.54 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.629 -0.669 . . . . 0.0 110.916 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.45 -26.44 60.05 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.315 -0.865 . . . . 0.0 110.26 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -100.72 -25.68 14.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.223 -0.923 . . . . 0.0 110.335 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.92 19.1 3.39 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.893 -1.146 . . . . 0.0 110.244 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.2 mt -111.19 116.59 51.1 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 120.897 -1.355 . . . . 0.0 109.717 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.35 172.18 13.7 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.503 1.265 . . . . 0.0 110.611 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.54 -164.14 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.724 1.381 . . . . 0.0 110.145 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 47.61 27.33 4.36 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.406 ' O ' ' CB ' ' A' ' 19' ' ' PRO . 89.9 m -128.73 119.53 20.21 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.12 -1.223 . . . . 0.0 110.245 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -73.78 159.47 45.29 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 O-C-N 123.525 1.276 . . . . 0.0 110.878 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.479 ' CZ ' ' HE2' ' A' ' 50' ' ' LYS . 44.2 t80 -65.79 -28.93 69.37 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.448 -0.783 . . . . 0.0 110.157 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.2 m -69.45 -9.83 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -0.904 . . . . 0.0 110.809 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.67 -1.96 23.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.965 -1.085 . . . . 0.0 110.892 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.9 mt -52.07 162.57 0.45 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.883 -1.136 . . . . 0.0 110.27 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.7 t -49.57 164.86 0.08 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.31 -0.869 . . . . 0.0 110.44 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.46 -26.0 68.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.916 . . . . 0.0 110.233 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.9 p -131.65 52.73 2.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.271 -0.893 . . . . 0.0 110.46 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.47 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 26.9 t80 -63.46 132.17 50.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.216 -0.927 . . . . 0.0 109.785 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -110.17 143.97 39.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.878 . . . . 0.0 109.663 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.449 ' HB3' ' N ' ' A' ' 47' ' ' ARG . 8.7 t -55.49 137.45 69.56 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 110.741 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -77.6 -1.68 11.85 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.58 1.305 . . . . 0.0 110.287 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -120.56 -39.81 2.72 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.146 -0.971 . . . . 0.0 110.533 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.417 ' SG ' ' CB ' ' A' ' 48' ' ' SER . 0.6 OUTLIER -121.82 10.42 10.24 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.087 -1.008 . . . . 0.0 110.836 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.449 ' N ' ' HB3' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 52.95 17.73 0.94 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.29 -0.881 . . . . 0.0 112.655 178.557 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.417 ' CB ' ' SG ' ' A' ' 46' ' ' CYS . 4.1 t -67.7 156.2 89.6 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.598 -1.313 . . . . 0.0 109.715 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.86 143.48 45.65 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 123.684 1.36 . . . . 0.0 110.486 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.484 ' HA ' ' CD1' ' A' ' 53' ' ' PHE . 22.1 tttm -50.32 -25.26 3.6 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.325 -0.86 . . . . 0.0 110.517 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 -67.24 -11.61 57.92 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.202 -0.936 . . . . 0.0 110.146 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.52 0.7 57.46 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.053 -1.029 . . . . 0.0 110.104 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.484 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 39.6 m-85 -89.99 125.67 35.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.951 -1.093 . . . . 0.0 110.428 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -100.75 131.54 46.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.391 -0.818 . . . . 0.0 109.579 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.508 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 2.5 t -60.89 179.34 0.18 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.124 -0.985 . . . . 0.0 110.316 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.447 ' CG2' ' O ' ' A' ' 55' ' ' SER . 7.9 pt -159.99 94.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.782 -0.573 . . . . 0.0 109.509 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 4' ' ' ASP . 12.9 ptpt -108.69 66.46 0.64 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.369 -0.832 . . . . 0.0 110.193 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.07 66.5 0.92 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.32 -0.863 . . . . 0.0 110.193 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.9 m -84.67 158.37 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.373 -0.83 . . . . 0.0 110.364 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 66.7 mt -123.18 80.88 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.345 -0.847 . . . . 0.0 110.104 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.61 161.86 2.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.191 -0.943 . . . . 0.0 110.389 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -134.47 -111.39 1.19 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -149.41 179.1 8.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.174 -1.192 . . . . 0.0 110.332 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -174.19 127.7 0.36 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.261 -0.899 . . . . 0.0 110.37 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -149.73 70.29 1.06 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.262 -0.899 . . . . 0.0 110.038 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -129.93 113.33 14.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 0.0 110.501 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.68 -167.31 1.27 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.279 -0.888 . . . . 0.0 110.038 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.5 mtpt -134.86 112.41 10.66 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.096 -1.003 . . . . 0.0 110.297 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -144.06 77.97 1.57 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 0.0 110.159 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 CA-C-O 117.959 -1.467 . . . . 0.0 109.479 -179.997 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.303 0.573 . . . . 0.0 110.235 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.412 ' OE2' ' CG1' ' A' ' 59' ' ' VAL . 0.8 OUTLIER 53.68 71.46 0.5 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.216 -0.927 . . . . 0.0 110.186 -179.927 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.416 ' CD1' HG22 ' A' ' 56' ' ' ILE . 25.9 pt -148.38 145.84 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.275 -0.891 . . . . 0.0 110.106 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.463 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 21.6 t0 -146.7 10.53 1.07 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.171 -0.955 . . . . 0.0 111.248 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -78.24 61.53 2.74 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.183 -0.948 . . . . 0.0 110.613 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.406 ' O ' ' HG3' ' A' ' 19' ' ' PRO . . . 50.91 23.97 7.77 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.437 ' O ' ' CG2' ' A' ' 56' ' ' ILE . 6.5 mttt -78.67 132.36 37.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.099 -1.236 . . . . 0.0 109.529 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.503 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 6.6 m-85 -111.93 132.19 54.91 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.055 -1.028 . . . . 0.0 110.354 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 17.3 tt0 -95.23 135.49 36.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.262 -0.899 . . . . 0.0 109.982 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.4 t -76.95 114.45 15.75 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.191 -0.943 . . . . 0.0 110.309 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -69.34 -11.47 60.84 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.192 -0.942 . . . . 0.0 109.722 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.2 -40.79 16.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.906 . . . . 0.0 111.819 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.454 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 14.0 p -124.53 -35.35 2.76 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.738 -1.226 . . . . 0.0 111.802 -178.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 116.94 20.5 4.87 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.616 -1.278 . . . . 0.0 109.988 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.453 ' CG ' ' N ' ' A' ' 16' ' ' ILE . 73.7 t80 -83.73 169.99 14.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -1.124 . . . . 0.0 109.51 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.453 ' N ' ' CG ' ' A' ' 15' ' ' TYR . 3.4 mp -132.7 110.23 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.119 -0.988 . . . . 0.0 110.064 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.501 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 73.3 t80 -70.06 140.28 52.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.265 -0.897 . . . . 0.0 110.109 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.403 ' HG2' ' HE2' ' A' ' 7' ' ' LYS . 14.6 mt-10 -115.26 108.21 48.26 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.545 -0.722 . . . . 0.0 109.857 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.406 ' HG3' ' O ' ' A' ' 6' ' ' GLY . 38.0 Cg_endo -68.81 -74.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.427 1.224 . . . . 0.0 111.042 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -46.85 -25.76 0.83 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.4 -0.812 . . . . 0.0 110.914 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.99 -38.2 11.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.13 -0.981 . . . . 0.0 110.44 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.37 148.52 24.1 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.09 61.99 7.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.399 -1.06 . . . . 0.0 110.07 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.18 -26.82 0.84 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.523 -0.735 . . . . 0.0 110.915 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -77.5 -23.0 50.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.173 -0.954 . . . . 0.0 110.333 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -102.69 -28.67 11.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.204 -0.935 . . . . 0.0 110.143 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.66 30.94 1.19 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.6 mt -122.89 122.39 27.09 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.123 -1.222 . . . . 0.0 109.783 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -70.71 173.06 12.38 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 O-C-N 123.516 1.272 . . . . 0.0 110.529 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -70.84 -163.54 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.788 1.415 . . . . 0.0 110.137 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 49.15 25.69 5.75 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 93.0 m -127.39 114.74 21.36 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.102 -1.234 . . . . 0.0 110.04 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -73.72 149.88 43.91 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.501 1.263 . . . . 0.0 110.78 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.501 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 55.0 t80 -53.9 -26.88 27.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.361 -0.837 . . . . 0.0 110.151 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.4 m -69.09 -16.11 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.172 -0.955 . . . . 0.0 110.632 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.19 -2.48 49.62 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.045 -1.034 . . . . 0.0 110.927 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.478 HD11 ' CD1' ' A' ' 34' ' ' PHE . 58.4 mt -59.0 158.56 8.31 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.919 -1.113 . . . . 0.0 110.155 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.0 t -54.55 166.84 0.4 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.302 -0.874 . . . . 0.0 110.227 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -72.3 -11.68 60.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.206 -0.934 . . . . 0.0 110.635 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 54.3 p -137.37 34.02 2.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.966 -1.084 . . . . 0.0 110.322 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.474 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 22.9 t80 -54.25 144.23 20.79 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.257 -0.902 . . . . 0.0 109.59 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.07 138.31 51.7 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.2 -0.938 . . . . 0.0 110.32 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 39.2 t -57.33 131.8 81.15 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.453 -0.779 . . . . 0.0 110.182 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.61 -3.26 13.6 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.489 1.257 . . . . 0.0 110.673 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -111.12 -30.19 7.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.004 -1.06 . . . . 0.0 110.686 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.454 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 1.5 p -135.17 7.94 3.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.995 -1.065 . . . . 0.0 111.313 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.3 16.32 3.06 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.207 -0.933 . . . . 0.0 112.897 178.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.4 p -72.66 156.93 89.65 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 120.626 -1.296 . . . . 0.0 109.884 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.0 140.67 46.16 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.551 1.29 . . . . 0.0 110.306 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.48 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 41.0 tttt -47.29 -30.42 3.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.31 -0.869 . . . . 0.0 111.481 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 29.6 p30 -63.18 -14.03 44.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.888 -1.133 . . . . 0.0 110.048 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.97 -2.83 58.66 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.101 -0.999 . . . . 0.0 110.146 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -81.95 168.04 18.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.958 -1.089 . . . . 0.0 110.21 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -147.28 132.79 18.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.376 -0.827 . . . . 0.0 109.471 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.503 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 64.5 p -65.52 174.82 2.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.973 -1.08 . . . . 0.0 110.91 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.437 ' CG2' ' O ' ' A' ' 7' ' ' LYS . 0.6 OUTLIER -160.03 81.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 121.418 0.628 . . . . 0.0 110.207 179.61 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 4' ' ' ASP . 13.5 mtpt -93.75 62.03 3.17 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -0.908 . . . . 0.0 109.785 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.5 mttp -122.12 124.62 44.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -0.907 . . . . 0.0 110.423 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.412 ' CG1' ' OE2' ' A' ' 2' ' ' GLU . 58.9 t -126.4 65.54 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 109.957 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.436 ' O ' ' CG2' ' A' ' 60' ' ' ILE . 7.1 tt -132.26 114.04 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.271 -0.893 . . . . 0.0 110.181 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -176.8 -56.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.188 -0.945 . . . . 0.0 110.044 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 152.28 -125.62 1.86 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -116.32 143.45 45.52 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.317 -1.108 . . . . 0.0 110.324 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -120.15 -35.76 3.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.339 -0.851 . . . . 0.0 109.957 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -63.6 -29.67 70.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.242 -0.911 . . . . 0.0 110.214 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -57.03 167.82 0.77 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.27 -0.894 . . . . 0.0 110.323 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -149.53 107.44 3.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.3 -0.875 . . . . 0.0 109.981 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.2 mtmt 55.32 173.75 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.188 -0.945 . . . . 0.0 110.125 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -147.09 -72.9 0.22 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 110.085 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 CA-C-O 117.968 -1.462 . . . . 0.0 109.463 179.996 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mtp . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.296 0.57 . . . . 0.0 110.018 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -155.85 121.95 5.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.407 -0.808 . . . . 0.0 109.888 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.42 ' CG2' HG13 ' A' ' 56' ' ' ILE . 3.3 mp -125.48 172.06 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 0.0 110.18 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -176.35 -30.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.242 -0.911 . . . . 0.0 110.967 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -78.59 -142.04 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.042 -1.037 . . . . 0.0 109.525 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.51 27.97 9.85 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.479 -1.343 . . . . 0.0 109.795 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.424 ' O ' ' CG1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -74.78 119.38 18.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.006 -1.291 . . . . 0.0 109.281 179.38 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.535 ' CE2' ' CD1' ' A' ' 34' ' ' PHE . 4.2 m-85 -104.41 166.68 10.24 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.113 -0.992 . . . . 0.0 110.565 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -131.12 134.33 46.47 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.344 -0.847 . . . . 0.0 110.279 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.9 t -74.85 112.42 11.04 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.204 -0.935 . . . . 0.0 109.991 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.61 -10.84 59.84 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.28 -0.968 . . . . 0.0 109.65 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.07 -39.93 17.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 111.767 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.437 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 13.0 p -124.54 -36.54 2.61 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.713 -1.242 . . . . 0.0 111.521 -178.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.27 21.16 4.15 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.407 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 37.5 t80 -81.19 160.62 24.29 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.206 -1.173 . . . . 0.0 109.756 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.444 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 2.8 mp -127.04 120.93 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.169 -0.957 . . . . 0.0 110.185 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.503 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 58.5 t80 -86.7 138.17 31.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.22 -0.925 . . . . 0.0 110.194 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -116.15 112.95 41.7 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.565 -0.709 . . . . 0.0 109.857 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -72.02 -66.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.58 1.305 . . . . 0.0 111.026 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.402 ' O ' ' CB ' ' A' ' 30' ' ' PRO . 1.4 tt0 -45.26 -27.04 0.58 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.698 -0.626 . . . . 0.0 110.97 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.1 tptt -99.86 -30.65 11.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 110.332 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.62 148.38 8.35 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -85.03 63.16 7.95 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.451 -1.029 . . . . 0.0 109.599 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -45.34 -29.29 1.01 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.606 -0.684 . . . . 0.0 110.899 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -68.69 -26.46 65.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.314 -0.866 . . . . 0.0 109.89 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -100.67 -28.89 12.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.335 -0.853 . . . . 0.0 109.995 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.05 15.71 3.76 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.955 -1.117 . . . . 0.0 110.462 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.9 mt -105.64 121.68 45.19 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.776 -1.426 . . . . 0.0 109.78 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -70.86 171.82 14.92 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.504 1.265 . . . . 0.0 110.691 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.402 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 49.6 Cg_endo -71.42 -163.83 0.14 Allowed 'Trans proline' 0 C--N 1.314 -1.285 0 O-C-N 123.771 1.406 . . . . 0.0 110.201 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 47.98 33.43 10.11 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 85.0 m -137.27 121.63 12.24 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.194 -1.18 . . . . 0.0 110.191 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -73.07 155.16 52.61 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.505 1.266 . . . . 0.0 110.745 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.535 ' CD1' ' CE2' ' A' ' 8' ' ' TYR . 24.5 t80 -58.04 -30.06 65.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.32 -0.862 . . . . 0.0 109.809 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.4 m -63.66 -14.84 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.321 -0.862 . . . . 0.0 110.691 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.64 0.94 45.77 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.053 -1.03 . . . . 0.0 111.001 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.521 ' CD1' ' CD2' ' A' ' 34' ' ' PHE . 21.3 mt -53.64 169.58 0.14 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.888 -1.133 . . . . 0.0 110.209 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.5 t -61.08 153.65 24.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.218 -0.927 . . . . 0.0 110.392 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -54.13 -39.3 66.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.262 -0.899 . . . . 0.0 110.445 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 96.7 p -120.04 43.85 2.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 110.489 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.439 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 40.7 t80 -63.26 137.01 58.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.202 -0.936 . . . . 0.0 109.971 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 45.2 mmm -111.47 164.43 12.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.206 -0.934 . . . . 0.0 109.575 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.3 t -76.63 133.27 70.7 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.291 -0.881 . . . . 0.0 110.3 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -75.09 -1.96 11.92 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.525 1.276 . . . . 0.0 110.287 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.96 -33.62 4.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.961 -1.087 . . . . 0.0 110.712 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.437 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.8 OUTLIER -129.38 7.12 5.34 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.995 -1.066 . . . . 0.0 111.188 -179.91 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.66 17.6 4.16 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.102 -0.999 . . . . 0.0 112.566 178.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.42 ' CB ' ' SG ' ' A' ' 46' ' ' CYS . 6.6 t -72.44 155.94 90.78 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 120.675 -1.266 . . . . 0.0 109.846 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.96 140.54 50.52 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.615 1.324 . . . . 0.0 110.377 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.447 ' HG2' ' CZ ' ' A' ' 34' ' ' PHE . 21.6 tttt -50.23 -25.41 3.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.238 -0.913 . . . . 0.0 110.735 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -66.6 -12.91 60.13 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.056 -1.028 . . . . 0.0 109.963 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.79 -2.88 58.91 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.07 -1.019 . . . . 0.0 110.08 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.471 ' HB2' ' CZ ' ' A' ' 34' ' ' PHE . 23.9 m-85 -86.41 134.33 33.71 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.956 -1.09 . . . . 0.0 110.072 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.68 139.11 52.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.203 -0.935 . . . . 0.0 109.612 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.519 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 35.5 p -63.83 176.91 0.83 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.935 . . . . 0.0 111.034 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.433 ' CG2' ' O ' ' A' ' 55' ' ' SER . 8.1 pt -158.78 89.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 121.261 0.553 . . . . 0.0 109.639 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.9 mtpt -105.59 67.48 0.76 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.362 -0.836 . . . . 0.0 110.033 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -155.87 144.19 20.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.391 -0.818 . . . . 0.0 110.009 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.0 m -133.17 149.25 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.354 -0.841 . . . . 0.0 110.237 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.2 tt -152.33 71.67 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 110.112 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -157.24 78.84 0.89 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.341 -0.849 . . . . 0.0 110.108 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 162.36 -99.2 0.17 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -147.36 -158.41 0.91 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.113 -1.228 . . . . 0.0 110.357 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.48 58.93 5.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.242 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -129.48 -165.51 1.53 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.125 -0.984 . . . . 0.0 110.051 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -170.65 -38.9 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.155 -0.966 . . . . 0.0 110.441 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.12 -164.07 1.17 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.188 -0.945 . . . . 0.0 110.212 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.5 mttp -113.79 -29.16 7.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.233 -0.917 . . . . 0.0 110.314 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -122.14 68.28 0.93 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.253 -0.904 . . . . 0.0 109.975 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.919 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.4 mtm . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.319 0.581 . . . . 0.0 110.053 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 54.19 94.03 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.365 -0.834 . . . . 0.0 110.347 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.404 ' O ' ' HB3' ' A' ' 4' ' ' ASP . 2.9 pt -151.49 140.94 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.349 -0.844 . . . . 0.0 110.167 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' A' ' 3' ' ' ILE . 9.7 p-10 179.56 112.77 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.365 -0.835 . . . . 0.0 109.65 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -158.61 26.27 0.23 Allowed 'General case' 0 C--N 1.29 -2.016 0 CA-C-O 121.245 0.545 . . . . 0.0 110.183 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 95.77 23.73 17.44 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.6 mtmt -83.88 134.98 34.66 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.303 -1.116 . . . . 0.0 109.611 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.537 ' CE2' ' CD2' ' A' ' 34' ' ' PHE . 14.9 m-85 -125.76 135.58 52.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.131 -0.981 . . . . 0.0 110.688 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -103.91 138.99 39.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.384 -0.822 . . . . 0.0 110.063 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.7 t -79.66 112.53 17.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.191 -0.943 . . . . 0.0 110.331 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.97 -11.18 60.49 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.147 -0.97 . . . . 0.0 109.658 178.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.03 -41.07 16.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.298 -0.876 . . . . 0.0 111.598 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.445 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 14.2 p -123.12 -35.51 2.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.699 -1.25 . . . . 0.0 111.428 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 116.65 20.62 4.94 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 119.677 -1.249 . . . . 0.0 110.071 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.476 ' CD2' ' N ' ' A' ' 16' ' ' ILE . 67.4 t80 -84.84 169.11 14.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.108 -1.231 . . . . 0.0 109.828 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.476 ' N ' ' CD2' ' A' ' 15' ' ' TYR . 3.3 mp -133.39 115.2 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.218 -0.926 . . . . 0.0 110.154 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.492 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 58.3 t80 -75.47 136.63 40.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.913 . . . . 0.0 110.086 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -113.5 112.3 48.81 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.549 -0.72 . . . . 0.0 109.632 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.06 -74.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.456 1.24 . . . . 0.0 111.554 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.411 ' O ' ' CB ' ' A' ' 30' ' ' PRO . 3.6 mm-40 -43.38 -27.3 0.25 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.525 -0.734 . . . . 0.0 111.398 -179.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.0 mmmt -93.65 -36.03 12.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.079 -1.013 . . . . 0.0 110.501 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.33 145.17 14.14 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -85.08 62.93 7.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.378 -1.072 . . . . 0.0 109.707 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -44.57 -27.17 0.44 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.595 -0.691 . . . . 0.0 111.251 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -74.6 -26.71 60.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.028 -1.045 . . . . 0.0 110.074 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -98.71 -27.93 13.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.219 -0.925 . . . . 0.0 109.983 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.05 30.72 1.42 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.477 HD12 ' CD1' ' A' ' 41' ' ' PHE . 11.4 mt -121.63 119.24 29.28 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.12 -1.224 . . . . 0.0 109.904 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.26 173.13 10.97 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.459 1.242 . . . . 0.0 110.359 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.411 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 47.1 Cg_endo -70.05 -163.85 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.68 1.358 . . . . 0.0 110.224 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 48.49 39.91 23.11 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.7 m -142.26 115.56 6.45 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.176 -1.191 . . . . 0.0 110.446 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -74.18 153.29 46.05 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.474 1.25 . . . . 0.0 110.51 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.537 ' CD2' ' CE2' ' A' ' 8' ' ' TYR . 43.3 t80 -61.74 -28.15 69.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.34 -0.85 . . . . 0.0 110.236 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.6 m -67.96 -9.73 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -0.933 . . . . 0.0 110.875 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -110.13 0.25 18.21 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.96 -1.087 . . . . 0.0 110.989 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.487 HD11 ' CD1' ' A' ' 34' ' ' PHE . 28.2 mt -51.02 164.09 0.17 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.997 -1.064 . . . . 0.0 110.285 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.4 m -50.18 157.59 0.65 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.189 -0.944 . . . . 0.0 110.446 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.18 -15.48 46.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.0 110.398 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.2 51.74 1.58 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.071 -1.018 . . . . 0.0 110.43 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.477 ' CD1' HD12 ' A' ' 28' ' ' ILE . 32.1 t80 -68.96 142.84 54.58 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.213 -0.929 . . . . 0.0 110.022 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 7.7 mtt -120.11 150.67 40.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.327 -0.858 . . . . 0.0 109.57 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.43 ' HB3' ' N ' ' A' ' 47' ' ' ARG . 7.3 t -58.13 135.92 84.37 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.223 -0.923 . . . . 0.0 110.26 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.78 -2.89 12.86 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.596 1.314 . . . . 0.0 110.437 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -121.66 -50.42 2.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.91 -1.119 . . . . 0.0 110.918 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.445 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -105.38 5.54 31.84 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.03 -1.044 . . . . 0.0 111.304 -179.345 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.43 ' N ' ' HB3' ' A' ' 43' ' ' CYS . 12.3 ttm-85 56.92 20.48 5.34 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.061 -1.024 . . . . 0.0 112.272 178.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.418 ' CB ' ' SG ' ' A' ' 46' ' ' CYS . 2.8 t -70.41 155.95 92.64 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 120.798 -1.188 . . . . 0.0 109.676 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.91 142.56 43.15 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.588 1.31 . . . . 0.0 110.266 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.484 ' HE2' ' CE2' ' A' ' 34' ' ' PHE . 22.4 tttt -51.77 -25.27 7.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.157 -0.964 . . . . 0.0 110.329 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.5 t30 -68.2 -11.95 60.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.136 -0.977 . . . . 0.0 109.826 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.83 1.36 57.22 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.162 -0.961 . . . . 0.0 110.077 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.458 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 34.6 m-85 -90.78 129.09 36.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.018 -1.051 . . . . 0.0 110.628 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.93 134.31 49.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.368 -0.832 . . . . 0.0 109.603 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.497 ' HB3' ' CE2' ' A' ' 8' ' ' TYR . 86.4 p -64.25 -179.94 0.5 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.074 -1.016 . . . . 0.0 110.984 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.7 tt -160.12 91.96 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.787 -0.57 . . . . 0.0 110.267 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.2 74.88 1.48 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.029 -1.044 . . . . 0.0 110.44 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.9 142.32 28.11 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.272 -0.892 . . . . 0.0 110.196 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.2 p -146.41 135.92 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.228 -0.92 . . . . 0.0 110.175 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.8 tp -135.45 146.77 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 110.146 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 55.64 -164.06 0.14 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.159 -0.963 . . . . 0.0 110.25 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.8 92.6 2.22 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -141.09 -177.31 5.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.228 -1.16 . . . . 0.0 110.147 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -153.38 40.36 0.52 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.178 -0.951 . . . . 0.0 110.318 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.62 132.38 45.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.317 -0.865 . . . . 0.0 110.034 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -114.46 49.91 0.99 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.256 -0.903 . . . . 0.0 110.403 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -77.42 168.29 20.25 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.12 -0.987 . . . . 0.0 110.043 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.35 -70.43 0.67 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.246 -0.909 . . . . 0.0 110.192 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -87.85 101.02 13.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.3 -0.875 . . . . 0.0 110.345 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 179.945 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 ttm . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.231 0.538 . . . . 0.0 110.265 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.7 160.53 17.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.187 -0.946 . . . . 0.0 110.339 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.408 ' CG2' ' CB ' ' A' ' 7' ' ' LYS . 4.2 mp -136.91 167.56 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.3 -0.875 . . . . 0.0 110.23 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER 171.77 -26.57 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.225 -0.922 . . . . 0.0 110.88 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.02 64.01 0.33 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.176 -0.953 . . . . 0.0 111.032 -179.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 49.23 24.26 4.78 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.417 ' HG2' ' CG2' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -78.35 112.39 15.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.913 -1.345 . . . . 0.0 109.263 179.375 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.575 ' CE2' ' CD1' ' A' ' 34' ' ' PHE . 4.4 m-85 -95.47 133.93 38.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 110.555 -179.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -101.54 132.06 47.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.42 -0.8 . . . . 0.0 110.281 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.1 t -74.39 119.45 18.61 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.2 -0.938 . . . . 0.0 110.169 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.3 -11.69 60.34 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.087 -1.008 . . . . 0.0 109.654 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.414 ' HB1' ' NE2' ' A' ' 52' ' ' GLN . . . -85.07 -37.85 19.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.241 -0.912 . . . . 0.0 111.699 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.447 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 13.7 p -126.63 -34.56 2.42 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.717 -1.24 . . . . 0.0 111.645 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.74 22.4 5.39 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -84.41 159.2 20.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.373 -1.074 . . . . 0.0 109.762 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.467 HG22 HD11 ' A' ' 16' ' ' ILE . 39.4 mm -123.6 111.0 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 0.0 110.655 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.432 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 53.1 t80 -75.75 130.65 38.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.41 -0.806 . . . . 0.0 110.175 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -108.38 113.25 60.49 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.434 -0.791 . . . . 0.0 109.406 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.405 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 38.3 Cg_endo -71.95 -64.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.495 1.261 . . . . 0.0 110.963 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -45.35 -26.82 0.58 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.702 -0.624 . . . . 0.0 111.12 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -97.07 -30.36 13.09 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.04 -1.037 . . . . 0.0 110.236 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.66 153.51 23.63 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.409 ' O ' ' N ' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -85.12 61.9 7.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.39 -1.064 . . . . 0.0 109.795 179.657 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.71 -28.51 0.63 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.513 -0.742 . . . . 0.0 110.953 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.8 -24.76 44.37 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.226 -0.921 . . . . 0.0 110.42 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -97.69 -27.48 14.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.154 -0.966 . . . . 0.0 110.213 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 119.48 27.57 2.14 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.5 mt -120.13 126.07 27.01 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.097 -1.237 . . . . 0.0 109.975 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.3 173.28 12.55 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.54 1.284 . . . . 0.0 110.289 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.76 -163.73 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.683 1.36 . . . . 0.0 110.088 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 47.71 26.79 4.2 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 91.8 m -124.22 111.34 28.52 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.138 -1.213 . . . . 0.0 110.292 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.405 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 47.3 Cg_endo -73.11 148.99 45.51 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.492 1.259 . . . . 0.0 110.614 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.575 ' CD1' ' CE2' ' A' ' 8' ' ' TYR . 12.7 t80 -52.46 -30.88 32.03 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.308 -0.87 . . . . 0.0 110.506 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.6 m -65.27 -17.49 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.23 -0.919 . . . . 0.0 110.841 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -99.73 -0.01 40.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.072 -1.017 . . . . 0.0 110.887 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.475 HD13 ' CD2' ' A' ' 34' ' ' PHE . 15.5 mt -53.66 170.68 0.11 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.853 -1.155 . . . . 0.0 110.248 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.8 m -57.82 166.2 1.51 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.207 -0.933 . . . . 0.0 110.412 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.44 -22.28 66.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.301 -0.874 . . . . 0.0 110.245 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.7 m -139.0 53.05 1.76 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.267 -0.896 . . . . 0.0 110.075 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.446 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 11.3 t80 -65.3 141.16 58.7 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.365 -0.834 . . . . 0.0 110.184 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 8.9 mtt -114.33 147.97 38.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.354 -0.841 . . . . 0.0 109.348 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 23.9 t -60.48 138.36 92.45 Favored Pre-proline 0 C--N 1.3 -1.552 0 O-C-N 121.278 -0.889 . . . . 0.0 110.582 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -78.79 3.14 7.59 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.643 1.338 . . . . 0.0 110.661 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -124.57 -35.83 2.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.913 -1.117 . . . . 0.0 110.782 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.447 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 1.2 p -124.66 4.62 8.21 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.989 -1.069 . . . . 0.0 111.334 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.44 18.87 7.24 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.163 -0.961 . . . . 0.0 112.478 178.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.3 p -71.51 162.0 75.36 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 120.573 -1.329 . . . . 0.0 109.507 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.4 144.86 51.81 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.596 1.314 . . . . 0.0 110.625 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.484 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 3.8 tttm -51.48 -31.23 22.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.219 -0.925 . . . . 0.0 110.496 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -65.25 -13.11 57.56 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.05 -1.032 . . . . 0.0 109.783 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.414 ' NE2' ' HB1' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -84.79 -5.22 59.32 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.12 -0.988 . . . . 0.0 109.762 178.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.429 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 21.5 m-85 -84.25 152.78 23.98 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.255 -0.903 . . . . 0.0 109.582 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.7 ttpp -142.57 131.55 23.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.175 -0.953 . . . . 0.0 110.034 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.505 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 9.1 p -59.88 172.42 0.75 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.158 -0.964 . . . . 0.0 110.444 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.432 ' O ' ' CG2' ' A' ' 56' ' ' ILE . 2.6 tt -159.97 84.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-O 121.572 0.701 . . . . 0.0 109.898 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 4' ' ' ASP . 1.0 OUTLIER -110.0 68.01 0.66 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.234 -0.916 . . . . 0.0 110.285 -179.689 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.6 mttp -144.56 127.02 15.93 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.27 -0.894 . . . . 0.0 110.355 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.9 m -71.5 151.08 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.159 -0.963 . . . . 0.0 110.045 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.6 pt -130.62 58.15 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.194 -0.941 . . . . 0.0 110.393 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.24 -23.56 8.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.173 -0.954 . . . . 0.0 110.205 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 178.76 -108.12 0.24 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.418 ' CZ ' ' HG3' ' A' ' 65' ' ' GLU . 45.8 p90 -156.77 34.89 0.3 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.313 -1.11 . . . . 0.0 110.281 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 52.57 78.09 0.14 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.221 -0.924 . . . . 0.0 110.312 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.418 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 3.9 mt-10 -52.22 147.57 7.54 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.231 -0.918 . . . . 0.0 110.256 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -119.94 39.9 3.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.283 -0.886 . . . . 0.0 110.166 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -125.45 -168.1 1.79 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.175 -0.953 . . . . 0.0 110.283 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.42 102.51 12.16 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.312 -0.868 . . . . 0.0 110.294 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -167.13 81.64 0.22 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.244 -0.91 . . . . 0.0 110.156 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 CA-C-O 117.986 -1.452 . . . . 0.0 109.552 -179.868 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.189 0.518 . . . . 0.0 110.301 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 52.71 69.77 0.65 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.186 -0.946 . . . . 0.0 110.246 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.435 HG22 HD11 ' A' ' 3' ' ' ILE . 20.4 pt -134.18 136.61 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.23 -0.919 . . . . 0.0 110.314 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' A' ' 3' ' ' ILE . 9.4 p-10 179.92 112.44 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 121.815 0.817 . . . . 0.0 109.424 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -168.03 46.38 0.05 OUTLIER 'General case' 0 C--N 1.29 -1.983 0 CA-C-O 121.32 0.581 . . . . 0.0 109.953 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 65.38 16.21 62.43 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -84.61 144.64 28.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.123 -1.222 . . . . 0.0 109.828 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.509 ' CE2' ' HB2' ' A' ' 55' ' ' SER . 27.1 m-85 -130.31 143.66 50.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.029 -1.044 . . . . 0.0 110.473 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.441 ' CG ' HD12 ' A' ' 16' ' ' ILE . 2.8 tm-20 -111.78 134.54 53.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.383 -0.823 . . . . 0.0 109.8 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.2 t -77.61 113.64 15.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.227 -0.921 . . . . 0.0 110.446 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -70.44 -11.23 60.78 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.182 -0.949 . . . . 0.0 109.556 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.99 -40.42 16.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.894 . . . . 0.0 111.579 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.452 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 12.5 p -124.18 -32.07 3.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.728 -1.232 . . . . 0.0 111.553 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.13 22.03 6.38 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.516 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 56.7 t80 -83.18 169.02 16.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.282 -1.128 . . . . 0.0 109.871 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.516 ' N ' ' CD1' ' A' ' 15' ' ' TYR . 40.9 mm -134.06 115.32 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.058 -1.026 . . . . 0.0 110.68 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.504 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 69.5 t80 -78.88 136.8 37.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.335 -0.853 . . . . 0.0 109.898 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -117.75 112.61 38.59 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.482 -0.761 . . . . 0.0 109.801 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -69.82 -63.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.442 1.233 . . . . 0.0 110.558 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -47.46 -25.47 1.08 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.691 -0.631 . . . . 0.0 110.635 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.56 -42.24 7.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 0.0 110.675 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.55 153.31 29.59 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.425 ' CB ' ' HB ' ' A' ' 28' ' ' ILE . 0.9 OUTLIER -85.12 60.44 6.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.369 -1.077 . . . . 0.0 109.975 179.762 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.99 -25.81 0.88 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.443 -0.786 . . . . 0.0 110.948 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.83 -20.95 41.3 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.179 -0.951 . . . . 0.0 110.318 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -104.39 -29.82 10.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.119 -0.988 . . . . 0.0 110.295 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 124.52 34.07 0.73 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.425 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 4.6 mt -128.73 125.65 23.09 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.162 -1.199 . . . . 0.0 109.712 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.86 173.26 14.3 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.468 1.246 . . . . 0.0 110.575 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.66 -163.79 0.13 Allowed 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.77 1.405 . . . . 0.0 109.913 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 48.72 25.72 5.01 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.5 m -125.84 115.68 24.43 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.295 -1.121 . . . . 0.0 109.979 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -72.64 149.71 49.5 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.448 1.236 . . . . 0.0 110.894 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.504 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 60.4 t80 -54.97 -25.88 32.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.425 -0.797 . . . . 0.0 110.342 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.0 m -70.13 -24.23 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.11 -0.993 . . . . 0.0 110.304 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -87.5 -6.12 58.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.181 -0.949 . . . . 0.0 110.758 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.485 HD11 ' CD1' ' A' ' 34' ' ' PHE . 20.3 mt -52.19 160.54 0.76 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.043 -1.036 . . . . 0.0 110.282 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.87 150.78 19.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -0.897 . . . . 0.0 109.981 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -56.04 -25.39 44.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.254 -0.904 . . . . 0.0 110.313 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.34 38.34 4.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.122 -0.986 . . . . 0.0 110.709 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.452 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 36.4 t80 -59.34 133.45 56.1 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.043 -1.036 . . . . 0.0 109.793 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 13.8 mtp -109.98 155.79 21.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.367 -0.833 . . . . 0.0 109.5 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 30.6 t -71.78 131.8 85.62 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.15 -0.969 . . . . 0.0 110.213 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -75.41 -2.18 12.24 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.585 1.308 . . . . 0.0 110.513 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -112.91 -32.5 6.37 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.055 -1.028 . . . . 0.0 110.403 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.452 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 1.3 p -133.61 7.78 3.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.075 -1.016 . . . . 0.0 111.178 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 58.75 13.65 2.79 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.175 -0.953 . . . . 0.0 112.935 177.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.9 m -68.37 163.12 55.87 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 120.604 -1.31 . . . . 0.0 110.052 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.6 143.59 38.33 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.699 1.368 . . . . 0.0 110.431 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.488 ' HE2' ' CE2' ' A' ' 34' ' ' PHE . 9.8 tttm -49.97 -26.39 4.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.039 -1.038 . . . . 0.0 110.666 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -66.64 -12.07 56.49 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.124 -0.985 . . . . 0.0 110.006 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.27 -4.56 59.19 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.169 -0.957 . . . . 0.0 110.174 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.412 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 44.1 m-85 -84.25 144.44 28.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.945 -1.097 . . . . 0.0 110.44 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.0 ttmm -124.56 119.19 28.37 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.365 -0.834 . . . . 0.0 109.535 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.509 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 3.7 t -50.95 177.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.058 -1.026 . . . . 0.0 110.573 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.1 pt -141.98 58.05 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.653 -0.654 . . . . 0.0 110.012 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.8 tttt -93.74 61.68 3.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.348 -0.845 . . . . 0.0 109.905 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.08 115.22 29.72 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.325 -0.859 . . . . 0.0 110.611 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.8 m -135.72 153.49 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.332 -0.855 . . . . 0.0 110.011 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.5 mm -123.18 155.22 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.937 . . . . 0.0 110.079 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -147.59 81.92 1.52 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.18 -0.95 . . . . 0.0 110.169 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -131.94 51.02 0.87 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -86.0 105.88 16.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -1.15 . . . . 0.0 110.297 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -144.89 -167.82 2.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.372 -0.83 . . . . 0.0 110.024 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -132.47 -163.59 1.36 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.191 -0.943 . . . . 0.0 110.275 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -126.02 136.12 52.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.304 -0.873 . . . . 0.0 110.203 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -89.48 159.72 17.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.177 -0.952 . . . . 0.0 110.008 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.1 mttm 52.89 -170.33 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.141 -0.975 . . . . 0.0 110.038 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -138.42 146.79 42.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.922 . . . . 0.0 110.185 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 CA-C-O 117.981 -1.455 . . . . 0.0 109.556 179.946 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 ptt? . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.215 0.531 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 51.8 74.23 0.27 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.233 -0.917 . . . . 0.0 110.114 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.438 ' CD1' HG22 ' A' ' 56' ' ' ILE . 44.9 mt -123.32 171.87 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.245 -0.91 . . . . 0.0 110.077 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER 178.91 -22.2 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.1 -1.0 . . . . 0.0 111.937 -179.576 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -79.13 -141.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.764 -1.21 . . . . 0.0 110.26 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.45 31.63 5.67 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.426 ' HB3' HG22 ' A' ' 3' ' ' ILE . 6.1 tttp -80.39 124.87 29.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.02 -1.283 . . . . 0.0 109.28 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.529 ' CE2' ' CD2' ' A' ' 34' ' ' PHE . 11.5 m-85 -112.28 155.27 24.34 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.981 -1.074 . . . . 0.0 110.602 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -122.29 130.74 53.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.462 -0.774 . . . . 0.0 109.827 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 t -73.35 114.67 11.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.096 -1.002 . . . . 0.0 110.373 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.71 -12.68 61.71 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.371 -0.931 . . . . 0.0 109.36 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.407 ' N ' ' NE2' ' A' ' 52' ' ' GLN . . . -85.03 -41.01 16.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.343 -0.848 . . . . 0.0 111.758 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.422 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 11.4 p -123.53 -28.58 3.89 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.583 -1.323 . . . . 0.0 111.795 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.71 20.06 8.76 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.226 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -83.0 159.54 22.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.135 -1.215 . . . . 0.0 109.867 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.487 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 2.9 mp -121.82 120.36 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.91 . . . . 0.0 109.835 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.488 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 61.4 t80 -84.12 138.0 33.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.908 . . . . 0.0 110.376 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.97 110.62 45.88 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.738 -0.601 . . . . 0.0 109.911 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -72.89 -65.06 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.494 1.26 . . . . 0.0 111.088 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.426 ' O ' ' CB ' ' A' ' 30' ' ' PRO . 3.3 tt0 -45.48 -25.44 0.43 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.692 -0.63 . . . . 0.0 111.374 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.54 -41.84 7.57 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.094 -1.004 . . . . 0.0 110.65 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.26 145.96 19.75 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -85.09 63.23 7.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.335 -1.097 . . . . 0.0 109.676 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -43.64 -27.64 0.32 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.725 -0.61 . . . . 0.0 111.254 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -71.85 -29.1 64.04 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.154 -0.966 . . . . 0.0 109.924 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -96.82 -27.53 14.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.411 -0.805 . . . . 0.0 110.048 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.26 25.86 2.84 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.8 mt -114.6 120.27 38.08 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.074 -1.251 . . . . 0.0 110.001 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.409 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 45.4 Cg_endo -70.74 174.01 10.99 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.534 1.281 . . . . 0.0 110.509 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.426 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 47.6 Cg_endo -70.95 -163.28 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.715 1.376 . . . . 0.0 110.112 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 50.3 24.88 7.53 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 91.9 m -126.0 113.32 24.27 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.092 -1.24 . . . . 0.0 110.295 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.1 149.68 52.72 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 O-C-N 123.532 1.28 . . . . 0.0 110.619 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.529 ' CD2' ' CE2' ' A' ' 8' ' ' TYR . 27.3 t80 -52.38 -28.67 20.58 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.371 -0.831 . . . . 0.0 109.957 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.8 m -70.23 -15.41 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.285 -0.884 . . . . 0.0 110.557 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -98.32 -6.43 30.91 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.025 -1.047 . . . . 0.0 110.752 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.444 HD23 ' CE1' ' A' ' 17' ' ' TYR . 27.2 mt -51.25 162.28 0.34 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.956 -1.09 . . . . 0.0 110.461 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.3 m -50.31 154.8 1.14 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.347 -0.846 . . . . 0.0 110.508 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.19 -24.03 66.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.286 -0.884 . . . . 0.0 110.1 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.2 t -127.91 38.41 4.03 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.236 -0.915 . . . . 0.0 110.205 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.447 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 45.7 t80 -54.98 138.03 44.62 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.297 -0.877 . . . . 0.0 110.263 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.3 mmt -113.74 135.82 53.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.291 -0.881 . . . . 0.0 109.74 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 24.4 t -53.79 133.03 56.82 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.249 -0.907 . . . . 0.0 110.585 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -75.06 -3.69 14.29 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.447 1.235 . . . . 0.0 110.506 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -112.17 -35.65 5.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.033 -1.042 . . . . 0.0 110.559 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.422 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 1.5 p -128.57 6.51 5.69 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.087 -1.008 . . . . 0.0 111.01 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 54.46 20.07 2.63 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.209 -0.932 . . . . 0.0 112.714 178.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.0 m -74.27 165.68 51.33 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 120.617 -1.302 . . . . 0.0 109.658 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.51 136.06 30.11 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.638 1.336 . . . . 0.0 110.177 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.448 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 14.5 tttm -48.32 -26.01 1.83 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.2 -0.938 . . . . 0.0 110.697 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -63.69 -15.07 57.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.167 -0.958 . . . . 0.0 109.822 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.407 ' NE2' ' N ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -85.13 -2.97 58.62 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.255 -0.903 . . . . 0.0 110.136 179.381 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 34' ' ' PHE . 11.3 m-85 -82.75 133.16 35.15 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.95 -1.094 . . . . 0.0 110.478 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.91 120.33 38.12 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.197 -0.939 . . . . 0.0 109.527 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.499 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 3.0 t -52.0 -178.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.338 -0.851 . . . . 0.0 110.625 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.438 HG22 ' CD1' ' A' ' 3' ' ' ILE . 3.0 tt -158.26 91.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.531 -0.731 . . . . 0.0 109.691 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 4' ' ' ASP . 5.1 mttt -105.73 67.86 0.77 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.4 -0.813 . . . . 0.0 110.124 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -127.08 141.8 51.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.324 -0.86 . . . . 0.0 110.338 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 88.6 t -127.53 140.67 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 110.155 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.408 ' O ' ' CG2' ' A' ' 60' ' ' ILE . 2.1 tp -150.93 110.95 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.908 . . . . 0.0 110.151 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -142.28 66.16 1.34 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.19 -0.944 . . . . 0.0 110.147 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.74 93.57 0.74 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -125.01 28.17 6.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.137 -1.214 . . . . 0.0 110.18 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -106.08 -76.92 0.6 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.245 -0.909 . . . . 0.0 110.194 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -109.17 -75.27 0.63 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.93 . . . . 0.0 110.42 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -165.61 -59.15 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.19 -0.944 . . . . 0.0 110.277 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -75.22 137.61 41.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.224 -0.923 . . . . 0.0 110.24 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.13 -56.35 23.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.238 -0.914 . . . . 0.0 110.134 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -58.37 -173.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.294 -0.879 . . . . 0.0 110.19 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 CA-C-O 117.975 -1.458 . . . . 0.0 109.559 -179.879 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 mtt . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.226 0.536 . . . . 0.0 110.173 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.15 113.53 18.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.318 -0.864 . . . . 0.0 110.129 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.407 ' CD1' HD11 ' A' ' 56' ' ' ILE . 12.8 pt -147.36 122.13 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.153 -0.967 . . . . 0.0 110.613 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 39.5 t0 -159.54 13.3 0.14 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.391 -0.818 . . . . 0.0 111.36 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.16 68.81 4.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.048 -1.033 . . . . 0.0 110.575 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 50.46 28.13 13.82 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.409 ' O ' ' CG1' ' A' ' 56' ' ' ILE . 0.4 OUTLIER -84.25 130.17 34.83 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.143 -1.21 . . . . 0.0 109.951 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.493 ' CE2' ' HB2' ' A' ' 55' ' ' SER . 22.9 m-85 -117.0 149.1 40.8 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.148 -0.97 . . . . 0.0 110.381 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -119.16 130.06 55.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 0.0 110.323 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.6 t -73.62 114.72 12.2 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.274 -0.891 . . . . 0.0 110.25 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -70.4 -11.39 60.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.071 -1.018 . . . . 0.0 109.624 178.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.09 -42.29 14.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.397 -0.814 . . . . 0.0 111.579 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.448 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 13.8 p -121.88 -31.04 4.0 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.709 -1.245 . . . . 0.0 111.418 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.65 23.0 6.73 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -82.31 159.25 23.15 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.34 -1.094 . . . . 0.0 109.517 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.3 mm -123.77 115.77 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.205 -0.934 . . . . 0.0 110.041 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.532 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 81.1 t80 -81.44 135.81 35.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.3 -0.875 . . . . 0.0 110.321 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -114.94 114.33 43.92 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.529 -0.732 . . . . 0.0 109.603 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -69.44 -67.04 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.531 1.28 . . . . 0.0 111.559 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -43.04 -28.0 0.24 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.739 -0.601 . . . . 0.0 111.225 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.4 tptt -96.8 -27.13 14.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.159 -0.963 . . . . 0.0 110.271 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.62 159.58 30.52 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.448 ' OD2' ' CZ ' ' A' ' 41' ' ' PHE . 1.0 OUTLIER -85.05 59.86 5.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.339 -1.095 . . . . 0.0 109.81 179.799 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -46.51 -26.51 0.89 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.406 -0.809 . . . . 0.0 110.613 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -76.01 -28.01 57.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 110.061 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -97.71 -27.45 14.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.304 -0.872 . . . . 0.0 110.192 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.16 22.67 2.58 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.43 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 5.0 mt -112.18 130.01 23.72 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 120.975 -1.309 . . . . 0.0 109.595 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.404 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 49.1 Cg_endo -74.38 173.48 14.17 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.483 1.254 . . . . 0.0 110.393 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.404 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 49.9 Cg_endo -71.68 -163.54 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.65 1.342 . . . . 0.0 110.065 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 51.17 32.98 29.68 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.794 -1.323 . . . . 0.0 109.794 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 93.8 m -137.63 122.03 12.1 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.209 -1.171 . . . . 0.0 110.064 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.32 151.84 34.19 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.547 1.288 . . . . 0.0 110.697 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.532 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 20.7 t80 -52.26 -33.25 40.86 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.305 -0.872 . . . . 0.0 109.84 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.3 m -64.69 -15.11 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.921 . . . . 0.0 110.506 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.53 -18.29 33.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.15 -0.968 . . . . 0.0 110.559 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 71.0 mt -51.81 146.45 8.13 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.046 -1.034 . . . . 0.0 110.29 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.93 160.0 0.36 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.194 -0.942 . . . . 0.0 110.519 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -66.83 -13.88 62.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -0.897 . . . . 0.0 110.624 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.6 t -122.11 25.5 9.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.023 -1.048 . . . . 0.0 110.365 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.461 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 25.4 t80 -54.81 135.22 47.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.131 -0.981 . . . . 0.0 109.871 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -109.42 150.66 27.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.369 -0.832 . . . . 0.0 109.58 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 18.1 t -66.38 134.76 94.62 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.113 -0.992 . . . . 0.0 110.347 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.71 -7.85 18.82 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.667 1.351 . . . . 0.0 110.185 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -110.19 -31.92 7.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.172 -0.955 . . . . 0.0 110.844 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.448 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.8 OUTLIER -134.49 7.31 3.57 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.021 -1.049 . . . . 0.0 111.353 -179.681 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 58.49 14.56 3.07 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.098 -1.001 . . . . 0.0 112.837 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.5 m -65.45 165.93 16.32 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 120.619 -1.301 . . . . 0.0 110.087 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.99 141.34 26.56 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.666 1.35 . . . . 0.0 110.152 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 41' ' ' PHE . 8.6 tttm -51.87 -26.21 9.61 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.215 -0.928 . . . . 0.0 110.261 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -68.53 -11.17 59.52 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.185 -0.947 . . . . 0.0 109.89 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.88 -2.35 58.55 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.175 -0.953 . . . . 0.0 110.076 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 17.9 m-85 -86.25 140.01 30.51 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.999 -1.063 . . . . 0.0 110.226 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.61 124.89 46.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.2 -0.938 . . . . 0.0 109.801 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.493 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 3.0 t -57.28 178.34 0.07 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.237 -0.914 . . . . 0.0 110.809 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.426 ' CG2' ' O ' ' A' ' 55' ' ' SER . 1.1 pt -155.35 84.52 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.828 -0.545 . . . . 0.0 109.832 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 4' ' ' ASP . 0.2 OUTLIER -99.17 63.86 1.34 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.172 -0.955 . . . . 0.0 110.142 -179.882 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.55 138.86 32.63 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.298 -0.877 . . . . 0.0 110.092 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.6 m -148.9 135.52 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 110.249 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.7 mp -129.04 -43.71 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.242 -0.911 . . . . 0.0 110.288 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -144.61 123.38 12.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -0.898 . . . . 0.0 110.241 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -151.71 -114.61 0.62 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -97.49 -50.95 4.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -1.143 . . . . 0.0 110.2 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -129.09 109.52 11.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.178 -0.952 . . . . 0.0 110.259 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -72.64 -158.37 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.22 -0.925 . . . . 0.0 110.211 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -165.14 74.0 0.22 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 110.049 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -60.57 114.71 3.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.152 -0.968 . . . . 0.0 110.246 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.5 tptt -140.99 -45.17 0.39 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.894 . . . . 0.0 110.084 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -174.8 152.05 1.51 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.312 -0.867 . . . . 0.0 110.202 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 CA-C-O 117.959 -1.467 . . . . 0.0 109.513 -179.975 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.0 ttp . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.241 0.544 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -142.52 91.4 2.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.203 -0.936 . . . . 0.0 110.3 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.444 ' CD1' ' HB ' ' A' ' 56' ' ' ILE . 8.2 pt -140.85 134.14 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.265 -0.897 . . . . 0.0 109.754 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.469 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 0.7 OUTLIER 179.91 -30.26 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.205 -0.934 . . . . 0.0 110.96 -179.398 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -67.49 71.2 0.12 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.354 -0.841 . . . . 0.0 110.36 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 51.33 23.66 9.08 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.411 ' O ' ' CG1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -79.37 125.33 29.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.124 -1.221 . . . . 0.0 109.223 179.213 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.499 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 7.8 m-85 -115.77 156.42 26.04 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.075 -1.015 . . . . 0.0 110.566 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.403 ' HG2' ' CG2' ' A' ' 56' ' ' ILE . 2.5 pp20? -126.43 136.26 52.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.367 -0.833 . . . . 0.0 110.168 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.0 t -78.25 111.84 14.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.945 . . . . 0.0 110.242 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.69 -10.83 59.82 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.204 -0.998 . . . . 0.0 109.426 178.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.429 ' HB1' ' NE2' ' A' ' 52' ' ' GLN . . . -84.68 -43.01 14.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.352 -0.843 . . . . 0.0 111.383 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.443 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 12.7 p -120.5 -31.66 4.26 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.632 -1.292 . . . . 0.0 111.273 -179.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.6 21.5 6.8 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.684 -1.246 . . . . 0.0 110.132 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.525 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 52.2 t80 -83.18 167.38 17.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.109 -1.23 . . . . 0.0 109.907 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.525 ' N ' ' CD1' ' A' ' 15' ' ' TYR . 36.5 mm -131.11 117.67 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.137 -0.977 . . . . 0.0 110.334 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.505 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 72.7 t80 -81.04 135.31 35.82 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.436 -0.79 . . . . 0.0 110.422 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -112.38 113.7 50.98 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.612 -0.68 . . . . 0.0 109.761 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -72.26 -68.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.414 1.218 . . . . 0.0 111.144 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -45.16 -26.63 0.5 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.581 -0.699 . . . . 0.0 111.2 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.99 -37.57 11.07 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.079 -1.013 . . . . 0.0 110.49 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.63 152.09 28.84 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' A' ' 26' ' ' ALA . 4.2 t0 -85.11 62.9 7.8 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.4 -1.059 . . . . 0.0 109.674 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.43 -27.37 0.44 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.647 -0.658 . . . . 0.0 111.03 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -77.22 -27.86 53.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.184 -0.947 . . . . 0.0 110.206 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -95.85 -28.83 14.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.251 -0.906 . . . . 0.0 110.362 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.08 11.55 5.21 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.815 -1.183 . . . . 0.0 110.296 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.6 mt -103.08 124.61 37.84 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 120.938 -1.33 . . . . 0.0 110.012 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.412 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 45.3 Cg_endo -71.91 173.74 12.31 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.468 1.246 . . . . 0.0 110.222 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.412 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 48.6 Cg_endo -70.19 -163.77 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.613 1.323 . . . . 0.0 110.252 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 49.94 27.17 9.52 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.4 m -128.12 116.51 20.33 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.333 -1.098 . . . . 0.0 110.279 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -73.55 150.33 45.58 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.53 1.279 . . . . 0.0 110.617 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.505 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 12.7 t80 -53.49 -29.53 36.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.413 -0.804 . . . . 0.0 109.979 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.3 m -67.22 -13.2 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 110.608 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.6 -4.03 38.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.069 -1.02 . . . . 0.0 110.93 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.405 ' CB ' ' HD2' ' A' ' 50' ' ' LYS . 28.1 mt -53.13 165.61 0.31 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.872 -1.142 . . . . 0.0 110.14 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.0 m -59.36 162.48 4.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.889 . . . . 0.0 110.279 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.36 -27.42 69.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.311 -0.868 . . . . 0.0 110.2 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.65 46.31 2.5 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.263 -0.898 . . . . 0.0 110.042 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.436 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 23.9 t80 -62.58 140.2 58.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.334 -0.854 . . . . 0.0 110.159 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 36.5 mtt -112.61 151.08 30.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.358 -0.839 . . . . 0.0 109.468 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 29.4 t -65.69 135.46 95.6 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.178 -0.951 . . . . 0.0 110.268 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -75.87 -0.02 9.76 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.503 1.265 . . . . 0.0 110.594 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -119.39 -38.77 2.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.01 -1.056 . . . . 0.0 110.825 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.443 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 1.4 p -123.12 8.16 9.2 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.025 -1.047 . . . . 0.0 111.13 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 27.3 mtt85 54.5 18.84 2.12 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.332 -0.855 . . . . 0.0 112.79 178.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.5 m -72.52 166.3 43.43 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 120.577 -1.327 . . . . 0.0 109.732 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.98 139.9 33.84 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.668 1.352 . . . . 0.0 110.387 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.492 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 9.6 tttm -48.98 -26.33 2.46 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.162 -0.961 . . . . 0.0 110.822 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -63.65 -14.9 56.22 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.127 -0.983 . . . . 0.0 109.862 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.429 ' NE2' ' HB1' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -83.87 -4.2 58.49 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.157 -0.965 . . . . 0.0 110.151 179.277 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -86.23 131.81 34.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.977 -1.077 . . . . 0.0 110.348 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.99 131.74 56.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.272 -0.893 . . . . 0.0 109.544 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.499 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 79.7 p -60.82 176.86 0.36 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.156 -0.965 . . . . 0.0 110.893 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.444 ' HB ' ' CD1' ' A' ' 3' ' ' ILE . 9.9 pt -159.48 92.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-O 121.362 0.601 . . . . 0.0 109.699 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 4' ' ' ASP . 0.4 OUTLIER -114.27 70.96 0.74 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.357 -0.84 . . . . 0.0 110.296 -179.582 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.7 ttpt -128.23 75.46 1.62 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 110.197 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 66.8 t -83.34 120.41 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 110.262 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -157.63 69.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.31 -0.869 . . . . 0.0 110.242 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.01 170.1 13.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.92 . . . . 0.0 110.197 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 143.63 -23.26 2.17 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -75.93 179.21 5.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.253 -1.145 . . . . 0.0 110.292 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -128.4 155.49 44.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 110.157 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -92.63 148.19 22.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.229 -0.919 . . . . 0.0 110.166 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -102.58 -64.57 1.06 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.258 -0.901 . . . . 0.0 110.45 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -139.75 -51.36 0.51 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.213 -0.929 . . . . 0.0 110.418 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.88 147.94 8.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.166 -0.959 . . . . 0.0 110.273 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -57.88 96.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.309 -0.869 . . . . 0.0 110.24 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.995 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mtp . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.188 0.518 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.2 146.85 36.77 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.168 -0.957 . . . . 0.0 110.156 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.409 ' HB ' HD13 ' A' ' 56' ' ' ILE . 13.3 pt -146.58 131.47 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.32 -0.863 . . . . 0.0 110.091 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 6' ' ' GLY . 33.1 t0 -177.87 -25.73 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.32 -0.862 . . . . 0.0 111.442 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -64.87 75.8 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.002 -1.061 . . . . 0.0 110.287 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 4' ' ' ASP . . . 56.29 20.65 29.97 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.431 ' O ' ' CG1' ' A' ' 56' ' ' ILE . 4.3 mmtt -80.12 116.56 20.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.158 -1.201 . . . . 0.0 109.501 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.587 ' CE2' ' CD2' ' A' ' 34' ' ' PHE . 7.5 m-85 -112.26 145.11 40.55 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.156 -0.965 . . . . 0.0 110.625 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -115.12 135.74 53.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.404 -0.81 . . . . 0.0 109.995 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.9 t -75.24 113.46 12.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.23 -0.919 . . . . 0.0 110.573 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -11.28 60.79 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.449 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.442 ' N ' ' NE2' ' A' ' 52' ' ' GLN . . . -85.14 -40.26 16.94 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.312 -0.867 . . . . 0.0 111.484 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.441 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 12.6 p -123.95 -32.51 3.26 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.683 -1.26 . . . . 0.0 111.484 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.55 21.71 6.37 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -83.56 162.3 20.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -1.123 . . . . 0.0 109.74 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.429 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 2.1 mp -123.51 116.39 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 0.0 109.939 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.49 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 78.3 t80 -82.86 127.87 33.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.164 -0.96 . . . . 0.0 110.15 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -106.4 111.08 64.25 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.698 -0.626 . . . . 0.0 109.614 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -70.28 -63.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.525 1.276 . . . . 0.0 110.806 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -46.8 -26.05 0.88 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.73 -0.606 . . . . 0.0 110.558 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -95.29 -31.16 13.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -0.924 . . . . 0.0 110.041 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.69 153.59 21.68 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -85.19 60.85 6.5 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.395 -1.062 . . . . 0.0 109.431 179.473 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -46.84 -26.76 1.04 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.536 -0.727 . . . . 0.0 110.682 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -81.14 -22.49 38.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.175 -0.953 . . . . 0.0 110.207 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -100.08 -27.61 13.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.229 -0.919 . . . . 0.0 110.012 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.51 28.98 1.36 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.4 mt -125.14 123.58 25.34 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.013 -1.286 . . . . 0.0 109.707 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.409 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 44.0 Cg_endo -70.0 173.47 11.14 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.525 1.276 . . . . 0.0 110.238 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 47.2 Cg_endo -69.99 -163.72 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.674 1.355 . . . . 0.0 110.233 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 49.04 26.0 5.7 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.6 m -125.34 121.11 24.97 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.272 -1.134 . . . . 0.0 110.257 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -76.41 158.16 36.69 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.477 1.251 . . . . 0.0 110.651 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.587 ' CD2' ' CE2' ' A' ' 8' ' ' TYR . 13.6 t80 -61.04 -34.18 74.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.349 -0.844 . . . . 0.0 109.945 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.8 m -65.51 -12.93 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.908 . . . . 0.0 110.529 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.57 -9.17 36.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.025 -1.047 . . . . 0.0 110.817 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 49.8 mt -53.85 156.07 3.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.0 -1.063 . . . . 0.0 110.185 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.9 t -52.56 147.78 7.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.168 -0.958 . . . . 0.0 110.255 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.64 -23.14 10.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 110.214 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 72.3 p -123.71 47.5 2.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.908 . . . . 0.0 110.487 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.464 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 27.7 t80 -70.56 145.63 50.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.164 -0.96 . . . . 0.0 109.835 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 28.3 mtm -121.11 138.02 54.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.293 -0.88 . . . . 0.0 109.994 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 27.5 t -54.68 133.81 64.8 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.368 -0.832 . . . . 0.0 110.235 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -76.33 -0.68 10.64 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.485 1.255 . . . . 0.0 110.627 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.72 -42.56 3.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.98 -1.075 . . . . 0.0 110.473 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.441 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 1.7 p -119.75 5.63 10.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.106 -0.996 . . . . 0.0 111.121 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 54.57 24.82 5.7 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.256 -0.902 . . . . 0.0 112.64 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.8 m -79.29 166.02 44.56 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 120.578 -1.327 . . . . 0.0 109.599 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.37 140.89 41.4 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.567 1.299 . . . . 0.0 110.75 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.476 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 23.8 tttt -50.58 -24.66 3.4 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.21 -0.931 . . . . 0.0 110.55 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -66.01 -13.41 59.83 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.08 -1.013 . . . . 0.0 109.933 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.442 ' NE2' ' N ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -85.05 -4.34 59.12 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.203 -0.936 . . . . 0.0 110.006 179.347 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -85.5 137.31 32.98 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.956 -1.09 . . . . 0.0 110.526 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.8 tttm -123.48 133.51 54.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.625 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.513 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 68.6 p -62.11 175.56 0.69 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.177 -0.952 . . . . 0.0 110.888 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.448 ' CG2' ' O ' ' A' ' 55' ' ' SER . 7.4 pt -159.42 90.81 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 CA-C-O 121.334 0.588 . . . . 0.0 110.079 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.428 ' HA ' ' CB ' ' A' ' 4' ' ' ASP . 0.0 OUTLIER -101.64 65.49 1.03 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.935 -1.103 . . . . 0.0 109.837 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.81 147.56 40.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.392 -0.818 . . . . 0.0 110.211 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 86.5 t -116.18 81.01 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.273 -0.892 . . . . 0.0 110.171 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 51.4 mm -85.05 73.33 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.328 -0.857 . . . . 0.0 110.284 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.86 83.4 6.6 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.126 -0.984 . . . . 0.0 110.246 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -139.58 36.0 1.89 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.6 t80 52.23 54.29 11.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.284 -1.127 . . . . 0.0 110.335 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.03 65.32 8.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.321 -0.862 . . . . 0.0 110.084 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.16 158.83 15.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.302 -0.873 . . . . 0.0 110.487 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -80.95 95.47 6.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.415 -0.803 . . . . 0.0 110.102 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -120.57 -175.81 3.1 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.206 -0.934 . . . . 0.0 110.277 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.3 mmtt -82.32 75.33 9.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.281 -0.887 . . . . 0.0 109.989 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -64.86 97.98 0.25 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.217 -0.927 . . . . 0.0 110.175 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.339 0 CA-C-O 118.026 -1.43 . . . . 0.0 109.572 179.948 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.7 mtp . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.285 0.564 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -131.8 80.83 1.94 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.301 -0.874 . . . . 0.0 110.018 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.408 ' O ' ' HB3' ' A' ' 4' ' ' ASP . 22.1 pt -151.43 144.49 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.27 -0.894 . . . . 0.0 110.452 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' A' ' 3' ' ' ILE . 8.1 p-10 178.83 112.75 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 121.756 0.788 . . . . 0.0 109.41 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -171.95 54.22 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.316 0.579 . . . . 0.0 110.023 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 63.39 17.7 59.98 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.405 ' O ' ' CG1' ' A' ' 56' ' ' ILE . 20.1 mttt -84.26 119.91 25.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.137 -1.213 . . . . 0.0 109.676 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.501 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 9.1 m-85 -112.26 150.09 31.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.115 -0.991 . . . . 0.0 110.432 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.408 ' HA ' HD12 ' A' ' 16' ' ' ILE . 43.7 tt0 -120.35 138.49 53.7 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.337 -0.852 . . . . 0.0 110.564 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.1 t -77.23 111.06 12.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.321 -0.862 . . . . 0.0 110.3 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -68.02 -11.23 58.53 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.36 -0.936 . . . . 0.0 109.568 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.36 -42.06 16.11 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.296 -0.878 . . . . 0.0 111.52 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.438 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 14.5 p -121.86 -34.75 3.31 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.707 -1.246 . . . . 0.0 111.498 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.06 22.08 5.06 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.442 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 29.5 t80 -84.27 158.82 21.1 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.308 -1.113 . . . . 0.0 109.804 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.442 ' N ' ' CD1' ' A' ' 15' ' ' TYR . 29.3 mm -122.5 120.04 59.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.318 -0.864 . . . . 0.0 110.267 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.502 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 80.6 t80 -83.25 130.03 35.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.909 . . . . 0.0 109.97 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -109.95 114.76 55.95 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.583 -0.698 . . . . 0.0 109.484 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.95 -68.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.529 1.279 . . . . 0.0 111.225 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -46.27 -25.48 0.63 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.476 -0.765 . . . . 0.0 111.175 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.66 -39.22 11.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.113 -0.992 . . . . 0.0 110.882 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.41 145.68 15.56 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -85.09 61.54 6.94 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.345 -1.091 . . . . 0.0 109.937 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.94 -25.92 1.54 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.397 -0.814 . . . . 0.0 110.461 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -75.49 -21.66 57.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.907 . . . . 0.0 110.092 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -105.56 -34.4 7.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.288 -0.883 . . . . 0.0 109.887 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 131.18 34.11 0.43 Allowed Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.892 -1.147 . . . . 0.0 110.361 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.2 mt -129.85 121.65 20.05 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 120.807 -1.408 . . . . 0.0 109.988 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.404 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 45.0 Cg_endo -70.13 173.93 10.58 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 O-C-N 123.613 1.323 . . . . 0.0 110.265 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.404 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 45.4 Cg_endo -68.59 -163.78 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.616 1.324 . . . . 0.0 110.176 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 47.76 27.79 4.91 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.4 m -125.75 113.9 24.81 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.218 -1.166 . . . . 0.0 110.344 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.31 146.92 41.02 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 123.472 1.248 . . . . 0.0 110.738 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.502 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 22.7 t80 -51.41 -34.02 32.94 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.433 -0.792 . . . . 0.0 110.561 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.0 m -65.75 -14.04 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.202 -0.936 . . . . 0.0 110.723 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -98.32 -1.61 41.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.998 -1.063 . . . . 0.0 110.996 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.458 HD23 ' CE1' ' A' ' 17' ' ' TYR . 26.0 mt -54.38 176.37 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.903 -1.123 . . . . 0.0 110.17 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.9 m -69.36 152.98 44.3 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.235 -0.916 . . . . 0.0 110.123 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.65 -23.28 40.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.161 -0.962 . . . . 0.0 110.216 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.4 m -129.28 43.52 3.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.167 -0.958 . . . . 0.0 110.27 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.46 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 20.0 t80 -62.89 132.65 52.83 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.377 -0.827 . . . . 0.0 109.85 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 7.0 mtt -111.33 148.19 33.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.376 -0.827 . . . . 0.0 109.668 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.428 ' HB3' ' N ' ' A' ' 47' ' ' ARG . 10.0 t -57.99 135.23 83.83 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.897 . . . . 0.0 110.422 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -76.12 -0.34 10.21 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 123.628 1.331 . . . . 0.0 110.578 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -122.88 -38.97 2.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.943 -1.098 . . . . 0.0 110.859 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.438 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -121.24 8.03 10.27 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.038 -1.039 . . . . 0.0 111.202 -179.62 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.428 ' N ' ' HB3' ' A' ' 43' ' ' CYS . 2.5 ttt180 58.37 13.84 2.62 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.183 -0.948 . . . . 0.0 112.786 178.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 m -63.63 156.81 69.9 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 120.594 -1.316 . . . . 0.0 109.714 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.77 146.54 43.07 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.665 1.35 . . . . 0.0 110.183 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.46 ' HB2' ' HB3' ' A' ' 41' ' ' PHE . 19.5 tttm -53.74 -27.19 26.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.022 -1.049 . . . . 0.0 110.235 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -67.98 -11.29 58.57 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.176 -0.952 . . . . 0.0 109.827 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.65 -2.67 58.72 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.21 -0.931 . . . . 0.0 110.016 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -89.9 126.06 35.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.012 -1.055 . . . . 0.0 110.348 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.2 tptt -108.8 134.13 51.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.209 -0.932 . . . . 0.0 109.739 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.501 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 80.0 p -63.72 179.46 0.49 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.121 -0.987 . . . . 0.0 110.761 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.405 ' CG1' ' O ' ' A' ' 7' ' ' LYS . 1.1 pt -151.48 76.49 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-O 121.271 0.557 . . . . 0.0 110.157 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -100.01 62.73 1.15 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.306 -0.871 . . . . 0.0 110.144 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.5 mttp -82.2 123.28 28.87 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.276 -0.89 . . . . 0.0 110.372 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 40.0 t -140.81 121.1 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.247 -0.908 . . . . 0.0 110.262 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -145.43 139.0 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.215 -0.928 . . . . 0.0 110.318 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.41 90.87 0.25 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.282 -0.886 . . . . 0.0 110.005 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -110.73 -62.94 0.5 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.25 151.15 28.14 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.302 -1.117 . . . . 0.0 110.317 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -173.47 142.16 0.95 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.319 -0.863 . . . . 0.0 110.22 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -134.72 129.72 35.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.223 -0.923 . . . . 0.0 110.223 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -147.91 48.86 1.07 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.314 -0.866 . . . . 0.0 110.04 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -152.69 40.5 0.58 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.282 -0.886 . . . . 0.0 110.064 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.88 -42.58 99.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.352 -0.842 . . . . 0.0 110.335 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -80.81 135.25 35.92 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.217 -0.927 . . . . 0.0 110.225 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.991 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtt . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.252 0.549 . . . . 0.0 110.126 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -115.31 77.5 1.08 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -0.905 . . . . 0.0 110.375 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.427 ' O ' ' HB3' ' A' ' 4' ' ' ASP . 45.0 mt -135.31 166.31 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.214 -0.929 . . . . 0.0 109.951 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.427 ' HB3' ' O ' ' A' ' 3' ' ' ILE . 8.2 p-10 176.54 113.26 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.718 0.77 . . . . 0.0 109.825 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -159.46 -148.89 0.19 Allowed 'General case' 0 C--N 1.291 -1.962 0 O-C-N 121.795 -0.566 . . . . 0.0 109.669 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.407 ' O ' ' HG3' ' A' ' 19' ' ' PRO . . . -97.68 19.23 55.45 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.416 ' CB ' HG12 ' A' ' 56' ' ' ILE . 29.2 mttt -82.47 136.73 34.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.071 -1.252 . . . . 0.0 109.656 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.506 ' CE2' ' CD2' ' A' ' 34' ' ' PHE . 13.4 m-85 -122.7 148.04 45.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.037 -1.039 . . . . 0.0 110.628 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.421 ' CG ' HD12 ' A' ' 16' ' ' ILE . 5.1 tm-20 -120.02 128.08 53.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.414 -0.804 . . . . 0.0 109.906 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.4 t -65.31 110.07 2.48 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.161 -0.962 . . . . 0.0 110.059 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.91 -11.92 57.77 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.206 -0.934 . . . . 0.0 109.612 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.01 -40.46 16.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.327 -0.858 . . . . 0.0 111.782 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 11.7 p -123.95 -32.71 3.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.647 -1.283 . . . . 0.0 111.523 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.09 18.9 6.57 Favored Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.713 -1.232 . . . . 0.0 110.256 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.529 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 42.7 t80 -76.28 167.98 20.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -1.175 . . . . 0.0 109.516 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.529 ' N ' ' CD1' ' A' ' 15' ' ' TYR . 35.1 mm -130.82 120.26 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 110.424 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.48 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 51.5 t80 -89.36 142.5 27.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.325 -0.86 . . . . 0.0 109.966 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -123.69 112.49 29.11 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.544 -0.723 . . . . 0.0 109.829 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.437 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 40.4 Cg_endo -72.2 -67.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.516 1.272 . . . . 0.0 111.284 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -44.22 -28.0 0.47 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.794 -0.566 . . . . 0.0 110.922 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.7 mttp -96.15 -40.06 9.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 0.0 110.24 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.29 147.85 22.53 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 26' ' ' ALA . 2.8 t0 -84.94 61.11 6.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.465 -1.021 . . . . 0.0 109.65 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -45.49 -27.08 0.67 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.444 -0.785 . . . . 0.0 110.955 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -74.69 -27.43 60.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.115 -0.99 . . . . 0.0 109.975 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -98.48 -22.83 15.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.346 -0.846 . . . . 0.0 109.9 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.12 23.23 3.94 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.4 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 9.2 mt -115.26 114.57 43.07 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.117 -1.225 . . . . 0.0 109.907 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.91 173.9 9.54 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 O-C-N 123.597 1.314 . . . . 0.0 110.294 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -67.89 -164.43 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.57 1.3 . . . . 0.0 110.024 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 48.19 34.02 11.83 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 m -134.48 109.35 11.24 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.121 -1.223 . . . . 0.0 110.52 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.437 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 44.6 Cg_endo -71.8 148.72 52.81 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.455 1.24 . . . . 0.0 110.344 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.506 ' CD2' ' CE2' ' A' ' 8' ' ' TYR . 38.8 t80 -52.92 -24.23 8.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.204 -0.935 . . . . 0.0 109.861 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.433 ' CG2' ' HB2' ' A' ' 33' ' ' PRO . 32.1 m -72.27 -17.49 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.169 -0.957 . . . . 0.0 110.201 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.68 0.6 47.4 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.183 -0.948 . . . . 0.0 110.708 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.473 HD11 ' CD1' ' A' ' 34' ' ' PHE . 21.8 mt -52.23 167.33 0.13 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.947 -1.095 . . . . 0.0 110.182 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.3 m -56.53 173.31 0.19 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 110.257 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.05 -27.62 65.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.33 -0.856 . . . . 0.0 110.211 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 65.9 p -134.13 45.79 2.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 110.345 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.466 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 27.2 t80 -54.26 130.97 40.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.932 . . . . 0.0 109.932 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -108.34 150.01 27.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.427 -0.796 . . . . 0.0 109.43 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.429 ' HB3' ' N ' ' A' ' 47' ' ' ARG . 12.8 t -63.55 135.82 96.43 Favored Pre-proline 0 C--N 1.3 -1.551 0 O-C-N 121.16 -0.963 . . . . 0.0 110.539 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.76 -1.52 11.47 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.589 1.31 . . . . 0.0 110.382 178.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -118.72 -41.57 2.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.052 -1.03 . . . . 0.0 110.867 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -119.81 2.91 11.11 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.121 -0.987 . . . . 0.0 111.141 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.429 ' N ' ' HB3' ' A' ' 43' ' ' CYS . 1.1 ttt-85 58.28 23.36 10.31 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.146 -0.971 . . . . 0.0 112.515 178.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.3 m -75.01 164.94 58.01 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 120.566 -1.333 . . . . 0.0 109.676 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.06 138.98 29.07 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.632 1.333 . . . . 0.0 110.434 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.482 ' HA ' ' CD1' ' A' ' 53' ' ' PHE . 15.9 tttm -48.93 -29.18 4.46 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.271 -0.893 . . . . 0.0 110.821 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -63.09 -14.54 49.66 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.113 -0.992 . . . . 0.0 109.967 179.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.21 -1.39 57.87 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.086 -1.009 . . . . 0.0 110.169 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.482 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 32.6 m-85 -88.17 127.84 35.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.906 -1.121 . . . . 0.0 110.425 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.18 128.11 55.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 109.587 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 89.0 p -54.14 -174.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 110.814 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.416 HG12 ' CB ' ' A' ' 7' ' ' LYS . 1.3 pp -132.38 78.38 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.679 -0.638 . . . . 0.0 109.875 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.54 70.86 0.74 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.458 -0.776 . . . . 0.0 110.041 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -106.37 122.03 45.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.322 -0.862 . . . . 0.0 110.338 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.419 ' N ' HD13 ' A' ' 60' ' ' ILE . 85.3 t -131.88 97.62 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.326 -0.859 . . . . 0.0 109.952 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.451 ' CD1' ' N ' ' A' ' 60' ' ' ILE . 4.9 mp -129.46 97.69 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.208 -0.933 . . . . 0.0 110.385 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 50.47 -149.41 0.28 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.331 -0.856 . . . . 0.0 110.504 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.2 -53.23 1.36 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 51.99 91.08 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -1.13 . . . . 0.0 110.285 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -97.59 -166.21 1.36 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.192 -0.942 . . . . 0.0 110.105 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -114.28 121.97 45.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.192 -0.942 . . . . 0.0 110.313 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -139.11 83.62 1.96 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 110.104 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 53.84 60.23 3.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.219 -0.926 . . . . 0.0 110.009 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.8 ttpt -113.55 -48.95 2.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.373 -0.829 . . . . 0.0 110.237 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -81.05 -40.85 23.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.228 -0.92 . . . . 0.0 110.246 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.943 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtt . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.252 0.549 . . . . 0.0 110.126 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -115.31 77.5 1.08 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -0.905 . . . . 0.0 110.375 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.427 ' O ' ' HB3' ' A' ' 4' ' ' ASP . 45.0 mt -135.31 166.31 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.214 -0.929 . . . . 0.0 109.951 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.427 ' HB3' ' O ' ' A' ' 3' ' ' ILE . 8.2 p-10 176.54 113.26 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.718 0.77 . . . . 0.0 109.825 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -159.46 -148.89 0.19 Allowed 'General case' 0 C--N 1.291 -1.962 0 O-C-N 121.795 -0.566 . . . . 0.0 109.669 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.407 ' O ' ' HG3' ' A' ' 19' ' ' PRO . . . -97.68 19.23 55.45 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.416 ' CB ' HG12 ' A' ' 56' ' ' ILE . 29.2 mttt -82.47 136.73 34.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.071 -1.252 . . . . 0.0 109.656 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.506 ' CE2' ' CD2' ' A' ' 34' ' ' PHE . 13.4 m-85 -122.7 148.04 45.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.037 -1.039 . . . . 0.0 110.628 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.421 ' CG ' HD12 ' A' ' 16' ' ' ILE . 5.1 tm-20 -120.02 128.08 53.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.414 -0.804 . . . . 0.0 109.906 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.4 t -65.31 110.07 2.48 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.161 -0.962 . . . . 0.0 110.059 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.91 -11.92 57.77 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.206 -0.934 . . . . 0.0 109.612 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.01 -40.46 16.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.327 -0.858 . . . . 0.0 111.782 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 11.7 p -123.95 -32.71 3.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.647 -1.283 . . . . 0.0 111.523 -179.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.09 18.9 6.57 Favored Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.713 -1.232 . . . . 0.0 110.256 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.529 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 42.7 t80 -76.28 167.98 20.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -1.175 . . . . 0.0 109.516 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.529 ' N ' ' CD1' ' A' ' 15' ' ' TYR . 35.1 mm -130.82 120.26 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 110.424 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.48 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 51.5 t80 -89.36 142.5 27.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.325 -0.86 . . . . 0.0 109.966 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -123.69 112.49 29.11 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.544 -0.723 . . . . 0.0 109.829 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.437 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 40.4 Cg_endo -72.2 -67.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.516 1.272 . . . . 0.0 111.284 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -44.22 -28.0 0.47 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.794 -0.566 . . . . 0.0 110.922 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.7 mttp -96.15 -40.06 9.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 0.0 110.24 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.29 147.85 22.53 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 26' ' ' ALA . 2.8 t0 -84.94 61.11 6.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.465 -1.021 . . . . 0.0 109.65 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -45.49 -27.08 0.67 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.444 -0.785 . . . . 0.0 110.955 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -74.69 -27.43 60.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.115 -0.99 . . . . 0.0 109.975 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 23' ' ' ASP . . . -98.48 -22.83 15.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.346 -0.846 . . . . 0.0 109.9 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.12 23.23 3.94 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.4 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 9.2 mt -115.26 114.57 43.07 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.117 -1.225 . . . . 0.0 109.907 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.91 173.9 9.54 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 O-C-N 123.597 1.314 . . . . 0.0 110.294 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -67.89 -164.43 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.57 1.3 . . . . 0.0 110.024 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 48.19 34.02 11.83 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 m -134.48 109.35 11.24 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.121 -1.223 . . . . 0.0 110.52 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.437 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 44.6 Cg_endo -71.8 148.72 52.81 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.455 1.24 . . . . 0.0 110.344 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.506 ' CD2' ' CE2' ' A' ' 8' ' ' TYR . 38.8 t80 -52.92 -24.23 8.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.204 -0.935 . . . . 0.0 109.861 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.433 ' CG2' ' HB2' ' A' ' 33' ' ' PRO . 32.1 m -72.27 -17.49 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.169 -0.957 . . . . 0.0 110.201 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.68 0.6 47.4 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.183 -0.948 . . . . 0.0 110.708 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.473 HD11 ' CD1' ' A' ' 34' ' ' PHE . 21.8 mt -52.23 167.33 0.13 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.947 -1.095 . . . . 0.0 110.182 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.3 m -56.53 173.31 0.19 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 110.257 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.05 -27.62 65.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.33 -0.856 . . . . 0.0 110.211 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 65.9 p -134.13 45.79 2.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 110.345 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.466 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 27.2 t80 -54.26 130.97 40.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.932 . . . . 0.0 109.932 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -108.34 150.01 27.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.427 -0.796 . . . . 0.0 109.43 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.429 ' HB3' ' N ' ' A' ' 47' ' ' ARG . 12.8 t -63.55 135.82 96.43 Favored Pre-proline 0 C--N 1.3 -1.551 0 O-C-N 121.16 -0.963 . . . . 0.0 110.539 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.76 -1.52 11.47 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.589 1.31 . . . . 0.0 110.382 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -118.72 -41.57 2.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.052 -1.03 . . . . 0.0 110.867 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -119.81 2.91 11.11 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.121 -0.987 . . . . 0.0 111.141 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.429 ' N ' ' HB3' ' A' ' 43' ' ' CYS . 1.1 ttt-85 58.28 23.36 10.31 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.146 -0.971 . . . . 0.0 112.515 178.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.3 m -75.01 164.94 58.01 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 120.566 -1.333 . . . . 0.0 109.676 179.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.06 138.98 29.07 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.632 1.333 . . . . 0.0 110.434 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.482 ' HA ' ' CD1' ' A' ' 53' ' ' PHE . 15.9 tttm -48.93 -29.18 4.46 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.271 -0.893 . . . . 0.0 110.821 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -63.09 -14.54 49.66 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.113 -0.992 . . . . 0.0 109.967 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.21 -1.39 57.87 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.086 -1.009 . . . . 0.0 110.169 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.482 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 32.6 m-85 -88.17 127.84 35.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.906 -1.121 . . . . 0.0 110.425 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.18 128.11 55.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 109.587 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 89.0 p -54.14 -174.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 110.814 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.416 HG12 ' CB ' ' A' ' 7' ' ' LYS . 1.3 pp -132.38 78.38 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.679 -0.638 . . . . 0.0 109.875 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.54 70.86 0.74 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.458 -0.776 . . . . 0.0 110.041 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -106.37 122.03 45.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.322 -0.862 . . . . 0.0 110.338 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.419 ' N ' HD13 ' A' ' 60' ' ' ILE . 85.3 t -131.88 97.62 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.326 -0.859 . . . . 0.0 109.952 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.451 ' CD1' ' N ' ' A' ' 60' ' ' ILE . 4.9 mp -129.46 97.69 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.208 -0.933 . . . . 0.0 110.385 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 50.47 -149.41 0.28 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.331 -0.856 . . . . 0.0 110.504 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.2 -53.23 1.36 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 51.99 91.08 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -1.13 . . . . 0.0 110.285 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -97.59 -166.21 1.36 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.192 -0.942 . . . . 0.0 110.105 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -114.28 121.97 45.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.192 -0.942 . . . . 0.0 110.313 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -139.11 83.62 1.96 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 110.104 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 53.84 60.23 3.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.219 -0.926 . . . . 0.0 110.009 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.8 ttpt -113.55 -48.95 2.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.373 -0.829 . . . . 0.0 110.237 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -81.05 -40.85 23.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.228 -0.92 . . . . 0.0 110.246 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.943 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.271 0.558 . . . . 0.0 110.253 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 52.64 65.02 1.64 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.228 -0.92 . . . . 0.0 110.197 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.406 ' O ' ' HB3' ' A' ' 4' ' ' ASP . 27.7 pt -142.05 156.42 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.155 -0.965 . . . . 0.0 110.469 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' A' ' 3' ' ' ILE . 6.0 p-10 179.22 112.19 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.831 0.824 . . . . 0.0 109.535 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -167.6 29.52 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.942 0 O-C-N 121.761 -0.587 . . . . 0.0 110.07 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.15 22.05 77.02 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.4 mtpt -84.85 130.1 34.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.171 -1.194 . . . . 0.0 109.599 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.53 ' CE2' ' CB ' ' A' ' 55' ' ' SER . 30.2 m-85 -115.78 139.26 50.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.034 -1.041 . . . . 0.0 110.789 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -105.56 132.83 51.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.309 -0.87 . . . . 0.0 110.241 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.7 t -75.56 110.33 9.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 0.0 110.121 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.71 -11.92 56.37 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.203 -0.936 . . . . 0.0 109.866 178.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.03 -41.19 16.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -0.92 . . . . 0.0 111.717 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.453 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 13.8 p -122.85 -34.47 3.19 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.604 -1.31 . . . . 0.0 111.454 -179.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.76 21.72 5.29 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 24.5 t80 -84.57 158.19 20.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.365 -1.079 . . . . 0.0 109.706 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.477 ' N ' ' CD1' ' A' ' 16' ' ' ILE . 3.2 mp -123.97 120.17 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.216 -0.928 . . . . 0.0 110.15 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.503 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 66.5 t80 -83.05 137.56 34.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.312 -0.868 . . . . 0.0 110.025 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -116.28 110.87 42.72 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.592 -0.693 . . . . 0.0 109.411 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.42 -71.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.507 1.267 . . . . 0.0 111.151 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.414 ' O ' ' CB ' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -47.4 -24.73 0.85 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.335 -0.853 . . . . 0.0 111.04 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.52 -39.27 10.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.973 -1.079 . . . . 0.0 110.48 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.16 137.93 9.29 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -85.07 63.73 8.28 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.392 -1.064 . . . . 0.0 109.679 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.96 -28.35 0.25 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.778 -0.576 . . . . 0.0 111.117 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -67.17 -33.62 75.8 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.202 -0.936 . . . . 0.0 109.795 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.94 -25.53 15.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.303 -0.873 . . . . 0.0 110.09 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.16 25.31 3.28 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.7 mt -112.15 118.74 45.48 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.071 -1.252 . . . . 0.0 110.079 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.419 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 45.4 Cg_endo -71.95 174.49 11.16 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 O-C-N 123.541 1.285 . . . . 0.0 110.219 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 46.8 Cg_endo -69.27 -164.72 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.582 1.306 . . . . 0.0 109.933 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 47.73 26.19 3.88 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 47.9 m -127.45 111.4 21.07 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.136 -1.214 . . . . 0.0 110.038 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.426 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . 45.0 Cg_endo -71.76 147.56 50.76 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.604 1.318 . . . . 0.0 110.77 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.503 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 47.3 t80 -54.42 -25.74 26.59 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.542 -0.723 . . . . 0.0 110.275 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.426 ' CG2' ' HB2' ' A' ' 33' ' ' PRO . 34.2 m -71.06 -13.59 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.272 -0.893 . . . . 0.0 110.647 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.56 -4.5 41.17 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.091 -1.005 . . . . 0.0 110.891 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.479 HD13 ' CD2' ' A' ' 34' ' ' PHE . 51.3 mt -51.0 164.53 0.15 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.91 -1.119 . . . . 0.0 110.428 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.03 173.31 1.44 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.324 -0.86 . . . . 0.0 110.244 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -74.17 -19.33 60.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.367 -0.833 . . . . 0.0 110.293 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.9 m -128.79 36.05 4.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.0 110.534 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.474 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 31.5 t80 -56.18 123.3 14.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.144 -0.973 . . . . 0.0 109.464 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 7.3 mtt -106.72 142.4 36.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 0.0 109.682 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.43 ' HB3' ' N ' ' A' ' 47' ' ' ARG . 5.4 t -52.58 136.41 43.36 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.27 -0.894 . . . . 0.0 110.426 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.66 -1.52 11.21 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.574 1.302 . . . . 0.0 110.673 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -123.9 -42.5 2.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.91 -1.119 . . . . 0.0 110.811 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.453 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -114.15 5.11 15.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.065 -1.022 . . . . 0.0 111.122 -179.703 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.43 ' N ' ' HB3' ' A' ' 43' ' ' CYS . 27.3 mtt180 54.43 25.65 6.3 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.171 -0.956 . . . . 0.0 112.408 178.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.417 ' CB ' ' SG ' ' A' ' 46' ' ' CYS . 2.5 t -75.6 157.68 83.98 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 120.702 -1.249 . . . . 0.0 109.779 178.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.16 139.45 35.49 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.675 1.355 . . . . 0.0 110.362 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.484 ' HA ' ' CD1' ' A' ' 53' ' ' PHE . 56.0 tttt -48.49 -28.26 3.22 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.184 -0.947 . . . . 0.0 110.901 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -67.14 -10.85 54.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.1 -1.0 . . . . 0.0 110.096 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.66 -2.38 58.28 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.191 -0.943 . . . . 0.0 110.193 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.484 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 33.1 m-85 -88.74 125.48 34.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.845 -1.159 . . . . 0.0 110.083 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -97.1 139.57 32.9 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.246 -0.909 . . . . 0.0 109.935 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.53 ' CB ' ' CE2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -80.12 153.99 28.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.426 -0.796 . . . . 0.0 110.187 -179.519 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.428 ' O ' ' CG2' ' A' ' 56' ' ' ILE . 1.2 tp -146.83 80.33 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.289 -0.882 . . . . 0.0 110.236 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.87 74.84 1.52 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.253 -0.904 . . . . 0.0 110.131 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.3 mppt? -130.75 174.25 10.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.18 -0.95 . . . . 0.0 110.156 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.0 m -144.49 160.4 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -0.934 . . . . 0.0 110.185 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 59.2 mt -112.19 116.93 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.245 -0.909 . . . . 0.0 109.912 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -114.47 -160.31 0.73 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.246 -0.909 . . . . 0.0 110.447 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -104.88 -99.29 2.58 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -164.36 159.8 20.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.29 -1.124 . . . . 0.0 110.451 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -140.82 53.07 1.6 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.249 -0.907 . . . . 0.0 109.888 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -108.47 46.63 0.95 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 110.407 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' A' ' 66' ' ' ASN . 17.1 p-10 -55.04 152.68 7.35 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.184 -0.947 . . . . 0.0 110.053 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -164.19 29.82 0.07 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.918 . . . . 0.0 110.203 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.83 47.31 1.34 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.93 . . . . 0.0 110.324 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -102.83 -171.51 1.96 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.13 -0.982 . . . . 0.0 110.29 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 179.971 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 ttt . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.159 0.504 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -138.88 76.95 1.6 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.273 -0.892 . . . . 0.0 110.352 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.3 mp -111.44 171.77 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.272 -0.892 . . . . 0.0 109.836 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -177.56 -29.96 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.055 -1.028 . . . . 0.0 111.385 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -78.85 -141.39 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.008 -1.057 . . . . 0.0 109.758 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.14 34.35 4.32 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -81.56 122.63 27.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.109 -1.23 . . . . 0.0 109.707 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.506 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 13.3 m-85 -108.34 152.08 25.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.055 -1.028 . . . . 0.0 110.561 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -119.91 122.99 42.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.442 -0.786 . . . . 0.0 109.814 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.4 t -64.39 111.16 2.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.109 -0.994 . . . . 0.0 110.515 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -67.51 -12.17 59.69 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.229 -0.919 . . . . 0.0 109.501 178.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.04 -39.98 17.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.285 -0.884 . . . . 0.0 111.647 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.433 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 11.9 p -125.07 -29.66 3.3 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.62 -1.3 . . . . 0.0 111.433 -179.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.08 18.93 8.85 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.585 -1.293 . . . . 0.0 110.421 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 48.1 t80 -78.87 167.12 21.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.126 -1.22 . . . . 0.0 109.547 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.52 ' N ' ' CD1' ' A' ' 15' ' ' TYR . 35.3 mm -129.06 115.54 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.17 -0.956 . . . . 0.0 110.454 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.517 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 73.1 t80 -82.17 136.31 35.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.436 -0.79 . . . . 0.0 110.378 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 22' ' ' GLY . 5.6 mt-10 -115.84 109.65 45.02 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.599 -0.688 . . . . 0.0 109.468 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.41 ' CB ' ' HA ' ' A' ' 33' ' ' PRO . 37.9 Cg_endo -68.77 -70.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.573 1.302 . . . . 0.0 111.467 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -44.75 -27.09 0.46 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.551 -0.718 . . . . 0.0 111.034 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.41 -22.56 15.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.165 -0.959 . . . . 0.0 110.078 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 18' ' ' GLU . . . 79.93 147.22 4.44 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.414 ' HB2' ' CE1' ' A' ' 17' ' ' TYR . 15.2 t0 -85.04 62.32 7.43 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.356 -1.085 . . . . 0.0 109.69 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.56 -28.8 0.41 Allowed 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 121.465 0.65 . . . . 0.0 110.827 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.85 -32.12 73.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.298 -0.876 . . . . 0.0 110.005 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -99.03 -28.0 13.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.263 -0.898 . . . . 0.0 110.368 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.81 25.13 2.17 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.488 HD12 ' CD1' ' A' ' 41' ' ' PHE . 9.8 mt -110.71 123.98 34.22 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 120.955 -1.32 . . . . 0.0 109.597 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -70.9 170.09 18.77 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.49 1.258 . . . . 0.0 110.588 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -71.85 -163.39 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.694 1.365 . . . . 0.0 110.296 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 49.14 31.52 11.67 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 84.3 m -136.88 116.69 10.65 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.163 -1.198 . . . . 0.0 110.289 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.41 ' HA ' ' CB ' ' A' ' 19' ' ' PRO . 47.2 Cg_endo -72.15 148.21 49.76 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 123.582 1.306 . . . . 0.0 110.345 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.517 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 5.5 t80 -51.08 -36.37 39.76 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.238 -0.914 . . . . 0.0 110.018 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.14 -13.79 12.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.408 -0.807 . . . . 0.0 110.748 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -98.58 -0.25 43.53 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.028 -1.045 . . . . 0.0 110.691 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.403 ' CB ' ' HD2' ' A' ' 50' ' ' LYS . 36.9 mt -55.82 163.59 1.39 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.913 -1.117 . . . . 0.0 110.248 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.9 m -53.73 168.38 0.19 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.323 -0.86 . . . . 0.0 110.367 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.98 -35.18 79.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.275 -0.891 . . . . 0.0 110.29 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.2 t -124.32 51.6 1.57 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.179 -0.95 . . . . 0.0 110.369 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.488 ' CD1' HD12 ' A' ' 28' ' ' ILE . 18.1 t80 -64.76 126.93 29.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.171 -0.956 . . . . 0.0 109.915 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 10.9 mtt -97.95 145.36 26.55 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.23 -0.919 . . . . 0.0 109.588 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 25.1 t -63.01 136.34 96.64 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.214 -0.929 . . . . 0.0 110.375 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -75.93 -3.27 13.63 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.581 1.306 . . . . 0.0 110.571 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -115.23 -37.9 3.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.038 -1.039 . . . . 0.0 110.823 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.433 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 1.6 p -124.72 7.07 8.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.045 -1.035 . . . . 0.0 111.152 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 57.2 17.16 3.4 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.195 -0.941 . . . . 0.0 112.804 178.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.6 m -74.7 163.09 70.63 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 120.589 -1.319 . . . . 0.0 109.899 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.23 141.78 36.43 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.666 1.35 . . . . 0.0 110.699 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.48 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 24.5 tttm -48.34 -27.85 2.81 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.327 -0.858 . . . . 0.0 110.833 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -62.07 -15.29 43.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.075 -1.016 . . . . 0.0 109.971 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.45 -1.93 58.01 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.106 -0.996 . . . . 0.0 110.276 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.47 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 20.9 m-85 -85.09 134.34 34.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.833 -1.167 . . . . 0.0 110.494 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.99 119.99 35.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.385 -0.822 . . . . 0.0 109.768 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.506 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 3.4 t -52.89 178.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 110.58 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.426 ' O ' ' CG2' ' A' ' 56' ' ' ILE . 2.7 tt -160.11 91.67 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.664 -0.647 . . . . 0.0 109.952 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.13 63.0 1.3 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.213 -0.929 . . . . 0.0 110.198 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.3 mmtt -121.92 139.01 54.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -0.894 . . . . 0.0 110.256 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.9 p -135.31 154.0 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -0.906 . . . . 0.0 109.99 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -142.23 144.28 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.104 -0.998 . . . . 0.0 110.473 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -101.04 -162.12 0.91 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.302 -0.874 . . . . 0.0 110.073 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.62 -158.91 25.29 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -74.03 156.43 37.5 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.267 -1.137 . . . . 0.0 110.407 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -122.25 67.42 0.93 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.217 -0.927 . . . . 0.0 110.05 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -98.29 44.22 1.04 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.244 -0.91 . . . . 0.0 110.41 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -169.19 33.75 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.256 -0.903 . . . . 0.0 110.261 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 56.4 168.34 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.356 -0.84 . . . . 0.0 110.513 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.8 143.93 45.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 110.047 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.94 121.88 45.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.222 -0.924 . . . . 0.0 110.27 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 CA-C-O 117.966 -1.464 . . . . 0.0 109.549 -179.989 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 mtm . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.215 0.531 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.401 ' CG ' ' O ' ' A' ' 2' ' ' GLU . 3.3 pm0 -173.94 76.7 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 110.308 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.446 ' O ' ' HB2' ' A' ' 4' ' ' ASP . 61.5 mt -134.63 169.49 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.231 -0.918 . . . . 0.0 109.845 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.454 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 7.4 t70 171.58 -21.26 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.471 0 O-C-N 121.639 -0.663 . . . . 0.0 110.692 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -67.89 65.27 0.09 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.012 -1.055 . . . . 0.0 110.714 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 4' ' ' ASP . . . 51.51 22.84 8.4 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.414 ' O ' ' CG2' ' A' ' 56' ' ' ILE . 4.0 mttt -81.57 120.88 25.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.99 -1.3 . . . . 0.0 109.371 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.508 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 6.8 m-85 -109.55 150.23 28.48 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.073 -1.017 . . . . 0.0 110.784 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.437 ' CG ' HD12 ' A' ' 16' ' ' ILE . 17.9 tt0 -119.46 132.57 55.82 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.433 -0.792 . . . . 0.0 109.555 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.9 t -72.91 114.6 11.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.103 -0.998 . . . . 0.0 110.591 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -70.84 -11.66 61.09 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.379 -0.928 . . . . 0.0 109.548 178.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.428 ' N ' ' NE2' ' A' ' 52' ' ' GLN . . . -85.07 -40.55 16.69 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.312 -0.867 . . . . 0.0 111.759 -179.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.438 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 12.6 p -123.53 -33.65 3.19 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.65 -1.281 . . . . 0.0 111.413 -178.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.23 21.45 5.89 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.129 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.524 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 49.9 t80 -84.45 168.67 15.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.296 -1.12 . . . . 0.0 109.812 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.524 ' N ' ' CD1' ' A' ' 15' ' ' TYR . 40.9 mm -131.47 117.54 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.185 -0.947 . . . . 0.0 110.621 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.517 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 61.3 t80 -83.64 128.76 34.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.408 -0.808 . . . . 0.0 110.133 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -106.51 111.9 63.91 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.361 -0.837 . . . . 0.0 109.749 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.78 -65.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.489 1.257 . . . . 0.0 111.085 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -45.64 -29.43 1.23 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.648 -0.658 . . . . 0.0 110.865 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.6 mttp -94.82 -38.05 10.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 0.0 110.173 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.29 150.65 26.34 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -85.08 63.86 8.35 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.438 -1.036 . . . . 0.0 109.653 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -46.39 -27.27 1.02 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.525 -0.735 . . . . 0.0 110.796 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -74.77 -23.15 58.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.22 -0.925 . . . . 0.0 109.985 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -100.99 -31.28 11.19 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.377 -0.827 . . . . 0.0 109.92 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.34 28.29 1.35 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 10.7 mt -118.84 123.7 28.85 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.906 -1.349 . . . . 0.0 109.774 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.94 173.41 11.17 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.486 1.256 . . . . 0.0 110.431 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -72.39 -164.09 0.17 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.564 1.297 . . . . 0.0 110.216 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 48.5 30.98 8.85 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.6 m -131.01 116.85 16.95 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.118 -1.225 . . . . 0.0 110.362 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -74.49 150.31 40.64 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.408 1.215 . . . . 0.0 110.469 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.517 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 11.8 t80 -56.94 -23.45 45.38 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.231 -0.918 . . . . 0.0 109.907 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.3 m -70.22 -15.61 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.288 -0.883 . . . . 0.0 110.718 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.12 -0.99 35.16 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.174 -0.954 . . . . 0.0 110.893 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.0 mt -54.28 161.27 1.39 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.826 -1.171 . . . . 0.0 110.159 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.7 m -52.68 177.67 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.216 -0.928 . . . . 0.0 110.187 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.7 -18.03 49.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.248 -0.907 . . . . 0.0 110.458 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.6 p -133.2 37.4 3.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.105 -0.997 . . . . 0.0 110.541 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.455 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 14.5 t80 -56.61 133.87 54.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.138 -0.976 . . . . 0.0 109.774 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 5.1 mtt -106.99 143.9 34.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 109.854 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 35.9 t -56.64 138.96 76.6 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.879 . . . . 0.0 110.472 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -77.8 2.79 7.52 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.523 1.275 . . . . 0.0 110.873 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -124.61 -38.23 2.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.961 -1.087 . . . . 0.0 110.873 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.438 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 1.6 p -121.59 6.17 10.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.091 -1.006 . . . . 0.0 111.43 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.36 17.73 4.99 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.033 -1.042 . . . . 0.0 112.622 178.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.4 m -72.81 163.06 71.13 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 120.56 -1.338 . . . . 0.0 109.628 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.38 145.74 54.44 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.667 1.351 . . . . 0.0 110.334 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.483 ' HG2' ' CZ ' ' A' ' 34' ' ' PHE . 31.1 tttt -51.6 -24.74 5.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.3 -0.875 . . . . 0.0 110.255 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -66.12 -13.95 60.99 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.248 -0.907 . . . . 0.0 109.773 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.428 ' NE2' ' N ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -85.73 -3.73 58.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.238 -0.914 . . . . 0.0 110.043 179.193 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.45 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 17.1 m-85 -84.77 134.75 34.31 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.039 -1.038 . . . . 0.0 110.437 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.47 130.36 55.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.307 -0.87 . . . . 0.0 109.736 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.508 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 74.7 p -63.7 179.54 0.48 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 111.188 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.414 ' CG2' ' O ' ' A' ' 7' ' ' LYS . 4.8 tp -159.98 91.81 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.348 0.594 . . . . 0.0 109.546 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 4' ' ' ASP . 1.2 pttt -115.2 71.76 0.77 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.166 -0.959 . . . . 0.0 110.531 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.61 64.77 0.84 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.466 -0.771 . . . . 0.0 109.849 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.428 HG11 ' N ' ' A' ' 60' ' ' ILE . 46.3 t -65.79 151.85 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.894 . . . . 0.0 110.218 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.428 ' N ' HG11 ' A' ' 59' ' ' VAL . 14.4 tt -128.78 142.87 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.308 -0.87 . . . . 0.0 110.089 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 53.51 -158.87 0.15 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.316 -0.865 . . . . 0.0 110.225 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 61.05 31.29 76.11 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -109.57 -68.68 0.91 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.255 -1.144 . . . . 0.0 110.286 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -132.7 175.73 9.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.288 -0.882 . . . . 0.0 110.182 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -128.29 105.74 8.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.197 -0.94 . . . . 0.0 110.374 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.3 m-20 -78.45 -72.99 0.35 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.193 -0.942 . . . . 0.0 109.97 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -120.41 -79.78 0.61 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.304 -0.872 . . . . 0.0 109.717 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -121.26 77.28 1.3 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.324 -0.86 . . . . 0.0 109.826 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -161.58 125.53 3.3 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.39 -0.819 . . . . 0.0 109.997 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 CA-C-O 117.998 -1.446 . . . . 0.0 109.583 179.939 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.285 0.565 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -114.35 58.81 0.69 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.178 -0.951 . . . . 0.0 110.199 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.8 mt -134.02 162.64 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 109.875 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 32.5 t70 -157.8 10.81 0.19 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.383 -0.823 . . . . 0.0 111.708 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -81.42 53.54 2.1 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.011 -1.056 . . . . 0.0 110.362 -179.812 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 51.52 25.19 13.05 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.432 ' O ' ' CG2' ' A' ' 56' ' ' ILE . 1.3 mttt -79.25 135.81 36.88 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.375 -1.074 . . . . 0.0 109.961 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.586 ' CE2' ' CD1' ' A' ' 34' ' ' PHE . 8.0 m-85 -113.95 125.54 54.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.131 -0.981 . . . . 0.0 109.931 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -88.85 128.78 35.67 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.239 -0.913 . . . . 0.0 110.168 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.6 t -72.35 115.16 11.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.195 -0.941 . . . . 0.0 110.242 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -70.37 -12.8 61.83 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.146 -0.971 . . . . 0.0 109.537 178.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.408 ' N ' ' NE2' ' A' ' 52' ' ' GLN . . . -85.08 -42.75 14.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.324 -0.86 . . . . 0.0 111.657 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.444 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 12.9 p -120.85 -27.29 5.05 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.72 -1.238 . . . . 0.0 111.382 -178.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.72 22.01 9.28 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.447 ' CG ' ' N ' ' A' ' 16' ' ' ILE . 60.7 t80 -81.88 168.35 18.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -1.117 . . . . 0.0 109.545 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.475 HG22 HD11 ' A' ' 16' ' ' ILE . 25.7 mm -127.58 102.65 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.238 -0.914 . . . . 0.0 109.935 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.516 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 76.4 t80 -66.91 134.82 52.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 109.693 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -114.4 110.6 47.47 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.475 -0.766 . . . . 0.0 110.01 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.418 ' CG ' ' O ' ' A' ' 5' ' ' GLU . 39.2 Cg_endo -71.04 -62.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.506 1.266 . . . . 0.0 110.641 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -45.1 -26.45 0.46 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.825 -0.547 . . . . 0.0 111.054 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.5 mtpp -103.16 -29.51 11.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.083 -1.01 . . . . 0.0 110.364 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.75 151.36 21.57 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.407 ' CB ' HD11 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -85.1 63.42 8.1 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.399 -1.06 . . . . 0.0 109.533 179.754 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.69 -26.6 0.96 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.517 -0.74 . . . . 0.0 110.79 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -78.88 -19.77 51.11 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.189 -0.944 . . . . 0.0 110.254 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -104.1 -32.36 9.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.259 -0.9 . . . . 0.0 109.965 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 125.09 32.3 0.8 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.416 HD12 ' CD1' ' A' ' 41' ' ' PHE . 3.3 mt -126.82 123.51 23.75 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.037 -1.272 . . . . 0.0 109.875 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -71.2 173.09 12.76 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.543 1.286 . . . . 0.0 110.596 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -72.45 -163.4 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.759 1.399 . . . . 0.0 110.255 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 49.77 26.43 8.05 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.3 m -132.75 117.94 15.37 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.161 -1.2 . . . . 0.0 110.3 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.4 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 48.4 Cg_endo -74.38 151.77 43.22 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.492 1.259 . . . . 0.0 110.755 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.586 ' CD1' ' CE2' ' A' ' 8' ' ' TYR . 9.2 t80 -55.47 -24.42 30.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.365 -0.834 . . . . 0.0 110.104 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.9 m -71.07 -17.21 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 0.0 110.532 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -100.24 3.54 43.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.051 -1.031 . . . . 0.0 110.859 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.487 HD13 ' CD2' ' A' ' 34' ' ' PHE . 40.9 mt -54.64 169.67 0.2 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.975 -1.078 . . . . 0.0 110.265 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.25 162.05 12.72 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.184 -0.947 . . . . 0.0 110.253 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.3 -19.36 61.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.274 -0.891 . . . . 0.0 110.339 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -132.76 54.1 1.97 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.219 -0.926 . . . . 0.0 110.136 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.459 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 30.7 t80 -70.19 129.5 39.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.298 -0.876 . . . . 0.0 109.98 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 6.8 mtp -112.0 141.06 46.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.231 -0.918 . . . . 0.0 109.605 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 17.7 t -55.45 133.42 70.61 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 0.0 110.527 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.72 -1.91 11.75 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.615 1.324 . . . . 0.0 110.458 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.84 -35.92 4.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.976 -1.077 . . . . 0.0 110.914 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.444 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.9 OUTLIER -127.15 16.4 7.24 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.989 -1.069 . . . . 0.0 110.943 -179.694 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 56.4 mtt85 45.48 23.56 0.14 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.371 -0.831 . . . . 0.0 112.611 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.417 ' CB ' ' SG ' ' A' ' 46' ' ' CYS . 7.3 t -75.66 156.03 85.02 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 120.61 -1.307 . . . . 0.0 109.872 179.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.44 141.18 50.22 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.604 1.318 . . . . 0.0 110.41 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.51 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 12.5 tttm -49.16 -26.92 3.13 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.33 -0.856 . . . . 0.0 110.789 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.71 -14.56 53.43 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.066 -1.021 . . . . 0.0 109.952 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.408 ' NE2' ' N ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -89.2 1.45 55.66 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.227 -0.921 . . . . 0.0 110.271 179.303 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -89.54 148.47 23.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.896 -1.127 . . . . 0.0 111.012 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.5 133.95 47.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.564 -0.71 . . . . 0.0 109.152 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 75.7 p -70.52 176.81 3.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.989 -1.069 . . . . 0.0 111.301 -179.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.432 ' CG2' ' O ' ' A' ' 7' ' ' LYS . 1.6 tt -155.95 67.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-O 121.361 0.601 . . . . 0.0 109.912 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 4' ' ' ASP . 0.3 OUTLIER -80.6 57.89 3.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.889 . . . . 0.0 110.155 -179.878 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -130.0 104.7 7.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.437 -0.79 . . . . 0.0 110.26 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.428 ' O ' ' CG1' ' A' ' 59' ' ' VAL . 9.3 p -130.24 106.2 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.166 -0.958 . . . . 0.0 110.156 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.6 mt -95.07 57.86 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.105 -0.997 . . . . 0.0 110.149 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -148.94 93.02 2.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -0.919 . . . . 0.0 110.422 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -151.29 -138.29 2.79 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -85.09 139.25 31.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.188 -1.184 . . . . 0.0 110.119 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.31 129.38 35.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.226 -0.921 . . . . 0.0 110.22 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -156.47 50.85 0.51 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.286 -0.884 . . . . 0.0 110.106 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -97.48 -36.51 10.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.237 -0.915 . . . . 0.0 110.081 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -149.63 95.94 2.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.316 -0.865 . . . . 0.0 110.132 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.75 156.29 36.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.886 . . . . 0.0 110.428 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -97.21 101.06 12.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.284 -0.885 . . . . 0.0 110.199 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 179.968 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.241 0.543 . . . . 0.0 110.253 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -173.52 66.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.364 -0.835 . . . . 0.0 109.898 179.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.454 ' CG1' ' N ' ' A' ' 4' ' ' ASP . 6.5 tt -159.25 169.11 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.383 -0.823 . . . . 0.0 110.145 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.454 ' N ' ' CG1' ' A' ' 3' ' ' ILE . 4.5 p-10 178.46 112.02 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.81 0.814 . . . . 0.0 109.526 179.408 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.47 65.7 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.933 0 CA-C-O 121.286 0.565 . . . . 0.0 110.122 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 56.0 20.72 28.25 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.6 mttm -87.35 131.17 34.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.071 -1.253 . . . . 0.0 109.64 179.608 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.489 ' CE2' ' HB2' ' A' ' 55' ' ' SER . 22.3 m-85 -122.64 139.56 53.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -0.906 . . . . 0.0 110.858 -179.385 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -110.13 141.15 43.41 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.361 -0.837 . . . . 0.0 109.836 179.409 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.7 t -81.01 114.1 19.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.068 -1.02 . . . . 0.0 110.37 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.27 -11.51 60.95 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.174 -0.954 . . . . 0.0 109.633 178.874 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.04 -42.22 15.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.369 -0.832 . . . . 0.0 111.759 -179.252 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.433 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 13.6 p -121.42 -34.71 3.4 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.668 -1.27 . . . . 0.0 111.424 -178.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.49 20.48 5.44 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 119.673 -1.251 . . . . 0.0 110.211 179.419 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 55.9 t80 -84.58 162.49 19.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.206 -1.173 . . . . 0.0 109.856 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.471 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 3.3 mp -128.29 115.13 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.125 -0.984 . . . . 0.0 110.018 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.503 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 71.2 t80 -77.44 131.18 37.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.316 -0.865 . . . . 0.0 110.187 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -109.5 115.71 55.65 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.427 -0.795 . . . . 0.0 109.415 179.371 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -71.0 -65.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.465 1.245 . . . . 0.0 111.041 -179.484 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' A' ' 30' ' ' PRO . 0.5 OUTLIER -47.86 -24.04 0.9 Allowed 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.552 -0.717 . . . . 0.0 111.023 -179.835 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.2 tttp -99.13 -40.06 8.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.923 -1.11 . . . . 0.0 110.732 -179.724 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.74 147.85 22.72 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -85.11 61.34 6.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.447 -1.031 . . . . 0.0 109.985 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -44.72 -27.31 0.48 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.622 -0.674 . . . . 0.0 111.039 -179.724 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -69.26 -28.33 66.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.118 -0.989 . . . . 0.0 109.88 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -100.88 -28.33 12.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.343 -0.848 . . . . 0.0 109.983 179.661 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.54 28.54 1.43 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 179.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.402 ' CD1' ' CE1' ' A' ' 41' ' ' PHE . 8.8 mt -116.87 119.82 34.82 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.046 -1.267 . . . . 0.0 109.739 179.647 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -71.81 172.95 13.47 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.496 1.261 . . . . 0.0 110.553 -179.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.425 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 49.1 Cg_endo -70.64 -163.37 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.741 1.39 . . . . 0.0 110.28 179.813 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 50.22 27.83 12.03 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 63.3 m -131.71 115.91 15.87 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.198 -1.178 . . . . 0.0 110.341 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.83 148.61 46.4 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.466 1.245 . . . . 0.0 110.586 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.503 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 30.1 t80 -53.06 -30.27 34.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.36 -0.838 . . . . 0.0 109.968 179.823 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.9 m -66.75 -11.78 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.844 . . . . 0.0 110.716 -179.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -103.2 -2.42 27.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.012 -1.055 . . . . 0.0 110.92 -179.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.451 HD11 ' CD2' ' A' ' 34' ' ' PHE . 19.7 mt -52.1 172.81 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.926 -1.109 . . . . 0.0 110.312 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.8 m -64.36 150.9 45.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.219 -0.926 . . . . 0.0 110.23 -179.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -57.65 -22.18 44.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 0.0 110.234 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.4 p -129.61 38.51 3.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 0.0 109.911 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.461 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 30.8 t80 -60.46 135.66 57.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 110.345 -179.784 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.81 149.55 29.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.336 -0.853 . . . . 0.0 109.558 179.214 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 18.1 t -61.1 137.0 94.05 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.104 -0.997 . . . . 0.0 110.52 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.11 -3.37 13.75 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.602 1.317 . . . . 0.0 110.353 179.383 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.97 -39.28 3.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.07 -1.019 . . . . 0.0 110.632 -179.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.433 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.9 OUTLIER -124.24 9.17 8.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.164 -0.96 . . . . 0.0 110.954 -179.801 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 54.39 15.98 1.14 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.31 -0.869 . . . . 0.0 112.964 178.147 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.4 m -67.25 165.38 28.73 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 120.621 -1.299 . . . . 0.0 109.746 179.293 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.439 ' HB2' ' ND2' ' A' ' 51' ' ' ASN . 43.5 Cg_endo -69.85 144.29 53.08 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.677 1.356 . . . . 0.0 110.492 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.488 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 37.4 tttt -53.57 -32.16 49.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.174 -0.954 . . . . 0.0 110.608 -179.679 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.439 ' ND2' ' HB2' ' A' ' 49' ' ' PRO . 24.5 p30 -63.29 -14.45 49.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.054 -1.029 . . . . 0.0 109.738 179.258 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.62 -7.66 59.35 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.069 -1.019 . . . . 0.0 109.755 178.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -82.56 124.62 30.3 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.107 -0.996 . . . . 0.0 109.678 179.375 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -104.03 123.78 47.83 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.142 -0.974 . . . . 0.0 109.545 179.52 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.489 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 2.2 t -52.12 -179.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.103 -0.998 . . . . 0.0 110.241 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.414 ' N ' ' OG ' ' A' ' 55' ' ' SER . 4.5 tt -158.53 67.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.457 -0.777 . . . . 0.0 110.046 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.58 61.39 0.82 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.416 -0.802 . . . . 0.0 110.194 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -106.13 125.16 50.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -0.899 . . . . 0.0 110.093 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.6 p -135.84 148.25 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.884 . . . . 0.0 110.123 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.419 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 0.5 OUTLIER -135.99 49.39 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.202 -0.936 . . . . 0.0 110.264 -179.956 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -128.92 21.73 5.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.202 -0.936 . . . . 0.0 110.282 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 162.49 130.73 1.14 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -116.43 138.45 51.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.259 -1.142 . . . . 0.0 110.314 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -121.99 20.31 10.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.219 -0.926 . . . . 0.0 110.23 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -136.78 17.27 3.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.139 -0.975 . . . . 0.0 110.48 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -160.49 -44.41 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.138 -0.976 . . . . 0.0 110.149 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.49 -173.32 2.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.277 -0.89 . . . . 0.0 110.113 179.837 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -168.18 -177.96 3.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 110.19 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -119.75 111.6 18.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.232 -0.918 . . . . 0.0 110.144 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 CA-C-O 118.006 -1.441 . . . . 0.0 109.547 179.994 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.777 ' O ' HG22 ' A' ' 56' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.159 0.504 . . . . 0.0 109.723 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.588 ' CE2' ' CD1' ' A' ' 34' ' ' PHE . 4.3 m-85 -100.4 147.05 26.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.13 -0.981 . . . . 0.0 109.908 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -117.71 128.15 54.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.234 -0.916 . . . . 0.0 110.222 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.9 t -69.86 112.04 6.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 110.178 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -11.54 59.54 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.135 -0.978 . . . . 0.0 109.592 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.19 -39.61 17.63 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.29 -0.881 . . . . 0.0 111.76 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.452 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 12.6 p -125.61 -32.99 2.82 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.672 -1.268 . . . . 0.0 111.752 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.83 21.61 5.97 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.777 ' C ' HD12 ' A' ' 16' ' ' ILE . 54.2 t80 -83.09 156.03 23.53 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.229 -1.16 . . . . 0.0 109.565 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.777 HD12 ' C ' ' A' ' 15' ' ' TYR . 2.7 mp -120.57 109.88 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 110.262 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.523 ' CE1' HD21 ' A' ' 37' ' ' LEU . 64.5 t80 -75.75 126.63 31.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.321 -0.862 . . . . 0.0 109.659 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.431 ' HB3' ' CB ' ' A' ' 21' ' ' LYS . 24.2 mt-10 -102.48 111.21 64.41 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.345 -0.847 . . . . 0.0 109.666 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.48 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 37.7 Cg_endo -68.77 -70.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.487 1.256 . . . . 0.0 110.939 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.403 ' O ' ' CB ' ' A' ' 30' ' ' PRO . 66.4 tt0 -47.45 -26.18 1.29 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.448 -0.783 . . . . 0.0 110.567 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.431 ' CB ' ' HB3' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -93.58 -33.75 13.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.241 -0.912 . . . . 0.0 110.196 179.833 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.91 157.03 32.27 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.471 ' HB3' HD12 ' A' ' 28' ' ' ILE . 8.5 t0 -85.04 61.34 6.81 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.479 -1.013 . . . . 0.0 109.854 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -46.54 -26.67 0.93 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.454 -0.779 . . . . 0.0 110.679 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -80.77 -25.28 38.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.265 -0.897 . . . . 0.0 110.125 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.443 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -97.82 -30.41 12.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.209 -0.932 . . . . 0.0 110.157 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 127.39 4.17 5.92 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.959 -1.115 . . . . 0.0 110.536 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.471 HD12 ' HB3' ' A' ' 23' ' ' ASP . 3.5 mt -98.19 129.04 31.65 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.824 -1.398 . . . . 0.0 110.162 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.417 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 47.0 Cg_endo -74.31 173.14 14.71 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 O-C-N 123.505 1.266 . . . . 0.0 110.557 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 49.9 Cg_endo -70.9 -163.38 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.623 1.328 . . . . 0.0 110.262 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 50.21 40.58 37.39 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 99.7 m -147.28 115.46 4.26 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.183 -1.187 . . . . 0.0 110.253 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.73 ' HB2' HG22 ' A' ' 35' ' ' VAL . 45.4 Cg_endo -71.98 151.55 56.35 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.514 1.27 . . . . 0.0 110.584 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.588 ' CD1' ' CE2' ' A' ' 8' ' ' TYR . 12.6 t80 -54.6 -32.5 58.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.328 -0.858 . . . . 0.0 110.066 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.73 HG22 ' HB2' ' A' ' 33' ' ' PRO . 24.4 m -63.56 -13.47 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.355 -0.841 . . . . 0.0 110.623 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -102.57 4.38 38.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.027 -1.045 . . . . 0.0 111.053 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.523 HD21 ' CE1' ' A' ' 17' ' ' TYR . 22.4 mt -56.61 178.97 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.832 -1.167 . . . . 0.0 110.044 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.8 m -69.18 164.96 21.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.215 -0.928 . . . . 0.0 110.324 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -63.93 -20.79 66.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.207 -0.933 . . . . 0.0 110.218 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.3 m -138.89 54.91 1.73 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.163 -0.961 . . . . 0.0 110.356 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.45 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 18.4 t80 -70.69 140.98 51.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.147 -0.971 . . . . 0.0 109.831 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.429 ' HA ' ' O ' ' A' ' 48' ' ' SER . 1.9 mtt -116.4 143.9 44.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.289 -0.882 . . . . 0.0 109.644 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 11.6 t -60.16 132.84 90.17 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.195 -0.941 . . . . 0.0 110.498 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.92 -9.22 20.79 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.569 1.3 . . . . 0.0 110.314 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -106.15 -40.04 5.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.078 -1.014 . . . . 0.0 110.707 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.452 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 1.3 p -122.72 5.1 9.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.133 -0.98 . . . . 0.0 111.113 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 4.2 mtm105 57.65 18.17 4.53 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.185 -0.947 . . . . 0.0 112.816 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.429 ' O ' ' HA ' ' A' ' 42' ' ' MET . 4.6 m -72.32 163.34 68.19 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 120.66 -1.275 . . . . 0.0 109.704 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -70.52 143.74 48.04 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.639 1.336 . . . . 0.0 110.235 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.511 ' HG2' ' CZ ' ' A' ' 34' ' ' PHE . 19.4 tttt -49.94 -24.63 2.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.208 -0.933 . . . . 0.0 110.549 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -66.17 -14.14 61.36 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.096 -1.002 . . . . 0.0 109.977 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -83.93 -5.56 59.24 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.141 -0.974 . . . . 0.0 109.999 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.523 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 12.7 m-85 -85.11 149.46 25.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.018 -1.051 . . . . 0.0 110.285 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.66 132.66 26.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.352 -0.842 . . . . 0.0 109.878 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.53 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 5.8 p -61.83 172.62 1.25 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.166 -0.959 . . . . 0.0 110.917 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.777 HG22 ' O ' ' A' ' 7' ' ' LYS . 3.2 tt . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.733 -0.605 . . . . 0.0 109.718 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.86 ' O ' HG22 ' A' ' 56' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.237 0.542 . . . . 0.0 109.936 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.564 ' CE2' ' CD2' ' A' ' 34' ' ' PHE . 7.4 m-85 -109.59 141.93 41.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.168 -0.957 . . . . 0.0 109.878 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.508 ' HA ' HD13 ' A' ' 16' ' ' ILE . 4.8 tt0 -106.18 129.88 54.16 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.162 -0.961 . . . . 0.0 110.275 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.9 t -71.42 116.17 11.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 110.339 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.73 -11.47 60.96 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.091 -1.006 . . . . 0.0 109.585 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.686 ' HB2' ' OE1' ' A' ' 52' ' ' GLN . . . -85.15 -41.37 15.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.309 -0.87 . . . . 0.0 111.653 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.472 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 14.3 p -123.12 -32.62 3.43 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.758 -1.214 . . . . 0.0 111.406 -179.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.0 24.0 5.92 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.46 ' CD2' ' N ' ' A' ' 16' ' ' ILE . 40.9 t80 -84.13 168.96 15.33 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.365 -1.079 . . . . 0.0 109.343 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.508 HD13 ' HA ' ' A' ' 9' ' ' GLU . 33.9 mm -129.41 117.59 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.27 -0.894 . . . . 0.0 110.309 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.543 ' CE1' HD21 ' A' ' 37' ' ' LEU . 56.1 t80 -80.54 129.17 34.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.429 -0.794 . . . . 0.0 109.912 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -104.91 110.73 64.87 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.488 -0.758 . . . . 0.0 109.546 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.464 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 37.5 Cg_endo -68.58 -76.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.591 1.311 . . . . 0.0 111.464 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -46.02 -26.58 0.75 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.285 -0.885 . . . . 0.0 111.037 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.5 tttp -87.95 -36.09 17.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 110.522 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.46 145.63 17.81 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.413 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 2.9 t0 -85.11 62.07 7.27 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.3 -1.118 . . . . 0.0 109.876 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.39 -26.5 2.1 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.249 -0.907 . . . . 0.0 110.416 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -74.51 -20.41 59.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.303 -0.873 . . . . 0.0 109.921 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.413 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -106.99 -33.28 7.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.929 . . . . 0.0 109.969 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.94 32.97 0.66 Allowed Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.948 -1.12 . . . . 0.0 110.309 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.1 mt -124.1 130.39 24.4 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 120.876 -1.367 . . . . 0.0 109.753 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.46 173.21 13.57 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 O-C-N 123.601 1.316 . . . . 0.0 110.394 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -72.19 -164.87 0.19 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.629 1.331 . . . . 0.0 110.186 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 49.76 27.87 10.18 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.9 m -127.94 112.08 20.28 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.099 -1.236 . . . . 0.0 110.228 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.75 ' HB2' HG22 ' A' ' 35' ' ' VAL . 44.3 Cg_endo -70.87 153.08 64.0 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.554 1.292 . . . . 0.0 110.478 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.763 ' CD1' HD12 ' A' ' 37' ' ' LEU . 27.5 t80 -55.48 -28.36 54.04 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.234 -0.916 . . . . 0.0 110.106 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.75 HG22 ' HB2' ' A' ' 33' ' ' PRO . 33.8 m -64.79 -20.16 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.207 -0.933 . . . . 0.0 110.077 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -90.54 -11.11 41.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.13 -0.981 . . . . 0.0 110.69 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.763 HD12 ' CD1' ' A' ' 34' ' ' PHE . 25.5 mt -52.54 157.65 1.47 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.974 -1.079 . . . . 0.0 110.322 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.34 139.34 58.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.307 -0.871 . . . . 0.0 109.99 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -51.17 -24.86 4.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.26 -0.9 . . . . 0.0 110.348 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.95 26.19 10.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.87 . . . . 0.0 110.177 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.455 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 18.3 t80 -56.04 131.96 48.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 109.844 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.1 mtt -113.3 147.46 37.55 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.265 -0.897 . . . . 0.0 109.545 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 7.9 t -58.72 134.25 86.39 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.0 110.44 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -77.83 1.09 9.21 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.533 1.281 . . . . 0.0 110.29 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -120.97 -34.96 3.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.027 -1.045 . . . . 0.0 110.923 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.472 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.7 OUTLIER -126.16 4.07 7.14 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.937 -1.102 . . . . 0.0 111.345 -179.668 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.78 17.75 10.13 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.085 -1.009 . . . . 0.0 112.142 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.41 ' OG ' ' HB3' ' A' ' 52' ' ' GLN . 5.0 t -70.44 153.39 95.11 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.822 -1.174 . . . . 0.0 109.707 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.16 145.33 43.89 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.587 1.309 . . . . 0.0 110.558 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.455 ' HB2' ' HB3' ' A' ' 41' ' ' PHE . 24.7 tttm -52.37 -32.03 36.6 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.175 -0.953 . . . . 0.0 110.186 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.15 -15.66 47.39 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.122 -0.987 . . . . 0.0 109.745 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.686 ' OE1' ' HB2' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -91.1 3.77 53.92 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.24 -0.912 . . . . 0.0 110.159 179.401 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.403 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 18.8 m-85 -92.84 128.16 38.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.896 -1.127 . . . . 0.0 110.209 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.86 135.73 50.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.301 -0.874 . . . . 0.0 109.737 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.529 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 77.9 p -68.15 -178.44 1.04 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 110.908 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.86 HG22 ' O ' ' A' ' 7' ' ' LYS . 7.2 tp . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.466 0.65 . . . . 0.0 109.691 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.872 ' O ' HG22 ' A' ' 56' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.219 0.533 . . . . 0.0 109.879 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.52 ' CE2' ' HB3' ' A' ' 55' ' ' SER . 8.9 m-85 -118.1 135.88 53.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.153 -0.967 . . . . 0.0 109.635 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.407 ' HA ' HD13 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -101.53 135.76 42.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.048 -1.033 . . . . 0.0 110.55 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.9 t -77.49 113.95 15.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.194 -0.941 . . . . 0.0 110.248 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.01 -10.26 59.45 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.004 -1.06 . . . . 0.0 109.572 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.05 -39.48 17.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.43 -0.794 . . . . 0.0 111.584 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.48 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 13.8 p -125.5 -35.24 2.58 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.652 -1.28 . . . . 0.0 111.531 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.02 22.8 4.81 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.466 ' CG ' ' N ' ' A' ' 16' ' ' ILE . 59.2 t80 -83.66 170.22 14.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.351 -1.088 . . . . 0.0 109.871 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.466 ' N ' ' CG ' ' A' ' 15' ' ' TYR . 37.2 mm -132.24 115.03 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 110.255 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.5 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 68.4 t80 -78.17 135.94 37.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.331 -0.856 . . . . 0.0 110.136 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.415 ' O ' ' N ' ' A' ' 22' ' ' GLY . 5.8 mt-10 -115.28 110.09 45.75 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.516 -0.74 . . . . 0.0 109.461 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.447 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 37.4 Cg_endo -68.99 -72.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.395 0 O-C-N 123.52 1.274 . . . . 0.0 111.237 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -44.81 -27.27 0.49 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.544 -0.722 . . . . 0.0 111.032 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -98.13 -24.02 15.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.207 -0.933 . . . . 0.0 110.147 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 18' ' ' GLU . . . 80.04 153.36 8.49 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.596 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 0.3 OUTLIER -84.93 61.2 6.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.361 -1.081 . . . . 0.0 109.595 179.627 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.45 -27.78 0.78 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.57 -0.706 . . . . 0.0 110.965 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.85 -28.08 60.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.187 -0.946 . . . . 0.0 109.899 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.596 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -96.54 -28.22 14.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.291 -0.88 . . . . 0.0 110.073 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.8 24.63 2.27 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.49 HD11 ' CD1' ' A' ' 41' ' ' PHE . 7.6 mt -113.98 128.86 25.32 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.959 -1.318 . . . . 0.0 109.684 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.33 170.45 19.87 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.598 1.315 . . . . 0.0 110.665 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.01 -163.59 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.674 1.355 . . . . 0.0 110.144 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 48.99 34.38 15.79 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 90.2 m -138.7 115.08 8.79 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.259 -1.142 . . . . 0.0 110.271 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.773 ' HB2' HG22 ' A' ' 35' ' ' VAL . 48.2 Cg_endo -72.08 148.8 51.3 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.568 1.299 . . . . 0.0 110.507 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.508 ' CZ ' ' HG2' ' A' ' 50' ' ' LYS . 19.1 t80 -51.59 -27.85 12.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.42 -0.8 . . . . 0.0 110.272 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.773 HG22 ' HB2' ' A' ' 33' ' ' PRO . 31.1 m -71.0 -19.59 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.936 . . . . 0.0 110.52 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.27 -2.26 55.21 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.186 -0.946 . . . . 0.0 110.924 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.469 HD23 ' HA ' ' A' ' 37' ' ' LEU . 25.2 mt -53.19 -179.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.971 -1.08 . . . . 0.0 110.372 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.15 156.48 38.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.381 -0.825 . . . . 0.0 110.232 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -53.11 -26.31 16.13 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.268 -0.895 . . . . 0.0 110.424 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.32 60.43 1.67 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.143 -0.973 . . . . 0.0 110.42 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.49 ' CD1' HD11 ' A' ' 28' ' ' ILE . 10.0 t80 -71.64 128.49 35.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.164 -0.96 . . . . 0.0 109.685 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.441 ' HA ' ' O ' ' A' ' 48' ' ' SER . 18.1 mmt -103.0 145.83 29.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -0.925 . . . . 0.0 109.795 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 8.3 t -58.36 138.12 85.11 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.403 -0.811 . . . . 0.0 110.67 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.4 ' HB3' ' HB2' ' A' ' 26' ' ' ALA . 53.0 Cg_endo -77.68 -0.57 10.77 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.686 1.361 . . . . 0.0 110.394 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -122.41 -34.15 3.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.032 -1.042 . . . . 0.0 111.022 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.48 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.8 OUTLIER -125.03 8.01 7.99 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.933 -1.105 . . . . 0.0 111.298 -179.655 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.69 21.41 4.59 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.122 -0.987 . . . . 0.0 112.432 178.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 42' ' ' MET . 10.9 t -77.23 153.25 82.11 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 120.666 -1.271 . . . . 0.0 109.627 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.26 142.06 49.04 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.584 1.307 . . . . 0.0 110.548 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.508 ' HG2' ' CZ ' ' A' ' 34' ' ' PHE . 4.4 ttpm? -48.4 -29.44 4.01 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.445 -0.784 . . . . 0.0 110.937 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -62.77 -14.79 49.13 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.986 -1.071 . . . . 0.0 109.967 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.09 1.1 56.08 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.125 -0.985 . . . . 0.0 110.03 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.494 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 16.6 m-85 -89.63 137.43 32.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.116 -0.99 . . . . 0.0 110.307 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -115.9 131.63 56.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.285 -0.885 . . . . 0.0 109.64 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.52 ' HB3' ' CE2' ' A' ' 8' ' ' TYR . 79.3 p -63.68 179.67 0.46 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.048 -1.032 . . . . 0.0 111.054 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.872 HG22 ' O ' ' A' ' 7' ' ' LYS . 1.2 tp . . . . . 0 C--N 1.297 -1.677 0 CA-C-O 121.405 0.622 . . . . 0.0 109.561 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.518 ' CE2' ' HB2' ' A' ' 55' ' ' SER . 22.2 m-85 -129.3 150.39 50.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.017 -1.052 . . . . 0.0 110.864 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.586 ' HA ' HD13 ' A' ' 16' ' ' ILE . 13.8 pt-20 -120.56 140.66 51.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.323 -0.861 . . . . 0.0 109.863 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 t -80.05 113.86 18.53 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.176 -0.953 . . . . 0.0 110.434 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.63 -11.71 61.11 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.115 -0.99 . . . . 0.0 109.613 178.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.08 -41.3 15.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 111.726 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.4 p -122.08 -32.85 3.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.726 -1.234 . . . . 0.0 111.551 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.14 21.12 6.03 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.507 ' CD2' ' N ' ' A' ' 16' ' ' ILE . 60.5 t80 -81.6 168.92 17.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.265 -1.138 . . . . 0.0 109.92 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.586 HD13 ' HA ' ' A' ' 9' ' ' GLU . 34.8 mm -135.11 116.25 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.246 -0.908 . . . . 0.0 110.201 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.548 ' CZ ' HD21 ' A' ' 37' ' ' LEU . 63.5 t80 -80.57 132.86 35.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -0.874 . . . . 0.0 110.109 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -113.93 113.86 46.78 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.561 -0.712 . . . . 0.0 109.655 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.493 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 38.5 Cg_endo -71.72 -65.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.474 1.25 . . . . 0.0 110.892 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -45.38 -27.33 0.67 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.715 -0.616 . . . . 0.0 110.776 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.12 -35.57 10.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.282 -0.886 . . . . 0.0 110.0 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.64 149.54 10.69 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.471 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 2.2 t0 -85.14 62.42 7.49 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.457 -1.025 . . . . 0.0 109.725 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -44.91 -27.5 0.54 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.629 -0.669 . . . . 0.0 110.916 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.45 -26.44 60.05 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.315 -0.865 . . . . 0.0 110.26 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.471 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -100.72 -25.68 14.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.223 -0.923 . . . . 0.0 110.335 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.92 19.1 3.39 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.893 -1.146 . . . . 0.0 110.244 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.2 mt -111.19 116.59 51.1 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 120.897 -1.355 . . . . 0.0 109.717 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.35 172.18 13.7 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.503 1.265 . . . . 0.0 110.611 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.54 -164.14 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.724 1.381 . . . . 0.0 110.145 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 47.61 27.33 4.36 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.406 ' O ' ' CB ' ' A' ' 19' ' ' PRO . 89.9 m -128.73 119.53 20.21 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.12 -1.223 . . . . 0.0 110.245 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.655 ' HB2' HG22 ' A' ' 35' ' ' VAL . 48.6 Cg_endo -73.78 159.47 45.29 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 O-C-N 123.525 1.276 . . . . 0.0 110.878 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.507 ' CD1' HD12 ' A' ' 37' ' ' LEU . 44.2 t80 -65.79 -28.93 69.37 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.448 -0.783 . . . . 0.0 110.157 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.655 HG22 ' HB2' ' A' ' 33' ' ' PRO . 23.2 m -69.45 -9.83 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -0.904 . . . . 0.0 110.809 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.67 -1.96 23.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.965 -1.085 . . . . 0.0 110.892 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.548 HD21 ' CZ ' ' A' ' 17' ' ' TYR . 46.9 mt -52.07 162.57 0.45 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.883 -1.136 . . . . 0.0 110.27 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.7 t -49.57 164.86 0.08 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.31 -0.869 . . . . 0.0 110.44 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.46 -26.0 68.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.916 . . . . 0.0 110.233 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.9 p -131.65 52.73 2.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.271 -0.893 . . . . 0.0 110.46 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.478 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 26.9 t80 -63.46 132.17 50.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.216 -0.927 . . . . 0.0 109.785 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -110.17 143.97 39.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.878 . . . . 0.0 109.663 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.461 ' HB3' ' N ' ' A' ' 47' ' ' ARG . 8.7 t -55.49 137.45 69.56 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 110.741 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -77.6 -1.68 11.85 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.58 1.305 . . . . 0.0 110.287 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -120.56 -39.81 2.72 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.146 -0.971 . . . . 0.0 110.533 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.417 ' SG ' ' CB ' ' A' ' 48' ' ' SER . 0.6 OUTLIER -121.82 10.42 10.24 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.087 -1.008 . . . . 0.0 110.836 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.461 ' N ' ' HB3' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 52.95 17.73 0.94 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.29 -0.881 . . . . 0.0 112.655 178.557 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.417 ' CB ' ' SG ' ' A' ' 46' ' ' CYS . 4.1 t -67.7 156.2 89.6 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.598 -1.313 . . . . 0.0 109.715 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.86 143.48 45.65 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 123.684 1.36 . . . . 0.0 110.486 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.524 ' HA ' ' CD1' ' A' ' 53' ' ' PHE . 22.1 tttm -50.32 -25.26 3.6 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.325 -0.86 . . . . 0.0 110.517 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 -67.24 -11.61 57.92 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.202 -0.936 . . . . 0.0 110.146 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -92.52 0.7 57.46 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.053 -1.029 . . . . 0.0 110.104 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.524 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 39.6 m-85 -89.99 125.67 35.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.951 -1.093 . . . . 0.0 110.428 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.408 ' O ' ' HG2' ' A' ' 9' ' ' GLU . 12.0 tttt -100.75 131.54 46.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.391 -0.818 . . . . 0.0 109.579 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.667 ' O ' HG23 ' A' ' 56' ' ' ILE . 2.5 t -60.89 179.34 0.18 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.124 -0.985 . . . . 0.0 110.316 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.667 HG23 ' O ' ' A' ' 55' ' ' SER . 7.9 pt . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.782 -0.573 . . . . 0.0 109.509 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.898 ' O ' HG22 ' A' ' 56' ' ' ILE . 6.5 mttt . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.524 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 6.6 m-85 -111.93 132.19 54.91 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.055 -1.028 . . . . 0.0 110.354 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 17.3 tt0 -95.23 135.49 36.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.262 -0.899 . . . . 0.0 109.982 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.4 t -76.95 114.45 15.75 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.191 -0.943 . . . . 0.0 110.309 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -69.34 -11.47 60.84 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.192 -0.942 . . . . 0.0 109.722 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.418 ' HB2' ' OE1' ' A' ' 52' ' ' GLN . . . -85.2 -40.79 16.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.906 . . . . 0.0 111.819 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.474 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 14.0 p -124.53 -35.35 2.76 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.738 -1.226 . . . . 0.0 111.802 -178.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 116.94 20.5 4.87 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.616 -1.278 . . . . 0.0 109.988 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.858 ' C ' HD12 ' A' ' 16' ' ' ILE . 73.7 t80 -83.73 169.99 14.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -1.124 . . . . 0.0 109.51 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.858 HD12 ' C ' ' A' ' 15' ' ' TYR . 3.4 mp -132.7 110.23 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.119 -0.988 . . . . 0.0 110.064 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.499 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 73.3 t80 -70.06 140.28 52.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.265 -0.897 . . . . 0.0 110.109 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.444 ' HG2' ' HE2' ' A' ' 7' ' ' LYS . 14.6 mt-10 -115.26 108.21 48.26 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.545 -0.722 . . . . 0.0 109.857 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.441 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 38.0 Cg_endo -68.81 -74.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.427 1.224 . . . . 0.0 111.042 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -46.85 -25.76 0.83 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.4 -0.812 . . . . 0.0 110.914 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.99 -38.2 11.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.13 -0.981 . . . . 0.0 110.44 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.37 148.52 24.1 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.588 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 0.6 OUTLIER -85.09 61.99 7.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.399 -1.06 . . . . 0.0 110.07 179.787 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.18 -26.82 0.84 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.523 -0.735 . . . . 0.0 110.915 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -77.5 -23.0 50.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.173 -0.954 . . . . 0.0 110.333 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.588 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -102.69 -28.67 11.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.204 -0.935 . . . . 0.0 110.143 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.66 30.94 1.19 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.6 mt -122.89 122.39 27.09 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.123 -1.222 . . . . 0.0 109.783 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.401 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 45.5 Cg_endo -70.71 173.06 12.38 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 O-C-N 123.516 1.272 . . . . 0.0 110.529 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.401 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 48.3 Cg_endo -70.84 -163.54 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.788 1.415 . . . . 0.0 110.137 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 49.15 25.69 5.75 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 93.0 m -127.39 114.74 21.36 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.102 -1.234 . . . . 0.0 110.04 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.839 ' HB2' HG22 ' A' ' 35' ' ' VAL . 48.8 Cg_endo -73.72 149.88 43.91 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.501 1.263 . . . . 0.0 110.78 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.645 ' CD1' HD12 ' A' ' 37' ' ' LEU . 55.0 t80 -53.9 -26.88 27.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.361 -0.837 . . . . 0.0 110.151 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.839 HG22 ' HB2' ' A' ' 33' ' ' PRO . 35.4 m -69.09 -16.11 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.172 -0.955 . . . . 0.0 110.632 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.19 -2.48 49.62 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.045 -1.034 . . . . 0.0 110.927 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.645 HD12 ' CD1' ' A' ' 34' ' ' PHE . 58.4 mt -59.0 158.56 8.31 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.919 -1.113 . . . . 0.0 110.155 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.0 t -54.55 166.84 0.4 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.302 -0.874 . . . . 0.0 110.227 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -72.3 -11.68 60.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.206 -0.934 . . . . 0.0 110.635 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 54.3 p -137.37 34.02 2.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.966 -1.084 . . . . 0.0 110.322 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.482 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 22.9 t80 -54.25 144.23 20.79 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.257 -0.902 . . . . 0.0 109.59 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.07 138.31 51.7 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.2 -0.938 . . . . 0.0 110.32 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 39.2 t -57.33 131.8 81.15 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.453 -0.779 . . . . 0.0 110.182 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.61 -3.26 13.6 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.489 1.257 . . . . 0.0 110.673 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -111.12 -30.19 7.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.004 -1.06 . . . . 0.0 110.686 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.474 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 1.5 p -135.17 7.94 3.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.995 -1.065 . . . . 0.0 111.313 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.3 16.32 3.06 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.207 -0.933 . . . . 0.0 112.897 178.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.4 p -72.66 156.93 89.65 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 120.626 -1.296 . . . . 0.0 109.884 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.4 ' HG2' ' OD1' ' A' ' 51' ' ' ASN . 43.0 Cg_endo -69.0 140.67 46.16 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.551 1.29 . . . . 0.0 110.306 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.51 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 41.0 tttt -47.29 -30.42 3.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.31 -0.869 . . . . 0.0 111.481 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.4 ' OD1' ' HG2' ' A' ' 49' ' ' PRO . 29.6 p30 -63.18 -14.03 44.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.888 -1.133 . . . . 0.0 110.048 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.418 ' OE1' ' HB2' ' A' ' 12' ' ' ALA . 0.7 OUTLIER -85.97 -2.83 58.66 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.101 -0.999 . . . . 0.0 110.146 179.313 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -81.95 168.04 18.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.958 -1.089 . . . . 0.0 110.21 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 9' ' ' GLU . 0.7 OUTLIER -147.28 132.79 18.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.376 -0.827 . . . . 0.0 109.471 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.524 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 64.5 p -65.52 174.82 2.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.973 -1.08 . . . . 0.0 110.91 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.898 HG22 ' O ' ' A' ' 7' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.418 0.628 . . . . 0.0 110.207 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.424 ' O ' ' CG1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.54 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 4.2 m-85 -104.41 166.68 10.24 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.113 -0.992 . . . . 0.0 110.565 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.473 ' HB2' HD13 ' A' ' 56' ' ' ILE . 28.1 tt0 -131.12 134.33 46.47 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.344 -0.847 . . . . 0.0 110.279 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.9 t -74.85 112.42 11.04 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.204 -0.935 . . . . 0.0 109.991 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.61 -10.84 59.84 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.28 -0.968 . . . . 0.0 109.65 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.07 -39.93 17.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 111.767 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.452 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 13.0 p -124.54 -36.54 2.61 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.713 -1.242 . . . . 0.0 111.521 -178.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.27 21.16 4.15 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.852 ' C ' HD12 ' A' ' 16' ' ' ILE . 37.5 t80 -81.19 160.62 24.29 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.206 -1.173 . . . . 0.0 109.756 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.852 HD12 ' C ' ' A' ' 15' ' ' TYR . 2.8 mp -127.04 120.93 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.169 -0.957 . . . . 0.0 110.185 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.547 ' CE1' HD21 ' A' ' 37' ' ' LEU . 58.5 t80 -86.7 138.17 31.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.22 -0.925 . . . . 0.0 110.194 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -116.15 112.95 41.7 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.565 -0.709 . . . . 0.0 109.857 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.423 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 38.1 Cg_endo -72.02 -66.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.58 1.305 . . . . 0.0 111.026 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.402 ' O ' ' CB ' ' A' ' 30' ' ' PRO . 1.4 tt0 -45.26 -27.04 0.58 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.698 -0.626 . . . . 0.0 110.97 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.1 tptt -99.86 -30.65 11.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 110.332 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.62 148.38 8.35 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.445 ' HB3' HD12 ' A' ' 28' ' ' ILE . 2.0 t70 -85.03 63.16 7.95 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.451 -1.029 . . . . 0.0 109.599 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -45.34 -29.29 1.01 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.606 -0.684 . . . . 0.0 110.899 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -68.69 -26.46 65.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.314 -0.866 . . . . 0.0 109.89 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -100.67 -28.89 12.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.335 -0.853 . . . . 0.0 109.995 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.05 15.71 3.76 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.955 -1.117 . . . . 0.0 110.462 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.722 HD13 ' CD2' ' A' ' 37' ' ' LEU . 11.9 mt -105.64 121.68 45.19 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.776 -1.426 . . . . 0.0 109.78 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -70.86 171.82 14.92 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.504 1.265 . . . . 0.0 110.691 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.402 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 49.6 Cg_endo -71.42 -163.83 0.14 Allowed 'Trans proline' 0 C--N 1.314 -1.285 0 O-C-N 123.771 1.406 . . . . 0.0 110.201 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 47.98 33.43 10.11 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 85.0 m -137.27 121.63 12.24 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.194 -1.18 . . . . 0.0 110.191 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.763 ' HB2' HG22 ' A' ' 35' ' ' VAL . 48.1 Cg_endo -73.07 155.16 52.61 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.505 1.266 . . . . 0.0 110.745 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.671 ' CD2' HD12 ' A' ' 37' ' ' LEU . 24.5 t80 -58.04 -30.06 65.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.32 -0.862 . . . . 0.0 109.809 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.763 HG22 ' HB2' ' A' ' 33' ' ' PRO . 22.4 m -63.66 -14.84 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.321 -0.862 . . . . 0.0 110.691 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.64 0.94 45.77 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.053 -1.03 . . . . 0.0 111.001 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.722 ' CD2' HD13 ' A' ' 28' ' ' ILE . 21.3 mt -53.64 169.58 0.14 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.888 -1.133 . . . . 0.0 110.209 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.5 t -61.08 153.65 24.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.218 -0.927 . . . . 0.0 110.392 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -54.13 -39.3 66.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.262 -0.899 . . . . 0.0 110.445 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 96.7 p -120.04 43.85 2.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 110.489 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.444 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 40.7 t80 -63.26 137.01 58.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.202 -0.936 . . . . 0.0 109.971 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 45.2 mmm -111.47 164.43 12.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.206 -0.934 . . . . 0.0 109.575 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.3 t -76.63 133.27 70.7 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.291 -0.881 . . . . 0.0 110.3 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -75.09 -1.96 11.92 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.525 1.276 . . . . 0.0 110.287 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.96 -33.62 4.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.961 -1.087 . . . . 0.0 110.712 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.452 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.8 OUTLIER -129.38 7.12 5.34 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.995 -1.066 . . . . 0.0 111.188 -179.91 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.66 17.6 4.16 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.102 -0.999 . . . . 0.0 112.566 178.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.42 ' CB ' ' SG ' ' A' ' 46' ' ' CYS . 6.6 t -72.44 155.94 90.78 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 120.675 -1.266 . . . . 0.0 109.846 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.96 140.54 50.52 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.615 1.324 . . . . 0.0 110.377 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.464 ' HG2' ' CZ ' ' A' ' 34' ' ' PHE . 21.6 tttt -50.23 -25.41 3.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.238 -0.913 . . . . 0.0 110.735 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -66.6 -12.91 60.13 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.056 -1.028 . . . . 0.0 109.963 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -86.79 -2.88 58.91 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.07 -1.019 . . . . 0.0 110.08 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.495 ' HB2' ' CZ ' ' A' ' 34' ' ' PHE . 23.9 m-85 -86.41 134.33 33.71 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.956 -1.09 . . . . 0.0 110.072 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.68 139.11 52.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.203 -0.935 . . . . 0.0 109.612 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.646 ' O ' HG23 ' A' ' 56' ' ' ILE . 35.5 p -63.83 176.91 0.83 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.935 . . . . 0.0 111.034 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.646 HG23 ' O ' ' A' ' 55' ' ' SER . 8.1 pt . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.261 0.553 . . . . 0.0 109.639 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.842 ' O ' HG22 ' A' ' 56' ' ' ILE . 20.6 mtmt . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.537 ' CE2' ' CD2' ' A' ' 34' ' ' PHE . 14.9 m-85 -125.76 135.58 52.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.131 -0.981 . . . . 0.0 110.688 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 44.8 tt0 -103.91 138.99 39.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.384 -0.822 . . . . 0.0 110.063 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.7 t -79.66 112.53 17.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.191 -0.943 . . . . 0.0 110.331 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.97 -11.18 60.49 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.147 -0.97 . . . . 0.0 109.658 178.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.03 -41.07 16.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.298 -0.876 . . . . 0.0 111.598 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.462 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 14.2 p -123.12 -35.51 2.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.699 -1.25 . . . . 0.0 111.428 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 116.65 20.62 4.94 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 119.677 -1.249 . . . . 0.0 110.071 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.786 ' C ' HD12 ' A' ' 16' ' ' ILE . 67.4 t80 -84.84 169.11 14.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.108 -1.231 . . . . 0.0 109.828 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.786 HD12 ' C ' ' A' ' 15' ' ' TYR . 3.3 mp -133.39 115.2 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.218 -0.926 . . . . 0.0 110.154 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.49 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 58.3 t80 -75.47 136.63 40.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.913 . . . . 0.0 110.086 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.403 ' HB3' ' HB2' ' A' ' 21' ' ' LYS . 88.8 mt-10 -113.5 112.3 48.81 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.549 -0.72 . . . . 0.0 109.632 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.463 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 38.0 Cg_endo -70.06 -74.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.456 1.24 . . . . 0.0 111.554 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.411 ' O ' ' CB ' ' A' ' 30' ' ' PRO . 3.6 mm-40 -43.38 -27.3 0.25 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.525 -0.734 . . . . 0.0 111.398 -179.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.403 ' HB2' ' HB3' ' A' ' 18' ' ' GLU . 2.0 mmmt -93.65 -36.03 12.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.079 -1.013 . . . . 0.0 110.501 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.33 145.17 14.14 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.472 ' HB3' HD12 ' A' ' 28' ' ' ILE . 10.0 t0 -85.08 62.93 7.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.378 -1.072 . . . . 0.0 109.707 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -44.57 -27.17 0.44 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.595 -0.691 . . . . 0.0 111.251 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -74.6 -26.71 60.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.028 -1.045 . . . . 0.0 110.074 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -98.71 -27.93 13.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.219 -0.925 . . . . 0.0 109.983 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.05 30.72 1.42 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.477 HD11 ' CD1' ' A' ' 41' ' ' PHE . 11.4 mt -121.63 119.24 29.28 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.12 -1.224 . . . . 0.0 109.904 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.402 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 43.1 Cg_endo -69.26 173.13 10.97 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.459 1.242 . . . . 0.0 110.359 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.411 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 47.1 Cg_endo -70.05 -163.85 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.68 1.358 . . . . 0.0 110.224 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 48.49 39.91 23.11 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.7 m -142.26 115.56 6.45 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.176 -1.191 . . . . 0.0 110.446 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.767 ' HB2' HG22 ' A' ' 35' ' ' VAL . 46.1 Cg_endo -74.18 153.29 46.05 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.474 1.25 . . . . 0.0 110.51 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.586 ' CD1' HD12 ' A' ' 37' ' ' LEU . 43.3 t80 -61.74 -28.15 69.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.34 -0.85 . . . . 0.0 110.236 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.767 HG22 ' HB2' ' A' ' 33' ' ' PRO . 35.6 m -67.96 -9.73 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -0.933 . . . . 0.0 110.875 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.403 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -110.13 0.25 18.21 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.96 -1.087 . . . . 0.0 110.989 -179.744 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.586 HD12 ' CD1' ' A' ' 34' ' ' PHE . 28.2 mt -51.02 164.09 0.17 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.997 -1.064 . . . . 0.0 110.285 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.4 m -50.18 157.59 0.65 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.189 -0.944 . . . . 0.0 110.446 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.18 -15.48 46.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.0 110.398 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.2 51.74 1.58 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.071 -1.018 . . . . 0.0 110.43 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.477 ' CD1' HD11 ' A' ' 28' ' ' ILE . 32.1 t80 -68.96 142.84 54.58 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.213 -0.929 . . . . 0.0 110.022 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.429 ' HA ' ' O ' ' A' ' 48' ' ' SER . 7.7 mtt -120.11 150.67 40.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.327 -0.858 . . . . 0.0 109.57 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.442 ' HB3' ' N ' ' A' ' 47' ' ' ARG . 7.3 t -58.13 135.92 84.37 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.223 -0.923 . . . . 0.0 110.26 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.78 -2.89 12.86 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.596 1.314 . . . . 0.0 110.437 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -121.66 -50.42 2.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.91 -1.119 . . . . 0.0 110.918 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.462 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -105.38 5.54 31.84 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.03 -1.044 . . . . 0.0 111.304 -179.345 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.442 ' N ' ' HB3' ' A' ' 43' ' ' CYS . 12.3 ttm-85 56.92 20.48 5.34 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.061 -1.024 . . . . 0.0 112.272 178.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.429 ' O ' ' HA ' ' A' ' 42' ' ' MET . 2.8 t -70.41 155.95 92.64 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 120.798 -1.188 . . . . 0.0 109.676 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.91 142.56 43.15 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.588 1.31 . . . . 0.0 110.266 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.514 ' HE2' ' CE2' ' A' ' 34' ' ' PHE . 22.4 tttt -51.77 -25.27 7.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.157 -0.964 . . . . 0.0 110.329 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.5 t30 -68.2 -11.95 60.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.136 -0.977 . . . . 0.0 109.826 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -91.83 1.36 57.22 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.162 -0.961 . . . . 0.0 110.077 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.499 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 34.6 m-85 -90.78 129.09 36.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.018 -1.051 . . . . 0.0 110.628 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.93 134.31 49.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.368 -0.832 . . . . 0.0 109.603 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.509 ' HB3' ' CE2' ' A' ' 8' ' ' TYR . 86.4 p -64.25 -179.94 0.5 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.074 -1.016 . . . . 0.0 110.984 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.842 HG22 ' O ' ' A' ' 7' ' ' LYS . 9.7 tt . . . . . 0 N--CA 1.493 1.701 0 O-C-N 121.787 -0.57 . . . . 0.0 110.267 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.826 ' O ' HG22 ' A' ' 56' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.575 ' CE2' ' CD1' ' A' ' 34' ' ' PHE . 4.4 m-85 -95.47 133.93 38.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 110.555 -179.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.628 ' HA ' HD13 ' A' ' 16' ' ' ILE . 11.0 tt0 -101.54 132.06 47.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.42 -0.8 . . . . 0.0 110.281 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.1 t -74.39 119.45 18.61 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.2 -0.938 . . . . 0.0 110.169 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.3 -11.69 60.34 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.087 -1.008 . . . . 0.0 109.654 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.07 -37.85 19.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.241 -0.912 . . . . 0.0 111.699 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.468 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 13.7 p -126.63 -34.56 2.42 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.717 -1.24 . . . . 0.0 111.645 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.74 22.4 5.39 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.449 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 55.9 t80 -84.41 159.2 20.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.373 -1.074 . . . . 0.0 109.762 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.628 HD13 ' HA ' ' A' ' 9' ' ' GLU . 39.4 mm -123.6 111.0 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 0.0 110.655 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.43 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 53.1 t80 -75.75 130.65 38.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.41 -0.806 . . . . 0.0 110.175 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -108.38 113.25 60.49 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.434 -0.791 . . . . 0.0 109.406 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.49 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 38.3 Cg_endo -71.95 -64.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.495 1.261 . . . . 0.0 110.963 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -45.35 -26.82 0.58 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.702 -0.624 . . . . 0.0 111.12 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -97.07 -30.36 13.09 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.04 -1.037 . . . . 0.0 110.236 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.66 153.51 23.63 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.734 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -85.12 61.9 7.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.39 -1.064 . . . . 0.0 109.795 179.657 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.71 -28.51 0.63 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.513 -0.742 . . . . 0.0 110.953 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.8 -24.76 44.37 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.226 -0.921 . . . . 0.0 110.42 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.734 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -97.69 -27.48 14.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.154 -0.966 . . . . 0.0 110.213 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 119.48 27.57 2.14 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.44 HD13 ' CD2' ' A' ' 37' ' ' LEU . 6.5 mt -120.13 126.07 27.01 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.097 -1.237 . . . . 0.0 109.975 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.409 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 43.9 Cg_endo -71.3 173.28 12.55 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.54 1.284 . . . . 0.0 110.289 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 49.1 Cg_endo -70.76 -163.73 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.683 1.36 . . . . 0.0 110.088 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 47.71 26.79 4.2 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 91.8 m -124.22 111.34 28.52 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.138 -1.213 . . . . 0.0 110.292 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.712 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.3 Cg_endo -73.11 148.99 45.51 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.492 1.259 . . . . 0.0 110.614 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.575 ' CD1' ' CE2' ' A' ' 8' ' ' TYR . 12.7 t80 -52.46 -30.88 32.03 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.308 -0.87 . . . . 0.0 110.506 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.712 HG22 ' HB2' ' A' ' 33' ' ' PRO . 26.6 m -65.27 -17.49 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.23 -0.919 . . . . 0.0 110.841 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -99.73 -0.01 40.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.072 -1.017 . . . . 0.0 110.887 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.495 ' HA ' HD23 ' A' ' 37' ' ' LEU . 15.5 mt -53.66 170.68 0.11 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.853 -1.155 . . . . 0.0 110.248 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.8 m -57.82 166.2 1.51 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.207 -0.933 . . . . 0.0 110.412 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.44 -22.28 66.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.301 -0.874 . . . . 0.0 110.245 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.7 m -139.0 53.05 1.76 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.267 -0.896 . . . . 0.0 110.075 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.44 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 11.3 t80 -65.3 141.16 58.7 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.365 -0.834 . . . . 0.0 110.184 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.418 ' HA ' ' O ' ' A' ' 48' ' ' SER . 8.9 mtt -114.33 147.97 38.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.354 -0.841 . . . . 0.0 109.348 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.401 ' HB2' ' OG ' ' A' ' 48' ' ' SER . 23.9 t -60.48 138.36 92.45 Favored Pre-proline 0 C--N 1.3 -1.552 0 O-C-N 121.278 -0.889 . . . . 0.0 110.582 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -78.79 3.14 7.59 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.643 1.338 . . . . 0.0 110.661 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -124.57 -35.83 2.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.913 -1.117 . . . . 0.0 110.782 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.468 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 1.2 p -124.66 4.62 8.21 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.989 -1.069 . . . . 0.0 111.334 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.44 18.87 7.24 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.163 -0.961 . . . . 0.0 112.478 178.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 42' ' ' MET . 26.3 p -71.51 162.0 75.36 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 120.573 -1.329 . . . . 0.0 109.507 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.406 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 43.5 Cg_endo -70.4 144.86 51.81 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.596 1.314 . . . . 0.0 110.625 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.501 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 3.8 tttm -51.48 -31.23 22.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.219 -0.925 . . . . 0.0 110.496 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -65.25 -13.11 57.56 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.05 -1.032 . . . . 0.0 109.783 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.406 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.7 OUTLIER -84.79 -5.22 59.32 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.12 -0.988 . . . . 0.0 109.762 178.963 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.429 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 21.5 m-85 -84.25 152.78 23.98 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.255 -0.903 . . . . 0.0 109.582 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.7 ttpp -142.57 131.55 23.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.175 -0.953 . . . . 0.0 110.034 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.52 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 9.1 p -59.88 172.42 0.75 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.158 -0.964 . . . . 0.0 110.444 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.826 HG22 ' O ' ' A' ' 7' ' ' LYS . 2.6 tt . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.572 0.701 . . . . 0.0 109.898 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.2 mttt . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.108 0.48 . . . . 0.0 109.828 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.519 ' CE2' ' HB2' ' A' ' 55' ' ' SER . 27.1 m-85 -130.31 143.66 50.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.029 -1.044 . . . . 0.0 110.473 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.638 ' HA ' HD13 ' A' ' 16' ' ' ILE . 2.8 tm-20 -111.78 134.54 53.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.383 -0.823 . . . . 0.0 109.8 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.2 t -77.61 113.64 15.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.227 -0.921 . . . . 0.0 110.446 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -70.44 -11.23 60.78 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.182 -0.949 . . . . 0.0 109.556 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.99 -40.42 16.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.894 . . . . 0.0 111.579 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.471 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 12.5 p -124.18 -32.07 3.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.728 -1.232 . . . . 0.0 111.553 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.13 22.03 6.38 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.516 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 56.7 t80 -83.18 169.02 16.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.282 -1.128 . . . . 0.0 109.871 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.638 HD13 ' HA ' ' A' ' 9' ' ' GLU . 40.9 mm -134.06 115.32 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.058 -1.026 . . . . 0.0 110.68 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.503 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 69.5 t80 -78.88 136.8 37.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.335 -0.853 . . . . 0.0 109.898 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -117.75 112.61 38.59 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.482 -0.761 . . . . 0.0 109.801 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.491 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 37.7 Cg_endo -69.82 -63.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.442 1.233 . . . . 0.0 110.558 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -47.46 -25.47 1.08 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.691 -0.631 . . . . 0.0 110.635 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.56 -42.24 7.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 0.0 110.675 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.55 153.31 29.59 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.489 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 0.9 OUTLIER -85.12 60.44 6.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.369 -1.077 . . . . 0.0 109.975 179.762 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.99 -25.81 0.88 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.443 -0.786 . . . . 0.0 110.948 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.83 -20.95 41.3 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.179 -0.951 . . . . 0.0 110.318 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.489 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -104.39 -29.82 10.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.119 -0.988 . . . . 0.0 110.295 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 124.52 34.07 0.73 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.435 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 4.6 mt -128.73 125.65 23.09 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.162 -1.199 . . . . 0.0 109.712 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.86 173.26 14.3 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.468 1.246 . . . . 0.0 110.575 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.66 -163.79 0.13 Allowed 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.77 1.405 . . . . 0.0 109.913 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 48.72 25.72 5.01 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.5 m -125.84 115.68 24.43 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.295 -1.121 . . . . 0.0 109.979 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.725 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.6 Cg_endo -72.64 149.71 49.5 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.448 1.236 . . . . 0.0 110.894 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.685 ' CD1' HD12 ' A' ' 37' ' ' LEU . 60.4 t80 -54.97 -25.88 32.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.425 -0.797 . . . . 0.0 110.342 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.725 HG22 ' HB2' ' A' ' 33' ' ' PRO . 25.0 m -70.13 -24.23 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.11 -0.993 . . . . 0.0 110.304 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.407 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 3.0 t70 -87.5 -6.12 58.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.181 -0.949 . . . . 0.0 110.758 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.685 HD12 ' CD1' ' A' ' 34' ' ' PHE . 20.3 mt -52.19 160.54 0.76 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.043 -1.036 . . . . 0.0 110.282 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.87 150.78 19.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -0.897 . . . . 0.0 109.981 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -56.04 -25.39 44.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.254 -0.904 . . . . 0.0 110.313 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.34 38.34 4.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.122 -0.986 . . . . 0.0 110.709 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.453 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 36.4 t80 -59.34 133.45 56.1 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.043 -1.036 . . . . 0.0 109.793 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 13.8 mtp -109.98 155.79 21.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.367 -0.833 . . . . 0.0 109.5 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 30.6 t -71.78 131.8 85.62 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.15 -0.969 . . . . 0.0 110.213 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -75.41 -2.18 12.24 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.585 1.308 . . . . 0.0 110.513 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -112.91 -32.5 6.37 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.055 -1.028 . . . . 0.0 110.403 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.471 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 1.3 p -133.61 7.78 3.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.075 -1.016 . . . . 0.0 111.178 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 58.75 13.65 2.79 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.175 -0.953 . . . . 0.0 112.935 177.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.9 m -68.37 163.12 55.87 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 120.604 -1.31 . . . . 0.0 110.052 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.405 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 46.6 Cg_endo -72.6 143.59 38.33 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.699 1.368 . . . . 0.0 110.431 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.5 ' HE2' ' CE2' ' A' ' 34' ' ' PHE . 9.8 tttm -49.97 -26.39 4.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.039 -1.038 . . . . 0.0 110.666 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -66.64 -12.07 56.49 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.124 -0.985 . . . . 0.0 110.006 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 1.0 OUTLIER -86.27 -4.56 59.19 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.169 -0.957 . . . . 0.0 110.174 179.237 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.464 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 44.1 m-85 -84.25 144.44 28.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.945 -1.097 . . . . 0.0 110.44 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.0 ttmm -124.56 119.19 28.37 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.365 -0.834 . . . . 0.0 109.535 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.519 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 3.7 t -50.95 177.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.058 -1.026 . . . . 0.0 110.573 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.1 pt . . . . . 0 C--N 1.297 -1.681 0 O-C-N 121.653 -0.654 . . . . 0.0 110.012 179.721 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.516 ' O ' HG22 ' A' ' 56' ' ' ILE . 6.1 tttp . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.529 ' CE2' ' CD2' ' A' ' 34' ' ' PHE . 11.5 m-85 -112.28 155.27 24.34 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.981 -1.074 . . . . 0.0 110.602 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 8.3 tt0 -122.29 130.74 53.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.462 -0.774 . . . . 0.0 109.827 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 t -73.35 114.67 11.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.096 -1.002 . . . . 0.0 110.373 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.71 -12.68 61.71 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.371 -0.931 . . . . 0.0 109.36 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.03 -41.01 16.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.343 -0.848 . . . . 0.0 111.758 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.438 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 11.4 p -123.53 -28.58 3.89 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.583 -1.323 . . . . 0.0 111.795 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.71 20.06 8.76 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.226 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.804 ' C ' HD12 ' A' ' 16' ' ' ILE . 35.8 t80 -83.0 159.54 22.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.135 -1.215 . . . . 0.0 109.867 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.804 HD12 ' C ' ' A' ' 15' ' ' TYR . 2.9 mp -121.82 120.36 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.91 . . . . 0.0 109.835 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.488 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 61.4 t80 -84.12 138.0 33.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.908 . . . . 0.0 110.376 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.97 110.62 45.88 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.738 -0.601 . . . . 0.0 109.911 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.474 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 38.7 Cg_endo -72.89 -65.06 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.494 1.26 . . . . 0.0 111.088 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.426 ' O ' ' CB ' ' A' ' 30' ' ' PRO . 3.3 tt0 -45.48 -25.44 0.43 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.692 -0.63 . . . . 0.0 111.374 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.54 -41.84 7.57 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.094 -1.004 . . . . 0.0 110.65 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.26 145.96 19.75 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.539 ' HB3' HD12 ' A' ' 28' ' ' ILE . 22.4 t0 -85.09 63.23 7.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.335 -1.097 . . . . 0.0 109.676 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -43.64 -27.64 0.32 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.725 -0.61 . . . . 0.0 111.254 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -71.85 -29.1 64.04 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.154 -0.966 . . . . 0.0 109.924 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.494 ' HB3' HD12 ' A' ' 28' ' ' ILE . . . -96.82 -27.53 14.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.411 -0.805 . . . . 0.0 110.048 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.26 25.86 2.84 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.539 HD12 ' HB3' ' A' ' 23' ' ' ASP . 5.8 mt -114.6 120.27 38.08 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.074 -1.251 . . . . 0.0 110.001 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.426 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 45.4 Cg_endo -70.74 174.01 10.99 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.534 1.281 . . . . 0.0 110.509 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.426 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 47.6 Cg_endo -70.95 -163.28 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.715 1.376 . . . . 0.0 110.112 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 50.3 24.88 7.53 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 91.9 m -126.0 113.32 24.27 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.092 -1.24 . . . . 0.0 110.295 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.777 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.2 Cg_endo -72.1 149.68 52.72 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 O-C-N 123.532 1.28 . . . . 0.0 110.619 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.529 ' CD2' ' CE2' ' A' ' 8' ' ' TYR . 27.3 t80 -52.38 -28.67 20.58 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.371 -0.831 . . . . 0.0 109.957 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.777 HG22 ' HB2' ' A' ' 33' ' ' PRO . 24.8 m -70.23 -15.41 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.285 -0.884 . . . . 0.0 110.557 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -98.32 -6.43 30.91 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.025 -1.047 . . . . 0.0 110.752 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.438 HD21 ' CZ ' ' A' ' 17' ' ' TYR . 27.2 mt -51.25 162.28 0.34 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.956 -1.09 . . . . 0.0 110.461 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.3 m -50.31 154.8 1.14 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.347 -0.846 . . . . 0.0 110.508 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.19 -24.03 66.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.286 -0.884 . . . . 0.0 110.1 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.2 t -127.91 38.41 4.03 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.236 -0.915 . . . . 0.0 110.205 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.457 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 45.7 t80 -54.98 138.03 44.62 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.297 -0.877 . . . . 0.0 110.263 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.3 mmt -113.74 135.82 53.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.291 -0.881 . . . . 0.0 109.74 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 24.4 t -53.79 133.03 56.82 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.249 -0.907 . . . . 0.0 110.585 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -75.06 -3.69 14.29 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.447 1.235 . . . . 0.0 110.506 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -112.17 -35.65 5.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.033 -1.042 . . . . 0.0 110.559 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.438 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 1.5 p -128.57 6.51 5.69 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.087 -1.008 . . . . 0.0 111.01 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 54.46 20.07 2.63 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.209 -0.932 . . . . 0.0 112.714 178.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.0 m -74.27 165.68 51.33 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 120.617 -1.302 . . . . 0.0 109.658 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.51 136.06 30.11 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.638 1.336 . . . . 0.0 110.177 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 41' ' ' PHE . 14.5 tttm -48.32 -26.01 1.83 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.2 -0.938 . . . . 0.0 110.697 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -63.69 -15.07 57.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.167 -0.958 . . . . 0.0 109.822 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.13 -2.97 58.62 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.255 -0.903 . . . . 0.0 110.136 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 34' ' ' PHE . 11.3 m-85 -82.75 133.16 35.15 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.95 -1.094 . . . . 0.0 110.478 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.91 120.33 38.12 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.197 -0.939 . . . . 0.0 109.527 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 3.0 t -52.0 -178.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.338 -0.851 . . . . 0.0 110.625 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.59 HG23 ' O ' ' A' ' 56' ' ' ILE . 3.0 tt . . . . . 0 C--N 1.3 -1.575 0 O-C-N 121.531 -0.731 . . . . 0.0 109.691 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.69 ' HB3' HD11 ' A' ' 56' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.152 0.501 . . . . 0.0 109.951 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.505 ' CE2' ' HB2' ' A' ' 55' ' ' SER . 22.9 m-85 -117.0 149.1 40.8 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.148 -0.97 . . . . 0.0 110.381 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.466 ' HA ' HD13 ' A' ' 16' ' ' ILE . 1.2 tm-20 -119.16 130.06 55.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 0.0 110.323 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.6 t -73.62 114.72 12.2 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.274 -0.891 . . . . 0.0 110.25 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -70.4 -11.39 60.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.071 -1.018 . . . . 0.0 109.624 178.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.09 -42.29 14.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.397 -0.814 . . . . 0.0 111.579 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.466 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 13.8 p -121.88 -31.04 4.0 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.709 -1.245 . . . . 0.0 111.418 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.65 23.0 6.73 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.427 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 44.6 t80 -82.31 159.25 23.15 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.34 -1.094 . . . . 0.0 109.517 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.466 HD13 ' HA ' ' A' ' 9' ' ' GLU . 41.3 mm -123.77 115.77 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.205 -0.934 . . . . 0.0 110.041 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.535 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 81.1 t80 -81.44 135.81 35.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.3 -0.875 . . . . 0.0 110.321 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -114.94 114.33 43.92 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.529 -0.732 . . . . 0.0 109.603 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.481 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 37.7 Cg_endo -69.44 -67.04 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.531 1.28 . . . . 0.0 111.559 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -43.04 -28.0 0.24 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.739 -0.601 . . . . 0.0 111.225 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.4 tptt -96.8 -27.13 14.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.159 -0.963 . . . . 0.0 110.271 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.62 159.58 30.52 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.55 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 1.0 OUTLIER -85.05 59.86 5.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.339 -1.095 . . . . 0.0 109.81 179.799 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -46.51 -26.51 0.89 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.406 -0.809 . . . . 0.0 110.613 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -76.01 -28.01 57.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 110.061 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.55 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -97.71 -27.45 14.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.304 -0.872 . . . . 0.0 110.192 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.16 22.67 2.58 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.5 HD12 ' HB3' ' A' ' 23' ' ' ASP . 5.0 mt -112.18 130.01 23.72 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 120.975 -1.309 . . . . 0.0 109.595 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.416 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 49.1 Cg_endo -74.38 173.48 14.17 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.483 1.254 . . . . 0.0 110.393 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.416 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 49.9 Cg_endo -71.68 -163.54 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.65 1.342 . . . . 0.0 110.065 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 51.17 32.98 29.68 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.794 -1.323 . . . . 0.0 109.794 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 93.8 m -137.63 122.03 12.1 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.209 -1.171 . . . . 0.0 110.064 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.77 ' HB2' HG22 ' A' ' 35' ' ' VAL . 50.1 Cg_endo -76.32 151.84 34.19 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.547 1.288 . . . . 0.0 110.697 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.535 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 20.7 t80 -52.26 -33.25 40.86 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.305 -0.872 . . . . 0.0 109.84 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.77 HG22 ' HB2' ' A' ' 33' ' ' PRO . 33.3 m -64.69 -15.11 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.921 . . . . 0.0 110.506 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.53 -18.29 33.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.15 -0.968 . . . . 0.0 110.559 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.487 HD11 ' CE1' ' A' ' 17' ' ' TYR . 71.0 mt -51.81 146.45 8.13 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.046 -1.034 . . . . 0.0 110.29 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.93 160.0 0.36 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.194 -0.942 . . . . 0.0 110.519 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -66.83 -13.88 62.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -0.897 . . . . 0.0 110.624 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.6 t -122.11 25.5 9.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.023 -1.048 . . . . 0.0 110.365 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.463 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 25.4 t80 -54.81 135.22 47.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.131 -0.981 . . . . 0.0 109.871 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -109.42 150.66 27.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.369 -0.832 . . . . 0.0 109.58 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 18.1 t -66.38 134.76 94.62 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.113 -0.992 . . . . 0.0 110.347 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.71 -7.85 18.82 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.667 1.351 . . . . 0.0 110.185 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -110.19 -31.92 7.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.172 -0.955 . . . . 0.0 110.844 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.466 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.8 OUTLIER -134.49 7.31 3.57 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.021 -1.049 . . . . 0.0 111.353 -179.681 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 58.49 14.56 3.07 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.098 -1.001 . . . . 0.0 112.837 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.5 m -65.45 165.93 16.32 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 120.619 -1.301 . . . . 0.0 110.087 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.99 141.34 26.56 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.666 1.35 . . . . 0.0 110.152 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.463 ' HB2' ' HB3' ' A' ' 41' ' ' PHE . 8.6 tttm -51.87 -26.21 9.61 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.215 -0.928 . . . . 0.0 110.261 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.53 -11.17 59.52 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.185 -0.947 . . . . 0.0 109.89 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -88.88 -2.35 58.55 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.175 -0.953 . . . . 0.0 110.076 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.412 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 17.9 m-85 -86.25 140.01 30.51 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.999 -1.063 . . . . 0.0 110.226 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.61 124.89 46.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.2 -0.938 . . . . 0.0 109.801 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.527 ' C ' HG23 ' A' ' 56' ' ' ILE . 3.0 t -57.28 178.34 0.07 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.237 -0.914 . . . . 0.0 110.809 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.69 HD11 ' HB3' ' A' ' 7' ' ' LYS . 1.1 pt . . . . . 0 N--CA 1.494 1.747 0 O-C-N 121.828 -0.545 . . . . 0.0 109.832 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.43 ' O ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.52 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 7.8 m-85 -115.77 156.42 26.04 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.075 -1.015 . . . . 0.0 110.566 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.529 ' HA ' HD13 ' A' ' 16' ' ' ILE . 2.5 pp20? -126.43 136.26 52.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.367 -0.833 . . . . 0.0 110.168 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.0 t -78.25 111.84 14.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.945 . . . . 0.0 110.242 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.69 -10.83 59.82 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.204 -0.998 . . . . 0.0 109.426 178.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.68 -43.01 14.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.352 -0.843 . . . . 0.0 111.383 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.46 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 12.7 p -120.5 -31.66 4.26 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.632 -1.292 . . . . 0.0 111.273 -179.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.6 21.5 6.8 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.684 -1.246 . . . . 0.0 110.132 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.525 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 52.2 t80 -83.18 167.38 17.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.109 -1.23 . . . . 0.0 109.907 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.529 HD13 ' HA ' ' A' ' 9' ' ' GLU . 36.5 mm -131.11 117.67 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.137 -0.977 . . . . 0.0 110.334 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.503 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 72.7 t80 -81.04 135.31 35.82 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.436 -0.79 . . . . 0.0 110.422 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -112.38 113.7 50.98 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.612 -0.68 . . . . 0.0 109.761 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.47 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 39.0 Cg_endo -72.26 -68.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.414 1.218 . . . . 0.0 111.144 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -45.16 -26.63 0.5 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.581 -0.699 . . . . 0.0 111.2 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.99 -37.57 11.07 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.079 -1.013 . . . . 0.0 110.49 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.63 152.09 28.84 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.549 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 4.2 t0 -85.11 62.9 7.8 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.4 -1.059 . . . . 0.0 109.674 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.43 -27.37 0.44 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.647 -0.658 . . . . 0.0 111.03 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -77.22 -27.86 53.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.184 -0.947 . . . . 0.0 110.206 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.549 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -95.85 -28.83 14.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.251 -0.906 . . . . 0.0 110.362 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.08 11.55 5.21 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.815 -1.183 . . . . 0.0 110.296 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.422 HD12 ' HB3' ' A' ' 23' ' ' ASP . 4.6 mt -103.08 124.61 37.84 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 120.938 -1.33 . . . . 0.0 110.012 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.423 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 45.3 Cg_endo -71.91 173.74 12.31 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.468 1.246 . . . . 0.0 110.222 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.423 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 48.6 Cg_endo -70.19 -163.77 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.613 1.323 . . . . 0.0 110.252 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 49.94 27.17 9.52 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.4 m -128.12 116.51 20.33 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.333 -1.098 . . . . 0.0 110.279 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.842 ' HB2' HG22 ' A' ' 35' ' ' VAL . 49.0 Cg_endo -73.55 150.33 45.58 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.53 1.279 . . . . 0.0 110.617 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.503 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 12.7 t80 -53.49 -29.53 36.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.413 -0.804 . . . . 0.0 109.979 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.842 HG22 ' HB2' ' A' ' 33' ' ' PRO . 35.3 m -67.22 -13.2 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 110.608 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.6 -4.03 38.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.069 -1.02 . . . . 0.0 110.93 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.458 ' HA ' HD23 ' A' ' 37' ' ' LEU . 28.1 mt -53.13 165.61 0.31 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.872 -1.142 . . . . 0.0 110.14 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.0 m -59.36 162.48 4.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.889 . . . . 0.0 110.279 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.36 -27.42 69.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.311 -0.868 . . . . 0.0 110.2 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.65 46.31 2.5 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.263 -0.898 . . . . 0.0 110.042 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.438 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 23.9 t80 -62.58 140.2 58.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.334 -0.854 . . . . 0.0 110.159 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 36.5 mtt -112.61 151.08 30.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.358 -0.839 . . . . 0.0 109.468 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 29.4 t -65.69 135.46 95.6 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.178 -0.951 . . . . 0.0 110.268 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -75.87 -0.02 9.76 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.503 1.265 . . . . 0.0 110.594 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -119.39 -38.77 2.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.01 -1.056 . . . . 0.0 110.825 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.46 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 1.4 p -123.12 8.16 9.2 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.025 -1.047 . . . . 0.0 111.13 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 27.3 mtt85 54.5 18.84 2.12 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.332 -0.855 . . . . 0.0 112.79 178.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.5 m -72.52 166.3 43.43 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 120.577 -1.327 . . . . 0.0 109.732 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.408 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 45.2 Cg_endo -71.98 139.9 33.84 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.668 1.352 . . . . 0.0 110.387 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.499 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 9.6 tttm -48.98 -26.33 2.46 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.162 -0.961 . . . . 0.0 110.822 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -63.65 -14.9 56.22 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.127 -0.983 . . . . 0.0 109.862 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 1.1 tm0? -83.87 -4.2 58.49 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.157 -0.965 . . . . 0.0 110.151 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -86.23 131.81 34.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.977 -1.077 . . . . 0.0 110.348 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.41 ' O ' ' HG3' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -117.99 131.74 56.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.272 -0.893 . . . . 0.0 109.544 179.28 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.653 ' O ' HG23 ' A' ' 56' ' ' ILE . 79.7 p -60.82 176.86 0.36 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.156 -0.965 . . . . 0.0 110.893 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.653 HG23 ' O ' ' A' ' 55' ' ' SER . 9.9 pt . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 121.362 0.601 . . . . 0.0 109.699 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.431 ' O ' ' CG1' ' A' ' 56' ' ' ILE . 4.3 mmtt . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.587 ' CE2' ' CD2' ' A' ' 34' ' ' PHE . 7.5 m-85 -112.26 145.11 40.55 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.156 -0.965 . . . . 0.0 110.625 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 3.1 tt0 -115.12 135.74 53.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.404 -0.81 . . . . 0.0 109.995 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.9 t -75.24 113.46 12.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.23 -0.919 . . . . 0.0 110.573 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -11.28 60.79 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.449 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.14 -40.26 16.94 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.312 -0.867 . . . . 0.0 111.484 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.462 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 12.6 p -123.95 -32.51 3.26 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.683 -1.26 . . . . 0.0 111.484 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.55 21.71 6.37 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.851 ' C ' HD12 ' A' ' 16' ' ' ILE . 46.6 t80 -83.56 162.3 20.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -1.123 . . . . 0.0 109.74 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.851 HD12 ' C ' ' A' ' 15' ' ' TYR . 2.1 mp -123.51 116.39 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 0.0 109.939 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.504 ' OH ' HD21 ' A' ' 37' ' ' LEU . 78.3 t80 -82.86 127.87 33.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.164 -0.96 . . . . 0.0 110.15 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -106.4 111.08 64.25 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.698 -0.626 . . . . 0.0 109.614 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.474 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 38.1 Cg_endo -70.28 -63.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.525 1.276 . . . . 0.0 110.806 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -46.8 -26.05 0.88 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.73 -0.606 . . . . 0.0 110.558 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -95.29 -31.16 13.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -0.924 . . . . 0.0 110.041 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.69 153.59 21.68 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.728 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -85.19 60.85 6.5 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.395 -1.062 . . . . 0.0 109.431 179.473 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -46.84 -26.76 1.04 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.536 -0.727 . . . . 0.0 110.682 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -81.14 -22.49 38.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.175 -0.953 . . . . 0.0 110.207 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.728 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -100.08 -27.61 13.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.229 -0.919 . . . . 0.0 110.012 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.51 28.98 1.36 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.573 HD13 ' CD2' ' A' ' 37' ' ' LEU . 5.4 mt -125.14 123.58 25.34 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.013 -1.286 . . . . 0.0 109.707 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.42 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 44.0 Cg_endo -70.0 173.47 11.14 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.525 1.276 . . . . 0.0 110.238 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 47.2 Cg_endo -69.99 -163.72 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.674 1.355 . . . . 0.0 110.233 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 49.04 26.0 5.7 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.6 m -125.34 121.11 24.97 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.272 -1.134 . . . . 0.0 110.257 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.653 ' HB2' HG22 ' A' ' 35' ' ' VAL . 50.3 Cg_endo -76.41 158.16 36.69 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.477 1.251 . . . . 0.0 110.651 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.587 ' CD2' ' CE2' ' A' ' 8' ' ' TYR . 13.6 t80 -61.04 -34.18 74.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.349 -0.844 . . . . 0.0 109.945 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.653 HG22 ' HB2' ' A' ' 33' ' ' PRO . 26.8 m -65.51 -12.93 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.908 . . . . 0.0 110.529 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.57 -9.17 36.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.025 -1.047 . . . . 0.0 110.817 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.573 ' CD2' HD13 ' A' ' 28' ' ' ILE . 49.8 mt -53.85 156.07 3.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.0 -1.063 . . . . 0.0 110.185 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.9 t -52.56 147.78 7.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.168 -0.958 . . . . 0.0 110.255 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.64 -23.14 10.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 110.214 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 72.3 p -123.71 47.5 2.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.908 . . . . 0.0 110.487 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.465 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 27.7 t80 -70.56 145.63 50.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.164 -0.96 . . . . 0.0 109.835 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.411 ' HA ' ' O ' ' A' ' 48' ' ' SER . 28.3 mtm -121.11 138.02 54.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.293 -0.88 . . . . 0.0 109.994 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 27.5 t -54.68 133.81 64.8 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.368 -0.832 . . . . 0.0 110.235 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -76.33 -0.68 10.64 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.485 1.255 . . . . 0.0 110.627 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.72 -42.56 3.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.98 -1.075 . . . . 0.0 110.473 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.462 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 1.7 p -119.75 5.63 10.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.106 -0.996 . . . . 0.0 111.121 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 54.57 24.82 5.7 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.256 -0.902 . . . . 0.0 112.64 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 42' ' ' MET . 5.8 m -79.29 166.02 44.56 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 120.578 -1.327 . . . . 0.0 109.599 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.4 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 43.8 Cg_endo -70.37 140.89 41.4 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.567 1.299 . . . . 0.0 110.75 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.509 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 23.8 tttt -50.58 -24.66 3.4 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.21 -0.931 . . . . 0.0 110.55 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -66.01 -13.41 59.83 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.08 -1.013 . . . . 0.0 109.933 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.4 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.9 OUTLIER -85.05 -4.34 59.12 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.203 -0.936 . . . . 0.0 110.006 179.347 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -85.5 137.31 32.98 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.956 -1.09 . . . . 0.0 110.526 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.8 tttm -123.48 133.51 54.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.625 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.634 ' O ' HG23 ' A' ' 56' ' ' ILE . 68.6 p -62.11 175.56 0.69 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.177 -0.952 . . . . 0.0 110.888 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.634 HG23 ' O ' ' A' ' 55' ' ' SER . 7.4 pt . . . . . 0 N--CA 1.497 1.89 0 CA-C-O 121.334 0.588 . . . . 0.0 110.079 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.405 ' O ' ' CG1' ' A' ' 56' ' ' ILE . 20.1 mttt . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.525 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 9.1 m-85 -112.26 150.09 31.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.115 -0.991 . . . . 0.0 110.432 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 43.7 tt0 -120.35 138.49 53.7 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.337 -0.852 . . . . 0.0 110.564 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.1 t -77.23 111.06 12.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.321 -0.862 . . . . 0.0 110.3 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -68.02 -11.23 58.53 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.36 -0.936 . . . . 0.0 109.568 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.36 -42.06 16.11 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.296 -0.878 . . . . 0.0 111.52 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.453 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 14.5 p -121.86 -34.75 3.31 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.707 -1.246 . . . . 0.0 111.498 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.06 22.08 5.06 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.452 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 29.5 t80 -84.27 158.82 21.1 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.308 -1.113 . . . . 0.0 109.804 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.442 ' N ' ' CD1' ' A' ' 15' ' ' TYR . 29.3 mm -122.5 120.04 59.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.318 -0.864 . . . . 0.0 110.267 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.5 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 80.6 t80 -83.25 130.03 35.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.909 . . . . 0.0 109.97 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -109.95 114.76 55.95 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.583 -0.698 . . . . 0.0 109.484 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.478 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 37.8 Cg_endo -69.95 -68.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.529 1.279 . . . . 0.0 111.225 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -46.27 -25.48 0.63 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.476 -0.765 . . . . 0.0 111.175 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.66 -39.22 11.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.113 -0.992 . . . . 0.0 110.882 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.41 145.68 15.56 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.42 ' HB3' HD12 ' A' ' 28' ' ' ILE . 25.1 t0 -85.09 61.54 6.94 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.345 -1.091 . . . . 0.0 109.937 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.94 -25.92 1.54 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.397 -0.814 . . . . 0.0 110.461 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -75.49 -21.66 57.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.907 . . . . 0.0 110.092 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -105.56 -34.4 7.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.288 -0.883 . . . . 0.0 109.887 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 131.18 34.11 0.43 Allowed Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.892 -1.147 . . . . 0.0 110.361 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.52 HD13 ' CD2' ' A' ' 37' ' ' LEU . 5.2 mt -129.85 121.65 20.05 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 120.807 -1.408 . . . . 0.0 109.988 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.411 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 45.0 Cg_endo -70.13 173.93 10.58 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 O-C-N 123.613 1.323 . . . . 0.0 110.265 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 45.4 Cg_endo -68.59 -163.78 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.616 1.324 . . . . 0.0 110.176 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 47.76 27.79 4.91 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 15.4 m -125.75 113.9 24.81 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.218 -1.166 . . . . 0.0 110.344 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.718 ' HB2' HG22 ' A' ' 35' ' ' VAL . 45.9 Cg_endo -73.31 146.92 41.02 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 123.472 1.248 . . . . 0.0 110.738 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.5 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 22.7 t80 -51.41 -34.02 32.94 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.433 -0.792 . . . . 0.0 110.561 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.718 HG22 ' HB2' ' A' ' 33' ' ' PRO . 30.0 m -65.75 -14.04 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.202 -0.936 . . . . 0.0 110.723 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.416 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 36.0 t0 -98.32 -1.61 41.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.998 -1.063 . . . . 0.0 110.996 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.52 ' CD2' HD13 ' A' ' 28' ' ' ILE . 26.0 mt -54.38 176.37 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.903 -1.123 . . . . 0.0 110.17 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.9 m -69.36 152.98 44.3 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.235 -0.916 . . . . 0.0 110.123 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.65 -23.28 40.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.161 -0.962 . . . . 0.0 110.216 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.4 m -129.28 43.52 3.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.167 -0.958 . . . . 0.0 110.27 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.462 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 20.0 t80 -62.89 132.65 52.83 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.377 -0.827 . . . . 0.0 109.85 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.409 ' HA ' ' O ' ' A' ' 48' ' ' SER . 7.0 mtt -111.33 148.19 33.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.376 -0.827 . . . . 0.0 109.668 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.437 ' HB3' ' N ' ' A' ' 47' ' ' ARG . 10.0 t -57.99 135.23 83.83 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.897 . . . . 0.0 110.422 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -76.12 -0.34 10.21 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 123.628 1.331 . . . . 0.0 110.578 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -122.88 -38.97 2.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.943 -1.098 . . . . 0.0 110.859 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.453 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -121.24 8.03 10.27 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.038 -1.039 . . . . 0.0 111.202 -179.62 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.437 ' N ' ' HB3' ' A' ' 43' ' ' CYS . 2.5 ttt180 58.37 13.84 2.62 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.183 -0.948 . . . . 0.0 112.786 178.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.409 ' O ' ' HA ' ' A' ' 42' ' ' MET . 1.3 m -63.63 156.81 69.9 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 120.594 -1.316 . . . . 0.0 109.714 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.403 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 46.8 Cg_endo -72.77 146.54 43.07 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.665 1.35 . . . . 0.0 110.183 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 41' ' ' PHE . 19.5 tttm -53.74 -27.19 26.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.022 -1.049 . . . . 0.0 110.235 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -67.98 -11.29 58.57 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.176 -0.952 . . . . 0.0 109.827 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.8 OUTLIER -88.65 -2.67 58.72 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.21 -0.931 . . . . 0.0 110.016 179.205 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -89.9 126.06 35.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.012 -1.055 . . . . 0.0 110.348 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.2 tptt -108.8 134.13 51.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.209 -0.932 . . . . 0.0 109.739 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.525 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 80.0 p -63.72 179.46 0.49 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.121 -0.987 . . . . 0.0 110.761 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.491 HG23 ' C ' ' A' ' 55' ' ' SER . 1.1 pt . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.271 0.557 . . . . 0.0 110.157 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.427 ' CB ' HG12 ' A' ' 56' ' ' ILE . 29.2 mttt . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.514 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 13.4 m-85 -122.7 148.04 45.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.037 -1.039 . . . . 0.0 110.628 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 5.1 tm-20 -120.02 128.08 53.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.414 -0.804 . . . . 0.0 109.906 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.4 t -65.31 110.07 2.48 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.161 -0.962 . . . . 0.0 110.059 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.91 -11.92 57.77 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.206 -0.934 . . . . 0.0 109.612 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.01 -40.46 16.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.327 -0.858 . . . . 0.0 111.782 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 11.7 p -123.95 -32.71 3.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.647 -1.283 . . . . 0.0 111.523 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.09 18.9 6.57 Favored Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.713 -1.232 . . . . 0.0 110.256 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.529 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 42.7 t80 -76.28 167.98 20.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -1.175 . . . . 0.0 109.516 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.529 ' N ' ' CD1' ' A' ' 15' ' ' TYR . 35.1 mm -130.82 120.26 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 110.424 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.474 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 51.5 t80 -89.36 142.5 27.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.325 -0.86 . . . . 0.0 109.966 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -123.69 112.49 29.11 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.544 -0.723 . . . . 0.0 109.829 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.523 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 40.4 Cg_endo -72.2 -67.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.516 1.272 . . . . 0.0 111.284 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -44.22 -28.0 0.47 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.794 -0.566 . . . . 0.0 110.922 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.7 mttp -96.15 -40.06 9.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 0.0 110.24 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.29 147.85 22.53 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.481 ' HB3' HD12 ' A' ' 28' ' ' ILE . 2.8 t0 -84.94 61.11 6.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.465 -1.021 . . . . 0.0 109.65 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -45.49 -27.08 0.67 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.444 -0.785 . . . . 0.0 110.955 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -74.69 -27.43 60.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.115 -0.99 . . . . 0.0 109.975 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.462 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -98.48 -22.83 15.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.346 -0.846 . . . . 0.0 109.9 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.12 23.23 3.94 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.481 HD12 ' HB3' ' A' ' 23' ' ' ASP . 9.2 mt -115.26 114.57 43.07 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.117 -1.225 . . . . 0.0 109.907 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.409 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 43.0 Cg_endo -68.91 173.9 9.54 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 O-C-N 123.597 1.314 . . . . 0.0 110.294 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 44.9 Cg_endo -67.89 -164.43 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.57 1.3 . . . . 0.0 110.024 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 48.19 34.02 11.83 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 m -134.48 109.35 11.24 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.121 -1.223 . . . . 0.0 110.52 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.879 ' HB2' HG22 ' A' ' 35' ' ' VAL . 44.6 Cg_endo -71.8 148.72 52.81 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.455 1.24 . . . . 0.0 110.344 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.532 ' CD1' HD12 ' A' ' 37' ' ' LEU . 38.8 t80 -52.92 -24.23 8.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.204 -0.935 . . . . 0.0 109.861 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.879 HG22 ' HB2' ' A' ' 33' ' ' PRO . 32.1 m -72.27 -17.49 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.169 -0.957 . . . . 0.0 110.201 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.68 0.6 47.4 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.183 -0.948 . . . . 0.0 110.708 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.532 HD12 ' CD1' ' A' ' 34' ' ' PHE . 21.8 mt -52.23 167.33 0.13 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.947 -1.095 . . . . 0.0 110.182 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.3 m -56.53 173.31 0.19 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 110.257 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.05 -27.62 65.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.33 -0.856 . . . . 0.0 110.211 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 65.9 p -134.13 45.79 2.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 110.345 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.47 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 27.2 t80 -54.26 130.97 40.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.932 . . . . 0.0 109.932 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -108.34 150.01 27.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.427 -0.796 . . . . 0.0 109.43 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.436 ' HB3' ' N ' ' A' ' 47' ' ' ARG . 12.8 t -63.55 135.82 96.43 Favored Pre-proline 0 C--N 1.3 -1.551 0 O-C-N 121.16 -0.963 . . . . 0.0 110.539 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.76 -1.52 11.47 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.589 1.31 . . . . 0.0 110.382 178.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -118.72 -41.57 2.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.052 -1.03 . . . . 0.0 110.867 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -119.81 2.91 11.11 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.121 -0.987 . . . . 0.0 111.141 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.436 ' N ' ' HB3' ' A' ' 43' ' ' CYS . 1.1 ttt-85 58.28 23.36 10.31 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.146 -0.971 . . . . 0.0 112.515 178.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.3 m -75.01 164.94 58.01 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 120.566 -1.333 . . . . 0.0 109.676 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.06 138.98 29.07 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.632 1.333 . . . . 0.0 110.434 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.536 ' HA ' ' CD1' ' A' ' 53' ' ' PHE . 15.9 tttm -48.93 -29.18 4.46 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.271 -0.893 . . . . 0.0 110.821 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -63.09 -14.54 49.66 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.113 -0.992 . . . . 0.0 109.967 179.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -87.21 -1.39 57.87 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.086 -1.009 . . . . 0.0 110.169 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.536 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 32.6 m-85 -88.17 127.84 35.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.906 -1.121 . . . . 0.0 110.425 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.18 128.11 55.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 109.587 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.514 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 89.0 p -54.14 -174.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 110.814 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.625 ' O ' HD12 ' A' ' 56' ' ' ILE . 1.3 pp . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.679 -0.638 . . . . 0.0 109.875 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.427 ' CB ' HG12 ' A' ' 56' ' ' ILE . 29.2 mttt . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.514 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 13.4 m-85 -122.7 148.04 45.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.037 -1.039 . . . . 0.0 110.628 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 5.1 tm-20 -120.02 128.08 53.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.414 -0.804 . . . . 0.0 109.906 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.4 t -65.31 110.07 2.48 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.161 -0.962 . . . . 0.0 110.059 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.91 -11.92 57.77 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.206 -0.934 . . . . 0.0 109.612 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.01 -40.46 16.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.327 -0.858 . . . . 0.0 111.782 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 11.7 p -123.95 -32.71 3.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.647 -1.283 . . . . 0.0 111.523 -179.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.09 18.9 6.57 Favored Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.713 -1.232 . . . . 0.0 110.256 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.529 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 42.7 t80 -76.28 167.98 20.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -1.175 . . . . 0.0 109.516 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.529 ' N ' ' CD1' ' A' ' 15' ' ' TYR . 35.1 mm -130.82 120.26 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 110.424 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.474 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 51.5 t80 -89.36 142.5 27.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.325 -0.86 . . . . 0.0 109.966 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -123.69 112.49 29.11 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.544 -0.723 . . . . 0.0 109.829 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.523 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 40.4 Cg_endo -72.2 -67.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.516 1.272 . . . . 0.0 111.284 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -44.22 -28.0 0.47 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.794 -0.566 . . . . 0.0 110.922 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.7 mttp -96.15 -40.06 9.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 0.0 110.24 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.29 147.85 22.53 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.481 ' HB3' HD12 ' A' ' 28' ' ' ILE . 2.8 t0 -84.94 61.11 6.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.465 -1.021 . . . . 0.0 109.65 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -45.49 -27.08 0.67 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.444 -0.785 . . . . 0.0 110.955 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -74.69 -27.43 60.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.115 -0.99 . . . . 0.0 109.975 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.462 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -98.48 -22.83 15.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.346 -0.846 . . . . 0.0 109.9 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.12 23.23 3.94 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.481 HD12 ' HB3' ' A' ' 23' ' ' ASP . 9.2 mt -115.26 114.57 43.07 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.117 -1.225 . . . . 0.0 109.907 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.409 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 43.0 Cg_endo -68.91 173.9 9.54 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 O-C-N 123.597 1.314 . . . . 0.0 110.294 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 44.9 Cg_endo -67.89 -164.43 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.57 1.3 . . . . 0.0 110.024 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 48.19 34.02 11.83 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 m -134.48 109.35 11.24 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.121 -1.223 . . . . 0.0 110.52 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.879 ' HB2' HG22 ' A' ' 35' ' ' VAL . 44.6 Cg_endo -71.8 148.72 52.81 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.455 1.24 . . . . 0.0 110.344 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.532 ' CD1' HD12 ' A' ' 37' ' ' LEU . 38.8 t80 -52.92 -24.23 8.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.204 -0.935 . . . . 0.0 109.861 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.879 HG22 ' HB2' ' A' ' 33' ' ' PRO . 32.1 m -72.27 -17.49 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.169 -0.957 . . . . 0.0 110.201 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.68 0.6 47.4 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.183 -0.948 . . . . 0.0 110.708 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.532 HD12 ' CD1' ' A' ' 34' ' ' PHE . 21.8 mt -52.23 167.33 0.13 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.947 -1.095 . . . . 0.0 110.182 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.3 m -56.53 173.31 0.19 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 110.257 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.05 -27.62 65.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.33 -0.856 . . . . 0.0 110.211 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 65.9 p -134.13 45.79 2.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 110.345 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.47 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 27.2 t80 -54.26 130.97 40.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.932 . . . . 0.0 109.932 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -108.34 150.01 27.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.427 -0.796 . . . . 0.0 109.43 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.436 ' HB3' ' N ' ' A' ' 47' ' ' ARG . 12.8 t -63.55 135.82 96.43 Favored Pre-proline 0 C--N 1.3 -1.551 0 O-C-N 121.16 -0.963 . . . . 0.0 110.539 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.76 -1.52 11.47 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.589 1.31 . . . . 0.0 110.382 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -118.72 -41.57 2.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.052 -1.03 . . . . 0.0 110.867 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -119.81 2.91 11.11 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.121 -0.987 . . . . 0.0 111.141 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.436 ' N ' ' HB3' ' A' ' 43' ' ' CYS . 1.1 ttt-85 58.28 23.36 10.31 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.146 -0.971 . . . . 0.0 112.515 178.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.3 m -75.01 164.94 58.01 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 120.566 -1.333 . . . . 0.0 109.676 179.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.06 138.98 29.07 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.632 1.333 . . . . 0.0 110.434 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.536 ' HA ' ' CD1' ' A' ' 53' ' ' PHE . 15.9 tttm -48.93 -29.18 4.46 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.271 -0.893 . . . . 0.0 110.821 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -63.09 -14.54 49.66 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.113 -0.992 . . . . 0.0 109.967 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -87.21 -1.39 57.87 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.086 -1.009 . . . . 0.0 110.169 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.536 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 32.6 m-85 -88.17 127.84 35.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.906 -1.121 . . . . 0.0 110.425 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.18 128.11 55.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 109.587 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.514 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 89.0 p -54.14 -174.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 110.814 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.625 ' O ' HD12 ' A' ' 56' ' ' ILE . 1.3 pp . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.679 -0.638 . . . . 0.0 109.875 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.4 mtpt . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.544 ' HE2' ' HG ' ' A' ' 55' ' ' SER . 30.2 m-85 -115.78 139.26 50.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.034 -1.041 . . . . 0.0 110.789 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 29.8 tt0 -105.56 132.83 51.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.309 -0.87 . . . . 0.0 110.241 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.7 t -75.56 110.33 9.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 0.0 110.121 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.71 -11.92 56.37 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.203 -0.936 . . . . 0.0 109.866 178.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.03 -41.19 16.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -0.92 . . . . 0.0 111.717 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.47 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 13.8 p -122.85 -34.47 3.19 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.604 -1.31 . . . . 0.0 111.454 -179.095 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.76 21.72 5.29 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.8 ' C ' HD12 ' A' ' 16' ' ' ILE . 24.5 t80 -84.57 158.19 20.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.365 -1.079 . . . . 0.0 109.706 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.8 HD12 ' C ' ' A' ' 15' ' ' TYR . 3.2 mp -123.97 120.17 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.216 -0.928 . . . . 0.0 110.15 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.503 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 66.5 t80 -83.05 137.56 34.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.312 -0.868 . . . . 0.0 110.025 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.426 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 53.5 mt-10 -116.28 110.87 42.72 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.592 -0.693 . . . . 0.0 109.411 179.249 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.474 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 37.9 Cg_endo -69.42 -71.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.507 1.267 . . . . 0.0 111.151 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.414 ' O ' ' CB ' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -47.4 -24.73 0.85 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.335 -0.853 . . . . 0.0 111.04 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -94.52 -39.27 10.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.973 -1.079 . . . . 0.0 110.48 -179.881 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.16 137.93 9.29 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -85.07 63.73 8.28 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.392 -1.064 . . . . 0.0 109.679 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.96 -28.35 0.25 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.778 -0.576 . . . . 0.0 111.117 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -67.17 -33.62 75.8 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.202 -0.936 . . . . 0.0 109.795 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.53 ' HB3' HD12 ' A' ' 28' ' ' ILE . . . -95.94 -25.53 15.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.303 -0.873 . . . . 0.0 110.09 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.16 25.31 3.28 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.53 HD12 ' HB3' ' A' ' 26' ' ' ALA . 4.7 mt -112.15 118.74 45.48 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.071 -1.252 . . . . 0.0 110.079 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.433 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 45.4 Cg_endo -71.95 174.49 11.16 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 O-C-N 123.541 1.285 . . . . 0.0 110.219 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.433 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 46.8 Cg_endo -69.27 -164.72 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.582 1.306 . . . . 0.0 109.933 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 47.73 26.19 3.88 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 47.9 m -127.45 111.4 21.07 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.136 -1.214 . . . . 0.0 110.038 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.853 ' HB2' HG22 ' A' ' 35' ' ' VAL . 45.0 Cg_endo -71.76 147.56 50.76 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.604 1.318 . . . . 0.0 110.77 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.513 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 47.3 t80 -54.42 -25.74 26.59 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.542 -0.723 . . . . 0.0 110.275 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.853 HG22 ' HB2' ' A' ' 33' ' ' PRO . 34.2 m -71.06 -13.59 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.272 -0.893 . . . . 0.0 110.647 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.56 -4.5 41.17 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.091 -1.005 . . . . 0.0 110.891 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 37' ' ' LEU . 51.3 mt -51.0 164.53 0.15 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.91 -1.119 . . . . 0.0 110.428 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.03 173.31 1.44 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.324 -0.86 . . . . 0.0 110.244 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -74.17 -19.33 60.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.367 -0.833 . . . . 0.0 110.293 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.9 m -128.79 36.05 4.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.0 110.534 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.484 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 31.5 t80 -56.18 123.3 14.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.144 -0.973 . . . . 0.0 109.464 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 7.3 mtt -106.72 142.4 36.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 0.0 109.682 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.445 ' HB3' ' N ' ' A' ' 47' ' ' ARG . 5.4 t -52.58 136.41 43.36 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.27 -0.894 . . . . 0.0 110.426 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.66 -1.52 11.21 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.574 1.302 . . . . 0.0 110.673 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -123.9 -42.5 2.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.91 -1.119 . . . . 0.0 110.811 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.47 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -114.15 5.11 15.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.065 -1.022 . . . . 0.0 111.122 -179.703 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.445 ' N ' ' HB3' ' A' ' 43' ' ' CYS . 27.3 mtt180 54.43 25.65 6.3 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.171 -0.956 . . . . 0.0 112.408 178.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.417 ' CB ' ' SG ' ' A' ' 46' ' ' CYS . 2.5 t -75.6 157.68 83.98 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 120.702 -1.249 . . . . 0.0 109.779 178.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.16 139.45 35.49 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.675 1.355 . . . . 0.0 110.362 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.529 ' HA ' ' CD1' ' A' ' 53' ' ' PHE . 56.0 tttt -48.49 -28.26 3.22 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.184 -0.947 . . . . 0.0 110.901 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -67.14 -10.85 54.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.1 -1.0 . . . . 0.0 110.096 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -89.66 -2.38 58.28 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.191 -0.943 . . . . 0.0 110.193 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.529 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 33.1 m-85 -88.74 125.48 34.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.845 -1.159 . . . . 0.0 110.083 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -97.1 139.57 32.9 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.246 -0.909 . . . . 0.0 109.935 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.544 ' HG ' ' HE2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -80.12 153.99 28.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.426 -0.796 . . . . 0.0 110.187 -179.519 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.677 HG23 ' O ' ' A' ' 56' ' ' ILE . 1.2 tp . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.289 -0.882 . . . . 0.0 110.236 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.447 ' O ' HG22 ' A' ' 56' ' ' ILE . 17.0 mttt . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.158 0.504 . . . . 0.0 109.707 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.516 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 13.3 m-85 -108.34 152.08 25.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.055 -1.028 . . . . 0.0 110.561 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.531 ' HA ' HD13 ' A' ' 16' ' ' ILE . 1.6 tm-20 -119.91 122.99 42.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.442 -0.786 . . . . 0.0 109.814 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.4 t -64.39 111.16 2.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.109 -0.994 . . . . 0.0 110.515 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -67.51 -12.17 59.69 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.229 -0.919 . . . . 0.0 109.501 178.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.04 -39.98 17.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.285 -0.884 . . . . 0.0 111.647 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.449 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 11.9 p -125.07 -29.66 3.3 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.62 -1.3 . . . . 0.0 111.433 -179.167 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.08 18.93 8.85 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.585 -1.293 . . . . 0.0 110.421 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 48.1 t80 -78.87 167.12 21.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.126 -1.22 . . . . 0.0 109.547 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.531 HD13 ' HA ' ' A' ' 9' ' ' GLU . 35.3 mm -129.06 115.54 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.17 -0.956 . . . . 0.0 110.454 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.517 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 73.1 t80 -82.17 136.31 35.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.436 -0.79 . . . . 0.0 110.378 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 22' ' ' GLY . 5.6 mt-10 -115.84 109.65 45.02 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.599 -0.688 . . . . 0.0 109.468 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.493 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 37.9 Cg_endo -68.77 -70.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.573 1.302 . . . . 0.0 111.467 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -44.75 -27.09 0.46 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.551 -0.718 . . . . 0.0 111.034 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.41 -22.56 15.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.165 -0.959 . . . . 0.0 110.078 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 18' ' ' GLU . . . 79.93 147.22 4.44 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.522 ' HB3' HD12 ' A' ' 28' ' ' ILE . 15.2 t0 -85.04 62.32 7.43 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.356 -1.085 . . . . 0.0 109.69 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.56 -28.8 0.41 Allowed 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 121.465 0.65 . . . . 0.0 110.827 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.85 -32.12 73.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.298 -0.876 . . . . 0.0 110.005 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -99.03 -28.0 13.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.263 -0.898 . . . . 0.0 110.368 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.81 25.13 2.17 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.578 HD11 ' CD1' ' A' ' 41' ' ' PHE . 9.8 mt -110.71 123.98 34.22 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 120.955 -1.32 . . . . 0.0 109.597 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -70.9 170.09 18.77 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.49 1.258 . . . . 0.0 110.588 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -71.85 -163.39 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.694 1.365 . . . . 0.0 110.296 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 49.14 31.52 11.67 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 84.3 m -136.88 116.69 10.65 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.163 -1.198 . . . . 0.0 110.289 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.493 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 47.2 Cg_endo -72.15 148.21 49.76 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 123.582 1.306 . . . . 0.0 110.345 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.517 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 5.5 t80 -51.08 -36.37 39.76 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.238 -0.914 . . . . 0.0 110.018 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.14 -13.79 12.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.408 -0.807 . . . . 0.0 110.748 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -98.58 -0.25 43.53 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.028 -1.045 . . . . 0.0 110.691 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.514 HD21 ' CE1' ' A' ' 17' ' ' TYR . 36.9 mt -55.82 163.59 1.39 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.913 -1.117 . . . . 0.0 110.248 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.9 m -53.73 168.38 0.19 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.323 -0.86 . . . . 0.0 110.367 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.98 -35.18 79.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.275 -0.891 . . . . 0.0 110.29 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.2 t -124.32 51.6 1.57 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.179 -0.95 . . . . 0.0 110.369 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.578 ' CD1' HD11 ' A' ' 28' ' ' ILE . 18.1 t80 -64.76 126.93 29.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.171 -0.956 . . . . 0.0 109.915 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.415 ' HA ' ' O ' ' A' ' 48' ' ' SER . 10.9 mtt -97.95 145.36 26.55 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.23 -0.919 . . . . 0.0 109.588 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 25.1 t -63.01 136.34 96.64 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.214 -0.929 . . . . 0.0 110.375 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -75.93 -3.27 13.63 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.581 1.306 . . . . 0.0 110.571 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -115.23 -37.9 3.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.038 -1.039 . . . . 0.0 110.823 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.449 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 1.6 p -124.72 7.07 8.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.045 -1.035 . . . . 0.0 111.152 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 57.2 17.16 3.4 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.195 -0.941 . . . . 0.0 112.804 178.101 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' A' ' 42' ' ' MET . 11.6 m -74.7 163.09 70.63 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 120.589 -1.319 . . . . 0.0 109.899 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.23 141.78 36.43 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.666 1.35 . . . . 0.0 110.699 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.519 ' HA ' ' CD1' ' A' ' 53' ' ' PHE . 24.5 tttm -48.34 -27.85 2.81 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.327 -0.858 . . . . 0.0 110.833 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -62.07 -15.29 43.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.075 -1.016 . . . . 0.0 109.971 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -86.45 -1.93 58.01 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.106 -0.996 . . . . 0.0 110.276 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.519 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 20.9 m-85 -85.09 134.34 34.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.833 -1.167 . . . . 0.0 110.494 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.99 119.99 35.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.385 -0.822 . . . . 0.0 109.768 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.516 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 3.4 t -52.89 178.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 110.58 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.661 HG23 ' O ' ' A' ' 56' ' ' ILE . 2.7 tt . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.664 -0.647 . . . . 0.0 109.952 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.826 ' O ' HG22 ' A' ' 56' ' ' ILE . 4.0 mttt . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.529 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 6.8 m-85 -109.55 150.23 28.48 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.073 -1.017 . . . . 0.0 110.784 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.682 ' HA ' HD13 ' A' ' 16' ' ' ILE . 17.9 tt0 -119.46 132.57 55.82 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.433 -0.792 . . . . 0.0 109.555 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.9 t -72.91 114.6 11.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.103 -0.998 . . . . 0.0 110.591 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -70.84 -11.66 61.09 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.379 -0.928 . . . . 0.0 109.548 178.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.07 -40.55 16.69 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.312 -0.867 . . . . 0.0 111.759 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.457 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 12.6 p -123.53 -33.65 3.19 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.65 -1.281 . . . . 0.0 111.413 -178.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.23 21.45 5.89 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.129 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.524 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 49.9 t80 -84.45 168.67 15.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.296 -1.12 . . . . 0.0 109.812 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.682 HD13 ' HA ' ' A' ' 9' ' ' GLU . 40.9 mm -131.47 117.54 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.185 -0.947 . . . . 0.0 110.621 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.52 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 61.3 t80 -83.64 128.76 34.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.408 -0.808 . . . . 0.0 110.133 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -106.51 111.9 63.91 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.361 -0.837 . . . . 0.0 109.749 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.495 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 37.9 Cg_endo -69.78 -65.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.489 1.257 . . . . 0.0 111.085 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -45.64 -29.43 1.23 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.648 -0.658 . . . . 0.0 110.865 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.6 mttp -94.82 -38.05 10.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 0.0 110.173 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.29 150.65 26.34 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.533 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 1.5 t0 -85.08 63.86 8.35 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.438 -1.036 . . . . 0.0 109.653 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -46.39 -27.27 1.02 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.525 -0.735 . . . . 0.0 110.796 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -74.77 -23.15 58.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.22 -0.925 . . . . 0.0 109.985 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.533 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -100.99 -31.28 11.19 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.377 -0.827 . . . . 0.0 109.92 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.34 28.29 1.35 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.488 HD13 ' CD2' ' A' ' 37' ' ' LEU . 10.7 mt -118.84 123.7 28.85 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.906 -1.349 . . . . 0.0 109.774 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.406 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 43.3 Cg_endo -69.94 173.41 11.17 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.486 1.256 . . . . 0.0 110.431 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 51.1 Cg_endo -72.39 -164.09 0.17 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.564 1.297 . . . . 0.0 110.216 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 48.5 30.98 8.85 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.6 m -131.01 116.85 16.95 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.118 -1.225 . . . . 0.0 110.362 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.825 ' HB2' HG22 ' A' ' 35' ' ' VAL . 49.1 Cg_endo -74.49 150.31 40.64 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.408 1.215 . . . . 0.0 110.469 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.545 ' CD2' HD12 ' A' ' 37' ' ' LEU . 11.8 t80 -56.94 -23.45 45.38 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.231 -0.918 . . . . 0.0 109.907 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.825 HG22 ' HB2' ' A' ' 33' ' ' PRO . 31.3 m -70.22 -15.61 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.288 -0.883 . . . . 0.0 110.718 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.12 -0.99 35.16 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.174 -0.954 . . . . 0.0 110.893 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.545 HD12 ' CD2' ' A' ' 34' ' ' PHE . 41.0 mt -54.28 161.27 1.39 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.826 -1.171 . . . . 0.0 110.159 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.7 m -52.68 177.67 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.216 -0.928 . . . . 0.0 110.187 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.7 -18.03 49.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.248 -0.907 . . . . 0.0 110.458 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.6 p -133.2 37.4 3.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.105 -0.997 . . . . 0.0 110.541 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.462 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 14.5 t80 -56.61 133.87 54.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.138 -0.976 . . . . 0.0 109.774 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.438 ' HA ' ' O ' ' A' ' 48' ' ' SER . 5.1 mtt -106.99 143.9 34.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 109.854 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 35.9 t -56.64 138.96 76.6 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.879 . . . . 0.0 110.472 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -77.8 2.79 7.52 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.523 1.275 . . . . 0.0 110.873 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -124.61 -38.23 2.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.961 -1.087 . . . . 0.0 110.873 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.457 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 1.6 p -121.59 6.17 10.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.091 -1.006 . . . . 0.0 111.43 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.36 17.73 4.99 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.033 -1.042 . . . . 0.0 112.622 178.042 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.438 ' O ' ' HA ' ' A' ' 42' ' ' MET . 4.4 m -72.81 163.06 71.13 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 120.56 -1.338 . . . . 0.0 109.628 179.209 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.38 145.74 54.44 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.667 1.351 . . . . 0.0 110.334 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.502 ' HG2' ' CZ ' ' A' ' 34' ' ' PHE . 31.1 tttt -51.6 -24.74 5.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.3 -0.875 . . . . 0.0 110.255 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -66.12 -13.95 60.99 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.248 -0.907 . . . . 0.0 109.773 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -85.73 -3.73 58.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.238 -0.914 . . . . 0.0 110.043 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.45 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 17.1 m-85 -84.77 134.75 34.31 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.039 -1.038 . . . . 0.0 110.437 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.47 130.36 55.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.307 -0.87 . . . . 0.0 109.736 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.529 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 74.7 p -63.7 179.54 0.48 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 111.188 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.826 HG22 ' O ' ' A' ' 7' ' ' LYS . 4.8 tp . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.348 0.594 . . . . 0.0 109.546 179.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.904 ' O ' HG22 ' A' ' 56' ' ' ILE . 1.3 mttt . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.193 0.521 . . . . 0.0 109.961 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.586 ' CE2' ' CD1' ' A' ' 34' ' ' PHE . 8.0 m-85 -113.95 125.54 54.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.131 -0.981 . . . . 0.0 109.931 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 2.1 tm-20 -88.85 128.78 35.67 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.239 -0.913 . . . . 0.0 110.168 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.6 t -72.35 115.16 11.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.195 -0.941 . . . . 0.0 110.242 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -70.37 -12.8 61.83 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.146 -0.971 . . . . 0.0 109.537 178.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.08 -42.75 14.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.324 -0.86 . . . . 0.0 111.657 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.46 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 12.9 p -120.85 -27.29 5.05 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.72 -1.238 . . . . 0.0 111.382 -178.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.72 22.01 9.28 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.447 ' CG ' ' N ' ' A' ' 16' ' ' ILE . 60.7 t80 -81.88 168.35 18.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -1.117 . . . . 0.0 109.545 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.447 ' N ' ' CG ' ' A' ' 15' ' ' TYR . 25.7 mm -127.58 102.65 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.238 -0.914 . . . . 0.0 109.935 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.519 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 76.4 t80 -66.91 134.82 52.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 109.693 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -114.4 110.6 47.47 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.475 -0.766 . . . . 0.0 110.01 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.501 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 39.2 Cg_endo -71.04 -62.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.506 1.266 . . . . 0.0 110.641 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -45.1 -26.45 0.46 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.825 -0.547 . . . . 0.0 111.054 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.5 mtpp -103.16 -29.51 11.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.083 -1.01 . . . . 0.0 110.364 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.75 151.36 21.57 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.736 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 0.3 OUTLIER -85.1 63.42 8.1 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.399 -1.06 . . . . 0.0 109.533 179.754 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.69 -26.6 0.96 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.517 -0.74 . . . . 0.0 110.79 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -78.88 -19.77 51.11 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.189 -0.944 . . . . 0.0 110.254 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.736 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -104.1 -32.36 9.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.259 -0.9 . . . . 0.0 109.965 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 125.09 32.3 0.8 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.3 mt -126.82 123.51 23.75 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.037 -1.272 . . . . 0.0 109.875 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.407 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 46.5 Cg_endo -71.2 173.09 12.76 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.543 1.286 . . . . 0.0 110.596 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 50.2 Cg_endo -72.45 -163.4 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.759 1.399 . . . . 0.0 110.255 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 49.77 26.43 8.05 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.3 m -132.75 117.94 15.37 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.161 -1.2 . . . . 0.0 110.3 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.822 ' HB2' HG22 ' A' ' 35' ' ' VAL . 48.4 Cg_endo -74.38 151.77 43.22 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.492 1.259 . . . . 0.0 110.755 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.586 ' CD1' ' CE2' ' A' ' 8' ' ' TYR . 9.2 t80 -55.47 -24.42 30.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.365 -0.834 . . . . 0.0 110.104 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.822 HG22 ' HB2' ' A' ' 33' ' ' PRO . 26.9 m -71.07 -17.21 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 0.0 110.532 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -100.24 3.54 43.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.051 -1.031 . . . . 0.0 110.859 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' A' ' 37' ' ' LEU . 40.9 mt -54.64 169.67 0.2 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.975 -1.078 . . . . 0.0 110.265 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.25 162.05 12.72 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.184 -0.947 . . . . 0.0 110.253 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.3 -19.36 61.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.274 -0.891 . . . . 0.0 110.339 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -132.76 54.1 1.97 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.219 -0.926 . . . . 0.0 110.136 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.465 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 30.7 t80 -70.19 129.5 39.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.298 -0.876 . . . . 0.0 109.98 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 6.8 mtp -112.0 141.06 46.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.231 -0.918 . . . . 0.0 109.605 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 17.7 t -55.45 133.42 70.61 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 0.0 110.527 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.72 -1.91 11.75 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.615 1.324 . . . . 0.0 110.458 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.84 -35.92 4.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.976 -1.077 . . . . 0.0 110.914 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.46 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.9 OUTLIER -127.15 16.4 7.24 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.989 -1.069 . . . . 0.0 110.943 -179.694 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 56.4 mtt85 45.48 23.56 0.14 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.371 -0.831 . . . . 0.0 112.611 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.417 ' CB ' ' SG ' ' A' ' 46' ' ' CYS . 7.3 t -75.66 156.03 85.02 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 120.61 -1.307 . . . . 0.0 109.872 179.087 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.44 141.18 50.22 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.604 1.318 . . . . 0.0 110.41 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.517 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 12.5 tttm -49.16 -26.92 3.13 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.33 -0.856 . . . . 0.0 110.789 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.71 -14.56 53.43 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.066 -1.021 . . . . 0.0 109.952 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -89.2 1.45 55.66 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.227 -0.921 . . . . 0.0 110.271 179.303 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -89.54 148.47 23.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.896 -1.127 . . . . 0.0 111.012 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.5 133.95 47.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.564 -0.71 . . . . 0.0 109.152 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.535 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 75.7 p -70.52 176.81 3.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.989 -1.069 . . . . 0.0 111.301 -179.092 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.904 HG22 ' O ' ' A' ' 7' ' ' LYS . 1.6 tt . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.361 0.601 . . . . 0.0 109.912 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.734 ' O ' HG22 ' A' ' 56' ' ' ILE . 19.6 mttm . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.503 ' CE2' ' HB2' ' A' ' 55' ' ' SER . 22.3 m-85 -122.64 139.56 53.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -0.906 . . . . 0.0 110.858 -179.385 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.4 OUTLIER -110.13 141.15 43.41 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.361 -0.837 . . . . 0.0 109.836 179.409 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.7 t -81.01 114.1 19.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.068 -1.02 . . . . 0.0 110.37 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.27 -11.51 60.95 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.174 -0.954 . . . . 0.0 109.633 178.874 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.04 -42.22 15.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.369 -0.832 . . . . 0.0 111.759 -179.252 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.449 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 13.6 p -121.42 -34.71 3.4 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.668 -1.27 . . . . 0.0 111.424 -178.946 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.49 20.48 5.44 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 119.673 -1.251 . . . . 0.0 110.211 179.419 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.864 ' C ' HD12 ' A' ' 16' ' ' ILE . 55.9 t80 -84.58 162.49 19.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.206 -1.173 . . . . 0.0 109.856 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.864 HD12 ' C ' ' A' ' 15' ' ' TYR . 3.3 mp -128.29 115.13 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.125 -0.984 . . . . 0.0 110.018 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.567 ' CE1' HD21 ' A' ' 37' ' ' LEU . 71.2 t80 -77.44 131.18 37.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.316 -0.865 . . . . 0.0 110.187 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -109.5 115.71 55.65 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.427 -0.795 . . . . 0.0 109.415 179.371 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.487 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 38.2 Cg_endo -71.0 -65.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.465 1.245 . . . . 0.0 111.041 -179.484 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' A' ' 30' ' ' PRO . 0.5 OUTLIER -47.86 -24.04 0.9 Allowed 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.552 -0.717 . . . . 0.0 111.023 -179.835 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.2 tttp -99.13 -40.06 8.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.923 -1.11 . . . . 0.0 110.732 -179.724 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.74 147.85 22.72 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -85.11 61.34 6.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.447 -1.031 . . . . 0.0 109.985 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -44.72 -27.31 0.48 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.622 -0.674 . . . . 0.0 111.039 -179.724 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -69.26 -28.33 66.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.118 -0.989 . . . . 0.0 109.88 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -100.88 -28.33 12.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.343 -0.848 . . . . 0.0 109.983 179.661 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.54 28.54 1.43 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 179.598 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.57 HD13 ' CD2' ' A' ' 37' ' ' LEU . 8.8 mt -116.87 119.82 34.82 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.046 -1.267 . . . . 0.0 109.739 179.647 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.403 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 48.0 Cg_endo -71.81 172.95 13.47 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.496 1.261 . . . . 0.0 110.553 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.425 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 49.1 Cg_endo -70.64 -163.37 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.741 1.39 . . . . 0.0 110.28 179.813 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 50.22 27.83 12.03 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.849 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 63.3 m -131.71 115.91 15.87 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.198 -1.178 . . . . 0.0 110.341 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.848 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.2 Cg_endo -72.83 148.61 46.4 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.466 1.245 . . . . 0.0 110.586 179.818 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.519 ' CE1' ' HE2' ' A' ' 50' ' ' LYS . 30.1 t80 -53.06 -30.27 34.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.36 -0.838 . . . . 0.0 109.968 179.823 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.848 HG22 ' HB2' ' A' ' 33' ' ' PRO . 33.9 m -66.75 -11.78 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.844 . . . . 0.0 110.716 -179.876 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.401 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 1.5 t70 -103.2 -2.42 27.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.012 -1.055 . . . . 0.0 110.92 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.57 ' CD2' HD13 ' A' ' 28' ' ' ILE . 19.7 mt -52.1 172.81 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.926 -1.109 . . . . 0.0 110.312 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.8 m -64.36 150.9 45.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.219 -0.926 . . . . 0.0 110.23 -179.9 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -57.65 -22.18 44.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 0.0 110.234 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.4 p -129.61 38.51 3.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 0.0 109.911 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.465 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 30.8 t80 -60.46 135.66 57.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 110.345 -179.784 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.432 ' HA ' ' O ' ' A' ' 48' ' ' SER . 0.0 OUTLIER -109.81 149.55 29.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.336 -0.853 . . . . 0.0 109.558 179.214 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 18.1 t -61.1 137.0 94.05 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.104 -0.997 . . . . 0.0 110.52 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.11 -3.37 13.75 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.602 1.317 . . . . 0.0 110.353 179.383 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.97 -39.28 3.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.07 -1.019 . . . . 0.0 110.632 -179.682 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.449 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.9 OUTLIER -124.24 9.17 8.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.164 -0.96 . . . . 0.0 110.954 -179.801 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 54.39 15.98 1.14 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.31 -0.869 . . . . 0.0 112.964 178.147 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.432 ' O ' ' HA ' ' A' ' 42' ' ' MET . 3.4 m -67.25 165.38 28.73 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 120.621 -1.299 . . . . 0.0 109.746 179.293 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.458 ' HB2' ' ND2' ' A' ' 51' ' ' ASN . 43.5 Cg_endo -69.85 144.29 53.08 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.677 1.356 . . . . 0.0 110.492 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.519 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 37.4 tttt -53.57 -32.16 49.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.174 -0.954 . . . . 0.0 110.608 -179.679 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.458 ' ND2' ' HB2' ' A' ' 49' ' ' PRO . 24.5 p30 -63.29 -14.45 49.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.054 -1.029 . . . . 0.0 109.738 179.258 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.7 OUTLIER -80.62 -7.66 59.35 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.069 -1.019 . . . . 0.0 109.755 178.985 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -82.56 124.62 30.3 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.107 -0.996 . . . . 0.0 109.678 179.375 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.416 ' O ' ' HG3' ' A' ' 9' ' ' GLU . 1.5 tttm -104.03 123.78 47.83 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.142 -0.974 . . . . 0.0 109.545 179.52 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.503 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 2.2 t -52.12 -179.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.103 -0.998 . . . . 0.0 110.241 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.734 HG22 ' O ' ' A' ' 7' ' ' LYS . 4.5 tt . . . . . 0 N--CA 1.493 1.716 0 O-C-N 121.457 -0.777 . . . . 0.0 110.046 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.408 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.206 0.527 . . . . 0.0 110.19 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.726 ' HG2' HG22 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -135.84 103.13 5.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.282 -0.886 . . . . 0.0 110.097 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.457 HG21 HG23 ' A' ' 56' ' ' ILE . 51.2 mt -137.98 166.45 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.148 -0.97 . . . . 0.0 110.328 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.423 ' HA ' ' CG ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER 174.02 -24.88 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.271 -0.893 . . . . 0.0 111.046 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.68 61.44 0.16 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.06 -1.025 . . . . 0.0 110.74 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 48.6 25.52 4.71 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.777 ' O ' HG22 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -76.12 117.36 17.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.096 -1.238 . . . . 0.0 109.723 179.566 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.588 ' CE2' ' CD1' ' A' ' 34' ' ' PHE . 4.3 m-85 -100.4 147.05 26.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.13 -0.981 . . . . 0.0 109.908 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -117.71 128.15 54.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.234 -0.916 . . . . 0.0 110.222 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.9 t -69.86 112.04 6.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 110.178 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -11.54 59.54 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.135 -0.978 . . . . 0.0 109.592 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.19 -39.61 17.63 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.29 -0.881 . . . . 0.0 111.76 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.452 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 12.6 p -125.61 -32.99 2.82 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.672 -1.268 . . . . 0.0 111.752 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.83 21.61 5.97 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.777 ' C ' HD12 ' A' ' 16' ' ' ILE . 54.2 t80 -83.09 156.03 23.53 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.229 -1.16 . . . . 0.0 109.565 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.777 HD12 ' C ' ' A' ' 15' ' ' TYR . 2.7 mp -120.57 109.88 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 110.262 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.523 ' CE1' HD21 ' A' ' 37' ' ' LEU . 64.5 t80 -75.75 126.63 31.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.321 -0.862 . . . . 0.0 109.659 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.431 ' HB3' ' CB ' ' A' ' 21' ' ' LYS . 24.2 mt-10 -102.48 111.21 64.41 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.345 -0.847 . . . . 0.0 109.666 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.48 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 37.7 Cg_endo -68.77 -70.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.487 1.256 . . . . 0.0 110.939 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.403 ' O ' ' CB ' ' A' ' 30' ' ' PRO . 66.4 tt0 -47.45 -26.18 1.29 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.448 -0.783 . . . . 0.0 110.567 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.431 ' CB ' ' HB3' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -93.58 -33.75 13.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.241 -0.912 . . . . 0.0 110.196 179.833 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.91 157.03 32.27 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.471 ' HB3' HD12 ' A' ' 28' ' ' ILE . 8.5 t0 -85.04 61.34 6.81 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.479 -1.013 . . . . 0.0 109.854 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -46.54 -26.67 0.93 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.454 -0.779 . . . . 0.0 110.679 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -80.77 -25.28 38.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.265 -0.897 . . . . 0.0 110.125 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.443 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -97.82 -30.41 12.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.209 -0.932 . . . . 0.0 110.157 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 127.39 4.17 5.92 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.959 -1.115 . . . . 0.0 110.536 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.471 HD12 ' HB3' ' A' ' 23' ' ' ASP . 3.5 mt -98.19 129.04 31.65 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.824 -1.398 . . . . 0.0 110.162 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.417 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 47.0 Cg_endo -74.31 173.14 14.71 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 O-C-N 123.505 1.266 . . . . 0.0 110.557 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 49.9 Cg_endo -70.9 -163.38 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.623 1.328 . . . . 0.0 110.262 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 50.21 40.58 37.39 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 99.7 m -147.28 115.46 4.26 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.183 -1.187 . . . . 0.0 110.253 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.73 ' HB2' HG22 ' A' ' 35' ' ' VAL . 45.4 Cg_endo -71.98 151.55 56.35 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.514 1.27 . . . . 0.0 110.584 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.588 ' CD1' ' CE2' ' A' ' 8' ' ' TYR . 12.6 t80 -54.6 -32.5 58.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.328 -0.858 . . . . 0.0 110.066 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.73 HG22 ' HB2' ' A' ' 33' ' ' PRO . 24.4 m -63.56 -13.47 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.355 -0.841 . . . . 0.0 110.623 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -102.57 4.38 38.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.027 -1.045 . . . . 0.0 111.053 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.523 HD21 ' CE1' ' A' ' 17' ' ' TYR . 22.4 mt -56.61 178.97 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.832 -1.167 . . . . 0.0 110.044 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.8 m -69.18 164.96 21.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.215 -0.928 . . . . 0.0 110.324 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -63.93 -20.79 66.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.207 -0.933 . . . . 0.0 110.218 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.3 m -138.89 54.91 1.73 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.163 -0.961 . . . . 0.0 110.356 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.45 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 18.4 t80 -70.69 140.98 51.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.147 -0.971 . . . . 0.0 109.831 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.429 ' HA ' ' O ' ' A' ' 48' ' ' SER . 1.9 mtt -116.4 143.9 44.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.289 -0.882 . . . . 0.0 109.644 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 11.6 t -60.16 132.84 90.17 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.195 -0.941 . . . . 0.0 110.498 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.92 -9.22 20.79 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.569 1.3 . . . . 0.0 110.314 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -106.15 -40.04 5.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.078 -1.014 . . . . 0.0 110.707 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.452 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 1.3 p -122.72 5.1 9.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.133 -0.98 . . . . 0.0 111.113 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 4.2 mtm105 57.65 18.17 4.53 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.185 -0.947 . . . . 0.0 112.816 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.429 ' O ' ' HA ' ' A' ' 42' ' ' MET . 4.6 m -72.32 163.34 68.19 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 120.66 -1.275 . . . . 0.0 109.704 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -70.52 143.74 48.04 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.639 1.336 . . . . 0.0 110.235 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.511 ' HG2' ' CZ ' ' A' ' 34' ' ' PHE . 19.4 tttt -49.94 -24.63 2.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.208 -0.933 . . . . 0.0 110.549 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -66.17 -14.14 61.36 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.096 -1.002 . . . . 0.0 109.977 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -83.93 -5.56 59.24 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.141 -0.974 . . . . 0.0 109.999 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.523 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 12.7 m-85 -85.11 149.46 25.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.018 -1.051 . . . . 0.0 110.285 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.66 132.66 26.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.352 -0.842 . . . . 0.0 109.878 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.53 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 5.8 p -61.83 172.62 1.25 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.166 -0.959 . . . . 0.0 110.917 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.777 HG22 ' O ' ' A' ' 7' ' ' LYS . 3.2 tt -159.99 77.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.733 -0.605 . . . . 0.0 109.718 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.423 ' CG ' ' HA ' ' A' ' 4' ' ' ASP . 0.5 OUTLIER -100.71 65.76 1.17 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.299 -0.876 . . . . 0.0 109.975 -179.877 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.49 153.15 50.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.5 -0.75 . . . . 0.0 110.131 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.726 HG22 ' HG2' ' A' ' 2' ' ' GLU . 98.8 t -125.4 113.2 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.24 -0.913 . . . . 0.0 110.16 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 mp -126.1 120.58 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.158 -0.963 . . . . 0.0 110.29 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -176.2 127.16 0.21 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.34 -0.85 . . . . 0.0 109.913 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -176.85 104.96 0.19 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.404 ' CE1' ' HB3' ' A' ' 64' ' ' ALA . 52.9 p90 -118.76 -27.22 5.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.209 -1.171 . . . . 0.0 110.377 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.404 ' HB3' ' CE1' ' A' ' 63' ' ' PHE . . . -141.97 145.27 34.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 110.322 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -154.36 79.01 1.1 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.302 -0.874 . . . . 0.0 110.146 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 m-20 -90.74 53.16 2.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.164 -0.96 . . . . 0.0 110.406 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -157.43 -177.38 6.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.192 -0.942 . . . . 0.0 110.296 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.38 30.29 3.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 110.203 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.2 t80 53.58 68.38 0.85 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.191 -0.943 . . . . 0.0 110.255 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 CA-C-O 118.03 -1.428 . . . . 0.0 109.584 179.933 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.424 ' N ' ' OE1' ' A' ' 9' ' ' GLU . 6.4 ttt . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.222 0.534 . . . . 0.0 110.057 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.79 ' O ' HD13 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -61.88 96.38 0.07 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 110.158 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.79 HD13 ' O ' ' A' ' 2' ' ' GLU . 29.8 mm -140.91 165.68 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.248 -0.908 . . . . 0.0 109.649 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.528 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 29.7 t70 -138.48 5.17 2.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.104 -0.997 . . . . 0.0 111.178 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.492 ' H ' HG22 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -90.57 -148.47 0.2 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.956 -1.09 . . . . 0.0 109.858 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.11 30.67 6.9 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.86 ' O ' HG22 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -80.24 130.39 35.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -1.152 . . . . 0.0 109.936 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.564 ' CE2' ' CD2' ' A' ' 34' ' ' PHE . 7.4 m-85 -109.59 141.93 41.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.168 -0.957 . . . . 0.0 109.878 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.508 ' HA ' HD13 ' A' ' 16' ' ' ILE . 4.8 tt0 -106.18 129.88 54.16 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.162 -0.961 . . . . 0.0 110.275 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.9 t -71.42 116.17 11.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 110.339 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.73 -11.47 60.96 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.091 -1.006 . . . . 0.0 109.585 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.686 ' HB2' ' OE1' ' A' ' 52' ' ' GLN . . . -85.15 -41.37 15.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.309 -0.87 . . . . 0.0 111.653 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.472 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 14.3 p -123.12 -32.62 3.43 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.758 -1.214 . . . . 0.0 111.406 -179.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.0 24.0 5.92 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.46 ' CD2' ' N ' ' A' ' 16' ' ' ILE . 40.9 t80 -84.13 168.96 15.33 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.365 -1.079 . . . . 0.0 109.343 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.508 HD13 ' HA ' ' A' ' 9' ' ' GLU . 33.9 mm -129.41 117.59 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.27 -0.894 . . . . 0.0 110.309 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.543 ' CE1' HD21 ' A' ' 37' ' ' LEU . 56.1 t80 -80.54 129.17 34.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.429 -0.794 . . . . 0.0 109.912 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -104.91 110.73 64.87 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.488 -0.758 . . . . 0.0 109.546 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.464 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 37.5 Cg_endo -68.58 -76.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.591 1.311 . . . . 0.0 111.464 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -46.02 -26.58 0.75 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.285 -0.885 . . . . 0.0 111.037 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.5 tttp -87.95 -36.09 17.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 110.522 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.46 145.63 17.81 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.413 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 2.9 t0 -85.11 62.07 7.27 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.3 -1.118 . . . . 0.0 109.876 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.39 -26.5 2.1 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.249 -0.907 . . . . 0.0 110.416 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -74.51 -20.41 59.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.303 -0.873 . . . . 0.0 109.921 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.413 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -106.99 -33.28 7.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.929 . . . . 0.0 109.969 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.94 32.97 0.66 Allowed Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.948 -1.12 . . . . 0.0 110.309 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.1 mt -124.1 130.39 24.4 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 120.876 -1.367 . . . . 0.0 109.753 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.46 173.21 13.57 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 O-C-N 123.601 1.316 . . . . 0.0 110.394 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -72.19 -164.87 0.19 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.629 1.331 . . . . 0.0 110.186 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 49.76 27.87 10.18 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.9 m -127.94 112.08 20.28 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.099 -1.236 . . . . 0.0 110.228 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.75 ' HB2' HG22 ' A' ' 35' ' ' VAL . 44.3 Cg_endo -70.87 153.08 64.0 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.554 1.292 . . . . 0.0 110.478 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.763 ' CD1' HD12 ' A' ' 37' ' ' LEU . 27.5 t80 -55.48 -28.36 54.04 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.234 -0.916 . . . . 0.0 110.106 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.75 HG22 ' HB2' ' A' ' 33' ' ' PRO . 33.8 m -64.79 -20.16 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.207 -0.933 . . . . 0.0 110.077 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -90.54 -11.11 41.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.13 -0.981 . . . . 0.0 110.69 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.763 HD12 ' CD1' ' A' ' 34' ' ' PHE . 25.5 mt -52.54 157.65 1.47 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.974 -1.079 . . . . 0.0 110.322 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.34 139.34 58.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.307 -0.871 . . . . 0.0 109.99 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -51.17 -24.86 4.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.26 -0.9 . . . . 0.0 110.348 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.95 26.19 10.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.87 . . . . 0.0 110.177 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.455 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 18.3 t80 -56.04 131.96 48.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 109.844 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.1 mtt -113.3 147.46 37.55 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.265 -0.897 . . . . 0.0 109.545 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 7.9 t -58.72 134.25 86.39 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.0 110.44 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -77.83 1.09 9.21 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.533 1.281 . . . . 0.0 110.29 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -120.97 -34.96 3.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.027 -1.045 . . . . 0.0 110.923 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.472 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.7 OUTLIER -126.16 4.07 7.14 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.937 -1.102 . . . . 0.0 111.345 -179.668 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.78 17.75 10.13 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.085 -1.009 . . . . 0.0 112.142 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.41 ' OG ' ' HB3' ' A' ' 52' ' ' GLN . 5.0 t -70.44 153.39 95.11 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.822 -1.174 . . . . 0.0 109.707 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.16 145.33 43.89 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.587 1.309 . . . . 0.0 110.558 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.455 ' HB2' ' HB3' ' A' ' 41' ' ' PHE . 24.7 tttm -52.37 -32.03 36.6 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.175 -0.953 . . . . 0.0 110.186 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.15 -15.66 47.39 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.122 -0.987 . . . . 0.0 109.745 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.686 ' OE1' ' HB2' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -91.1 3.77 53.92 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.24 -0.912 . . . . 0.0 110.159 179.401 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.403 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 18.8 m-85 -92.84 128.16 38.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.896 -1.127 . . . . 0.0 110.209 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.86 135.73 50.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.301 -0.874 . . . . 0.0 109.737 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.529 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 77.9 p -68.15 -178.44 1.04 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 110.908 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.86 HG22 ' O ' ' A' ' 7' ' ' LYS . 7.2 tp -160.0 88.12 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 121.466 0.65 . . . . 0.0 109.691 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 4' ' ' ASP . 6.0 ptmt -101.66 64.55 0.99 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.136 -0.978 . . . . 0.0 110.533 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -174.62 156.75 2.44 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.172 -0.955 . . . . 0.0 110.487 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.2 m -103.48 178.31 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 0.0 110.275 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.5 mm -112.4 -65.09 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.29 -0.881 . . . . 0.0 110.223 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.83 62.92 6.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.227 -0.921 . . . . 0.0 110.268 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -101.07 110.27 3.85 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -89.83 61.22 5.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -1.144 . . . . 0.0 110.438 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.3 -20.39 40.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 110.142 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.22 -33.49 11.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.295 -0.878 . . . . 0.0 110.291 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -88.16 121.98 31.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.278 -0.889 . . . . 0.0 110.264 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -103.54 62.89 0.78 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.205 -0.934 . . . . 0.0 110.177 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 20.2 tttm -109.86 -42.62 4.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.284 -0.885 . . . . 0.0 110.08 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.62 109.39 9.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -0.915 . . . . 0.0 110.099 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 CA-C-O 117.965 -1.464 . . . . 0.0 109.453 -179.878 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.151 0.5 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.0 65.16 1.34 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.166 -0.959 . . . . 0.0 110.691 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.477 HG22 ' N ' ' A' ' 4' ' ' ASP . 4.2 mp -128.72 169.31 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.187 -0.946 . . . . 0.0 109.478 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.533 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 29.4 t70 -141.42 4.53 1.79 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.003 -1.061 . . . . 0.0 111.62 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.456 ' H ' HG22 ' A' ' 3' ' ' ILE . 16.8 mm-40 -91.38 -146.95 0.21 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.809 -1.182 . . . . 0.0 109.662 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.74 33.58 5.11 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.872 ' O ' HG22 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -80.19 133.65 36.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.334 -1.098 . . . . 0.0 109.879 179.875 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.52 ' CE2' ' HB3' ' A' ' 55' ' ' SER . 8.9 m-85 -118.1 135.88 53.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.153 -0.967 . . . . 0.0 109.635 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.407 ' HA ' HD13 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -101.53 135.76 42.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.048 -1.033 . . . . 0.0 110.55 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.9 t -77.49 113.95 15.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.194 -0.941 . . . . 0.0 110.248 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.01 -10.26 59.45 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.004 -1.06 . . . . 0.0 109.572 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.05 -39.48 17.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.43 -0.794 . . . . 0.0 111.584 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.48 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 13.8 p -125.5 -35.24 2.58 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.652 -1.28 . . . . 0.0 111.531 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.02 22.8 4.81 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.466 ' CG ' ' N ' ' A' ' 16' ' ' ILE . 59.2 t80 -83.66 170.22 14.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.351 -1.088 . . . . 0.0 109.871 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.466 ' N ' ' CG ' ' A' ' 15' ' ' TYR . 37.2 mm -132.24 115.03 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 110.255 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.5 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 68.4 t80 -78.17 135.94 37.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.331 -0.856 . . . . 0.0 110.136 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.415 ' O ' ' N ' ' A' ' 22' ' ' GLY . 5.8 mt-10 -115.28 110.09 45.75 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.516 -0.74 . . . . 0.0 109.461 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.447 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 37.4 Cg_endo -68.99 -72.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.395 0 O-C-N 123.52 1.274 . . . . 0.0 111.237 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -44.81 -27.27 0.49 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.544 -0.722 . . . . 0.0 111.032 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -98.13 -24.02 15.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.207 -0.933 . . . . 0.0 110.147 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 18' ' ' GLU . . . 80.04 153.36 8.49 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.596 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 0.3 OUTLIER -84.93 61.2 6.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.361 -1.081 . . . . 0.0 109.595 179.627 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.45 -27.78 0.78 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.57 -0.706 . . . . 0.0 110.965 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.85 -28.08 60.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.187 -0.946 . . . . 0.0 109.899 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.596 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -96.54 -28.22 14.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.291 -0.88 . . . . 0.0 110.073 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.8 24.63 2.27 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.49 HD11 ' CD1' ' A' ' 41' ' ' PHE . 7.6 mt -113.98 128.86 25.32 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.959 -1.318 . . . . 0.0 109.684 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.33 170.45 19.87 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.598 1.315 . . . . 0.0 110.665 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.01 -163.59 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.674 1.355 . . . . 0.0 110.144 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 48.99 34.38 15.79 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 90.2 m -138.7 115.08 8.79 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.259 -1.142 . . . . 0.0 110.271 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.773 ' HB2' HG22 ' A' ' 35' ' ' VAL . 48.2 Cg_endo -72.08 148.8 51.3 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.568 1.299 . . . . 0.0 110.507 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.508 ' CZ ' ' HG2' ' A' ' 50' ' ' LYS . 19.1 t80 -51.59 -27.85 12.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.42 -0.8 . . . . 0.0 110.272 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.773 HG22 ' HB2' ' A' ' 33' ' ' PRO . 31.1 m -71.0 -19.59 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.936 . . . . 0.0 110.52 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.27 -2.26 55.21 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.186 -0.946 . . . . 0.0 110.924 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.469 HD23 ' HA ' ' A' ' 37' ' ' LEU . 25.2 mt -53.19 -179.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.971 -1.08 . . . . 0.0 110.372 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.15 156.48 38.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.381 -0.825 . . . . 0.0 110.232 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -53.11 -26.31 16.13 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.268 -0.895 . . . . 0.0 110.424 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.32 60.43 1.67 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.143 -0.973 . . . . 0.0 110.42 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.49 ' CD1' HD11 ' A' ' 28' ' ' ILE . 10.0 t80 -71.64 128.49 35.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.164 -0.96 . . . . 0.0 109.685 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.441 ' HA ' ' O ' ' A' ' 48' ' ' SER . 18.1 mmt -103.0 145.83 29.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -0.925 . . . . 0.0 109.795 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 8.3 t -58.36 138.12 85.11 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.403 -0.811 . . . . 0.0 110.67 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.4 ' HB3' ' HB2' ' A' ' 26' ' ' ALA . 53.0 Cg_endo -77.68 -0.57 10.77 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.686 1.361 . . . . 0.0 110.394 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -122.41 -34.15 3.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.032 -1.042 . . . . 0.0 111.022 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.48 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.8 OUTLIER -125.03 8.01 7.99 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.933 -1.105 . . . . 0.0 111.298 -179.655 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.69 21.41 4.59 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.122 -0.987 . . . . 0.0 112.432 178.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 42' ' ' MET . 10.9 t -77.23 153.25 82.11 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 120.666 -1.271 . . . . 0.0 109.627 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.26 142.06 49.04 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.584 1.307 . . . . 0.0 110.548 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.508 ' HG2' ' CZ ' ' A' ' 34' ' ' PHE . 4.4 ttpm? -48.4 -29.44 4.01 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.445 -0.784 . . . . 0.0 110.937 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -62.77 -14.79 49.13 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.986 -1.071 . . . . 0.0 109.967 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.09 1.1 56.08 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.125 -0.985 . . . . 0.0 110.03 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.494 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 16.6 m-85 -89.63 137.43 32.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.116 -0.99 . . . . 0.0 110.307 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -115.9 131.63 56.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.285 -0.885 . . . . 0.0 109.64 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.52 ' HB3' ' CE2' ' A' ' 8' ' ' TYR . 79.3 p -63.68 179.67 0.46 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.048 -1.032 . . . . 0.0 111.054 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.872 HG22 ' O ' ' A' ' 7' ' ' LYS . 1.2 tp -157.6 69.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-O 121.405 0.622 . . . . 0.0 109.561 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 4' ' ' ASP . 39.5 mttt -91.12 65.61 5.56 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.438 -0.788 . . . . 0.0 109.717 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -170.47 148.59 3.15 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.474 -0.766 . . . . 0.0 110.474 -179.72 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.2 t -123.88 122.54 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.249 -0.907 . . . . 0.0 110.217 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.6 tp -125.72 154.07 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.305 -0.872 . . . . 0.0 110.21 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -153.36 23.23 0.54 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.197 -0.939 . . . . 0.0 110.147 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -144.07 103.22 0.3 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.1 128.7 55.21 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.255 -1.144 . . . . 0.0 110.248 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -100.77 -40.32 7.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.209 -0.932 . . . . 0.0 110.219 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 53.46 79.38 0.13 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.905 . . . . 0.0 110.275 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -146.92 46.38 1.17 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.224 -0.923 . . . . 0.0 110.329 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -70.83 -25.78 62.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 0.0 109.955 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.3 mttt 52.06 43.15 30.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.284 -0.885 . . . . 0.0 110.333 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -141.53 64.33 1.41 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.221 -0.924 . . . . 0.0 110.374 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.944 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 ttm . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.313 0.578 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -84.65 90.29 7.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 0.0 110.231 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.647 HD12 ' HB ' ' A' ' 56' ' ' ILE . 13.1 pt -134.88 126.17 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.229 -0.92 . . . . 0.0 110.204 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.449 ' HB2' HG13 ' A' ' 59' ' ' VAL . 12.6 t0 178.06 -32.02 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.62 -0.675 . . . . 0.0 110.18 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.413 ' O ' ' CG ' ' A' ' 19' ' ' PRO . 25.6 mt-10 -66.66 78.03 0.11 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 110.104 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 55.06 22.46 28.5 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.53 131.7 35.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.211 -1.17 . . . . 0.0 109.468 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.518 ' CE2' ' HB2' ' A' ' 55' ' ' SER . 22.2 m-85 -129.3 150.39 50.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.017 -1.052 . . . . 0.0 110.864 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.586 ' HA ' HD13 ' A' ' 16' ' ' ILE . 13.8 pt-20 -120.56 140.66 51.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.323 -0.861 . . . . 0.0 109.863 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 t -80.05 113.86 18.53 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.176 -0.953 . . . . 0.0 110.434 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.63 -11.71 61.11 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.115 -0.99 . . . . 0.0 109.613 178.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.08 -41.3 15.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 111.726 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.4 p -122.08 -32.85 3.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.726 -1.234 . . . . 0.0 111.551 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.14 21.12 6.03 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.507 ' CD2' ' N ' ' A' ' 16' ' ' ILE . 60.5 t80 -81.6 168.92 17.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.265 -1.138 . . . . 0.0 109.92 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.586 HD13 ' HA ' ' A' ' 9' ' ' GLU . 34.8 mm -135.11 116.25 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.246 -0.908 . . . . 0.0 110.201 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.548 ' CZ ' HD21 ' A' ' 37' ' ' LEU . 63.5 t80 -80.57 132.86 35.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -0.874 . . . . 0.0 110.109 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -113.93 113.86 46.78 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.561 -0.712 . . . . 0.0 109.655 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.493 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 38.5 Cg_endo -71.72 -65.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.474 1.25 . . . . 0.0 110.892 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -45.38 -27.33 0.67 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.715 -0.616 . . . . 0.0 110.776 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.12 -35.57 10.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.282 -0.886 . . . . 0.0 110.0 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.64 149.54 10.69 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.471 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 2.2 t0 -85.14 62.42 7.49 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.457 -1.025 . . . . 0.0 109.725 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -44.91 -27.5 0.54 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.629 -0.669 . . . . 0.0 110.916 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.45 -26.44 60.05 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.315 -0.865 . . . . 0.0 110.26 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.471 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -100.72 -25.68 14.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.223 -0.923 . . . . 0.0 110.335 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.92 19.1 3.39 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.893 -1.146 . . . . 0.0 110.244 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.2 mt -111.19 116.59 51.1 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 120.897 -1.355 . . . . 0.0 109.717 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.35 172.18 13.7 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.503 1.265 . . . . 0.0 110.611 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.54 -164.14 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.724 1.381 . . . . 0.0 110.145 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 47.61 27.33 4.36 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.406 ' O ' ' CB ' ' A' ' 19' ' ' PRO . 89.9 m -128.73 119.53 20.21 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.12 -1.223 . . . . 0.0 110.245 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.655 ' HB2' HG22 ' A' ' 35' ' ' VAL . 48.6 Cg_endo -73.78 159.47 45.29 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 O-C-N 123.525 1.276 . . . . 0.0 110.878 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.507 ' CD1' HD12 ' A' ' 37' ' ' LEU . 44.2 t80 -65.79 -28.93 69.37 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.448 -0.783 . . . . 0.0 110.157 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.655 HG22 ' HB2' ' A' ' 33' ' ' PRO . 23.2 m -69.45 -9.83 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -0.904 . . . . 0.0 110.809 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.67 -1.96 23.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.965 -1.085 . . . . 0.0 110.892 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.548 HD21 ' CZ ' ' A' ' 17' ' ' TYR . 46.9 mt -52.07 162.57 0.45 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.883 -1.136 . . . . 0.0 110.27 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.7 t -49.57 164.86 0.08 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.31 -0.869 . . . . 0.0 110.44 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.46 -26.0 68.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.916 . . . . 0.0 110.233 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.9 p -131.65 52.73 2.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.271 -0.893 . . . . 0.0 110.46 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.478 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 26.9 t80 -63.46 132.17 50.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.216 -0.927 . . . . 0.0 109.785 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -110.17 143.97 39.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.878 . . . . 0.0 109.663 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.461 ' HB3' ' N ' ' A' ' 47' ' ' ARG . 8.7 t -55.49 137.45 69.56 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 110.741 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -77.6 -1.68 11.85 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.58 1.305 . . . . 0.0 110.287 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -120.56 -39.81 2.72 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.146 -0.971 . . . . 0.0 110.533 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.417 ' SG ' ' CB ' ' A' ' 48' ' ' SER . 0.6 OUTLIER -121.82 10.42 10.24 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.087 -1.008 . . . . 0.0 110.836 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.461 ' N ' ' HB3' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 52.95 17.73 0.94 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.29 -0.881 . . . . 0.0 112.655 178.557 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.417 ' CB ' ' SG ' ' A' ' 46' ' ' CYS . 4.1 t -67.7 156.2 89.6 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.598 -1.313 . . . . 0.0 109.715 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.86 143.48 45.65 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 123.684 1.36 . . . . 0.0 110.486 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.524 ' HA ' ' CD1' ' A' ' 53' ' ' PHE . 22.1 tttm -50.32 -25.26 3.6 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.325 -0.86 . . . . 0.0 110.517 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 -67.24 -11.61 57.92 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.202 -0.936 . . . . 0.0 110.146 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -92.52 0.7 57.46 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.053 -1.029 . . . . 0.0 110.104 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.524 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 39.6 m-85 -89.99 125.67 35.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.951 -1.093 . . . . 0.0 110.428 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.408 ' O ' ' HG2' ' A' ' 9' ' ' GLU . 12.0 tttt -100.75 131.54 46.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.391 -0.818 . . . . 0.0 109.579 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.667 ' O ' HG23 ' A' ' 56' ' ' ILE . 2.5 t -60.89 179.34 0.18 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.124 -0.985 . . . . 0.0 110.316 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.667 HG23 ' O ' ' A' ' 55' ' ' SER . 7.9 pt -159.99 94.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.782 -0.573 . . . . 0.0 109.509 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -108.69 66.46 0.64 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.369 -0.832 . . . . 0.0 110.193 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.07 66.5 0.92 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.32 -0.863 . . . . 0.0 110.193 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.449 HG13 ' HB2' ' A' ' 4' ' ' ASP . 33.9 m -84.67 158.37 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.373 -0.83 . . . . 0.0 110.364 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 66.7 mt -123.18 80.88 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.345 -0.847 . . . . 0.0 110.104 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.61 161.86 2.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.191 -0.943 . . . . 0.0 110.389 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -134.47 -111.39 1.19 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -149.41 179.1 8.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.174 -1.192 . . . . 0.0 110.332 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -174.19 127.7 0.36 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.261 -0.899 . . . . 0.0 110.37 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -149.73 70.29 1.06 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.262 -0.899 . . . . 0.0 110.038 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -129.93 113.33 14.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 0.0 110.501 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.68 -167.31 1.27 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.279 -0.888 . . . . 0.0 110.038 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.5 mtpt -134.86 112.41 10.66 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.096 -1.003 . . . . 0.0 110.297 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -144.06 77.97 1.57 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 0.0 110.159 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 CA-C-O 117.959 -1.467 . . . . 0.0 109.479 -179.997 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.482 ' O ' HG23 ' A' ' 3' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.303 0.573 . . . . 0.0 110.235 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.923 ' OE2' HG13 ' A' ' 59' ' ' VAL . 0.8 OUTLIER 53.68 71.46 0.5 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.216 -0.927 . . . . 0.0 110.186 -179.927 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.482 HG23 ' O ' ' A' ' 1' ' ' MET . 25.9 pt -148.38 145.84 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.275 -0.891 . . . . 0.0 110.106 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 21.6 t0 -146.7 10.53 1.07 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.171 -0.955 . . . . 0.0 111.248 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -78.24 61.53 2.74 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.183 -0.948 . . . . 0.0 110.613 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.4 ' O ' ' HG3' ' A' ' 19' ' ' PRO . . . 50.91 23.97 7.77 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.898 ' O ' HG22 ' A' ' 56' ' ' ILE . 6.5 mttt -78.67 132.36 37.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.099 -1.236 . . . . 0.0 109.529 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.524 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 6.6 m-85 -111.93 132.19 54.91 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.055 -1.028 . . . . 0.0 110.354 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 17.3 tt0 -95.23 135.49 36.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.262 -0.899 . . . . 0.0 109.982 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.4 t -76.95 114.45 15.75 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.191 -0.943 . . . . 0.0 110.309 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -69.34 -11.47 60.84 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.192 -0.942 . . . . 0.0 109.722 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.418 ' HB2' ' OE1' ' A' ' 52' ' ' GLN . . . -85.2 -40.79 16.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.906 . . . . 0.0 111.819 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.474 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 14.0 p -124.53 -35.35 2.76 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.738 -1.226 . . . . 0.0 111.802 -178.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 116.94 20.5 4.87 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.616 -1.278 . . . . 0.0 109.988 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.858 ' C ' HD12 ' A' ' 16' ' ' ILE . 73.7 t80 -83.73 169.99 14.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -1.124 . . . . 0.0 109.51 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.858 HD12 ' C ' ' A' ' 15' ' ' TYR . 3.4 mp -132.7 110.23 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.119 -0.988 . . . . 0.0 110.064 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.499 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 73.3 t80 -70.06 140.28 52.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.265 -0.897 . . . . 0.0 110.109 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.444 ' HG2' ' HE2' ' A' ' 7' ' ' LYS . 14.6 mt-10 -115.26 108.21 48.26 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.545 -0.722 . . . . 0.0 109.857 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.441 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 38.0 Cg_endo -68.81 -74.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.427 1.224 . . . . 0.0 111.042 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -46.85 -25.76 0.83 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.4 -0.812 . . . . 0.0 110.914 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.99 -38.2 11.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.13 -0.981 . . . . 0.0 110.44 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.37 148.52 24.1 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.588 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 0.6 OUTLIER -85.09 61.99 7.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.399 -1.06 . . . . 0.0 110.07 179.787 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.18 -26.82 0.84 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.523 -0.735 . . . . 0.0 110.915 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -77.5 -23.0 50.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.173 -0.954 . . . . 0.0 110.333 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.588 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -102.69 -28.67 11.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.204 -0.935 . . . . 0.0 110.143 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.66 30.94 1.19 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.6 mt -122.89 122.39 27.09 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.123 -1.222 . . . . 0.0 109.783 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.401 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 45.5 Cg_endo -70.71 173.06 12.38 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 O-C-N 123.516 1.272 . . . . 0.0 110.529 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.401 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 48.3 Cg_endo -70.84 -163.54 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.788 1.415 . . . . 0.0 110.137 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 49.15 25.69 5.75 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 93.0 m -127.39 114.74 21.36 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.102 -1.234 . . . . 0.0 110.04 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.839 ' HB2' HG22 ' A' ' 35' ' ' VAL . 48.8 Cg_endo -73.72 149.88 43.91 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.501 1.263 . . . . 0.0 110.78 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.645 ' CD1' HD12 ' A' ' 37' ' ' LEU . 55.0 t80 -53.9 -26.88 27.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.361 -0.837 . . . . 0.0 110.151 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.839 HG22 ' HB2' ' A' ' 33' ' ' PRO . 35.4 m -69.09 -16.11 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.172 -0.955 . . . . 0.0 110.632 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.19 -2.48 49.62 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.045 -1.034 . . . . 0.0 110.927 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.645 HD12 ' CD1' ' A' ' 34' ' ' PHE . 58.4 mt -59.0 158.56 8.31 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.919 -1.113 . . . . 0.0 110.155 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.0 t -54.55 166.84 0.4 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.302 -0.874 . . . . 0.0 110.227 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -72.3 -11.68 60.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.206 -0.934 . . . . 0.0 110.635 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 54.3 p -137.37 34.02 2.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.966 -1.084 . . . . 0.0 110.322 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.482 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 22.9 t80 -54.25 144.23 20.79 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.257 -0.902 . . . . 0.0 109.59 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.07 138.31 51.7 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.2 -0.938 . . . . 0.0 110.32 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 39.2 t -57.33 131.8 81.15 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.453 -0.779 . . . . 0.0 110.182 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.61 -3.26 13.6 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.489 1.257 . . . . 0.0 110.673 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -111.12 -30.19 7.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.004 -1.06 . . . . 0.0 110.686 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.474 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 1.5 p -135.17 7.94 3.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.995 -1.065 . . . . 0.0 111.313 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.3 16.32 3.06 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.207 -0.933 . . . . 0.0 112.897 178.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.4 p -72.66 156.93 89.65 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 120.626 -1.296 . . . . 0.0 109.884 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.4 ' HG2' ' OD1' ' A' ' 51' ' ' ASN . 43.0 Cg_endo -69.0 140.67 46.16 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.551 1.29 . . . . 0.0 110.306 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.51 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 41.0 tttt -47.29 -30.42 3.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.31 -0.869 . . . . 0.0 111.481 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.4 ' OD1' ' HG2' ' A' ' 49' ' ' PRO . 29.6 p30 -63.18 -14.03 44.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.888 -1.133 . . . . 0.0 110.048 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.418 ' OE1' ' HB2' ' A' ' 12' ' ' ALA . 0.7 OUTLIER -85.97 -2.83 58.66 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.101 -0.999 . . . . 0.0 110.146 179.313 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -81.95 168.04 18.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.958 -1.089 . . . . 0.0 110.21 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 9' ' ' GLU . 0.7 OUTLIER -147.28 132.79 18.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.376 -0.827 . . . . 0.0 109.471 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.524 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 64.5 p -65.52 174.82 2.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.973 -1.08 . . . . 0.0 110.91 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.898 HG22 ' O ' ' A' ' 7' ' ' LYS . 0.6 OUTLIER -160.03 81.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 121.418 0.628 . . . . 0.0 110.207 179.61 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 4' ' ' ASP . 13.5 mtpt -93.75 62.03 3.17 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -0.908 . . . . 0.0 109.785 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.5 mttp -122.12 124.62 44.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -0.907 . . . . 0.0 110.423 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.923 HG13 ' OE2' ' A' ' 2' ' ' GLU . 58.9 t -126.4 65.54 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 109.957 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.648 ' O ' HG23 ' A' ' 60' ' ' ILE . 7.1 tt -132.26 114.04 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.271 -0.893 . . . . 0.0 110.181 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.513 ' HB3' ' HG3' ' A' ' 2' ' ' GLU . . . -176.8 -56.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.188 -0.945 . . . . 0.0 110.044 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 152.28 -125.62 1.86 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -116.32 143.45 45.52 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.317 -1.108 . . . . 0.0 110.324 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -120.15 -35.76 3.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.339 -0.851 . . . . 0.0 109.957 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -63.6 -29.67 70.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.242 -0.911 . . . . 0.0 110.214 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -57.03 167.82 0.77 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.27 -0.894 . . . . 0.0 110.323 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -149.53 107.44 3.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.3 -0.875 . . . . 0.0 109.981 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.2 mtmt 55.32 173.75 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.188 -0.945 . . . . 0.0 110.125 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -147.09 -72.9 0.22 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 110.085 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 CA-C-O 117.968 -1.462 . . . . 0.0 109.463 179.996 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mtp . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.296 0.57 . . . . 0.0 110.018 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -155.85 121.95 5.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.407 -0.808 . . . . 0.0 109.888 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.759 HG21 HG13 ' A' ' 56' ' ' ILE . 3.3 mp -125.48 172.06 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 0.0 110.18 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.499 ' N ' HG22 ' A' ' 3' ' ' ILE . 1.1 t70 -176.35 -30.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.242 -0.911 . . . . 0.0 110.967 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -78.59 -142.04 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.042 -1.037 . . . . 0.0 109.525 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.51 27.97 9.85 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.479 -1.343 . . . . 0.0 109.795 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.424 ' O ' ' CG1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -74.78 119.38 18.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.006 -1.291 . . . . 0.0 109.281 179.38 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.54 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 4.2 m-85 -104.41 166.68 10.24 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.113 -0.992 . . . . 0.0 110.565 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.473 ' HB2' HD13 ' A' ' 56' ' ' ILE . 28.1 tt0 -131.12 134.33 46.47 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.344 -0.847 . . . . 0.0 110.279 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.9 t -74.85 112.42 11.04 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.204 -0.935 . . . . 0.0 109.991 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.61 -10.84 59.84 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.28 -0.968 . . . . 0.0 109.65 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.07 -39.93 17.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 111.767 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.452 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 13.0 p -124.54 -36.54 2.61 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.713 -1.242 . . . . 0.0 111.521 -178.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.27 21.16 4.15 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.852 ' C ' HD12 ' A' ' 16' ' ' ILE . 37.5 t80 -81.19 160.62 24.29 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.206 -1.173 . . . . 0.0 109.756 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.852 HD12 ' C ' ' A' ' 15' ' ' TYR . 2.8 mp -127.04 120.93 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.169 -0.957 . . . . 0.0 110.185 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.547 ' CE1' HD21 ' A' ' 37' ' ' LEU . 58.5 t80 -86.7 138.17 31.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.22 -0.925 . . . . 0.0 110.194 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -116.15 112.95 41.7 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.565 -0.709 . . . . 0.0 109.857 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.423 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 38.1 Cg_endo -72.02 -66.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.58 1.305 . . . . 0.0 111.026 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.402 ' O ' ' CB ' ' A' ' 30' ' ' PRO . 1.4 tt0 -45.26 -27.04 0.58 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.698 -0.626 . . . . 0.0 110.97 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.1 tptt -99.86 -30.65 11.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 110.332 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.62 148.38 8.35 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.445 ' HB3' HD12 ' A' ' 28' ' ' ILE . 2.0 t70 -85.03 63.16 7.95 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.451 -1.029 . . . . 0.0 109.599 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -45.34 -29.29 1.01 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.606 -0.684 . . . . 0.0 110.899 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -68.69 -26.46 65.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.314 -0.866 . . . . 0.0 109.89 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -100.67 -28.89 12.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.335 -0.853 . . . . 0.0 109.995 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.05 15.71 3.76 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.955 -1.117 . . . . 0.0 110.462 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.722 HD13 ' CD2' ' A' ' 37' ' ' LEU . 11.9 mt -105.64 121.68 45.19 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.776 -1.426 . . . . 0.0 109.78 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -70.86 171.82 14.92 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.504 1.265 . . . . 0.0 110.691 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.402 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 49.6 Cg_endo -71.42 -163.83 0.14 Allowed 'Trans proline' 0 C--N 1.314 -1.285 0 O-C-N 123.771 1.406 . . . . 0.0 110.201 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 47.98 33.43 10.11 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 85.0 m -137.27 121.63 12.24 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.194 -1.18 . . . . 0.0 110.191 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.763 ' HB2' HG22 ' A' ' 35' ' ' VAL . 48.1 Cg_endo -73.07 155.16 52.61 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.505 1.266 . . . . 0.0 110.745 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.671 ' CD2' HD12 ' A' ' 37' ' ' LEU . 24.5 t80 -58.04 -30.06 65.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.32 -0.862 . . . . 0.0 109.809 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.763 HG22 ' HB2' ' A' ' 33' ' ' PRO . 22.4 m -63.66 -14.84 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.321 -0.862 . . . . 0.0 110.691 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.64 0.94 45.77 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.053 -1.03 . . . . 0.0 111.001 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.722 ' CD2' HD13 ' A' ' 28' ' ' ILE . 21.3 mt -53.64 169.58 0.14 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.888 -1.133 . . . . 0.0 110.209 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.5 t -61.08 153.65 24.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.218 -0.927 . . . . 0.0 110.392 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -54.13 -39.3 66.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.262 -0.899 . . . . 0.0 110.445 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 96.7 p -120.04 43.85 2.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 110.489 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.444 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 40.7 t80 -63.26 137.01 58.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.202 -0.936 . . . . 0.0 109.971 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 45.2 mmm -111.47 164.43 12.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.206 -0.934 . . . . 0.0 109.575 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.3 t -76.63 133.27 70.7 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.291 -0.881 . . . . 0.0 110.3 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -75.09 -1.96 11.92 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.525 1.276 . . . . 0.0 110.287 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.96 -33.62 4.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.961 -1.087 . . . . 0.0 110.712 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.452 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.8 OUTLIER -129.38 7.12 5.34 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.995 -1.066 . . . . 0.0 111.188 -179.91 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.66 17.6 4.16 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.102 -0.999 . . . . 0.0 112.566 178.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.42 ' CB ' ' SG ' ' A' ' 46' ' ' CYS . 6.6 t -72.44 155.94 90.78 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 120.675 -1.266 . . . . 0.0 109.846 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.96 140.54 50.52 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.615 1.324 . . . . 0.0 110.377 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.464 ' HG2' ' CZ ' ' A' ' 34' ' ' PHE . 21.6 tttt -50.23 -25.41 3.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.238 -0.913 . . . . 0.0 110.735 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -66.6 -12.91 60.13 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.056 -1.028 . . . . 0.0 109.963 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -86.79 -2.88 58.91 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.07 -1.019 . . . . 0.0 110.08 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.495 ' HB2' ' CZ ' ' A' ' 34' ' ' PHE . 23.9 m-85 -86.41 134.33 33.71 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.956 -1.09 . . . . 0.0 110.072 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.68 139.11 52.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.203 -0.935 . . . . 0.0 109.612 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.646 ' O ' HG23 ' A' ' 56' ' ' ILE . 35.5 p -63.83 176.91 0.83 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.935 . . . . 0.0 111.034 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.759 HG13 HG21 ' A' ' 3' ' ' ILE . 8.1 pt -158.78 89.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 121.261 0.553 . . . . 0.0 109.639 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.9 mtpt -105.59 67.48 0.76 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.362 -0.836 . . . . 0.0 110.033 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -155.87 144.19 20.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.391 -0.818 . . . . 0.0 110.009 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.0 m -133.17 149.25 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.354 -0.841 . . . . 0.0 110.237 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.592 ' O ' HG23 ' A' ' 60' ' ' ILE . 5.2 tt -152.33 71.67 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 110.112 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -157.24 78.84 0.89 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.341 -0.849 . . . . 0.0 110.108 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 162.36 -99.2 0.17 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -147.36 -158.41 0.91 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.113 -1.228 . . . . 0.0 110.357 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.48 58.93 5.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.242 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -129.48 -165.51 1.53 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.125 -0.984 . . . . 0.0 110.051 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -170.65 -38.9 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.155 -0.966 . . . . 0.0 110.441 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.12 -164.07 1.17 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.188 -0.945 . . . . 0.0 110.212 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.5 mttp -113.79 -29.16 7.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.233 -0.917 . . . . 0.0 110.314 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -122.14 68.28 0.93 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.253 -0.904 . . . . 0.0 109.975 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.919 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.4 mtm . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.319 0.581 . . . . 0.0 110.053 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.403 ' C ' HG23 ' A' ' 3' ' ' ILE . 19.5 tt0 54.19 94.03 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.365 -0.834 . . . . 0.0 110.347 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.403 HG23 ' C ' ' A' ' 2' ' ' GLU . 2.9 pt -151.49 140.94 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.349 -0.844 . . . . 0.0 110.167 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.4 ' HB3' ' O ' ' A' ' 3' ' ' ILE . 9.7 p-10 179.56 112.77 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.365 -0.835 . . . . 0.0 109.65 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -158.61 26.27 0.23 Allowed 'General case' 0 C--N 1.29 -2.016 0 CA-C-O 121.245 0.545 . . . . 0.0 110.183 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 95.77 23.73 17.44 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.842 ' O ' HG22 ' A' ' 56' ' ' ILE . 20.6 mtmt -83.88 134.98 34.66 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.303 -1.116 . . . . 0.0 109.611 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.537 ' CE2' ' CD2' ' A' ' 34' ' ' PHE . 14.9 m-85 -125.76 135.58 52.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.131 -0.981 . . . . 0.0 110.688 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 44.8 tt0 -103.91 138.99 39.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.384 -0.822 . . . . 0.0 110.063 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.7 t -79.66 112.53 17.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.191 -0.943 . . . . 0.0 110.331 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.97 -11.18 60.49 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.147 -0.97 . . . . 0.0 109.658 178.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.03 -41.07 16.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.298 -0.876 . . . . 0.0 111.598 -179.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.462 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 14.2 p -123.12 -35.51 2.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.699 -1.25 . . . . 0.0 111.428 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 116.65 20.62 4.94 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 119.677 -1.249 . . . . 0.0 110.071 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.786 ' C ' HD12 ' A' ' 16' ' ' ILE . 67.4 t80 -84.84 169.11 14.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.108 -1.231 . . . . 0.0 109.828 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.786 HD12 ' C ' ' A' ' 15' ' ' TYR . 3.3 mp -133.39 115.2 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.218 -0.926 . . . . 0.0 110.154 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.49 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 58.3 t80 -75.47 136.63 40.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.913 . . . . 0.0 110.086 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.403 ' HB3' ' HB2' ' A' ' 21' ' ' LYS . 88.8 mt-10 -113.5 112.3 48.81 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.549 -0.72 . . . . 0.0 109.632 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.463 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 38.0 Cg_endo -70.06 -74.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.456 1.24 . . . . 0.0 111.554 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.411 ' O ' ' CB ' ' A' ' 30' ' ' PRO . 3.6 mm-40 -43.38 -27.3 0.25 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.525 -0.734 . . . . 0.0 111.398 -179.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.403 ' HB2' ' HB3' ' A' ' 18' ' ' GLU . 2.0 mmmt -93.65 -36.03 12.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.079 -1.013 . . . . 0.0 110.501 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.33 145.17 14.14 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.472 ' HB3' HD12 ' A' ' 28' ' ' ILE . 10.0 t0 -85.08 62.93 7.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.378 -1.072 . . . . 0.0 109.707 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -44.57 -27.17 0.44 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.595 -0.691 . . . . 0.0 111.251 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -74.6 -26.71 60.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.028 -1.045 . . . . 0.0 110.074 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -98.71 -27.93 13.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.219 -0.925 . . . . 0.0 109.983 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.05 30.72 1.42 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.477 HD11 ' CD1' ' A' ' 41' ' ' PHE . 11.4 mt -121.63 119.24 29.28 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.12 -1.224 . . . . 0.0 109.904 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.402 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 43.1 Cg_endo -69.26 173.13 10.97 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.459 1.242 . . . . 0.0 110.359 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.411 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 47.1 Cg_endo -70.05 -163.85 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.68 1.358 . . . . 0.0 110.224 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 48.49 39.91 23.11 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.7 m -142.26 115.56 6.45 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.176 -1.191 . . . . 0.0 110.446 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.767 ' HB2' HG22 ' A' ' 35' ' ' VAL . 46.1 Cg_endo -74.18 153.29 46.05 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.474 1.25 . . . . 0.0 110.51 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.586 ' CD1' HD12 ' A' ' 37' ' ' LEU . 43.3 t80 -61.74 -28.15 69.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.34 -0.85 . . . . 0.0 110.236 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.767 HG22 ' HB2' ' A' ' 33' ' ' PRO . 35.6 m -67.96 -9.73 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -0.933 . . . . 0.0 110.875 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.403 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -110.13 0.25 18.21 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.96 -1.087 . . . . 0.0 110.989 -179.744 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.586 HD12 ' CD1' ' A' ' 34' ' ' PHE . 28.2 mt -51.02 164.09 0.17 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.997 -1.064 . . . . 0.0 110.285 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.4 m -50.18 157.59 0.65 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.189 -0.944 . . . . 0.0 110.446 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.18 -15.48 46.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.0 110.398 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.2 51.74 1.58 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.071 -1.018 . . . . 0.0 110.43 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.477 ' CD1' HD11 ' A' ' 28' ' ' ILE . 32.1 t80 -68.96 142.84 54.58 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.213 -0.929 . . . . 0.0 110.022 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.429 ' HA ' ' O ' ' A' ' 48' ' ' SER . 7.7 mtt -120.11 150.67 40.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.327 -0.858 . . . . 0.0 109.57 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.442 ' HB3' ' N ' ' A' ' 47' ' ' ARG . 7.3 t -58.13 135.92 84.37 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.223 -0.923 . . . . 0.0 110.26 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.78 -2.89 12.86 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.596 1.314 . . . . 0.0 110.437 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -121.66 -50.42 2.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.91 -1.119 . . . . 0.0 110.918 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.462 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -105.38 5.54 31.84 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.03 -1.044 . . . . 0.0 111.304 -179.345 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.442 ' N ' ' HB3' ' A' ' 43' ' ' CYS . 12.3 ttm-85 56.92 20.48 5.34 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.061 -1.024 . . . . 0.0 112.272 178.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.429 ' O ' ' HA ' ' A' ' 42' ' ' MET . 2.8 t -70.41 155.95 92.64 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 120.798 -1.188 . . . . 0.0 109.676 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.91 142.56 43.15 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.588 1.31 . . . . 0.0 110.266 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.514 ' HE2' ' CE2' ' A' ' 34' ' ' PHE . 22.4 tttt -51.77 -25.27 7.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.157 -0.964 . . . . 0.0 110.329 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.5 t30 -68.2 -11.95 60.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.136 -0.977 . . . . 0.0 109.826 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -91.83 1.36 57.22 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.162 -0.961 . . . . 0.0 110.077 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.499 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 34.6 m-85 -90.78 129.09 36.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.018 -1.051 . . . . 0.0 110.628 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.93 134.31 49.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.368 -0.832 . . . . 0.0 109.603 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.509 ' HB3' ' CE2' ' A' ' 8' ' ' TYR . 86.4 p -64.25 -179.94 0.5 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.074 -1.016 . . . . 0.0 110.984 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.842 HG22 ' O ' ' A' ' 7' ' ' LYS . 9.7 tt -160.12 91.96 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.787 -0.57 . . . . 0.0 110.267 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.2 74.88 1.48 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.029 -1.044 . . . . 0.0 110.44 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.9 142.32 28.11 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.272 -0.892 . . . . 0.0 110.196 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.413 ' O ' HG13 ' A' ' 59' ' ' VAL . 9.2 p -146.41 135.92 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.228 -0.92 . . . . 0.0 110.175 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.431 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 5.8 tp -135.45 146.77 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 110.146 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 60' ' ' ILE . . . 55.64 -164.06 0.14 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.159 -0.963 . . . . 0.0 110.25 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.8 92.6 2.22 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -141.09 -177.31 5.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.228 -1.16 . . . . 0.0 110.147 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -153.38 40.36 0.52 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.178 -0.951 . . . . 0.0 110.318 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.62 132.38 45.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.317 -0.865 . . . . 0.0 110.034 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -114.46 49.91 0.99 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.256 -0.903 . . . . 0.0 110.403 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -77.42 168.29 20.25 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.12 -0.987 . . . . 0.0 110.043 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.35 -70.43 0.67 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.246 -0.909 . . . . 0.0 110.192 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -87.85 101.02 13.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.3 -0.875 . . . . 0.0 110.345 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 179.945 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 ttm . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.231 0.538 . . . . 0.0 110.265 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.7 160.53 17.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.187 -0.946 . . . . 0.0 110.339 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.556 HG21 HG23 ' A' ' 56' ' ' ILE . 4.2 mp -136.91 167.56 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.3 -0.875 . . . . 0.0 110.23 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.431 ' N ' HG22 ' A' ' 3' ' ' ILE . 0.2 OUTLIER 171.77 -26.57 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.225 -0.922 . . . . 0.0 110.88 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.401 ' HB3' ' HE2' ' A' ' 7' ' ' LYS . 0.5 OUTLIER -71.02 64.01 0.33 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.176 -0.953 . . . . 0.0 111.032 -179.188 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 49.23 24.26 4.78 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.826 ' O ' HG22 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -78.35 112.39 15.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.913 -1.345 . . . . 0.0 109.263 179.375 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.575 ' CE2' ' CD1' ' A' ' 34' ' ' PHE . 4.4 m-85 -95.47 133.93 38.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 110.555 -179.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.628 ' HA ' HD13 ' A' ' 16' ' ' ILE . 11.0 tt0 -101.54 132.06 47.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.42 -0.8 . . . . 0.0 110.281 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.1 t -74.39 119.45 18.61 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.2 -0.938 . . . . 0.0 110.169 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.3 -11.69 60.34 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.087 -1.008 . . . . 0.0 109.654 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.07 -37.85 19.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.241 -0.912 . . . . 0.0 111.699 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.468 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 13.7 p -126.63 -34.56 2.42 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.717 -1.24 . . . . 0.0 111.645 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.74 22.4 5.39 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.449 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 55.9 t80 -84.41 159.2 20.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.373 -1.074 . . . . 0.0 109.762 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.628 HD13 ' HA ' ' A' ' 9' ' ' GLU . 39.4 mm -123.6 111.0 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 0.0 110.655 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.43 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 53.1 t80 -75.75 130.65 38.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.41 -0.806 . . . . 0.0 110.175 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -108.38 113.25 60.49 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.434 -0.791 . . . . 0.0 109.406 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.49 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 38.3 Cg_endo -71.95 -64.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.495 1.261 . . . . 0.0 110.963 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -45.35 -26.82 0.58 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.702 -0.624 . . . . 0.0 111.12 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -97.07 -30.36 13.09 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.04 -1.037 . . . . 0.0 110.236 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.66 153.51 23.63 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.734 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -85.12 61.9 7.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.39 -1.064 . . . . 0.0 109.795 179.657 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.71 -28.51 0.63 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.513 -0.742 . . . . 0.0 110.953 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.8 -24.76 44.37 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.226 -0.921 . . . . 0.0 110.42 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.734 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -97.69 -27.48 14.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.154 -0.966 . . . . 0.0 110.213 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 119.48 27.57 2.14 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.44 HD13 ' CD2' ' A' ' 37' ' ' LEU . 6.5 mt -120.13 126.07 27.01 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.097 -1.237 . . . . 0.0 109.975 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.409 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 43.9 Cg_endo -71.3 173.28 12.55 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.54 1.284 . . . . 0.0 110.289 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 49.1 Cg_endo -70.76 -163.73 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.683 1.36 . . . . 0.0 110.088 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 47.71 26.79 4.2 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 91.8 m -124.22 111.34 28.52 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.138 -1.213 . . . . 0.0 110.292 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.712 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.3 Cg_endo -73.11 148.99 45.51 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.492 1.259 . . . . 0.0 110.614 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.575 ' CD1' ' CE2' ' A' ' 8' ' ' TYR . 12.7 t80 -52.46 -30.88 32.03 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.308 -0.87 . . . . 0.0 110.506 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.712 HG22 ' HB2' ' A' ' 33' ' ' PRO . 26.6 m -65.27 -17.49 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.23 -0.919 . . . . 0.0 110.841 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -99.73 -0.01 40.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.072 -1.017 . . . . 0.0 110.887 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.495 ' HA ' HD23 ' A' ' 37' ' ' LEU . 15.5 mt -53.66 170.68 0.11 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.853 -1.155 . . . . 0.0 110.248 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.8 m -57.82 166.2 1.51 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.207 -0.933 . . . . 0.0 110.412 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.44 -22.28 66.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.301 -0.874 . . . . 0.0 110.245 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.7 m -139.0 53.05 1.76 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.267 -0.896 . . . . 0.0 110.075 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.44 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 11.3 t80 -65.3 141.16 58.7 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.365 -0.834 . . . . 0.0 110.184 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.418 ' HA ' ' O ' ' A' ' 48' ' ' SER . 8.9 mtt -114.33 147.97 38.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.354 -0.841 . . . . 0.0 109.348 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.401 ' HB2' ' OG ' ' A' ' 48' ' ' SER . 23.9 t -60.48 138.36 92.45 Favored Pre-proline 0 C--N 1.3 -1.552 0 O-C-N 121.278 -0.889 . . . . 0.0 110.582 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -78.79 3.14 7.59 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.643 1.338 . . . . 0.0 110.661 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -124.57 -35.83 2.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.913 -1.117 . . . . 0.0 110.782 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.468 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 1.2 p -124.66 4.62 8.21 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.989 -1.069 . . . . 0.0 111.334 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.44 18.87 7.24 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.163 -0.961 . . . . 0.0 112.478 178.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 42' ' ' MET . 26.3 p -71.51 162.0 75.36 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 120.573 -1.329 . . . . 0.0 109.507 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.406 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 43.5 Cg_endo -70.4 144.86 51.81 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.596 1.314 . . . . 0.0 110.625 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.501 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 3.8 tttm -51.48 -31.23 22.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.219 -0.925 . . . . 0.0 110.496 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -65.25 -13.11 57.56 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.05 -1.032 . . . . 0.0 109.783 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.406 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.7 OUTLIER -84.79 -5.22 59.32 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.12 -0.988 . . . . 0.0 109.762 178.963 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.429 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 21.5 m-85 -84.25 152.78 23.98 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.255 -0.903 . . . . 0.0 109.582 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.7 ttpp -142.57 131.55 23.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.175 -0.953 . . . . 0.0 110.034 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.52 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 9.1 p -59.88 172.42 0.75 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.158 -0.964 . . . . 0.0 110.444 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.826 HG22 ' O ' ' A' ' 7' ' ' LYS . 2.6 tt -159.97 84.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-O 121.572 0.701 . . . . 0.0 109.898 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.0 68.01 0.66 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.234 -0.916 . . . . 0.0 110.285 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.6 mttp -144.56 127.02 15.93 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.27 -0.894 . . . . 0.0 110.355 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.9 m -71.5 151.08 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.159 -0.963 . . . . 0.0 110.045 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.6 pt -130.62 58.15 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.194 -0.941 . . . . 0.0 110.393 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.24 -23.56 8.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.173 -0.954 . . . . 0.0 110.205 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 178.76 -108.12 0.24 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.435 ' CZ ' ' HG3' ' A' ' 65' ' ' GLU . 45.8 p90 -156.77 34.89 0.3 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.313 -1.11 . . . . 0.0 110.281 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 52.57 78.09 0.14 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.221 -0.924 . . . . 0.0 110.312 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.435 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 3.9 mt-10 -52.22 147.57 7.54 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.231 -0.918 . . . . 0.0 110.256 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -119.94 39.9 3.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.283 -0.886 . . . . 0.0 110.166 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -125.45 -168.1 1.79 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.175 -0.953 . . . . 0.0 110.283 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.42 102.51 12.16 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.312 -0.868 . . . . 0.0 110.294 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -167.13 81.64 0.22 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.244 -0.91 . . . . 0.0 110.156 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 CA-C-O 117.986 -1.452 . . . . 0.0 109.552 -179.868 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.189 0.518 . . . . 0.0 110.301 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 52.71 69.77 0.65 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.186 -0.946 . . . . 0.0 110.246 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.403 ' O ' ' HB3' ' A' ' 4' ' ' ASP . 20.4 pt -134.18 136.61 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.23 -0.919 . . . . 0.0 110.314 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.403 ' HB3' ' O ' ' A' ' 3' ' ' ILE . 9.4 p-10 179.92 112.44 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 121.815 0.817 . . . . 0.0 109.424 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -168.03 46.38 0.05 OUTLIER 'General case' 0 C--N 1.29 -1.983 0 CA-C-O 121.32 0.581 . . . . 0.0 109.953 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 65.38 16.21 62.43 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -84.61 144.64 28.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.123 -1.222 . . . . 0.0 109.828 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.519 ' CE2' ' HB2' ' A' ' 55' ' ' SER . 27.1 m-85 -130.31 143.66 50.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.029 -1.044 . . . . 0.0 110.473 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.638 ' HA ' HD13 ' A' ' 16' ' ' ILE . 2.8 tm-20 -111.78 134.54 53.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.383 -0.823 . . . . 0.0 109.8 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.2 t -77.61 113.64 15.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.227 -0.921 . . . . 0.0 110.446 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -70.44 -11.23 60.78 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.182 -0.949 . . . . 0.0 109.556 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.99 -40.42 16.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.894 . . . . 0.0 111.579 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.471 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 12.5 p -124.18 -32.07 3.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.728 -1.232 . . . . 0.0 111.553 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.13 22.03 6.38 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.516 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 56.7 t80 -83.18 169.02 16.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.282 -1.128 . . . . 0.0 109.871 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.638 HD13 ' HA ' ' A' ' 9' ' ' GLU . 40.9 mm -134.06 115.32 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.058 -1.026 . . . . 0.0 110.68 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.503 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 69.5 t80 -78.88 136.8 37.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.335 -0.853 . . . . 0.0 109.898 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -117.75 112.61 38.59 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.482 -0.761 . . . . 0.0 109.801 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.491 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 37.7 Cg_endo -69.82 -63.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.442 1.233 . . . . 0.0 110.558 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -47.46 -25.47 1.08 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.691 -0.631 . . . . 0.0 110.635 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.56 -42.24 7.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 0.0 110.675 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.55 153.31 29.59 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.489 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 0.9 OUTLIER -85.12 60.44 6.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.369 -1.077 . . . . 0.0 109.975 179.762 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.99 -25.81 0.88 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.443 -0.786 . . . . 0.0 110.948 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.83 -20.95 41.3 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.179 -0.951 . . . . 0.0 110.318 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.489 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -104.39 -29.82 10.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.119 -0.988 . . . . 0.0 110.295 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 124.52 34.07 0.73 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.435 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 4.6 mt -128.73 125.65 23.09 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.162 -1.199 . . . . 0.0 109.712 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.86 173.26 14.3 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.468 1.246 . . . . 0.0 110.575 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.66 -163.79 0.13 Allowed 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.77 1.405 . . . . 0.0 109.913 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 48.72 25.72 5.01 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.5 m -125.84 115.68 24.43 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.295 -1.121 . . . . 0.0 109.979 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.725 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.6 Cg_endo -72.64 149.71 49.5 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.448 1.236 . . . . 0.0 110.894 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.685 ' CD1' HD12 ' A' ' 37' ' ' LEU . 60.4 t80 -54.97 -25.88 32.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.425 -0.797 . . . . 0.0 110.342 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.725 HG22 ' HB2' ' A' ' 33' ' ' PRO . 25.0 m -70.13 -24.23 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.11 -0.993 . . . . 0.0 110.304 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.407 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 3.0 t70 -87.5 -6.12 58.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.181 -0.949 . . . . 0.0 110.758 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.685 HD12 ' CD1' ' A' ' 34' ' ' PHE . 20.3 mt -52.19 160.54 0.76 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.043 -1.036 . . . . 0.0 110.282 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.87 150.78 19.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -0.897 . . . . 0.0 109.981 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -56.04 -25.39 44.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.254 -0.904 . . . . 0.0 110.313 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.34 38.34 4.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.122 -0.986 . . . . 0.0 110.709 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.453 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 36.4 t80 -59.34 133.45 56.1 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.043 -1.036 . . . . 0.0 109.793 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 13.8 mtp -109.98 155.79 21.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.367 -0.833 . . . . 0.0 109.5 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 30.6 t -71.78 131.8 85.62 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.15 -0.969 . . . . 0.0 110.213 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -75.41 -2.18 12.24 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.585 1.308 . . . . 0.0 110.513 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -112.91 -32.5 6.37 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.055 -1.028 . . . . 0.0 110.403 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.471 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 1.3 p -133.61 7.78 3.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.075 -1.016 . . . . 0.0 111.178 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 58.75 13.65 2.79 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.175 -0.953 . . . . 0.0 112.935 177.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.9 m -68.37 163.12 55.87 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 120.604 -1.31 . . . . 0.0 110.052 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.405 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 46.6 Cg_endo -72.6 143.59 38.33 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.699 1.368 . . . . 0.0 110.431 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.5 ' HE2' ' CE2' ' A' ' 34' ' ' PHE . 9.8 tttm -49.97 -26.39 4.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.039 -1.038 . . . . 0.0 110.666 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -66.64 -12.07 56.49 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.124 -0.985 . . . . 0.0 110.006 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 1.0 OUTLIER -86.27 -4.56 59.19 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.169 -0.957 . . . . 0.0 110.174 179.237 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.464 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 44.1 m-85 -84.25 144.44 28.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.945 -1.097 . . . . 0.0 110.44 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.0 ttmm -124.56 119.19 28.37 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.365 -0.834 . . . . 0.0 109.535 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.519 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 3.7 t -50.95 177.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.058 -1.026 . . . . 0.0 110.573 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.1 pt -141.98 58.05 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.653 -0.654 . . . . 0.0 110.012 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.8 tttt -93.74 61.68 3.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.348 -0.845 . . . . 0.0 109.905 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.08 115.22 29.72 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.325 -0.859 . . . . 0.0 110.611 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.8 m -135.72 153.49 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.332 -0.855 . . . . 0.0 110.011 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.5 mm -123.18 155.22 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.937 . . . . 0.0 110.079 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -147.59 81.92 1.52 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.18 -0.95 . . . . 0.0 110.169 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -131.94 51.02 0.87 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -86.0 105.88 16.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -1.15 . . . . 0.0 110.297 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -144.89 -167.82 2.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.372 -0.83 . . . . 0.0 110.024 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -132.47 -163.59 1.36 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.191 -0.943 . . . . 0.0 110.275 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -126.02 136.12 52.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.304 -0.873 . . . . 0.0 110.203 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -89.48 159.72 17.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.177 -0.952 . . . . 0.0 110.008 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.1 mttm 52.89 -170.33 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.141 -0.975 . . . . 0.0 110.038 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -138.42 146.79 42.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.922 . . . . 0.0 110.185 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 CA-C-O 117.981 -1.455 . . . . 0.0 109.556 179.946 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 ptt? . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.215 0.531 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 51.8 74.23 0.27 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.233 -0.917 . . . . 0.0 110.114 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.595 HG21 HG23 ' A' ' 56' ' ' ILE . 44.9 mt -123.32 171.87 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.245 -0.91 . . . . 0.0 110.077 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.492 ' N ' HG22 ' A' ' 3' ' ' ILE . 0.2 OUTLIER 178.91 -22.2 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.1 -1.0 . . . . 0.0 111.937 -179.576 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -79.13 -141.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.764 -1.21 . . . . 0.0 110.26 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.45 31.63 5.67 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.516 ' O ' HG22 ' A' ' 56' ' ' ILE . 6.1 tttp -80.39 124.87 29.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.02 -1.283 . . . . 0.0 109.28 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.529 ' CE2' ' CD2' ' A' ' 34' ' ' PHE . 11.5 m-85 -112.28 155.27 24.34 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.981 -1.074 . . . . 0.0 110.602 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 8.3 tt0 -122.29 130.74 53.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.462 -0.774 . . . . 0.0 109.827 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 t -73.35 114.67 11.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.096 -1.002 . . . . 0.0 110.373 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.71 -12.68 61.71 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.371 -0.931 . . . . 0.0 109.36 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.03 -41.01 16.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.343 -0.848 . . . . 0.0 111.758 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.438 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 11.4 p -123.53 -28.58 3.89 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.583 -1.323 . . . . 0.0 111.795 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.71 20.06 8.76 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.226 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.804 ' C ' HD12 ' A' ' 16' ' ' ILE . 35.8 t80 -83.0 159.54 22.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.135 -1.215 . . . . 0.0 109.867 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.804 HD12 ' C ' ' A' ' 15' ' ' TYR . 2.9 mp -121.82 120.36 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.91 . . . . 0.0 109.835 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.488 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 61.4 t80 -84.12 138.0 33.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.908 . . . . 0.0 110.376 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.97 110.62 45.88 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.738 -0.601 . . . . 0.0 109.911 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.474 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 38.7 Cg_endo -72.89 -65.06 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.494 1.26 . . . . 0.0 111.088 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.426 ' O ' ' CB ' ' A' ' 30' ' ' PRO . 3.3 tt0 -45.48 -25.44 0.43 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.692 -0.63 . . . . 0.0 111.374 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.54 -41.84 7.57 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.094 -1.004 . . . . 0.0 110.65 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.26 145.96 19.75 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.539 ' HB3' HD12 ' A' ' 28' ' ' ILE . 22.4 t0 -85.09 63.23 7.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.335 -1.097 . . . . 0.0 109.676 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -43.64 -27.64 0.32 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.725 -0.61 . . . . 0.0 111.254 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -71.85 -29.1 64.04 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.154 -0.966 . . . . 0.0 109.924 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.494 ' HB3' HD12 ' A' ' 28' ' ' ILE . . . -96.82 -27.53 14.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.411 -0.805 . . . . 0.0 110.048 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.26 25.86 2.84 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.539 HD12 ' HB3' ' A' ' 23' ' ' ASP . 5.8 mt -114.6 120.27 38.08 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.074 -1.251 . . . . 0.0 110.001 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.426 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 45.4 Cg_endo -70.74 174.01 10.99 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.534 1.281 . . . . 0.0 110.509 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.426 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 47.6 Cg_endo -70.95 -163.28 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.715 1.376 . . . . 0.0 110.112 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 50.3 24.88 7.53 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 91.9 m -126.0 113.32 24.27 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.092 -1.24 . . . . 0.0 110.295 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.777 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.2 Cg_endo -72.1 149.68 52.72 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 O-C-N 123.532 1.28 . . . . 0.0 110.619 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.529 ' CD2' ' CE2' ' A' ' 8' ' ' TYR . 27.3 t80 -52.38 -28.67 20.58 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.371 -0.831 . . . . 0.0 109.957 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.777 HG22 ' HB2' ' A' ' 33' ' ' PRO . 24.8 m -70.23 -15.41 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.285 -0.884 . . . . 0.0 110.557 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -98.32 -6.43 30.91 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.025 -1.047 . . . . 0.0 110.752 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.438 HD21 ' CZ ' ' A' ' 17' ' ' TYR . 27.2 mt -51.25 162.28 0.34 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.956 -1.09 . . . . 0.0 110.461 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.3 m -50.31 154.8 1.14 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.347 -0.846 . . . . 0.0 110.508 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.19 -24.03 66.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.286 -0.884 . . . . 0.0 110.1 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.2 t -127.91 38.41 4.03 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.236 -0.915 . . . . 0.0 110.205 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.457 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 45.7 t80 -54.98 138.03 44.62 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.297 -0.877 . . . . 0.0 110.263 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.3 mmt -113.74 135.82 53.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.291 -0.881 . . . . 0.0 109.74 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 24.4 t -53.79 133.03 56.82 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.249 -0.907 . . . . 0.0 110.585 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -75.06 -3.69 14.29 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.447 1.235 . . . . 0.0 110.506 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -112.17 -35.65 5.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.033 -1.042 . . . . 0.0 110.559 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.438 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 1.5 p -128.57 6.51 5.69 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.087 -1.008 . . . . 0.0 111.01 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 54.46 20.07 2.63 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.209 -0.932 . . . . 0.0 112.714 178.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.0 m -74.27 165.68 51.33 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 120.617 -1.302 . . . . 0.0 109.658 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.51 136.06 30.11 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.638 1.336 . . . . 0.0 110.177 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 41' ' ' PHE . 14.5 tttm -48.32 -26.01 1.83 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.2 -0.938 . . . . 0.0 110.697 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -63.69 -15.07 57.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.167 -0.958 . . . . 0.0 109.822 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.13 -2.97 58.62 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.255 -0.903 . . . . 0.0 110.136 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 34' ' ' PHE . 11.3 m-85 -82.75 133.16 35.15 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.95 -1.094 . . . . 0.0 110.478 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.91 120.33 38.12 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.197 -0.939 . . . . 0.0 109.527 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 3.0 t -52.0 -178.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.338 -0.851 . . . . 0.0 110.625 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.595 HG23 HG21 ' A' ' 3' ' ' ILE . 3.0 tt -158.26 91.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.531 -0.731 . . . . 0.0 109.691 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 4' ' ' ASP . 5.1 mttt -105.73 67.86 0.77 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.4 -0.813 . . . . 0.0 110.124 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -127.08 141.8 51.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.324 -0.86 . . . . 0.0 110.338 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.451 HG23 ' OD1' ' A' ' 4' ' ' ASP . 88.6 t -127.53 140.67 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 110.155 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.644 ' O ' HG23 ' A' ' 60' ' ' ILE . 2.1 tp -150.93 110.95 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.908 . . . . 0.0 110.151 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -142.28 66.16 1.34 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.19 -0.944 . . . . 0.0 110.147 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.74 93.57 0.74 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -125.01 28.17 6.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.137 -1.214 . . . . 0.0 110.18 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -106.08 -76.92 0.6 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.245 -0.909 . . . . 0.0 110.194 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -109.17 -75.27 0.63 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.93 . . . . 0.0 110.42 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -165.61 -59.15 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.19 -0.944 . . . . 0.0 110.277 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -75.22 137.61 41.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.224 -0.923 . . . . 0.0 110.24 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.13 -56.35 23.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.238 -0.914 . . . . 0.0 110.134 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -58.37 -173.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.294 -0.879 . . . . 0.0 110.19 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 CA-C-O 117.975 -1.458 . . . . 0.0 109.559 -179.879 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 mtt . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.226 0.536 . . . . 0.0 110.173 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.15 113.53 18.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.318 -0.864 . . . . 0.0 110.129 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.546 HD12 HD13 ' A' ' 56' ' ' ILE . 12.8 pt -147.36 122.13 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.153 -0.967 . . . . 0.0 110.613 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.419 ' OD1' ' CB ' ' A' ' 57' ' ' LYS . 39.5 t0 -159.54 13.3 0.14 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.391 -0.818 . . . . 0.0 111.36 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.16 68.81 4.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.048 -1.033 . . . . 0.0 110.575 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 50.46 28.13 13.82 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.69 ' HB3' HD11 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -84.25 130.17 34.83 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.143 -1.21 . . . . 0.0 109.951 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.505 ' CE2' ' HB2' ' A' ' 55' ' ' SER . 22.9 m-85 -117.0 149.1 40.8 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.148 -0.97 . . . . 0.0 110.381 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.466 ' HA ' HD13 ' A' ' 16' ' ' ILE . 1.2 tm-20 -119.16 130.06 55.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 0.0 110.323 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.6 t -73.62 114.72 12.2 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.274 -0.891 . . . . 0.0 110.25 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -70.4 -11.39 60.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.071 -1.018 . . . . 0.0 109.624 178.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.09 -42.29 14.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.397 -0.814 . . . . 0.0 111.579 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.466 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 13.8 p -121.88 -31.04 4.0 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.709 -1.245 . . . . 0.0 111.418 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.65 23.0 6.73 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.427 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 44.6 t80 -82.31 159.25 23.15 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.34 -1.094 . . . . 0.0 109.517 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.466 HD13 ' HA ' ' A' ' 9' ' ' GLU . 41.3 mm -123.77 115.77 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.205 -0.934 . . . . 0.0 110.041 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.535 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 81.1 t80 -81.44 135.81 35.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.3 -0.875 . . . . 0.0 110.321 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -114.94 114.33 43.92 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.529 -0.732 . . . . 0.0 109.603 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.481 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 37.7 Cg_endo -69.44 -67.04 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.531 1.28 . . . . 0.0 111.559 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -43.04 -28.0 0.24 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.739 -0.601 . . . . 0.0 111.225 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.4 tptt -96.8 -27.13 14.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.159 -0.963 . . . . 0.0 110.271 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.62 159.58 30.52 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.55 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 1.0 OUTLIER -85.05 59.86 5.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.339 -1.095 . . . . 0.0 109.81 179.799 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -46.51 -26.51 0.89 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.406 -0.809 . . . . 0.0 110.613 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -76.01 -28.01 57.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 110.061 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.55 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -97.71 -27.45 14.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.304 -0.872 . . . . 0.0 110.192 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.16 22.67 2.58 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.5 HD12 ' HB3' ' A' ' 23' ' ' ASP . 5.0 mt -112.18 130.01 23.72 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 120.975 -1.309 . . . . 0.0 109.595 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.416 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 49.1 Cg_endo -74.38 173.48 14.17 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.483 1.254 . . . . 0.0 110.393 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.416 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 49.9 Cg_endo -71.68 -163.54 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.65 1.342 . . . . 0.0 110.065 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 51.17 32.98 29.68 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.794 -1.323 . . . . 0.0 109.794 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 93.8 m -137.63 122.03 12.1 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.209 -1.171 . . . . 0.0 110.064 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.77 ' HB2' HG22 ' A' ' 35' ' ' VAL . 50.1 Cg_endo -76.32 151.84 34.19 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.547 1.288 . . . . 0.0 110.697 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.535 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 20.7 t80 -52.26 -33.25 40.86 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.305 -0.872 . . . . 0.0 109.84 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.77 HG22 ' HB2' ' A' ' 33' ' ' PRO . 33.3 m -64.69 -15.11 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.921 . . . . 0.0 110.506 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.53 -18.29 33.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.15 -0.968 . . . . 0.0 110.559 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.487 HD11 ' CE1' ' A' ' 17' ' ' TYR . 71.0 mt -51.81 146.45 8.13 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.046 -1.034 . . . . 0.0 110.29 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.93 160.0 0.36 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.194 -0.942 . . . . 0.0 110.519 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -66.83 -13.88 62.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -0.897 . . . . 0.0 110.624 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.6 t -122.11 25.5 9.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.023 -1.048 . . . . 0.0 110.365 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.463 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 25.4 t80 -54.81 135.22 47.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.131 -0.981 . . . . 0.0 109.871 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -109.42 150.66 27.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.369 -0.832 . . . . 0.0 109.58 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 18.1 t -66.38 134.76 94.62 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.113 -0.992 . . . . 0.0 110.347 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.71 -7.85 18.82 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.667 1.351 . . . . 0.0 110.185 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -110.19 -31.92 7.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.172 -0.955 . . . . 0.0 110.844 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.466 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.8 OUTLIER -134.49 7.31 3.57 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.021 -1.049 . . . . 0.0 111.353 -179.681 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 58.49 14.56 3.07 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.098 -1.001 . . . . 0.0 112.837 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.5 m -65.45 165.93 16.32 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 120.619 -1.301 . . . . 0.0 110.087 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.99 141.34 26.56 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.666 1.35 . . . . 0.0 110.152 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.463 ' HB2' ' HB3' ' A' ' 41' ' ' PHE . 8.6 tttm -51.87 -26.21 9.61 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.215 -0.928 . . . . 0.0 110.261 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.53 -11.17 59.52 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.185 -0.947 . . . . 0.0 109.89 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -88.88 -2.35 58.55 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.175 -0.953 . . . . 0.0 110.076 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.412 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 17.9 m-85 -86.25 140.01 30.51 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.999 -1.063 . . . . 0.0 110.226 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.61 124.89 46.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.2 -0.938 . . . . 0.0 109.801 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.527 ' C ' HG23 ' A' ' 56' ' ' ILE . 3.0 t -57.28 178.34 0.07 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.237 -0.914 . . . . 0.0 110.809 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.69 HD11 ' HB3' ' A' ' 7' ' ' LYS . 1.1 pt -155.35 84.52 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.828 -0.545 . . . . 0.0 109.832 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.419 ' CB ' ' OD1' ' A' ' 4' ' ' ASP . 0.2 OUTLIER -99.17 63.86 1.34 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.172 -0.955 . . . . 0.0 110.142 -179.882 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.477 ' C ' HG13 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -95.55 138.86 32.63 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.298 -0.877 . . . . 0.0 110.092 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.477 HG13 ' C ' ' A' ' 58' ' ' LYS . 29.6 m -148.9 135.52 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 110.249 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.449 ' N ' HD12 ' A' ' 60' ' ' ILE . 4.7 mp -129.04 -43.71 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.242 -0.911 . . . . 0.0 110.288 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -144.61 123.38 12.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -0.898 . . . . 0.0 110.241 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -151.71 -114.61 0.62 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -97.49 -50.95 4.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -1.143 . . . . 0.0 110.2 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -129.09 109.52 11.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.178 -0.952 . . . . 0.0 110.259 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -72.64 -158.37 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.22 -0.925 . . . . 0.0 110.211 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -165.14 74.0 0.22 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 110.049 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -60.57 114.71 3.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.152 -0.968 . . . . 0.0 110.246 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.5 tptt -140.99 -45.17 0.39 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.894 . . . . 0.0 110.084 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -174.8 152.05 1.51 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.312 -0.867 . . . . 0.0 110.202 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 CA-C-O 117.959 -1.467 . . . . 0.0 109.513 -179.975 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.0 ttp . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.241 0.544 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -142.52 91.4 2.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.203 -0.936 . . . . 0.0 110.3 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.845 HD12 ' HB ' ' A' ' 56' ' ' ILE . 8.2 pt -140.85 134.14 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.265 -0.897 . . . . 0.0 109.754 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' A' ' 6' ' ' GLY . 0.7 OUTLIER 179.91 -30.26 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.205 -0.934 . . . . 0.0 110.96 -179.398 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -67.49 71.2 0.12 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.354 -0.841 . . . . 0.0 110.36 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 4' ' ' ASP . . . 51.33 23.66 9.08 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.43 ' O ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -79.37 125.33 29.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.124 -1.221 . . . . 0.0 109.223 179.213 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.52 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 7.8 m-85 -115.77 156.42 26.04 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.075 -1.015 . . . . 0.0 110.566 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.529 ' HA ' HD13 ' A' ' 16' ' ' ILE . 2.5 pp20? -126.43 136.26 52.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.367 -0.833 . . . . 0.0 110.168 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.0 t -78.25 111.84 14.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.945 . . . . 0.0 110.242 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.69 -10.83 59.82 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.204 -0.998 . . . . 0.0 109.426 178.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.68 -43.01 14.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.352 -0.843 . . . . 0.0 111.383 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.46 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 12.7 p -120.5 -31.66 4.26 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.632 -1.292 . . . . 0.0 111.273 -179.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.6 21.5 6.8 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.684 -1.246 . . . . 0.0 110.132 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.525 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 52.2 t80 -83.18 167.38 17.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.109 -1.23 . . . . 0.0 109.907 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.529 HD13 ' HA ' ' A' ' 9' ' ' GLU . 36.5 mm -131.11 117.67 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.137 -0.977 . . . . 0.0 110.334 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.503 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 72.7 t80 -81.04 135.31 35.82 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.436 -0.79 . . . . 0.0 110.422 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -112.38 113.7 50.98 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.612 -0.68 . . . . 0.0 109.761 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.47 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 39.0 Cg_endo -72.26 -68.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.414 1.218 . . . . 0.0 111.144 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -45.16 -26.63 0.5 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.581 -0.699 . . . . 0.0 111.2 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.99 -37.57 11.07 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.079 -1.013 . . . . 0.0 110.49 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.63 152.09 28.84 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.549 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 4.2 t0 -85.11 62.9 7.8 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.4 -1.059 . . . . 0.0 109.674 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.43 -27.37 0.44 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.647 -0.658 . . . . 0.0 111.03 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -77.22 -27.86 53.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.184 -0.947 . . . . 0.0 110.206 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.549 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -95.85 -28.83 14.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.251 -0.906 . . . . 0.0 110.362 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.08 11.55 5.21 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.815 -1.183 . . . . 0.0 110.296 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.422 HD12 ' HB3' ' A' ' 23' ' ' ASP . 4.6 mt -103.08 124.61 37.84 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 120.938 -1.33 . . . . 0.0 110.012 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.423 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 45.3 Cg_endo -71.91 173.74 12.31 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.468 1.246 . . . . 0.0 110.222 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.423 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 48.6 Cg_endo -70.19 -163.77 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.613 1.323 . . . . 0.0 110.252 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 49.94 27.17 9.52 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.4 m -128.12 116.51 20.33 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.333 -1.098 . . . . 0.0 110.279 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.842 ' HB2' HG22 ' A' ' 35' ' ' VAL . 49.0 Cg_endo -73.55 150.33 45.58 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.53 1.279 . . . . 0.0 110.617 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.503 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 12.7 t80 -53.49 -29.53 36.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.413 -0.804 . . . . 0.0 109.979 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.842 HG22 ' HB2' ' A' ' 33' ' ' PRO . 35.3 m -67.22 -13.2 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 110.608 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.6 -4.03 38.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.069 -1.02 . . . . 0.0 110.93 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.458 ' HA ' HD23 ' A' ' 37' ' ' LEU . 28.1 mt -53.13 165.61 0.31 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.872 -1.142 . . . . 0.0 110.14 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.0 m -59.36 162.48 4.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.889 . . . . 0.0 110.279 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.36 -27.42 69.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.311 -0.868 . . . . 0.0 110.2 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.65 46.31 2.5 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.263 -0.898 . . . . 0.0 110.042 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.438 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 23.9 t80 -62.58 140.2 58.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.334 -0.854 . . . . 0.0 110.159 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 36.5 mtt -112.61 151.08 30.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.358 -0.839 . . . . 0.0 109.468 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 29.4 t -65.69 135.46 95.6 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.178 -0.951 . . . . 0.0 110.268 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -75.87 -0.02 9.76 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.503 1.265 . . . . 0.0 110.594 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -119.39 -38.77 2.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.01 -1.056 . . . . 0.0 110.825 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.46 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 1.4 p -123.12 8.16 9.2 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.025 -1.047 . . . . 0.0 111.13 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 27.3 mtt85 54.5 18.84 2.12 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.332 -0.855 . . . . 0.0 112.79 178.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.5 m -72.52 166.3 43.43 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 120.577 -1.327 . . . . 0.0 109.732 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.408 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 45.2 Cg_endo -71.98 139.9 33.84 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.668 1.352 . . . . 0.0 110.387 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.499 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 9.6 tttm -48.98 -26.33 2.46 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.162 -0.961 . . . . 0.0 110.822 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -63.65 -14.9 56.22 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.127 -0.983 . . . . 0.0 109.862 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 1.1 tm0? -83.87 -4.2 58.49 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.157 -0.965 . . . . 0.0 110.151 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -86.23 131.81 34.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.977 -1.077 . . . . 0.0 110.348 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.41 ' O ' ' HG3' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -117.99 131.74 56.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.272 -0.893 . . . . 0.0 109.544 179.28 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.653 ' O ' HG23 ' A' ' 56' ' ' ILE . 79.7 p -60.82 176.86 0.36 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.156 -0.965 . . . . 0.0 110.893 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.845 ' HB ' HD12 ' A' ' 3' ' ' ILE . 9.9 pt -159.48 92.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-O 121.362 0.601 . . . . 0.0 109.699 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 0.4 OUTLIER -114.27 70.96 0.74 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.357 -0.84 . . . . 0.0 110.296 -179.582 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.7 ttpt -128.23 75.46 1.62 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 110.197 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 66.8 t -83.34 120.41 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 110.262 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.508 ' O ' HG23 ' A' ' 60' ' ' ILE . 0.7 OUTLIER -157.63 69.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.31 -0.869 . . . . 0.0 110.242 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.01 170.1 13.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.92 . . . . 0.0 110.197 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 143.63 -23.26 2.17 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -75.93 179.21 5.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.253 -1.145 . . . . 0.0 110.292 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -128.4 155.49 44.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 110.157 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -92.63 148.19 22.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.229 -0.919 . . . . 0.0 110.166 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -102.58 -64.57 1.06 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.258 -0.901 . . . . 0.0 110.45 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -139.75 -51.36 0.51 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.213 -0.929 . . . . 0.0 110.418 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.88 147.94 8.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.166 -0.959 . . . . 0.0 110.273 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -57.88 96.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.309 -0.869 . . . . 0.0 110.24 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.995 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mtp . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.188 0.518 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.2 146.85 36.77 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.168 -0.957 . . . . 0.0 110.156 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 1.083 HD12 HD12 ' A' ' 56' ' ' ILE . 13.3 pt -146.58 131.47 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.32 -0.863 . . . . 0.0 110.091 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.45 ' CB ' ' HA ' ' A' ' 57' ' ' LYS . 33.1 t0 -177.87 -25.73 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.32 -0.862 . . . . 0.0 111.442 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -64.87 75.8 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.002 -1.061 . . . . 0.0 110.287 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 4' ' ' ASP . . . 56.29 20.65 29.97 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.431 ' O ' ' CG1' ' A' ' 56' ' ' ILE . 4.3 mmtt -80.12 116.56 20.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.158 -1.201 . . . . 0.0 109.501 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.587 ' CE2' ' CD2' ' A' ' 34' ' ' PHE . 7.5 m-85 -112.26 145.11 40.55 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.156 -0.965 . . . . 0.0 110.625 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 3.1 tt0 -115.12 135.74 53.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.404 -0.81 . . . . 0.0 109.995 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.9 t -75.24 113.46 12.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.23 -0.919 . . . . 0.0 110.573 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -11.28 60.79 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.449 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.14 -40.26 16.94 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.312 -0.867 . . . . 0.0 111.484 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.462 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 12.6 p -123.95 -32.51 3.26 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.683 -1.26 . . . . 0.0 111.484 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.55 21.71 6.37 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.851 ' C ' HD12 ' A' ' 16' ' ' ILE . 46.6 t80 -83.56 162.3 20.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -1.123 . . . . 0.0 109.74 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.851 HD12 ' C ' ' A' ' 15' ' ' TYR . 2.1 mp -123.51 116.39 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 0.0 109.939 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.504 ' OH ' HD21 ' A' ' 37' ' ' LEU . 78.3 t80 -82.86 127.87 33.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.164 -0.96 . . . . 0.0 110.15 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -106.4 111.08 64.25 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.698 -0.626 . . . . 0.0 109.614 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.474 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 38.1 Cg_endo -70.28 -63.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.525 1.276 . . . . 0.0 110.806 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -46.8 -26.05 0.88 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.73 -0.606 . . . . 0.0 110.558 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -95.29 -31.16 13.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -0.924 . . . . 0.0 110.041 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.69 153.59 21.68 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.728 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -85.19 60.85 6.5 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.395 -1.062 . . . . 0.0 109.431 179.473 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -46.84 -26.76 1.04 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.536 -0.727 . . . . 0.0 110.682 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -81.14 -22.49 38.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.175 -0.953 . . . . 0.0 110.207 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.728 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -100.08 -27.61 13.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.229 -0.919 . . . . 0.0 110.012 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.51 28.98 1.36 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.573 HD13 ' CD2' ' A' ' 37' ' ' LEU . 5.4 mt -125.14 123.58 25.34 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.013 -1.286 . . . . 0.0 109.707 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.42 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 44.0 Cg_endo -70.0 173.47 11.14 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.525 1.276 . . . . 0.0 110.238 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 47.2 Cg_endo -69.99 -163.72 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.674 1.355 . . . . 0.0 110.233 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 49.04 26.0 5.7 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.6 m -125.34 121.11 24.97 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.272 -1.134 . . . . 0.0 110.257 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.653 ' HB2' HG22 ' A' ' 35' ' ' VAL . 50.3 Cg_endo -76.41 158.16 36.69 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.477 1.251 . . . . 0.0 110.651 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.587 ' CD2' ' CE2' ' A' ' 8' ' ' TYR . 13.6 t80 -61.04 -34.18 74.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.349 -0.844 . . . . 0.0 109.945 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.653 HG22 ' HB2' ' A' ' 33' ' ' PRO . 26.8 m -65.51 -12.93 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.908 . . . . 0.0 110.529 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.57 -9.17 36.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.025 -1.047 . . . . 0.0 110.817 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.573 ' CD2' HD13 ' A' ' 28' ' ' ILE . 49.8 mt -53.85 156.07 3.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.0 -1.063 . . . . 0.0 110.185 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.9 t -52.56 147.78 7.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.168 -0.958 . . . . 0.0 110.255 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.64 -23.14 10.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 110.214 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 72.3 p -123.71 47.5 2.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.908 . . . . 0.0 110.487 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.465 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 27.7 t80 -70.56 145.63 50.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.164 -0.96 . . . . 0.0 109.835 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.411 ' HA ' ' O ' ' A' ' 48' ' ' SER . 28.3 mtm -121.11 138.02 54.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.293 -0.88 . . . . 0.0 109.994 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 27.5 t -54.68 133.81 64.8 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.368 -0.832 . . . . 0.0 110.235 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -76.33 -0.68 10.64 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.485 1.255 . . . . 0.0 110.627 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.72 -42.56 3.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.98 -1.075 . . . . 0.0 110.473 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.462 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 1.7 p -119.75 5.63 10.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.106 -0.996 . . . . 0.0 111.121 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 54.57 24.82 5.7 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.256 -0.902 . . . . 0.0 112.64 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 42' ' ' MET . 5.8 m -79.29 166.02 44.56 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 120.578 -1.327 . . . . 0.0 109.599 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.4 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 43.8 Cg_endo -70.37 140.89 41.4 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.567 1.299 . . . . 0.0 110.75 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.509 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 23.8 tttt -50.58 -24.66 3.4 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.21 -0.931 . . . . 0.0 110.55 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -66.01 -13.41 59.83 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.08 -1.013 . . . . 0.0 109.933 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.4 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.9 OUTLIER -85.05 -4.34 59.12 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.203 -0.936 . . . . 0.0 110.006 179.347 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -85.5 137.31 32.98 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.956 -1.09 . . . . 0.0 110.526 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.8 tttm -123.48 133.51 54.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.625 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.634 ' O ' HG23 ' A' ' 56' ' ' ILE . 68.6 p -62.11 175.56 0.69 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.177 -0.952 . . . . 0.0 110.888 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.083 HD12 HD12 ' A' ' 3' ' ' ILE . 7.4 pt -159.42 90.81 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 CA-C-O 121.334 0.588 . . . . 0.0 110.079 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.45 ' HA ' ' CB ' ' A' ' 4' ' ' ASP . 0.0 OUTLIER -101.64 65.49 1.03 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.935 -1.103 . . . . 0.0 109.837 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.81 147.56 40.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.392 -0.818 . . . . 0.0 110.211 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.408 ' O ' HG12 ' A' ' 59' ' ' VAL . 86.5 t -116.18 81.01 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.273 -0.892 . . . . 0.0 110.171 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 51.4 mm -85.05 73.33 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.328 -0.857 . . . . 0.0 110.284 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.86 83.4 6.6 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.126 -0.984 . . . . 0.0 110.246 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -139.58 36.0 1.89 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.6 t80 52.23 54.29 11.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.284 -1.127 . . . . 0.0 110.335 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.03 65.32 8.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.321 -0.862 . . . . 0.0 110.084 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.16 158.83 15.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.302 -0.873 . . . . 0.0 110.487 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -80.95 95.47 6.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.415 -0.803 . . . . 0.0 110.102 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -120.57 -175.81 3.1 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.206 -0.934 . . . . 0.0 110.277 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.3 mmtt -82.32 75.33 9.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.281 -0.887 . . . . 0.0 109.989 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -64.86 97.98 0.25 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.217 -0.927 . . . . 0.0 110.175 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.339 0 CA-C-O 118.026 -1.43 . . . . 0.0 109.572 179.948 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.404 ' O ' HG22 ' A' ' 60' ' ' ILE . 93.7 mtp . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.285 0.564 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.474 ' C ' HG23 ' A' ' 3' ' ' ILE . 32.3 mt-10 -131.8 80.83 1.94 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.301 -0.874 . . . . 0.0 110.018 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.474 HG23 ' C ' ' A' ' 2' ' ' GLU . 22.1 pt -151.43 144.49 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.27 -0.894 . . . . 0.0 110.452 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' A' ' 3' ' ' ILE . 8.1 p-10 178.83 112.75 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 121.756 0.788 . . . . 0.0 109.41 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -171.95 54.22 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.316 0.579 . . . . 0.0 110.023 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 63.39 17.7 59.98 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.405 ' O ' ' CG1' ' A' ' 56' ' ' ILE . 20.1 mttt -84.26 119.91 25.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.137 -1.213 . . . . 0.0 109.676 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.525 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 9.1 m-85 -112.26 150.09 31.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.115 -0.991 . . . . 0.0 110.432 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 43.7 tt0 -120.35 138.49 53.7 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.337 -0.852 . . . . 0.0 110.564 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.1 t -77.23 111.06 12.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.321 -0.862 . . . . 0.0 110.3 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -68.02 -11.23 58.53 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.36 -0.936 . . . . 0.0 109.568 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.36 -42.06 16.11 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.296 -0.878 . . . . 0.0 111.52 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.453 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 14.5 p -121.86 -34.75 3.31 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.707 -1.246 . . . . 0.0 111.498 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.06 22.08 5.06 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.452 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 29.5 t80 -84.27 158.82 21.1 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.308 -1.113 . . . . 0.0 109.804 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.442 ' N ' ' CD1' ' A' ' 15' ' ' TYR . 29.3 mm -122.5 120.04 59.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.318 -0.864 . . . . 0.0 110.267 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.5 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 80.6 t80 -83.25 130.03 35.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.909 . . . . 0.0 109.97 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -109.95 114.76 55.95 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.583 -0.698 . . . . 0.0 109.484 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.478 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 37.8 Cg_endo -69.95 -68.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.529 1.279 . . . . 0.0 111.225 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -46.27 -25.48 0.63 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.476 -0.765 . . . . 0.0 111.175 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.66 -39.22 11.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.113 -0.992 . . . . 0.0 110.882 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.41 145.68 15.56 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.42 ' HB3' HD12 ' A' ' 28' ' ' ILE . 25.1 t0 -85.09 61.54 6.94 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.345 -1.091 . . . . 0.0 109.937 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.94 -25.92 1.54 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.397 -0.814 . . . . 0.0 110.461 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -75.49 -21.66 57.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.907 . . . . 0.0 110.092 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -105.56 -34.4 7.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.288 -0.883 . . . . 0.0 109.887 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 131.18 34.11 0.43 Allowed Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.892 -1.147 . . . . 0.0 110.361 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.52 HD13 ' CD2' ' A' ' 37' ' ' LEU . 5.2 mt -129.85 121.65 20.05 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 120.807 -1.408 . . . . 0.0 109.988 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.411 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 45.0 Cg_endo -70.13 173.93 10.58 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 O-C-N 123.613 1.323 . . . . 0.0 110.265 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 45.4 Cg_endo -68.59 -163.78 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.616 1.324 . . . . 0.0 110.176 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 47.76 27.79 4.91 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 15.4 m -125.75 113.9 24.81 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.218 -1.166 . . . . 0.0 110.344 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.718 ' HB2' HG22 ' A' ' 35' ' ' VAL . 45.9 Cg_endo -73.31 146.92 41.02 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 123.472 1.248 . . . . 0.0 110.738 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.5 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 22.7 t80 -51.41 -34.02 32.94 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.433 -0.792 . . . . 0.0 110.561 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.718 HG22 ' HB2' ' A' ' 33' ' ' PRO . 30.0 m -65.75 -14.04 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.202 -0.936 . . . . 0.0 110.723 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.416 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 36.0 t0 -98.32 -1.61 41.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.998 -1.063 . . . . 0.0 110.996 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.52 ' CD2' HD13 ' A' ' 28' ' ' ILE . 26.0 mt -54.38 176.37 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.903 -1.123 . . . . 0.0 110.17 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.9 m -69.36 152.98 44.3 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.235 -0.916 . . . . 0.0 110.123 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.65 -23.28 40.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.161 -0.962 . . . . 0.0 110.216 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.4 m -129.28 43.52 3.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.167 -0.958 . . . . 0.0 110.27 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.462 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 20.0 t80 -62.89 132.65 52.83 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.377 -0.827 . . . . 0.0 109.85 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.409 ' HA ' ' O ' ' A' ' 48' ' ' SER . 7.0 mtt -111.33 148.19 33.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.376 -0.827 . . . . 0.0 109.668 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.437 ' HB3' ' N ' ' A' ' 47' ' ' ARG . 10.0 t -57.99 135.23 83.83 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.897 . . . . 0.0 110.422 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -76.12 -0.34 10.21 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 123.628 1.331 . . . . 0.0 110.578 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -122.88 -38.97 2.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.943 -1.098 . . . . 0.0 110.859 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.453 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -121.24 8.03 10.27 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.038 -1.039 . . . . 0.0 111.202 -179.62 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.437 ' N ' ' HB3' ' A' ' 43' ' ' CYS . 2.5 ttt180 58.37 13.84 2.62 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.183 -0.948 . . . . 0.0 112.786 178.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.409 ' O ' ' HA ' ' A' ' 42' ' ' MET . 1.3 m -63.63 156.81 69.9 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 120.594 -1.316 . . . . 0.0 109.714 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.403 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 46.8 Cg_endo -72.77 146.54 43.07 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.665 1.35 . . . . 0.0 110.183 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 41' ' ' PHE . 19.5 tttm -53.74 -27.19 26.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.022 -1.049 . . . . 0.0 110.235 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -67.98 -11.29 58.57 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.176 -0.952 . . . . 0.0 109.827 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.8 OUTLIER -88.65 -2.67 58.72 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.21 -0.931 . . . . 0.0 110.016 179.205 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -89.9 126.06 35.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.012 -1.055 . . . . 0.0 110.348 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.2 tptt -108.8 134.13 51.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.209 -0.932 . . . . 0.0 109.739 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.525 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 80.0 p -63.72 179.46 0.49 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.121 -0.987 . . . . 0.0 110.761 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.491 HG23 ' C ' ' A' ' 55' ' ' SER . 1.1 pt -151.48 76.49 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-O 121.271 0.557 . . . . 0.0 110.157 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -100.01 62.73 1.15 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.306 -0.871 . . . . 0.0 110.144 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.5 mttp -82.2 123.28 28.87 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.276 -0.89 . . . . 0.0 110.372 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 40.0 t -140.81 121.1 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.247 -0.908 . . . . 0.0 110.262 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.404 HG22 ' O ' ' A' ' 1' ' ' MET . 0.4 OUTLIER -145.43 139.0 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.215 -0.928 . . . . 0.0 110.318 179.853 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.41 90.87 0.25 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.282 -0.886 . . . . 0.0 110.005 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -110.73 -62.94 0.5 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.25 151.15 28.14 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.302 -1.117 . . . . 0.0 110.317 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -173.47 142.16 0.95 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.319 -0.863 . . . . 0.0 110.22 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -134.72 129.72 35.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.223 -0.923 . . . . 0.0 110.223 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -147.91 48.86 1.07 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.314 -0.866 . . . . 0.0 110.04 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -152.69 40.5 0.58 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.282 -0.886 . . . . 0.0 110.064 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.88 -42.58 99.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.352 -0.842 . . . . 0.0 110.335 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -80.81 135.25 35.92 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.217 -0.927 . . . . 0.0 110.225 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.991 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtt . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.252 0.549 . . . . 0.0 110.126 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -115.31 77.5 1.08 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -0.905 . . . . 0.0 110.375 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.425 ' O ' ' HB3' ' A' ' 4' ' ' ASP . 45.0 mt -135.31 166.31 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.214 -0.929 . . . . 0.0 109.951 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.425 ' HB3' ' O ' ' A' ' 3' ' ' ILE . 8.2 p-10 176.54 113.26 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.718 0.77 . . . . 0.0 109.825 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -159.46 -148.89 0.19 Allowed 'General case' 0 C--N 1.291 -1.962 0 O-C-N 121.795 -0.566 . . . . 0.0 109.669 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.68 19.23 55.45 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.427 ' CB ' HG12 ' A' ' 56' ' ' ILE . 29.2 mttt -82.47 136.73 34.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.071 -1.252 . . . . 0.0 109.656 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.514 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 13.4 m-85 -122.7 148.04 45.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.037 -1.039 . . . . 0.0 110.628 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 5.1 tm-20 -120.02 128.08 53.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.414 -0.804 . . . . 0.0 109.906 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.4 t -65.31 110.07 2.48 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.161 -0.962 . . . . 0.0 110.059 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.91 -11.92 57.77 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.206 -0.934 . . . . 0.0 109.612 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.01 -40.46 16.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.327 -0.858 . . . . 0.0 111.782 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 11.7 p -123.95 -32.71 3.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.647 -1.283 . . . . 0.0 111.523 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.09 18.9 6.57 Favored Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.713 -1.232 . . . . 0.0 110.256 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.529 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 42.7 t80 -76.28 167.98 20.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -1.175 . . . . 0.0 109.516 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.529 ' N ' ' CD1' ' A' ' 15' ' ' TYR . 35.1 mm -130.82 120.26 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 110.424 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.474 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 51.5 t80 -89.36 142.5 27.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.325 -0.86 . . . . 0.0 109.966 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -123.69 112.49 29.11 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.544 -0.723 . . . . 0.0 109.829 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.523 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 40.4 Cg_endo -72.2 -67.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.516 1.272 . . . . 0.0 111.284 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -44.22 -28.0 0.47 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.794 -0.566 . . . . 0.0 110.922 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.7 mttp -96.15 -40.06 9.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 0.0 110.24 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.29 147.85 22.53 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.481 ' HB3' HD12 ' A' ' 28' ' ' ILE . 2.8 t0 -84.94 61.11 6.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.465 -1.021 . . . . 0.0 109.65 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -45.49 -27.08 0.67 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.444 -0.785 . . . . 0.0 110.955 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -74.69 -27.43 60.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.115 -0.99 . . . . 0.0 109.975 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.462 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -98.48 -22.83 15.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.346 -0.846 . . . . 0.0 109.9 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.12 23.23 3.94 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.481 HD12 ' HB3' ' A' ' 23' ' ' ASP . 9.2 mt -115.26 114.57 43.07 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.117 -1.225 . . . . 0.0 109.907 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.409 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 43.0 Cg_endo -68.91 173.9 9.54 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 O-C-N 123.597 1.314 . . . . 0.0 110.294 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 44.9 Cg_endo -67.89 -164.43 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.57 1.3 . . . . 0.0 110.024 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 48.19 34.02 11.83 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 m -134.48 109.35 11.24 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.121 -1.223 . . . . 0.0 110.52 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.879 ' HB2' HG22 ' A' ' 35' ' ' VAL . 44.6 Cg_endo -71.8 148.72 52.81 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.455 1.24 . . . . 0.0 110.344 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.532 ' CD1' HD12 ' A' ' 37' ' ' LEU . 38.8 t80 -52.92 -24.23 8.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.204 -0.935 . . . . 0.0 109.861 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.879 HG22 ' HB2' ' A' ' 33' ' ' PRO . 32.1 m -72.27 -17.49 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.169 -0.957 . . . . 0.0 110.201 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.68 0.6 47.4 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.183 -0.948 . . . . 0.0 110.708 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.532 HD12 ' CD1' ' A' ' 34' ' ' PHE . 21.8 mt -52.23 167.33 0.13 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.947 -1.095 . . . . 0.0 110.182 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.3 m -56.53 173.31 0.19 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 110.257 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.05 -27.62 65.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.33 -0.856 . . . . 0.0 110.211 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 65.9 p -134.13 45.79 2.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 110.345 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.47 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 27.2 t80 -54.26 130.97 40.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.932 . . . . 0.0 109.932 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -108.34 150.01 27.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.427 -0.796 . . . . 0.0 109.43 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.436 ' HB3' ' N ' ' A' ' 47' ' ' ARG . 12.8 t -63.55 135.82 96.43 Favored Pre-proline 0 C--N 1.3 -1.551 0 O-C-N 121.16 -0.963 . . . . 0.0 110.539 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.76 -1.52 11.47 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.589 1.31 . . . . 0.0 110.382 178.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -118.72 -41.57 2.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.052 -1.03 . . . . 0.0 110.867 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -119.81 2.91 11.11 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.121 -0.987 . . . . 0.0 111.141 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.436 ' N ' ' HB3' ' A' ' 43' ' ' CYS . 1.1 ttt-85 58.28 23.36 10.31 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.146 -0.971 . . . . 0.0 112.515 178.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.3 m -75.01 164.94 58.01 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 120.566 -1.333 . . . . 0.0 109.676 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.06 138.98 29.07 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.632 1.333 . . . . 0.0 110.434 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.536 ' HA ' ' CD1' ' A' ' 53' ' ' PHE . 15.9 tttm -48.93 -29.18 4.46 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.271 -0.893 . . . . 0.0 110.821 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -63.09 -14.54 49.66 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.113 -0.992 . . . . 0.0 109.967 179.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -87.21 -1.39 57.87 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.086 -1.009 . . . . 0.0 110.169 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.536 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 32.6 m-85 -88.17 127.84 35.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.906 -1.121 . . . . 0.0 110.425 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.18 128.11 55.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 109.587 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.514 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 89.0 p -54.14 -174.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 110.814 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.625 ' O ' HD12 ' A' ' 56' ' ' ILE . 1.3 pp -132.38 78.38 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.679 -0.638 . . . . 0.0 109.875 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.54 70.86 0.74 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.458 -0.776 . . . . 0.0 110.041 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -106.37 122.03 45.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.322 -0.862 . . . . 0.0 110.338 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.623 ' C ' HD12 ' A' ' 60' ' ' ILE . 85.3 t -131.88 97.62 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.326 -0.859 . . . . 0.0 109.952 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.689 ' N ' HD12 ' A' ' 60' ' ' ILE . 4.9 mp -129.46 97.69 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.208 -0.933 . . . . 0.0 110.385 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 50.47 -149.41 0.28 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.331 -0.856 . . . . 0.0 110.504 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.2 -53.23 1.36 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 51.99 91.08 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -1.13 . . . . 0.0 110.285 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -97.59 -166.21 1.36 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.192 -0.942 . . . . 0.0 110.105 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -114.28 121.97 45.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.192 -0.942 . . . . 0.0 110.313 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -139.11 83.62 1.96 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 110.104 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 53.84 60.23 3.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.219 -0.926 . . . . 0.0 110.009 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.8 ttpt -113.55 -48.95 2.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.373 -0.829 . . . . 0.0 110.237 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -81.05 -40.85 23.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.228 -0.92 . . . . 0.0 110.246 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.943 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtt . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.252 0.549 . . . . 0.0 110.126 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -115.31 77.5 1.08 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -0.905 . . . . 0.0 110.375 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.425 ' O ' ' HB3' ' A' ' 4' ' ' ASP . 45.0 mt -135.31 166.31 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.214 -0.929 . . . . 0.0 109.951 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.425 ' HB3' ' O ' ' A' ' 3' ' ' ILE . 8.2 p-10 176.54 113.26 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.718 0.77 . . . . 0.0 109.825 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -159.46 -148.89 0.19 Allowed 'General case' 0 C--N 1.291 -1.962 0 O-C-N 121.795 -0.566 . . . . 0.0 109.669 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.68 19.23 55.45 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.427 ' CB ' HG12 ' A' ' 56' ' ' ILE . 29.2 mttt -82.47 136.73 34.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.071 -1.252 . . . . 0.0 109.656 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.514 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 13.4 m-85 -122.7 148.04 45.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.037 -1.039 . . . . 0.0 110.628 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 5.1 tm-20 -120.02 128.08 53.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.414 -0.804 . . . . 0.0 109.906 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.4 t -65.31 110.07 2.48 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.161 -0.962 . . . . 0.0 110.059 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.91 -11.92 57.77 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.206 -0.934 . . . . 0.0 109.612 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.01 -40.46 16.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.327 -0.858 . . . . 0.0 111.782 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 11.7 p -123.95 -32.71 3.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.647 -1.283 . . . . 0.0 111.523 -179.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.09 18.9 6.57 Favored Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.713 -1.232 . . . . 0.0 110.256 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.529 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 42.7 t80 -76.28 167.98 20.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -1.175 . . . . 0.0 109.516 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.529 ' N ' ' CD1' ' A' ' 15' ' ' TYR . 35.1 mm -130.82 120.26 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 110.424 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.474 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 51.5 t80 -89.36 142.5 27.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.325 -0.86 . . . . 0.0 109.966 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -123.69 112.49 29.11 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.544 -0.723 . . . . 0.0 109.829 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.523 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 40.4 Cg_endo -72.2 -67.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.516 1.272 . . . . 0.0 111.284 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -44.22 -28.0 0.47 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.794 -0.566 . . . . 0.0 110.922 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.7 mttp -96.15 -40.06 9.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 0.0 110.24 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.29 147.85 22.53 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.481 ' HB3' HD12 ' A' ' 28' ' ' ILE . 2.8 t0 -84.94 61.11 6.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.465 -1.021 . . . . 0.0 109.65 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -45.49 -27.08 0.67 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.444 -0.785 . . . . 0.0 110.955 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -74.69 -27.43 60.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.115 -0.99 . . . . 0.0 109.975 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.462 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -98.48 -22.83 15.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.346 -0.846 . . . . 0.0 109.9 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.12 23.23 3.94 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.481 HD12 ' HB3' ' A' ' 23' ' ' ASP . 9.2 mt -115.26 114.57 43.07 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.117 -1.225 . . . . 0.0 109.907 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.409 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 43.0 Cg_endo -68.91 173.9 9.54 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 O-C-N 123.597 1.314 . . . . 0.0 110.294 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 44.9 Cg_endo -67.89 -164.43 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.57 1.3 . . . . 0.0 110.024 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 48.19 34.02 11.83 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 m -134.48 109.35 11.24 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.121 -1.223 . . . . 0.0 110.52 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.879 ' HB2' HG22 ' A' ' 35' ' ' VAL . 44.6 Cg_endo -71.8 148.72 52.81 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.455 1.24 . . . . 0.0 110.344 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.532 ' CD1' HD12 ' A' ' 37' ' ' LEU . 38.8 t80 -52.92 -24.23 8.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.204 -0.935 . . . . 0.0 109.861 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.879 HG22 ' HB2' ' A' ' 33' ' ' PRO . 32.1 m -72.27 -17.49 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.169 -0.957 . . . . 0.0 110.201 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.68 0.6 47.4 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.183 -0.948 . . . . 0.0 110.708 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.532 HD12 ' CD1' ' A' ' 34' ' ' PHE . 21.8 mt -52.23 167.33 0.13 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.947 -1.095 . . . . 0.0 110.182 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.3 m -56.53 173.31 0.19 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 110.257 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.05 -27.62 65.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.33 -0.856 . . . . 0.0 110.211 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 65.9 p -134.13 45.79 2.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 110.345 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.47 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 27.2 t80 -54.26 130.97 40.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.932 . . . . 0.0 109.932 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -108.34 150.01 27.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.427 -0.796 . . . . 0.0 109.43 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.436 ' HB3' ' N ' ' A' ' 47' ' ' ARG . 12.8 t -63.55 135.82 96.43 Favored Pre-proline 0 C--N 1.3 -1.551 0 O-C-N 121.16 -0.963 . . . . 0.0 110.539 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.76 -1.52 11.47 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.589 1.31 . . . . 0.0 110.382 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -118.72 -41.57 2.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.052 -1.03 . . . . 0.0 110.867 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -119.81 2.91 11.11 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.121 -0.987 . . . . 0.0 111.141 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.436 ' N ' ' HB3' ' A' ' 43' ' ' CYS . 1.1 ttt-85 58.28 23.36 10.31 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.146 -0.971 . . . . 0.0 112.515 178.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.3 m -75.01 164.94 58.01 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 120.566 -1.333 . . . . 0.0 109.676 179.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.06 138.98 29.07 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.632 1.333 . . . . 0.0 110.434 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.536 ' HA ' ' CD1' ' A' ' 53' ' ' PHE . 15.9 tttm -48.93 -29.18 4.46 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.271 -0.893 . . . . 0.0 110.821 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -63.09 -14.54 49.66 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.113 -0.992 . . . . 0.0 109.967 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -87.21 -1.39 57.87 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.086 -1.009 . . . . 0.0 110.169 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.536 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 32.6 m-85 -88.17 127.84 35.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.906 -1.121 . . . . 0.0 110.425 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.18 128.11 55.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 109.587 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.514 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 89.0 p -54.14 -174.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 110.814 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.625 ' O ' HD12 ' A' ' 56' ' ' ILE . 1.3 pp -132.38 78.38 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.679 -0.638 . . . . 0.0 109.875 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.54 70.86 0.74 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.458 -0.776 . . . . 0.0 110.041 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -106.37 122.03 45.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.322 -0.862 . . . . 0.0 110.338 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.623 ' C ' HD12 ' A' ' 60' ' ' ILE . 85.3 t -131.88 97.62 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.326 -0.859 . . . . 0.0 109.952 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.689 ' N ' HD12 ' A' ' 60' ' ' ILE . 4.9 mp -129.46 97.69 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.208 -0.933 . . . . 0.0 110.385 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 50.47 -149.41 0.28 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.331 -0.856 . . . . 0.0 110.504 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.2 -53.23 1.36 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 51.99 91.08 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -1.13 . . . . 0.0 110.285 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -97.59 -166.21 1.36 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.192 -0.942 . . . . 0.0 110.105 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -114.28 121.97 45.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.192 -0.942 . . . . 0.0 110.313 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -139.11 83.62 1.96 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 110.104 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 53.84 60.23 3.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.219 -0.926 . . . . 0.0 110.009 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.8 ttpt -113.55 -48.95 2.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.373 -0.829 . . . . 0.0 110.237 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -81.05 -40.85 23.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.228 -0.92 . . . . 0.0 110.246 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.943 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.58 ' O ' HG23 ' A' ' 3' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.271 0.558 . . . . 0.0 110.253 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 52.64 65.02 1.64 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.228 -0.92 . . . . 0.0 110.197 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.58 HG23 ' O ' ' A' ' 1' ' ' MET . 27.7 pt -142.05 156.42 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.155 -0.965 . . . . 0.0 110.469 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 3' ' ' ILE . 6.0 p-10 179.22 112.19 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.831 0.824 . . . . 0.0 109.535 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -167.6 29.52 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.942 0 O-C-N 121.761 -0.587 . . . . 0.0 110.07 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.403 ' HA3' ' HG3' ' A' ' 19' ' ' PRO . . . 75.15 22.05 77.02 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.4 mtpt -84.85 130.1 34.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.171 -1.194 . . . . 0.0 109.599 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.544 ' HE2' ' HG ' ' A' ' 55' ' ' SER . 30.2 m-85 -115.78 139.26 50.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.034 -1.041 . . . . 0.0 110.789 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 29.8 tt0 -105.56 132.83 51.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.309 -0.87 . . . . 0.0 110.241 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.7 t -75.56 110.33 9.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 0.0 110.121 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.71 -11.92 56.37 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.203 -0.936 . . . . 0.0 109.866 178.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.03 -41.19 16.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -0.92 . . . . 0.0 111.717 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.47 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 13.8 p -122.85 -34.47 3.19 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.604 -1.31 . . . . 0.0 111.454 -179.095 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.76 21.72 5.29 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.8 ' C ' HD12 ' A' ' 16' ' ' ILE . 24.5 t80 -84.57 158.19 20.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.365 -1.079 . . . . 0.0 109.706 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.8 HD12 ' C ' ' A' ' 15' ' ' TYR . 3.2 mp -123.97 120.17 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.216 -0.928 . . . . 0.0 110.15 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.503 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 66.5 t80 -83.05 137.56 34.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.312 -0.868 . . . . 0.0 110.025 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.426 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 53.5 mt-10 -116.28 110.87 42.72 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.592 -0.693 . . . . 0.0 109.411 179.249 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.474 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 37.9 Cg_endo -69.42 -71.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.507 1.267 . . . . 0.0 111.151 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.414 ' O ' ' CB ' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -47.4 -24.73 0.85 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.335 -0.853 . . . . 0.0 111.04 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -94.52 -39.27 10.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.973 -1.079 . . . . 0.0 110.48 -179.881 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.16 137.93 9.29 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -85.07 63.73 8.28 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.392 -1.064 . . . . 0.0 109.679 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.96 -28.35 0.25 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.778 -0.576 . . . . 0.0 111.117 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -67.17 -33.62 75.8 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.202 -0.936 . . . . 0.0 109.795 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.53 ' HB3' HD12 ' A' ' 28' ' ' ILE . . . -95.94 -25.53 15.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.303 -0.873 . . . . 0.0 110.09 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.16 25.31 3.28 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.53 HD12 ' HB3' ' A' ' 26' ' ' ALA . 4.7 mt -112.15 118.74 45.48 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.071 -1.252 . . . . 0.0 110.079 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.433 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 45.4 Cg_endo -71.95 174.49 11.16 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 O-C-N 123.541 1.285 . . . . 0.0 110.219 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.433 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 46.8 Cg_endo -69.27 -164.72 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.582 1.306 . . . . 0.0 109.933 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 47.73 26.19 3.88 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 47.9 m -127.45 111.4 21.07 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.136 -1.214 . . . . 0.0 110.038 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.853 ' HB2' HG22 ' A' ' 35' ' ' VAL . 45.0 Cg_endo -71.76 147.56 50.76 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.604 1.318 . . . . 0.0 110.77 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.513 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 47.3 t80 -54.42 -25.74 26.59 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.542 -0.723 . . . . 0.0 110.275 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.853 HG22 ' HB2' ' A' ' 33' ' ' PRO . 34.2 m -71.06 -13.59 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.272 -0.893 . . . . 0.0 110.647 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.56 -4.5 41.17 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.091 -1.005 . . . . 0.0 110.891 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 37' ' ' LEU . 51.3 mt -51.0 164.53 0.15 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.91 -1.119 . . . . 0.0 110.428 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.03 173.31 1.44 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.324 -0.86 . . . . 0.0 110.244 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -74.17 -19.33 60.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.367 -0.833 . . . . 0.0 110.293 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.9 m -128.79 36.05 4.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.0 110.534 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.484 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 31.5 t80 -56.18 123.3 14.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.144 -0.973 . . . . 0.0 109.464 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 7.3 mtt -106.72 142.4 36.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 0.0 109.682 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.445 ' HB3' ' N ' ' A' ' 47' ' ' ARG . 5.4 t -52.58 136.41 43.36 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.27 -0.894 . . . . 0.0 110.426 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.66 -1.52 11.21 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.574 1.302 . . . . 0.0 110.673 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -123.9 -42.5 2.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.91 -1.119 . . . . 0.0 110.811 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.47 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -114.15 5.11 15.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.065 -1.022 . . . . 0.0 111.122 -179.703 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.445 ' N ' ' HB3' ' A' ' 43' ' ' CYS . 27.3 mtt180 54.43 25.65 6.3 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.171 -0.956 . . . . 0.0 112.408 178.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.417 ' CB ' ' SG ' ' A' ' 46' ' ' CYS . 2.5 t -75.6 157.68 83.98 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 120.702 -1.249 . . . . 0.0 109.779 178.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.16 139.45 35.49 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.675 1.355 . . . . 0.0 110.362 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.529 ' HA ' ' CD1' ' A' ' 53' ' ' PHE . 56.0 tttt -48.49 -28.26 3.22 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.184 -0.947 . . . . 0.0 110.901 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -67.14 -10.85 54.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.1 -1.0 . . . . 0.0 110.096 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -89.66 -2.38 58.28 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.191 -0.943 . . . . 0.0 110.193 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.529 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 33.1 m-85 -88.74 125.48 34.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.845 -1.159 . . . . 0.0 110.083 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -97.1 139.57 32.9 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.246 -0.909 . . . . 0.0 109.935 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.544 ' HG ' ' HE2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -80.12 153.99 28.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.426 -0.796 . . . . 0.0 110.187 -179.519 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.677 HG23 ' O ' ' A' ' 56' ' ' ILE . 1.2 tp -146.83 80.33 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.289 -0.882 . . . . 0.0 110.236 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.87 74.84 1.52 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.253 -0.904 . . . . 0.0 110.131 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.3 mppt? -130.75 174.25 10.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.18 -0.95 . . . . 0.0 110.156 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.0 m -144.49 160.4 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -0.934 . . . . 0.0 110.185 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 59.2 mt -112.19 116.93 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.245 -0.909 . . . . 0.0 109.912 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -114.47 -160.31 0.73 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.246 -0.909 . . . . 0.0 110.447 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -104.88 -99.29 2.58 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -164.36 159.8 20.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.29 -1.124 . . . . 0.0 110.451 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -140.82 53.07 1.6 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.249 -0.907 . . . . 0.0 109.888 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -108.47 46.63 0.95 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 110.407 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' A' ' 66' ' ' ASN . 17.1 p-10 -55.04 152.68 7.35 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.184 -0.947 . . . . 0.0 110.053 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -164.19 29.82 0.07 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.918 . . . . 0.0 110.203 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.83 47.31 1.34 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.93 . . . . 0.0 110.324 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -102.83 -171.51 1.96 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.13 -0.982 . . . . 0.0 110.29 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 179.971 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 ttt . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.159 0.504 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.57 ' HG3' HG23 ' A' ' 59' ' ' VAL . 35.5 tt0 -138.88 76.95 1.6 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.273 -0.892 . . . . 0.0 110.352 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.809 HG21 HG23 ' A' ' 56' ' ' ILE . 3.3 mp -111.44 171.77 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.272 -0.892 . . . . 0.0 109.836 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.509 ' N ' HG22 ' A' ' 3' ' ' ILE . 0.7 OUTLIER -177.56 -29.96 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.055 -1.028 . . . . 0.0 111.385 -179.71 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -78.85 -141.39 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.008 -1.057 . . . . 0.0 109.758 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.14 34.35 4.32 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.447 ' O ' HG22 ' A' ' 56' ' ' ILE . 17.0 mttt -81.56 122.63 27.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.109 -1.23 . . . . 0.0 109.707 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.516 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 13.3 m-85 -108.34 152.08 25.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.055 -1.028 . . . . 0.0 110.561 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.531 ' HA ' HD13 ' A' ' 16' ' ' ILE . 1.6 tm-20 -119.91 122.99 42.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.442 -0.786 . . . . 0.0 109.814 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.4 t -64.39 111.16 2.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.109 -0.994 . . . . 0.0 110.515 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -67.51 -12.17 59.69 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.229 -0.919 . . . . 0.0 109.501 178.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.04 -39.98 17.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.285 -0.884 . . . . 0.0 111.647 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.449 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 11.9 p -125.07 -29.66 3.3 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.62 -1.3 . . . . 0.0 111.433 -179.167 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.08 18.93 8.85 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.585 -1.293 . . . . 0.0 110.421 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 48.1 t80 -78.87 167.12 21.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.126 -1.22 . . . . 0.0 109.547 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.531 HD13 ' HA ' ' A' ' 9' ' ' GLU . 35.3 mm -129.06 115.54 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.17 -0.956 . . . . 0.0 110.454 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.517 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 73.1 t80 -82.17 136.31 35.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.436 -0.79 . . . . 0.0 110.378 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 22' ' ' GLY . 5.6 mt-10 -115.84 109.65 45.02 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.599 -0.688 . . . . 0.0 109.468 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.493 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 37.9 Cg_endo -68.77 -70.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.573 1.302 . . . . 0.0 111.467 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -44.75 -27.09 0.46 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.551 -0.718 . . . . 0.0 111.034 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.41 -22.56 15.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.165 -0.959 . . . . 0.0 110.078 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 18' ' ' GLU . . . 79.93 147.22 4.44 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.522 ' HB3' HD12 ' A' ' 28' ' ' ILE . 15.2 t0 -85.04 62.32 7.43 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.356 -1.085 . . . . 0.0 109.69 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.56 -28.8 0.41 Allowed 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 121.465 0.65 . . . . 0.0 110.827 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.85 -32.12 73.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.298 -0.876 . . . . 0.0 110.005 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -99.03 -28.0 13.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.263 -0.898 . . . . 0.0 110.368 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.81 25.13 2.17 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.578 HD11 ' CD1' ' A' ' 41' ' ' PHE . 9.8 mt -110.71 123.98 34.22 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 120.955 -1.32 . . . . 0.0 109.597 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -70.9 170.09 18.77 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.49 1.258 . . . . 0.0 110.588 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -71.85 -163.39 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.694 1.365 . . . . 0.0 110.296 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 49.14 31.52 11.67 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 84.3 m -136.88 116.69 10.65 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.163 -1.198 . . . . 0.0 110.289 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.493 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 47.2 Cg_endo -72.15 148.21 49.76 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 123.582 1.306 . . . . 0.0 110.345 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.517 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 5.5 t80 -51.08 -36.37 39.76 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.238 -0.914 . . . . 0.0 110.018 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.14 -13.79 12.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.408 -0.807 . . . . 0.0 110.748 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -98.58 -0.25 43.53 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.028 -1.045 . . . . 0.0 110.691 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.514 HD21 ' CE1' ' A' ' 17' ' ' TYR . 36.9 mt -55.82 163.59 1.39 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.913 -1.117 . . . . 0.0 110.248 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.9 m -53.73 168.38 0.19 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.323 -0.86 . . . . 0.0 110.367 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.98 -35.18 79.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.275 -0.891 . . . . 0.0 110.29 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.2 t -124.32 51.6 1.57 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.179 -0.95 . . . . 0.0 110.369 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.578 ' CD1' HD11 ' A' ' 28' ' ' ILE . 18.1 t80 -64.76 126.93 29.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.171 -0.956 . . . . 0.0 109.915 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.415 ' HA ' ' O ' ' A' ' 48' ' ' SER . 10.9 mtt -97.95 145.36 26.55 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.23 -0.919 . . . . 0.0 109.588 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 25.1 t -63.01 136.34 96.64 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.214 -0.929 . . . . 0.0 110.375 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -75.93 -3.27 13.63 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.581 1.306 . . . . 0.0 110.571 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -115.23 -37.9 3.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.038 -1.039 . . . . 0.0 110.823 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.449 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 1.6 p -124.72 7.07 8.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.045 -1.035 . . . . 0.0 111.152 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 57.2 17.16 3.4 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.195 -0.941 . . . . 0.0 112.804 178.101 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' A' ' 42' ' ' MET . 11.6 m -74.7 163.09 70.63 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 120.589 -1.319 . . . . 0.0 109.899 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.23 141.78 36.43 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.666 1.35 . . . . 0.0 110.699 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.519 ' HA ' ' CD1' ' A' ' 53' ' ' PHE . 24.5 tttm -48.34 -27.85 2.81 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.327 -0.858 . . . . 0.0 110.833 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -62.07 -15.29 43.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.075 -1.016 . . . . 0.0 109.971 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -86.45 -1.93 58.01 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.106 -0.996 . . . . 0.0 110.276 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.519 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 20.9 m-85 -85.09 134.34 34.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.833 -1.167 . . . . 0.0 110.494 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.99 119.99 35.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.385 -0.822 . . . . 0.0 109.768 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.516 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 3.4 t -52.89 178.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 110.58 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.809 HG23 HG21 ' A' ' 3' ' ' ILE . 2.7 tt -160.11 91.67 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.664 -0.647 . . . . 0.0 109.952 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 4' ' ' ASP . 0.0 OUTLIER -99.13 63.0 1.3 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.213 -0.929 . . . . 0.0 110.198 -179.788 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.3 mmtt -121.92 139.01 54.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -0.894 . . . . 0.0 110.256 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.57 HG23 ' HG3' ' A' ' 2' ' ' GLU . 13.9 p -135.31 154.0 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -0.906 . . . . 0.0 109.99 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -142.23 144.28 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.104 -0.998 . . . . 0.0 110.473 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -101.04 -162.12 0.91 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.302 -0.874 . . . . 0.0 110.073 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.62 -158.91 25.29 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -74.03 156.43 37.5 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.267 -1.137 . . . . 0.0 110.407 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -122.25 67.42 0.93 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.217 -0.927 . . . . 0.0 110.05 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -98.29 44.22 1.04 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.244 -0.91 . . . . 0.0 110.41 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -169.19 33.75 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.256 -0.903 . . . . 0.0 110.261 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 56.4 168.34 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.356 -0.84 . . . . 0.0 110.513 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.8 143.93 45.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 110.047 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.94 121.88 45.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.222 -0.924 . . . . 0.0 110.27 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 CA-C-O 117.966 -1.464 . . . . 0.0 109.549 -179.989 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 mtm . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.215 0.531 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.401 ' CG ' ' O ' ' A' ' 2' ' ' GLU . 3.3 pm0 -173.94 76.7 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 110.308 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 4' ' ' ASP . 61.5 mt -134.63 169.49 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.231 -0.918 . . . . 0.0 109.845 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.484 ' N ' HG22 ' A' ' 3' ' ' ILE . 7.4 t70 171.58 -21.26 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.471 0 O-C-N 121.639 -0.663 . . . . 0.0 110.692 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -67.89 65.27 0.09 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.012 -1.055 . . . . 0.0 110.714 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 4' ' ' ASP . . . 51.51 22.84 8.4 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.826 ' O ' HG22 ' A' ' 56' ' ' ILE . 4.0 mttt -81.57 120.88 25.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.99 -1.3 . . . . 0.0 109.371 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.529 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 6.8 m-85 -109.55 150.23 28.48 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.073 -1.017 . . . . 0.0 110.784 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.682 ' HA ' HD13 ' A' ' 16' ' ' ILE . 17.9 tt0 -119.46 132.57 55.82 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.433 -0.792 . . . . 0.0 109.555 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.9 t -72.91 114.6 11.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.103 -0.998 . . . . 0.0 110.591 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -70.84 -11.66 61.09 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.379 -0.928 . . . . 0.0 109.548 178.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.07 -40.55 16.69 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.312 -0.867 . . . . 0.0 111.759 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.457 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 12.6 p -123.53 -33.65 3.19 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.65 -1.281 . . . . 0.0 111.413 -178.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.23 21.45 5.89 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.129 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.524 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 49.9 t80 -84.45 168.67 15.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.296 -1.12 . . . . 0.0 109.812 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.682 HD13 ' HA ' ' A' ' 9' ' ' GLU . 40.9 mm -131.47 117.54 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.185 -0.947 . . . . 0.0 110.621 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.52 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 61.3 t80 -83.64 128.76 34.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.408 -0.808 . . . . 0.0 110.133 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -106.51 111.9 63.91 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.361 -0.837 . . . . 0.0 109.749 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.495 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 37.9 Cg_endo -69.78 -65.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.489 1.257 . . . . 0.0 111.085 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -45.64 -29.43 1.23 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.648 -0.658 . . . . 0.0 110.865 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.6 mttp -94.82 -38.05 10.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 0.0 110.173 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.29 150.65 26.34 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.533 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 1.5 t0 -85.08 63.86 8.35 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.438 -1.036 . . . . 0.0 109.653 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -46.39 -27.27 1.02 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.525 -0.735 . . . . 0.0 110.796 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -74.77 -23.15 58.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.22 -0.925 . . . . 0.0 109.985 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.533 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -100.99 -31.28 11.19 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.377 -0.827 . . . . 0.0 109.92 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.34 28.29 1.35 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.488 HD13 ' CD2' ' A' ' 37' ' ' LEU . 10.7 mt -118.84 123.7 28.85 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.906 -1.349 . . . . 0.0 109.774 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.406 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 43.3 Cg_endo -69.94 173.41 11.17 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.486 1.256 . . . . 0.0 110.431 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 51.1 Cg_endo -72.39 -164.09 0.17 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.564 1.297 . . . . 0.0 110.216 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 48.5 30.98 8.85 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.6 m -131.01 116.85 16.95 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.118 -1.225 . . . . 0.0 110.362 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.825 ' HB2' HG22 ' A' ' 35' ' ' VAL . 49.1 Cg_endo -74.49 150.31 40.64 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.408 1.215 . . . . 0.0 110.469 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.545 ' CD2' HD12 ' A' ' 37' ' ' LEU . 11.8 t80 -56.94 -23.45 45.38 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.231 -0.918 . . . . 0.0 109.907 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.825 HG22 ' HB2' ' A' ' 33' ' ' PRO . 31.3 m -70.22 -15.61 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.288 -0.883 . . . . 0.0 110.718 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.12 -0.99 35.16 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.174 -0.954 . . . . 0.0 110.893 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.545 HD12 ' CD2' ' A' ' 34' ' ' PHE . 41.0 mt -54.28 161.27 1.39 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.826 -1.171 . . . . 0.0 110.159 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.7 m -52.68 177.67 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.216 -0.928 . . . . 0.0 110.187 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.7 -18.03 49.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.248 -0.907 . . . . 0.0 110.458 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.6 p -133.2 37.4 3.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.105 -0.997 . . . . 0.0 110.541 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.462 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 14.5 t80 -56.61 133.87 54.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.138 -0.976 . . . . 0.0 109.774 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.438 ' HA ' ' O ' ' A' ' 48' ' ' SER . 5.1 mtt -106.99 143.9 34.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 109.854 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 35.9 t -56.64 138.96 76.6 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.879 . . . . 0.0 110.472 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -77.8 2.79 7.52 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.523 1.275 . . . . 0.0 110.873 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -124.61 -38.23 2.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.961 -1.087 . . . . 0.0 110.873 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.457 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 1.6 p -121.59 6.17 10.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.091 -1.006 . . . . 0.0 111.43 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.36 17.73 4.99 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.033 -1.042 . . . . 0.0 112.622 178.042 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.438 ' O ' ' HA ' ' A' ' 42' ' ' MET . 4.4 m -72.81 163.06 71.13 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 120.56 -1.338 . . . . 0.0 109.628 179.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.38 145.74 54.44 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.667 1.351 . . . . 0.0 110.334 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.502 ' HG2' ' CZ ' ' A' ' 34' ' ' PHE . 31.1 tttt -51.6 -24.74 5.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.3 -0.875 . . . . 0.0 110.255 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -66.12 -13.95 60.99 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.248 -0.907 . . . . 0.0 109.773 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -85.73 -3.73 58.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.238 -0.914 . . . . 0.0 110.043 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.45 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 17.1 m-85 -84.77 134.75 34.31 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.039 -1.038 . . . . 0.0 110.437 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.47 130.36 55.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.307 -0.87 . . . . 0.0 109.736 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.529 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 74.7 p -63.7 179.54 0.48 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 111.188 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.826 HG22 ' O ' ' A' ' 7' ' ' LYS . 4.8 tp -159.98 91.81 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.348 0.594 . . . . 0.0 109.546 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 1.2 pttt -115.2 71.76 0.77 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.166 -0.959 . . . . 0.0 110.531 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.61 64.77 0.84 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.466 -0.771 . . . . 0.0 109.849 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.3 t -65.79 151.85 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.894 . . . . 0.0 110.218 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.4 tt -128.78 142.87 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.308 -0.87 . . . . 0.0 110.089 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 53.51 -158.87 0.15 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.316 -0.865 . . . . 0.0 110.225 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 61.05 31.29 76.11 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -109.57 -68.68 0.91 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.255 -1.144 . . . . 0.0 110.286 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -132.7 175.73 9.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.288 -0.882 . . . . 0.0 110.182 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -128.29 105.74 8.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.197 -0.94 . . . . 0.0 110.374 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.3 m-20 -78.45 -72.99 0.35 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.193 -0.942 . . . . 0.0 109.97 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -120.41 -79.78 0.61 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.304 -0.872 . . . . 0.0 109.717 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -121.26 77.28 1.3 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.324 -0.86 . . . . 0.0 109.826 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -161.58 125.53 3.3 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.39 -0.819 . . . . 0.0 109.997 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 CA-C-O 117.998 -1.446 . . . . 0.0 109.583 179.939 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.285 0.565 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -114.35 58.81 0.69 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.178 -0.951 . . . . 0.0 110.199 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.8 mt -134.02 162.64 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 109.875 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 32.5 t70 -157.8 10.81 0.19 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.383 -0.823 . . . . 0.0 111.708 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -81.42 53.54 2.1 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.011 -1.056 . . . . 0.0 110.362 -179.812 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 51.52 25.19 13.05 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.904 ' O ' HG22 ' A' ' 56' ' ' ILE . 1.3 mttt -79.25 135.81 36.88 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.375 -1.074 . . . . 0.0 109.961 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.586 ' CE2' ' CD1' ' A' ' 34' ' ' PHE . 8.0 m-85 -113.95 125.54 54.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.131 -0.981 . . . . 0.0 109.931 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 2.1 tm-20 -88.85 128.78 35.67 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.239 -0.913 . . . . 0.0 110.168 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.6 t -72.35 115.16 11.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.195 -0.941 . . . . 0.0 110.242 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -70.37 -12.8 61.83 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.146 -0.971 . . . . 0.0 109.537 178.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.08 -42.75 14.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.324 -0.86 . . . . 0.0 111.657 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.46 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 12.9 p -120.85 -27.29 5.05 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.72 -1.238 . . . . 0.0 111.382 -178.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.72 22.01 9.28 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.447 ' CG ' ' N ' ' A' ' 16' ' ' ILE . 60.7 t80 -81.88 168.35 18.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -1.117 . . . . 0.0 109.545 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.447 ' N ' ' CG ' ' A' ' 15' ' ' TYR . 25.7 mm -127.58 102.65 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.238 -0.914 . . . . 0.0 109.935 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.519 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 76.4 t80 -66.91 134.82 52.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 109.693 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -114.4 110.6 47.47 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.475 -0.766 . . . . 0.0 110.01 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.501 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 39.2 Cg_endo -71.04 -62.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.506 1.266 . . . . 0.0 110.641 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -45.1 -26.45 0.46 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.825 -0.547 . . . . 0.0 111.054 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.5 mtpp -103.16 -29.51 11.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.083 -1.01 . . . . 0.0 110.364 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.75 151.36 21.57 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.736 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 0.3 OUTLIER -85.1 63.42 8.1 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.399 -1.06 . . . . 0.0 109.533 179.754 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.69 -26.6 0.96 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.517 -0.74 . . . . 0.0 110.79 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -78.88 -19.77 51.11 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.189 -0.944 . . . . 0.0 110.254 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.736 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -104.1 -32.36 9.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.259 -0.9 . . . . 0.0 109.965 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 125.09 32.3 0.8 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.3 mt -126.82 123.51 23.75 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.037 -1.272 . . . . 0.0 109.875 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.407 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 46.5 Cg_endo -71.2 173.09 12.76 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.543 1.286 . . . . 0.0 110.596 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 50.2 Cg_endo -72.45 -163.4 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.759 1.399 . . . . 0.0 110.255 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 49.77 26.43 8.05 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.3 m -132.75 117.94 15.37 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.161 -1.2 . . . . 0.0 110.3 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.822 ' HB2' HG22 ' A' ' 35' ' ' VAL . 48.4 Cg_endo -74.38 151.77 43.22 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.492 1.259 . . . . 0.0 110.755 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.586 ' CD1' ' CE2' ' A' ' 8' ' ' TYR . 9.2 t80 -55.47 -24.42 30.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.365 -0.834 . . . . 0.0 110.104 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.822 HG22 ' HB2' ' A' ' 33' ' ' PRO . 26.9 m -71.07 -17.21 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 0.0 110.532 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -100.24 3.54 43.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.051 -1.031 . . . . 0.0 110.859 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' A' ' 37' ' ' LEU . 40.9 mt -54.64 169.67 0.2 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.975 -1.078 . . . . 0.0 110.265 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.25 162.05 12.72 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.184 -0.947 . . . . 0.0 110.253 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.3 -19.36 61.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.274 -0.891 . . . . 0.0 110.339 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -132.76 54.1 1.97 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.219 -0.926 . . . . 0.0 110.136 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.465 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 30.7 t80 -70.19 129.5 39.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.298 -0.876 . . . . 0.0 109.98 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 6.8 mtp -112.0 141.06 46.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.231 -0.918 . . . . 0.0 109.605 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 17.7 t -55.45 133.42 70.61 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 0.0 110.527 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.72 -1.91 11.75 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.615 1.324 . . . . 0.0 110.458 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.84 -35.92 4.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.976 -1.077 . . . . 0.0 110.914 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.46 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.9 OUTLIER -127.15 16.4 7.24 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.989 -1.069 . . . . 0.0 110.943 -179.694 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 56.4 mtt85 45.48 23.56 0.14 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.371 -0.831 . . . . 0.0 112.611 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.417 ' CB ' ' SG ' ' A' ' 46' ' ' CYS . 7.3 t -75.66 156.03 85.02 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 120.61 -1.307 . . . . 0.0 109.872 179.087 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.44 141.18 50.22 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.604 1.318 . . . . 0.0 110.41 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.517 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 12.5 tttm -49.16 -26.92 3.13 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.33 -0.856 . . . . 0.0 110.789 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.71 -14.56 53.43 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.066 -1.021 . . . . 0.0 109.952 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -89.2 1.45 55.66 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.227 -0.921 . . . . 0.0 110.271 179.303 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -89.54 148.47 23.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.896 -1.127 . . . . 0.0 111.012 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.5 133.95 47.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.564 -0.71 . . . . 0.0 109.152 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.535 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 75.7 p -70.52 176.81 3.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.989 -1.069 . . . . 0.0 111.301 -179.092 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.904 HG22 ' O ' ' A' ' 7' ' ' LYS . 1.6 tt -155.95 67.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-O 121.361 0.601 . . . . 0.0 109.912 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 4' ' ' ASP . 0.3 OUTLIER -80.6 57.89 3.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.889 . . . . 0.0 110.155 -179.878 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -130.0 104.7 7.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.437 -0.79 . . . . 0.0 110.26 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.665 ' O ' HG13 ' A' ' 59' ' ' VAL . 9.3 p -130.24 106.2 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.166 -0.958 . . . . 0.0 110.156 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.6 mt -95.07 57.86 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.105 -0.997 . . . . 0.0 110.149 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -148.94 93.02 2.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -0.919 . . . . 0.0 110.422 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -151.29 -138.29 2.79 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -85.09 139.25 31.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.188 -1.184 . . . . 0.0 110.119 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.31 129.38 35.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.226 -0.921 . . . . 0.0 110.22 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -156.47 50.85 0.51 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.286 -0.884 . . . . 0.0 110.106 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -97.48 -36.51 10.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.237 -0.915 . . . . 0.0 110.081 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -149.63 95.94 2.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.316 -0.865 . . . . 0.0 110.132 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.75 156.29 36.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.886 . . . . 0.0 110.428 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -97.21 101.06 12.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.284 -0.885 . . . . 0.0 110.199 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 179.968 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.241 0.543 . . . . 0.0 110.253 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -173.52 66.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.364 -0.835 . . . . 0.0 109.898 179.807 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.762 HD11 ' CD ' ' A' ' 7' ' ' LYS . 6.5 tt -159.25 169.11 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.383 -0.823 . . . . 0.0 110.145 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.454 ' N ' ' CG1' ' A' ' 3' ' ' ILE . 4.5 p-10 178.46 112.02 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.81 0.814 . . . . 0.0 109.526 179.408 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.47 65.7 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.933 0 CA-C-O 121.286 0.565 . . . . 0.0 110.122 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 56.0 20.72 28.25 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.762 ' CD ' HD11 ' A' ' 3' ' ' ILE . 19.6 mttm -87.35 131.17 34.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.071 -1.253 . . . . 0.0 109.64 179.608 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.503 ' CE2' ' HB2' ' A' ' 55' ' ' SER . 22.3 m-85 -122.64 139.56 53.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -0.906 . . . . 0.0 110.858 -179.385 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.4 OUTLIER -110.13 141.15 43.41 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.361 -0.837 . . . . 0.0 109.836 179.409 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.7 t -81.01 114.1 19.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.068 -1.02 . . . . 0.0 110.37 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.27 -11.51 60.95 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.174 -0.954 . . . . 0.0 109.633 178.874 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.04 -42.22 15.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.369 -0.832 . . . . 0.0 111.759 -179.252 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.449 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 13.6 p -121.42 -34.71 3.4 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.668 -1.27 . . . . 0.0 111.424 -178.946 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.49 20.48 5.44 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 119.673 -1.251 . . . . 0.0 110.211 179.419 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.864 ' C ' HD12 ' A' ' 16' ' ' ILE . 55.9 t80 -84.58 162.49 19.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.206 -1.173 . . . . 0.0 109.856 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.864 HD12 ' C ' ' A' ' 15' ' ' TYR . 3.3 mp -128.29 115.13 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.125 -0.984 . . . . 0.0 110.018 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.567 ' CE1' HD21 ' A' ' 37' ' ' LEU . 71.2 t80 -77.44 131.18 37.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.316 -0.865 . . . . 0.0 110.187 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -109.5 115.71 55.65 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.427 -0.795 . . . . 0.0 109.415 179.371 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.487 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 38.2 Cg_endo -71.0 -65.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.465 1.245 . . . . 0.0 111.041 -179.484 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' A' ' 30' ' ' PRO . 0.5 OUTLIER -47.86 -24.04 0.9 Allowed 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.552 -0.717 . . . . 0.0 111.023 -179.835 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.2 tttp -99.13 -40.06 8.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.923 -1.11 . . . . 0.0 110.732 -179.724 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.74 147.85 22.72 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -85.11 61.34 6.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.447 -1.031 . . . . 0.0 109.985 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -44.72 -27.31 0.48 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.622 -0.674 . . . . 0.0 111.039 -179.724 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -69.26 -28.33 66.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.118 -0.989 . . . . 0.0 109.88 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -100.88 -28.33 12.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.343 -0.848 . . . . 0.0 109.983 179.661 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.54 28.54 1.43 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 179.598 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.57 HD13 ' CD2' ' A' ' 37' ' ' LEU . 8.8 mt -116.87 119.82 34.82 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.046 -1.267 . . . . 0.0 109.739 179.647 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.403 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 48.0 Cg_endo -71.81 172.95 13.47 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.496 1.261 . . . . 0.0 110.553 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.425 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 49.1 Cg_endo -70.64 -163.37 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.741 1.39 . . . . 0.0 110.28 179.813 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 50.22 27.83 12.03 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.849 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 63.3 m -131.71 115.91 15.87 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.198 -1.178 . . . . 0.0 110.341 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.848 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.2 Cg_endo -72.83 148.61 46.4 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.466 1.245 . . . . 0.0 110.586 179.818 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.519 ' CE1' ' HE2' ' A' ' 50' ' ' LYS . 30.1 t80 -53.06 -30.27 34.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.36 -0.838 . . . . 0.0 109.968 179.823 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.848 HG22 ' HB2' ' A' ' 33' ' ' PRO . 33.9 m -66.75 -11.78 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.844 . . . . 0.0 110.716 -179.876 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.401 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 1.5 t70 -103.2 -2.42 27.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.012 -1.055 . . . . 0.0 110.92 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.57 ' CD2' HD13 ' A' ' 28' ' ' ILE . 19.7 mt -52.1 172.81 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.926 -1.109 . . . . 0.0 110.312 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.8 m -64.36 150.9 45.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.219 -0.926 . . . . 0.0 110.23 -179.9 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -57.65 -22.18 44.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 0.0 110.234 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.4 p -129.61 38.51 3.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 0.0 109.911 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.465 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 30.8 t80 -60.46 135.66 57.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 110.345 -179.784 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.432 ' HA ' ' O ' ' A' ' 48' ' ' SER . 0.0 OUTLIER -109.81 149.55 29.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.336 -0.853 . . . . 0.0 109.558 179.214 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 18.1 t -61.1 137.0 94.05 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.104 -0.997 . . . . 0.0 110.52 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.11 -3.37 13.75 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.602 1.317 . . . . 0.0 110.353 179.383 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.97 -39.28 3.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.07 -1.019 . . . . 0.0 110.632 -179.682 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.449 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.9 OUTLIER -124.24 9.17 8.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.164 -0.96 . . . . 0.0 110.954 -179.801 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 54.39 15.98 1.14 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.31 -0.869 . . . . 0.0 112.964 178.147 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.432 ' O ' ' HA ' ' A' ' 42' ' ' MET . 3.4 m -67.25 165.38 28.73 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 120.621 -1.299 . . . . 0.0 109.746 179.293 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.458 ' HB2' ' ND2' ' A' ' 51' ' ' ASN . 43.5 Cg_endo -69.85 144.29 53.08 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.677 1.356 . . . . 0.0 110.492 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.519 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 37.4 tttt -53.57 -32.16 49.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.174 -0.954 . . . . 0.0 110.608 -179.679 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.458 ' ND2' ' HB2' ' A' ' 49' ' ' PRO . 24.5 p30 -63.29 -14.45 49.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.054 -1.029 . . . . 0.0 109.738 179.258 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.7 OUTLIER -80.62 -7.66 59.35 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.069 -1.019 . . . . 0.0 109.755 178.985 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -82.56 124.62 30.3 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.107 -0.996 . . . . 0.0 109.678 179.375 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.416 ' O ' ' HG3' ' A' ' 9' ' ' GLU . 1.5 tttm -104.03 123.78 47.83 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.142 -0.974 . . . . 0.0 109.545 179.52 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.503 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 2.2 t -52.12 -179.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.103 -0.998 . . . . 0.0 110.241 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.734 HG22 ' O ' ' A' ' 7' ' ' LYS . 4.5 tt -158.53 67.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.457 -0.777 . . . . 0.0 110.046 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.441 ' HA ' ' HB3' ' A' ' 4' ' ' ASP . 0.0 OUTLIER -102.58 61.39 0.82 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.416 -0.802 . . . . 0.0 110.194 -179.975 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -106.13 125.16 50.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -0.899 . . . . 0.0 110.093 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.6 p -135.84 148.25 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.884 . . . . 0.0 110.123 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.419 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 0.5 OUTLIER -135.99 49.39 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.202 -0.936 . . . . 0.0 110.264 -179.956 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -128.92 21.73 5.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.202 -0.936 . . . . 0.0 110.282 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 162.49 130.73 1.14 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -116.43 138.45 51.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.259 -1.142 . . . . 0.0 110.314 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -121.99 20.31 10.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.219 -0.926 . . . . 0.0 110.23 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -136.78 17.27 3.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.139 -0.975 . . . . 0.0 110.48 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -160.49 -44.41 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.138 -0.976 . . . . 0.0 110.149 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.49 -173.32 2.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.277 -0.89 . . . . 0.0 110.113 179.837 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -168.18 -177.96 3.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 110.19 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -119.75 111.6 18.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.232 -0.918 . . . . 0.0 110.144 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 CA-C-O 118.006 -1.441 . . . . 0.0 109.547 179.994 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.777 ' O ' HG22 ' A' ' 56' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.159 0.504 . . . . 0.0 109.723 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.588 ' CE2' ' CD1' ' A' ' 34' ' ' PHE . 4.3 m-85 -100.4 147.05 26.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.13 -0.981 . . . . 0.0 109.908 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -117.71 128.15 54.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.234 -0.916 . . . . 0.0 110.222 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.9 t -69.86 112.04 6.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 110.178 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -11.54 59.54 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.135 -0.978 . . . . 0.0 109.592 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.19 -39.61 17.63 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.29 -0.881 . . . . 0.0 111.76 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.452 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 12.6 p -125.61 -32.99 2.82 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.672 -1.268 . . . . 0.0 111.752 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.83 21.61 5.97 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.777 ' C ' HD12 ' A' ' 16' ' ' ILE . 54.2 t80 -83.09 156.03 23.53 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.229 -1.16 . . . . 0.0 109.565 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.777 HD12 ' C ' ' A' ' 15' ' ' TYR . 2.7 mp -120.57 109.88 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 110.262 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.523 ' CE1' HD21 ' A' ' 37' ' ' LEU . 64.5 t80 -75.75 126.63 31.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.321 -0.862 . . . . 0.0 109.659 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.431 ' HB3' ' CB ' ' A' ' 21' ' ' LYS . 24.2 mt-10 -102.48 111.21 64.41 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.345 -0.847 . . . . 0.0 109.666 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.48 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 37.7 Cg_endo -68.77 -70.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.487 1.256 . . . . 0.0 110.939 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.403 ' O ' ' CB ' ' A' ' 30' ' ' PRO . 66.4 tt0 -47.45 -26.18 1.29 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.448 -0.783 . . . . 0.0 110.567 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.431 ' CB ' ' HB3' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -93.58 -33.75 13.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.241 -0.912 . . . . 0.0 110.196 179.833 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.91 157.03 32.27 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.471 ' HB3' HD12 ' A' ' 28' ' ' ILE . 8.5 t0 -85.04 61.34 6.81 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.479 -1.013 . . . . 0.0 109.854 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -46.54 -26.67 0.93 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.454 -0.779 . . . . 0.0 110.679 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -80.77 -25.28 38.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.265 -0.897 . . . . 0.0 110.125 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.443 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -97.82 -30.41 12.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.209 -0.932 . . . . 0.0 110.157 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 127.39 4.17 5.92 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.959 -1.115 . . . . 0.0 110.536 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.471 HD12 ' HB3' ' A' ' 23' ' ' ASP . 3.5 mt -98.19 129.04 31.65 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.824 -1.398 . . . . 0.0 110.162 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.417 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 47.0 Cg_endo -74.31 173.14 14.71 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 O-C-N 123.505 1.266 . . . . 0.0 110.557 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 49.9 Cg_endo -70.9 -163.38 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.623 1.328 . . . . 0.0 110.262 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 50.21 40.58 37.39 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 99.7 m -147.28 115.46 4.26 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.183 -1.187 . . . . 0.0 110.253 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.73 ' HB2' HG22 ' A' ' 35' ' ' VAL . 45.4 Cg_endo -71.98 151.55 56.35 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.514 1.27 . . . . 0.0 110.584 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.588 ' CD1' ' CE2' ' A' ' 8' ' ' TYR . 12.6 t80 -54.6 -32.5 58.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.328 -0.858 . . . . 0.0 110.066 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.73 HG22 ' HB2' ' A' ' 33' ' ' PRO . 24.4 m -63.56 -13.47 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.355 -0.841 . . . . 0.0 110.623 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -102.57 4.38 38.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.027 -1.045 . . . . 0.0 111.053 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.523 HD21 ' CE1' ' A' ' 17' ' ' TYR . 22.4 mt -56.61 178.97 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.832 -1.167 . . . . 0.0 110.044 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.8 m -69.18 164.96 21.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.215 -0.928 . . . . 0.0 110.324 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -63.93 -20.79 66.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.207 -0.933 . . . . 0.0 110.218 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.3 m -138.89 54.91 1.73 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.163 -0.961 . . . . 0.0 110.356 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.45 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 18.4 t80 -70.69 140.98 51.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.147 -0.971 . . . . 0.0 109.831 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.429 ' HA ' ' O ' ' A' ' 48' ' ' SER . 1.9 mtt -116.4 143.9 44.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.289 -0.882 . . . . 0.0 109.644 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 11.6 t -60.16 132.84 90.17 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.195 -0.941 . . . . 0.0 110.498 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.92 -9.22 20.79 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.569 1.3 . . . . 0.0 110.314 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -106.15 -40.04 5.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.078 -1.014 . . . . 0.0 110.707 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.452 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 1.3 p -122.72 5.1 9.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.133 -0.98 . . . . 0.0 111.113 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 4.2 mtm105 57.65 18.17 4.53 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.185 -0.947 . . . . 0.0 112.816 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.429 ' O ' ' HA ' ' A' ' 42' ' ' MET . 4.6 m -72.32 163.34 68.19 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 120.66 -1.275 . . . . 0.0 109.704 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -70.52 143.74 48.04 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.639 1.336 . . . . 0.0 110.235 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.511 ' HG2' ' CZ ' ' A' ' 34' ' ' PHE . 19.4 tttt -49.94 -24.63 2.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.208 -0.933 . . . . 0.0 110.549 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -66.17 -14.14 61.36 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.096 -1.002 . . . . 0.0 109.977 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.93 -5.56 59.24 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.141 -0.974 . . . . 0.0 109.999 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.523 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 12.7 m-85 -85.11 149.46 25.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.018 -1.051 . . . . 0.0 110.285 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.66 132.66 26.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.352 -0.842 . . . . 0.0 109.878 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.53 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 5.8 p -61.83 172.62 1.25 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.166 -0.959 . . . . 0.0 110.917 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.777 HG22 ' O ' ' A' ' 7' ' ' LYS . 3.2 tt . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.733 -0.605 . . . . 0.0 109.718 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.86 ' O ' HG22 ' A' ' 56' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.237 0.542 . . . . 0.0 109.936 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.564 ' CE2' ' CD2' ' A' ' 34' ' ' PHE . 7.4 m-85 -109.59 141.93 41.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.168 -0.957 . . . . 0.0 109.878 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.508 ' HA ' HD13 ' A' ' 16' ' ' ILE . 4.8 tt0 -106.18 129.88 54.16 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.162 -0.961 . . . . 0.0 110.275 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.9 t -71.42 116.17 11.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 110.339 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.73 -11.47 60.96 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.091 -1.006 . . . . 0.0 109.585 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.686 ' HB2' ' OE1' ' A' ' 52' ' ' GLN . . . -85.15 -41.37 15.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.309 -0.87 . . . . 0.0 111.653 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.472 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 14.3 p -123.12 -32.62 3.43 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.758 -1.214 . . . . 0.0 111.406 -179.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.0 24.0 5.92 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.46 ' CD2' ' N ' ' A' ' 16' ' ' ILE . 40.9 t80 -84.13 168.96 15.33 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.365 -1.079 . . . . 0.0 109.343 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.508 HD13 ' HA ' ' A' ' 9' ' ' GLU . 33.9 mm -129.41 117.59 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.27 -0.894 . . . . 0.0 110.309 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.543 ' CE1' HD21 ' A' ' 37' ' ' LEU . 56.1 t80 -80.54 129.17 34.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.429 -0.794 . . . . 0.0 109.912 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -104.91 110.73 64.87 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.488 -0.758 . . . . 0.0 109.546 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.464 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 37.5 Cg_endo -68.58 -76.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.591 1.311 . . . . 0.0 111.464 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -46.02 -26.58 0.75 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.285 -0.885 . . . . 0.0 111.037 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.5 tttp -87.95 -36.09 17.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 110.522 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.46 145.63 17.81 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.413 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 2.9 t0 -85.11 62.07 7.27 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.3 -1.118 . . . . 0.0 109.876 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.39 -26.5 2.1 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.249 -0.907 . . . . 0.0 110.416 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -74.51 -20.41 59.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.303 -0.873 . . . . 0.0 109.921 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.413 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -106.99 -33.28 7.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.929 . . . . 0.0 109.969 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.94 32.97 0.66 Allowed Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.948 -1.12 . . . . 0.0 110.309 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.1 mt -124.1 130.39 24.4 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 120.876 -1.367 . . . . 0.0 109.753 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.46 173.21 13.57 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 O-C-N 123.601 1.316 . . . . 0.0 110.394 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -72.19 -164.87 0.19 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.629 1.331 . . . . 0.0 110.186 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 49.76 27.87 10.18 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.9 m -127.94 112.08 20.28 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.099 -1.236 . . . . 0.0 110.228 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.75 ' HB2' HG22 ' A' ' 35' ' ' VAL . 44.3 Cg_endo -70.87 153.08 64.0 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.554 1.292 . . . . 0.0 110.478 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.763 ' CD1' HD12 ' A' ' 37' ' ' LEU . 27.5 t80 -55.48 -28.36 54.04 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.234 -0.916 . . . . 0.0 110.106 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.75 HG22 ' HB2' ' A' ' 33' ' ' PRO . 33.8 m -64.79 -20.16 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.207 -0.933 . . . . 0.0 110.077 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -90.54 -11.11 41.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.13 -0.981 . . . . 0.0 110.69 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.763 HD12 ' CD1' ' A' ' 34' ' ' PHE . 25.5 mt -52.54 157.65 1.47 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.974 -1.079 . . . . 0.0 110.322 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.34 139.34 58.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.307 -0.871 . . . . 0.0 109.99 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -51.17 -24.86 4.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.26 -0.9 . . . . 0.0 110.348 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.95 26.19 10.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.87 . . . . 0.0 110.177 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.455 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 18.3 t80 -56.04 131.96 48.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 109.844 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.1 mtt -113.3 147.46 37.55 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.265 -0.897 . . . . 0.0 109.545 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 7.9 t -58.72 134.25 86.39 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.0 110.44 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -77.83 1.09 9.21 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.533 1.281 . . . . 0.0 110.29 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -120.97 -34.96 3.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.027 -1.045 . . . . 0.0 110.923 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.472 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.7 OUTLIER -126.16 4.07 7.14 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.937 -1.102 . . . . 0.0 111.345 -179.668 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.78 17.75 10.13 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.085 -1.009 . . . . 0.0 112.142 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.41 ' OG ' ' HB3' ' A' ' 52' ' ' GLN . 5.0 t -70.44 153.39 95.11 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.822 -1.174 . . . . 0.0 109.707 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.16 145.33 43.89 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.587 1.309 . . . . 0.0 110.558 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.455 ' HB2' ' HB3' ' A' ' 41' ' ' PHE . 24.7 tttm -52.37 -32.03 36.6 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.175 -0.953 . . . . 0.0 110.186 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.15 -15.66 47.39 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.122 -0.987 . . . . 0.0 109.745 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.686 ' OE1' ' HB2' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -91.1 3.77 53.92 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.24 -0.912 . . . . 0.0 110.159 179.401 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.403 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 18.8 m-85 -92.84 128.16 38.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.896 -1.127 . . . . 0.0 110.209 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.86 135.73 50.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.301 -0.874 . . . . 0.0 109.737 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.529 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 77.9 p -68.15 -178.44 1.04 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 110.908 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.86 HG22 ' O ' ' A' ' 7' ' ' LYS . 7.2 tp . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.466 0.65 . . . . 0.0 109.691 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.872 ' O ' HG22 ' A' ' 56' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.219 0.533 . . . . 0.0 109.879 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.52 ' CE2' ' HB3' ' A' ' 55' ' ' SER . 8.9 m-85 -118.1 135.88 53.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.153 -0.967 . . . . 0.0 109.635 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.407 ' HA ' HD13 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -101.53 135.76 42.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.048 -1.033 . . . . 0.0 110.55 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.9 t -77.49 113.95 15.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.194 -0.941 . . . . 0.0 110.248 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.01 -10.26 59.45 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.004 -1.06 . . . . 0.0 109.572 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.05 -39.48 17.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.43 -0.794 . . . . 0.0 111.584 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.48 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 13.8 p -125.5 -35.24 2.58 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.652 -1.28 . . . . 0.0 111.531 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.02 22.8 4.81 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.466 ' CG ' ' N ' ' A' ' 16' ' ' ILE . 59.2 t80 -83.66 170.22 14.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.351 -1.088 . . . . 0.0 109.871 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.466 ' N ' ' CG ' ' A' ' 15' ' ' TYR . 37.2 mm -132.24 115.03 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 110.255 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.5 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 68.4 t80 -78.17 135.94 37.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.331 -0.856 . . . . 0.0 110.136 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.415 ' O ' ' N ' ' A' ' 22' ' ' GLY . 5.8 mt-10 -115.28 110.09 45.75 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.516 -0.74 . . . . 0.0 109.461 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.447 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 37.4 Cg_endo -68.99 -72.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.395 0 O-C-N 123.52 1.274 . . . . 0.0 111.237 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -44.81 -27.27 0.49 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.544 -0.722 . . . . 0.0 111.032 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -98.13 -24.02 15.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.207 -0.933 . . . . 0.0 110.147 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 18' ' ' GLU . . . 80.04 153.36 8.49 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.596 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 0.3 OUTLIER -84.93 61.2 6.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.361 -1.081 . . . . 0.0 109.595 179.627 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.45 -27.78 0.78 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.57 -0.706 . . . . 0.0 110.965 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.85 -28.08 60.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.187 -0.946 . . . . 0.0 109.899 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.596 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -96.54 -28.22 14.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.291 -0.88 . . . . 0.0 110.073 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.8 24.63 2.27 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.49 HD11 ' CD1' ' A' ' 41' ' ' PHE . 7.6 mt -113.98 128.86 25.32 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.959 -1.318 . . . . 0.0 109.684 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.33 170.45 19.87 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.598 1.315 . . . . 0.0 110.665 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.01 -163.59 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.674 1.355 . . . . 0.0 110.144 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 48.99 34.38 15.79 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 90.2 m -138.7 115.08 8.79 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.259 -1.142 . . . . 0.0 110.271 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.773 ' HB2' HG22 ' A' ' 35' ' ' VAL . 48.2 Cg_endo -72.08 148.8 51.3 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.568 1.299 . . . . 0.0 110.507 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.508 ' CZ ' ' HG2' ' A' ' 50' ' ' LYS . 19.1 t80 -51.59 -27.85 12.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.42 -0.8 . . . . 0.0 110.272 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.773 HG22 ' HB2' ' A' ' 33' ' ' PRO . 31.1 m -71.0 -19.59 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.936 . . . . 0.0 110.52 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.27 -2.26 55.21 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.186 -0.946 . . . . 0.0 110.924 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.469 HD23 ' HA ' ' A' ' 37' ' ' LEU . 25.2 mt -53.19 -179.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.971 -1.08 . . . . 0.0 110.372 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.15 156.48 38.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.381 -0.825 . . . . 0.0 110.232 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -53.11 -26.31 16.13 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.268 -0.895 . . . . 0.0 110.424 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.32 60.43 1.67 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.143 -0.973 . . . . 0.0 110.42 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.49 ' CD1' HD11 ' A' ' 28' ' ' ILE . 10.0 t80 -71.64 128.49 35.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.164 -0.96 . . . . 0.0 109.685 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.441 ' HA ' ' O ' ' A' ' 48' ' ' SER . 18.1 mmt -103.0 145.83 29.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -0.925 . . . . 0.0 109.795 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 8.3 t -58.36 138.12 85.11 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.403 -0.811 . . . . 0.0 110.67 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.4 ' HB3' ' HB2' ' A' ' 26' ' ' ALA . 53.0 Cg_endo -77.68 -0.57 10.77 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.686 1.361 . . . . 0.0 110.394 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -122.41 -34.15 3.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.032 -1.042 . . . . 0.0 111.022 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.48 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.8 OUTLIER -125.03 8.01 7.99 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.933 -1.105 . . . . 0.0 111.298 -179.655 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.69 21.41 4.59 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.122 -0.987 . . . . 0.0 112.432 178.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 42' ' ' MET . 10.9 t -77.23 153.25 82.11 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 120.666 -1.271 . . . . 0.0 109.627 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.26 142.06 49.04 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.584 1.307 . . . . 0.0 110.548 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.508 ' HG2' ' CZ ' ' A' ' 34' ' ' PHE . 4.4 ttpm? -48.4 -29.44 4.01 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.445 -0.784 . . . . 0.0 110.937 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -62.77 -14.79 49.13 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.986 -1.071 . . . . 0.0 109.967 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.09 1.1 56.08 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.125 -0.985 . . . . 0.0 110.03 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.494 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 16.6 m-85 -89.63 137.43 32.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.116 -0.99 . . . . 0.0 110.307 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -115.9 131.63 56.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.285 -0.885 . . . . 0.0 109.64 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.52 ' HB3' ' CE2' ' A' ' 8' ' ' TYR . 79.3 p -63.68 179.67 0.46 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.048 -1.032 . . . . 0.0 111.054 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.872 HG22 ' O ' ' A' ' 7' ' ' LYS . 1.2 tp . . . . . 0 C--N 1.297 -1.677 0 CA-C-O 121.405 0.622 . . . . 0.0 109.561 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.518 ' CE2' ' HB2' ' A' ' 55' ' ' SER . 22.2 m-85 -129.3 150.39 50.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.017 -1.052 . . . . 0.0 110.864 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.586 ' HA ' HD13 ' A' ' 16' ' ' ILE . 13.8 pt-20 -120.56 140.66 51.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.323 -0.861 . . . . 0.0 109.863 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 t -80.05 113.86 18.53 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.176 -0.953 . . . . 0.0 110.434 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.63 -11.71 61.11 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.115 -0.99 . . . . 0.0 109.613 178.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.08 -41.3 15.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 111.726 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.4 p -122.08 -32.85 3.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.726 -1.234 . . . . 0.0 111.551 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.14 21.12 6.03 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.507 ' CD2' ' N ' ' A' ' 16' ' ' ILE . 60.5 t80 -81.6 168.92 17.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.265 -1.138 . . . . 0.0 109.92 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.586 HD13 ' HA ' ' A' ' 9' ' ' GLU . 34.8 mm -135.11 116.25 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.246 -0.908 . . . . 0.0 110.201 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.548 ' CZ ' HD21 ' A' ' 37' ' ' LEU . 63.5 t80 -80.57 132.86 35.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -0.874 . . . . 0.0 110.109 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -113.93 113.86 46.78 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.561 -0.712 . . . . 0.0 109.655 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.493 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 38.5 Cg_endo -71.72 -65.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.474 1.25 . . . . 0.0 110.892 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -45.38 -27.33 0.67 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.715 -0.616 . . . . 0.0 110.776 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.12 -35.57 10.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.282 -0.886 . . . . 0.0 110.0 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.64 149.54 10.69 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.471 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 2.2 t0 -85.14 62.42 7.49 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.457 -1.025 . . . . 0.0 109.725 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -44.91 -27.5 0.54 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.629 -0.669 . . . . 0.0 110.916 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.45 -26.44 60.05 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.315 -0.865 . . . . 0.0 110.26 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.471 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -100.72 -25.68 14.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.223 -0.923 . . . . 0.0 110.335 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.92 19.1 3.39 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.893 -1.146 . . . . 0.0 110.244 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.2 mt -111.19 116.59 51.1 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 120.897 -1.355 . . . . 0.0 109.717 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.35 172.18 13.7 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.503 1.265 . . . . 0.0 110.611 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.54 -164.14 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.724 1.381 . . . . 0.0 110.145 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 47.61 27.33 4.36 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.406 ' O ' ' CB ' ' A' ' 19' ' ' PRO . 89.9 m -128.73 119.53 20.21 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.12 -1.223 . . . . 0.0 110.245 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.655 ' HB2' HG22 ' A' ' 35' ' ' VAL . 48.6 Cg_endo -73.78 159.47 45.29 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 O-C-N 123.525 1.276 . . . . 0.0 110.878 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.507 ' CD1' HD12 ' A' ' 37' ' ' LEU . 44.2 t80 -65.79 -28.93 69.37 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.448 -0.783 . . . . 0.0 110.157 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.655 HG22 ' HB2' ' A' ' 33' ' ' PRO . 23.2 m -69.45 -9.83 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -0.904 . . . . 0.0 110.809 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.67 -1.96 23.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.965 -1.085 . . . . 0.0 110.892 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.548 HD21 ' CZ ' ' A' ' 17' ' ' TYR . 46.9 mt -52.07 162.57 0.45 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.883 -1.136 . . . . 0.0 110.27 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.7 t -49.57 164.86 0.08 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.31 -0.869 . . . . 0.0 110.44 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.46 -26.0 68.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.916 . . . . 0.0 110.233 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.9 p -131.65 52.73 2.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.271 -0.893 . . . . 0.0 110.46 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.478 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 26.9 t80 -63.46 132.17 50.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.216 -0.927 . . . . 0.0 109.785 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -110.17 143.97 39.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.878 . . . . 0.0 109.663 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.461 ' HB3' ' N ' ' A' ' 47' ' ' ARG . 8.7 t -55.49 137.45 69.56 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 110.741 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -77.6 -1.68 11.85 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.58 1.305 . . . . 0.0 110.287 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -120.56 -39.81 2.72 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.146 -0.971 . . . . 0.0 110.533 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.417 ' SG ' ' CB ' ' A' ' 48' ' ' SER . 0.6 OUTLIER -121.82 10.42 10.24 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.087 -1.008 . . . . 0.0 110.836 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.461 ' N ' ' HB3' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 52.95 17.73 0.94 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.29 -0.881 . . . . 0.0 112.655 178.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.417 ' CB ' ' SG ' ' A' ' 46' ' ' CYS . 4.1 t -67.7 156.2 89.6 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.598 -1.313 . . . . 0.0 109.715 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.86 143.48 45.65 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 123.684 1.36 . . . . 0.0 110.486 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.524 ' HA ' ' CD1' ' A' ' 53' ' ' PHE . 22.1 tttm -50.32 -25.26 3.6 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.325 -0.86 . . . . 0.0 110.517 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 -67.24 -11.61 57.92 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.202 -0.936 . . . . 0.0 110.146 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.52 0.7 57.46 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.053 -1.029 . . . . 0.0 110.104 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.524 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 39.6 m-85 -89.99 125.67 35.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.951 -1.093 . . . . 0.0 110.428 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.408 ' O ' ' HG2' ' A' ' 9' ' ' GLU . 12.0 tttt -100.75 131.54 46.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.391 -0.818 . . . . 0.0 109.579 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.667 ' O ' HG23 ' A' ' 56' ' ' ILE . 2.5 t -60.89 179.34 0.18 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.124 -0.985 . . . . 0.0 110.316 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.667 HG23 ' O ' ' A' ' 55' ' ' SER . 7.9 pt . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.782 -0.573 . . . . 0.0 109.509 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.898 ' O ' HG22 ' A' ' 56' ' ' ILE . 6.5 mttt . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.524 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 6.6 m-85 -111.93 132.19 54.91 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.055 -1.028 . . . . 0.0 110.354 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 17.3 tt0 -95.23 135.49 36.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.262 -0.899 . . . . 0.0 109.982 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.4 t -76.95 114.45 15.75 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.191 -0.943 . . . . 0.0 110.309 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -69.34 -11.47 60.84 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.192 -0.942 . . . . 0.0 109.722 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.568 ' HB2' ' NE2' ' A' ' 52' ' ' GLN . . . -85.2 -40.79 16.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.906 . . . . 0.0 111.819 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.474 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 14.0 p -124.53 -35.35 2.76 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.738 -1.226 . . . . 0.0 111.802 -178.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 116.94 20.5 4.87 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.616 -1.278 . . . . 0.0 109.988 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.858 ' C ' HD12 ' A' ' 16' ' ' ILE . 73.7 t80 -83.73 169.99 14.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -1.124 . . . . 0.0 109.51 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.858 HD12 ' C ' ' A' ' 15' ' ' TYR . 3.4 mp -132.7 110.23 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.119 -0.988 . . . . 0.0 110.064 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.499 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 73.3 t80 -70.06 140.28 52.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.265 -0.897 . . . . 0.0 110.109 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.444 ' HG2' ' HE2' ' A' ' 7' ' ' LYS . 14.6 mt-10 -115.26 108.21 48.26 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.545 -0.722 . . . . 0.0 109.857 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.441 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 38.0 Cg_endo -68.81 -74.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.427 1.224 . . . . 0.0 111.042 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -46.85 -25.76 0.83 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.4 -0.812 . . . . 0.0 110.914 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.99 -38.2 11.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.13 -0.981 . . . . 0.0 110.44 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.37 148.52 24.1 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.588 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 0.6 OUTLIER -85.09 61.99 7.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.399 -1.06 . . . . 0.0 110.07 179.787 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.18 -26.82 0.84 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.523 -0.735 . . . . 0.0 110.915 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -77.5 -23.0 50.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.173 -0.954 . . . . 0.0 110.333 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.588 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -102.69 -28.67 11.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.204 -0.935 . . . . 0.0 110.143 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.66 30.94 1.19 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.6 mt -122.89 122.39 27.09 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.123 -1.222 . . . . 0.0 109.783 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.401 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 45.5 Cg_endo -70.71 173.06 12.38 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 O-C-N 123.516 1.272 . . . . 0.0 110.529 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.401 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 48.3 Cg_endo -70.84 -163.54 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.788 1.415 . . . . 0.0 110.137 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 49.15 25.69 5.75 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 93.0 m -127.39 114.74 21.36 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.102 -1.234 . . . . 0.0 110.04 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.839 ' HB2' HG22 ' A' ' 35' ' ' VAL . 48.8 Cg_endo -73.72 149.88 43.91 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.501 1.263 . . . . 0.0 110.78 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.645 ' CD1' HD12 ' A' ' 37' ' ' LEU . 55.0 t80 -53.9 -26.88 27.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.361 -0.837 . . . . 0.0 110.151 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.839 HG22 ' HB2' ' A' ' 33' ' ' PRO . 35.4 m -69.09 -16.11 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.172 -0.955 . . . . 0.0 110.632 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.19 -2.48 49.62 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.045 -1.034 . . . . 0.0 110.927 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.645 HD12 ' CD1' ' A' ' 34' ' ' PHE . 58.4 mt -59.0 158.56 8.31 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.919 -1.113 . . . . 0.0 110.155 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.0 t -54.55 166.84 0.4 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.302 -0.874 . . . . 0.0 110.227 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -72.3 -11.68 60.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.206 -0.934 . . . . 0.0 110.635 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 54.3 p -137.37 34.02 2.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.966 -1.084 . . . . 0.0 110.322 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.482 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 22.9 t80 -54.25 144.23 20.79 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.257 -0.902 . . . . 0.0 109.59 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.07 138.31 51.7 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.2 -0.938 . . . . 0.0 110.32 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 39.2 t -57.33 131.8 81.15 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.453 -0.779 . . . . 0.0 110.182 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.61 -3.26 13.6 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.489 1.257 . . . . 0.0 110.673 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -111.12 -30.19 7.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.004 -1.06 . . . . 0.0 110.686 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.474 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 1.5 p -135.17 7.94 3.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.995 -1.065 . . . . 0.0 111.313 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.3 16.32 3.06 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.207 -0.933 . . . . 0.0 112.897 178.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.4 p -72.66 156.93 89.65 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 120.626 -1.296 . . . . 0.0 109.884 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.4 ' HG2' ' OD1' ' A' ' 51' ' ' ASN . 43.0 Cg_endo -69.0 140.67 46.16 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.551 1.29 . . . . 0.0 110.306 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.51 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 41.0 tttt -47.29 -30.42 3.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.31 -0.869 . . . . 0.0 111.481 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.4 ' OD1' ' HG2' ' A' ' 49' ' ' PRO . 29.6 p30 -63.18 -14.03 44.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.888 -1.133 . . . . 0.0 110.048 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.568 ' NE2' ' HB2' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -85.97 -2.83 58.66 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.101 -0.999 . . . . 0.0 110.146 179.313 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -81.95 168.04 18.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.958 -1.089 . . . . 0.0 110.21 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 9' ' ' GLU . 0.7 OUTLIER -147.28 132.79 18.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.376 -0.827 . . . . 0.0 109.471 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.524 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 64.5 p -65.52 174.82 2.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.973 -1.08 . . . . 0.0 110.91 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.898 HG22 ' O ' ' A' ' 7' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.418 0.628 . . . . 0.0 110.207 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.424 ' O ' ' CG1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.54 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 4.2 m-85 -104.41 166.68 10.24 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.113 -0.992 . . . . 0.0 110.565 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.473 ' HB2' HD13 ' A' ' 56' ' ' ILE . 28.1 tt0 -131.12 134.33 46.47 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.344 -0.847 . . . . 0.0 110.279 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.9 t -74.85 112.42 11.04 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.204 -0.935 . . . . 0.0 109.991 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.61 -10.84 59.84 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.28 -0.968 . . . . 0.0 109.65 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.07 -39.93 17.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 111.767 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.452 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 13.0 p -124.54 -36.54 2.61 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.713 -1.242 . . . . 0.0 111.521 -178.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.27 21.16 4.15 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.852 ' C ' HD12 ' A' ' 16' ' ' ILE . 37.5 t80 -81.19 160.62 24.29 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.206 -1.173 . . . . 0.0 109.756 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.852 HD12 ' C ' ' A' ' 15' ' ' TYR . 2.8 mp -127.04 120.93 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.169 -0.957 . . . . 0.0 110.185 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.547 ' CE1' HD21 ' A' ' 37' ' ' LEU . 58.5 t80 -86.7 138.17 31.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.22 -0.925 . . . . 0.0 110.194 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -116.15 112.95 41.7 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.565 -0.709 . . . . 0.0 109.857 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.423 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 38.1 Cg_endo -72.02 -66.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.58 1.305 . . . . 0.0 111.026 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.402 ' O ' ' CB ' ' A' ' 30' ' ' PRO . 1.4 tt0 -45.26 -27.04 0.58 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.698 -0.626 . . . . 0.0 110.97 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.1 tptt -99.86 -30.65 11.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 110.332 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.62 148.38 8.35 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.445 ' HB3' HD12 ' A' ' 28' ' ' ILE . 2.0 t70 -85.03 63.16 7.95 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.451 -1.029 . . . . 0.0 109.599 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -45.34 -29.29 1.01 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.606 -0.684 . . . . 0.0 110.899 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -68.69 -26.46 65.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.314 -0.866 . . . . 0.0 109.89 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -100.67 -28.89 12.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.335 -0.853 . . . . 0.0 109.995 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.05 15.71 3.76 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.955 -1.117 . . . . 0.0 110.462 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.722 HD13 ' CD2' ' A' ' 37' ' ' LEU . 11.9 mt -105.64 121.68 45.19 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.776 -1.426 . . . . 0.0 109.78 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -70.86 171.82 14.92 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.504 1.265 . . . . 0.0 110.691 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.402 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 49.6 Cg_endo -71.42 -163.83 0.14 Allowed 'Trans proline' 0 C--N 1.314 -1.285 0 O-C-N 123.771 1.406 . . . . 0.0 110.201 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 47.98 33.43 10.11 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 85.0 m -137.27 121.63 12.24 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.194 -1.18 . . . . 0.0 110.191 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.763 ' HB2' HG22 ' A' ' 35' ' ' VAL . 48.1 Cg_endo -73.07 155.16 52.61 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.505 1.266 . . . . 0.0 110.745 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.671 ' CD2' HD12 ' A' ' 37' ' ' LEU . 24.5 t80 -58.04 -30.06 65.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.32 -0.862 . . . . 0.0 109.809 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.763 HG22 ' HB2' ' A' ' 33' ' ' PRO . 22.4 m -63.66 -14.84 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.321 -0.862 . . . . 0.0 110.691 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.64 0.94 45.77 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.053 -1.03 . . . . 0.0 111.001 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.722 ' CD2' HD13 ' A' ' 28' ' ' ILE . 21.3 mt -53.64 169.58 0.14 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.888 -1.133 . . . . 0.0 110.209 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.5 t -61.08 153.65 24.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.218 -0.927 . . . . 0.0 110.392 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -54.13 -39.3 66.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.262 -0.899 . . . . 0.0 110.445 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 96.7 p -120.04 43.85 2.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 110.489 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.444 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 40.7 t80 -63.26 137.01 58.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.202 -0.936 . . . . 0.0 109.971 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 45.2 mmm -111.47 164.43 12.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.206 -0.934 . . . . 0.0 109.575 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.3 t -76.63 133.27 70.7 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.291 -0.881 . . . . 0.0 110.3 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -75.09 -1.96 11.92 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.525 1.276 . . . . 0.0 110.287 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.96 -33.62 4.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.961 -1.087 . . . . 0.0 110.712 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.452 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.8 OUTLIER -129.38 7.12 5.34 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.995 -1.066 . . . . 0.0 111.188 -179.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.66 17.6 4.16 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.102 -0.999 . . . . 0.0 112.566 178.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.42 ' CB ' ' SG ' ' A' ' 46' ' ' CYS . 6.6 t -72.44 155.94 90.78 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 120.675 -1.266 . . . . 0.0 109.846 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.96 140.54 50.52 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.615 1.324 . . . . 0.0 110.377 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.464 ' HG2' ' CZ ' ' A' ' 34' ' ' PHE . 21.6 tttt -50.23 -25.41 3.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.238 -0.913 . . . . 0.0 110.735 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -66.6 -12.91 60.13 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.056 -1.028 . . . . 0.0 109.963 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.79 -2.88 58.91 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.07 -1.019 . . . . 0.0 110.08 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.495 ' HB2' ' CZ ' ' A' ' 34' ' ' PHE . 23.9 m-85 -86.41 134.33 33.71 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.956 -1.09 . . . . 0.0 110.072 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.68 139.11 52.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.203 -0.935 . . . . 0.0 109.612 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.646 ' O ' HG23 ' A' ' 56' ' ' ILE . 35.5 p -63.83 176.91 0.83 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.935 . . . . 0.0 111.034 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.646 HG23 ' O ' ' A' ' 55' ' ' SER . 8.1 pt . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.261 0.553 . . . . 0.0 109.639 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.842 ' O ' HG22 ' A' ' 56' ' ' ILE . 20.6 mtmt . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.537 ' CE2' ' CD2' ' A' ' 34' ' ' PHE . 14.9 m-85 -125.76 135.58 52.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.131 -0.981 . . . . 0.0 110.688 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 44.8 tt0 -103.91 138.99 39.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.384 -0.822 . . . . 0.0 110.063 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.7 t -79.66 112.53 17.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.191 -0.943 . . . . 0.0 110.331 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.97 -11.18 60.49 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.147 -0.97 . . . . 0.0 109.658 178.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.412 ' HB2' ' NE2' ' A' ' 52' ' ' GLN . . . -85.03 -41.07 16.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.298 -0.876 . . . . 0.0 111.598 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.462 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 14.2 p -123.12 -35.51 2.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.699 -1.25 . . . . 0.0 111.428 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 116.65 20.62 4.94 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 119.677 -1.249 . . . . 0.0 110.071 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.786 ' C ' HD12 ' A' ' 16' ' ' ILE . 67.4 t80 -84.84 169.11 14.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.108 -1.231 . . . . 0.0 109.828 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.786 HD12 ' C ' ' A' ' 15' ' ' TYR . 3.3 mp -133.39 115.2 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.218 -0.926 . . . . 0.0 110.154 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.49 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 58.3 t80 -75.47 136.63 40.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.913 . . . . 0.0 110.086 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.403 ' HB3' ' HB2' ' A' ' 21' ' ' LYS . 88.8 mt-10 -113.5 112.3 48.81 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.549 -0.72 . . . . 0.0 109.632 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.463 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 38.0 Cg_endo -70.06 -74.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.456 1.24 . . . . 0.0 111.554 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.411 ' O ' ' CB ' ' A' ' 30' ' ' PRO . 3.6 mm-40 -43.38 -27.3 0.25 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.525 -0.734 . . . . 0.0 111.398 -179.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.403 ' HB2' ' HB3' ' A' ' 18' ' ' GLU . 2.0 mmmt -93.65 -36.03 12.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.079 -1.013 . . . . 0.0 110.501 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.33 145.17 14.14 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.472 ' HB3' HD12 ' A' ' 28' ' ' ILE . 10.0 t0 -85.08 62.93 7.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.378 -1.072 . . . . 0.0 109.707 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -44.57 -27.17 0.44 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.595 -0.691 . . . . 0.0 111.251 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -74.6 -26.71 60.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.028 -1.045 . . . . 0.0 110.074 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -98.71 -27.93 13.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.219 -0.925 . . . . 0.0 109.983 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.05 30.72 1.42 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.477 HD11 ' CD1' ' A' ' 41' ' ' PHE . 11.4 mt -121.63 119.24 29.28 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.12 -1.224 . . . . 0.0 109.904 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.402 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 43.1 Cg_endo -69.26 173.13 10.97 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.459 1.242 . . . . 0.0 110.359 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.411 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 47.1 Cg_endo -70.05 -163.85 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.68 1.358 . . . . 0.0 110.224 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 48.49 39.91 23.11 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.7 m -142.26 115.56 6.45 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.176 -1.191 . . . . 0.0 110.446 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.767 ' HB2' HG22 ' A' ' 35' ' ' VAL . 46.1 Cg_endo -74.18 153.29 46.05 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.474 1.25 . . . . 0.0 110.51 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.586 ' CD1' HD12 ' A' ' 37' ' ' LEU . 43.3 t80 -61.74 -28.15 69.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.34 -0.85 . . . . 0.0 110.236 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.767 HG22 ' HB2' ' A' ' 33' ' ' PRO . 35.6 m -67.96 -9.73 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -0.933 . . . . 0.0 110.875 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.403 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -110.13 0.25 18.21 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.96 -1.087 . . . . 0.0 110.989 -179.744 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.586 HD12 ' CD1' ' A' ' 34' ' ' PHE . 28.2 mt -51.02 164.09 0.17 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.997 -1.064 . . . . 0.0 110.285 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.4 m -50.18 157.59 0.65 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.189 -0.944 . . . . 0.0 110.446 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.18 -15.48 46.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.0 110.398 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.2 51.74 1.58 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.071 -1.018 . . . . 0.0 110.43 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.477 ' CD1' HD11 ' A' ' 28' ' ' ILE . 32.1 t80 -68.96 142.84 54.58 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.213 -0.929 . . . . 0.0 110.022 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.429 ' HA ' ' O ' ' A' ' 48' ' ' SER . 7.7 mtt -120.11 150.67 40.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.327 -0.858 . . . . 0.0 109.57 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.442 ' HB3' ' N ' ' A' ' 47' ' ' ARG . 7.3 t -58.13 135.92 84.37 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.223 -0.923 . . . . 0.0 110.26 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.78 -2.89 12.86 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.596 1.314 . . . . 0.0 110.437 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -121.66 -50.42 2.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.91 -1.119 . . . . 0.0 110.918 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.462 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -105.38 5.54 31.84 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.03 -1.044 . . . . 0.0 111.304 -179.345 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.442 ' N ' ' HB3' ' A' ' 43' ' ' CYS . 12.3 ttm-85 56.92 20.48 5.34 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.061 -1.024 . . . . 0.0 112.272 178.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.429 ' O ' ' HA ' ' A' ' 42' ' ' MET . 2.8 t -70.41 155.95 92.64 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 120.798 -1.188 . . . . 0.0 109.676 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.91 142.56 43.15 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.588 1.31 . . . . 0.0 110.266 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.514 ' HE2' ' CE2' ' A' ' 34' ' ' PHE . 22.4 tttt -51.77 -25.27 7.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.157 -0.964 . . . . 0.0 110.329 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.5 t30 -68.2 -11.95 60.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.136 -0.977 . . . . 0.0 109.826 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.412 ' NE2' ' HB2' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -91.83 1.36 57.22 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.162 -0.961 . . . . 0.0 110.077 179.352 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.499 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 34.6 m-85 -90.78 129.09 36.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.018 -1.051 . . . . 0.0 110.628 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.93 134.31 49.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.368 -0.832 . . . . 0.0 109.603 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.509 ' HB3' ' CE2' ' A' ' 8' ' ' TYR . 86.4 p -64.25 -179.94 0.5 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.074 -1.016 . . . . 0.0 110.984 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.842 HG22 ' O ' ' A' ' 7' ' ' LYS . 9.7 tt . . . . . 0 N--CA 1.493 1.701 0 O-C-N 121.787 -0.57 . . . . 0.0 110.267 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.826 ' O ' HG22 ' A' ' 56' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.575 ' CE2' ' CD1' ' A' ' 34' ' ' PHE . 4.4 m-85 -95.47 133.93 38.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 110.555 -179.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.628 ' HA ' HD13 ' A' ' 16' ' ' ILE . 11.0 tt0 -101.54 132.06 47.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.42 -0.8 . . . . 0.0 110.281 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.1 t -74.39 119.45 18.61 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.2 -0.938 . . . . 0.0 110.169 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.3 -11.69 60.34 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.087 -1.008 . . . . 0.0 109.654 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.425 ' HB2' ' NE2' ' A' ' 52' ' ' GLN . . . -85.07 -37.85 19.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.241 -0.912 . . . . 0.0 111.699 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.468 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 13.7 p -126.63 -34.56 2.42 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.717 -1.24 . . . . 0.0 111.645 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.74 22.4 5.39 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.449 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 55.9 t80 -84.41 159.2 20.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.373 -1.074 . . . . 0.0 109.762 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.628 HD13 ' HA ' ' A' ' 9' ' ' GLU . 39.4 mm -123.6 111.0 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 0.0 110.655 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.43 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 53.1 t80 -75.75 130.65 38.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.41 -0.806 . . . . 0.0 110.175 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -108.38 113.25 60.49 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.434 -0.791 . . . . 0.0 109.406 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.49 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 38.3 Cg_endo -71.95 -64.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.495 1.261 . . . . 0.0 110.963 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -45.35 -26.82 0.58 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.702 -0.624 . . . . 0.0 111.12 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -97.07 -30.36 13.09 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.04 -1.037 . . . . 0.0 110.236 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.66 153.51 23.63 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.734 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -85.12 61.9 7.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.39 -1.064 . . . . 0.0 109.795 179.657 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.71 -28.51 0.63 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.513 -0.742 . . . . 0.0 110.953 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.8 -24.76 44.37 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.226 -0.921 . . . . 0.0 110.42 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.734 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -97.69 -27.48 14.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.154 -0.966 . . . . 0.0 110.213 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 119.48 27.57 2.14 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.44 HD13 ' CD2' ' A' ' 37' ' ' LEU . 6.5 mt -120.13 126.07 27.01 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.097 -1.237 . . . . 0.0 109.975 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.409 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 43.9 Cg_endo -71.3 173.28 12.55 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.54 1.284 . . . . 0.0 110.289 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 49.1 Cg_endo -70.76 -163.73 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.683 1.36 . . . . 0.0 110.088 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 47.71 26.79 4.2 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 91.8 m -124.22 111.34 28.52 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.138 -1.213 . . . . 0.0 110.292 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.712 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.3 Cg_endo -73.11 148.99 45.51 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.492 1.259 . . . . 0.0 110.614 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.575 ' CD1' ' CE2' ' A' ' 8' ' ' TYR . 12.7 t80 -52.46 -30.88 32.03 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.308 -0.87 . . . . 0.0 110.506 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.712 HG22 ' HB2' ' A' ' 33' ' ' PRO . 26.6 m -65.27 -17.49 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.23 -0.919 . . . . 0.0 110.841 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -99.73 -0.01 40.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.072 -1.017 . . . . 0.0 110.887 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.495 ' HA ' HD23 ' A' ' 37' ' ' LEU . 15.5 mt -53.66 170.68 0.11 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.853 -1.155 . . . . 0.0 110.248 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.8 m -57.82 166.2 1.51 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.207 -0.933 . . . . 0.0 110.412 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.44 -22.28 66.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.301 -0.874 . . . . 0.0 110.245 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.7 m -139.0 53.05 1.76 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.267 -0.896 . . . . 0.0 110.075 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.44 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 11.3 t80 -65.3 141.16 58.7 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.365 -0.834 . . . . 0.0 110.184 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.418 ' HA ' ' O ' ' A' ' 48' ' ' SER . 8.9 mtt -114.33 147.97 38.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.354 -0.841 . . . . 0.0 109.348 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.401 ' HB2' ' OG ' ' A' ' 48' ' ' SER . 23.9 t -60.48 138.36 92.45 Favored Pre-proline 0 C--N 1.3 -1.552 0 O-C-N 121.278 -0.889 . . . . 0.0 110.582 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -78.79 3.14 7.59 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.643 1.338 . . . . 0.0 110.661 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -124.57 -35.83 2.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.913 -1.117 . . . . 0.0 110.782 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.468 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 1.2 p -124.66 4.62 8.21 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.989 -1.069 . . . . 0.0 111.334 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.44 18.87 7.24 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.163 -0.961 . . . . 0.0 112.478 178.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 42' ' ' MET . 26.3 p -71.51 162.0 75.36 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 120.573 -1.329 . . . . 0.0 109.507 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.406 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 43.5 Cg_endo -70.4 144.86 51.81 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.596 1.314 . . . . 0.0 110.625 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.501 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 3.8 tttm -51.48 -31.23 22.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.219 -0.925 . . . . 0.0 110.496 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -65.25 -13.11 57.56 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.05 -1.032 . . . . 0.0 109.783 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.425 ' NE2' ' HB2' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -84.79 -5.22 59.32 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.12 -0.988 . . . . 0.0 109.762 178.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.429 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 21.5 m-85 -84.25 152.78 23.98 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.255 -0.903 . . . . 0.0 109.582 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.7 ttpp -142.57 131.55 23.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.175 -0.953 . . . . 0.0 110.034 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.52 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 9.1 p -59.88 172.42 0.75 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.158 -0.964 . . . . 0.0 110.444 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.826 HG22 ' O ' ' A' ' 7' ' ' LYS . 2.6 tt . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.572 0.701 . . . . 0.0 109.898 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.2 mttt . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.108 0.48 . . . . 0.0 109.828 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.519 ' CE2' ' HB2' ' A' ' 55' ' ' SER . 27.1 m-85 -130.31 143.66 50.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.029 -1.044 . . . . 0.0 110.473 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.638 ' HA ' HD13 ' A' ' 16' ' ' ILE . 2.8 tm-20 -111.78 134.54 53.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.383 -0.823 . . . . 0.0 109.8 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.2 t -77.61 113.64 15.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.227 -0.921 . . . . 0.0 110.446 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -70.44 -11.23 60.78 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.182 -0.949 . . . . 0.0 109.556 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.99 -40.42 16.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.894 . . . . 0.0 111.579 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.471 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 12.5 p -124.18 -32.07 3.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.728 -1.232 . . . . 0.0 111.553 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.13 22.03 6.38 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.516 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 56.7 t80 -83.18 169.02 16.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.282 -1.128 . . . . 0.0 109.871 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.638 HD13 ' HA ' ' A' ' 9' ' ' GLU . 40.9 mm -134.06 115.32 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.058 -1.026 . . . . 0.0 110.68 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.503 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 69.5 t80 -78.88 136.8 37.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.335 -0.853 . . . . 0.0 109.898 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -117.75 112.61 38.59 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.482 -0.761 . . . . 0.0 109.801 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.491 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 37.7 Cg_endo -69.82 -63.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.442 1.233 . . . . 0.0 110.558 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -47.46 -25.47 1.08 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.691 -0.631 . . . . 0.0 110.635 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.56 -42.24 7.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 0.0 110.675 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.55 153.31 29.59 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.489 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 0.9 OUTLIER -85.12 60.44 6.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.369 -1.077 . . . . 0.0 109.975 179.762 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.99 -25.81 0.88 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.443 -0.786 . . . . 0.0 110.948 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.83 -20.95 41.3 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.179 -0.951 . . . . 0.0 110.318 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.489 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -104.39 -29.82 10.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.119 -0.988 . . . . 0.0 110.295 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 124.52 34.07 0.73 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.435 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 4.6 mt -128.73 125.65 23.09 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.162 -1.199 . . . . 0.0 109.712 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.86 173.26 14.3 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.468 1.246 . . . . 0.0 110.575 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.66 -163.79 0.13 Allowed 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.77 1.405 . . . . 0.0 109.913 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 48.72 25.72 5.01 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.5 m -125.84 115.68 24.43 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.295 -1.121 . . . . 0.0 109.979 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.725 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.6 Cg_endo -72.64 149.71 49.5 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.448 1.236 . . . . 0.0 110.894 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.685 ' CD1' HD12 ' A' ' 37' ' ' LEU . 60.4 t80 -54.97 -25.88 32.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.425 -0.797 . . . . 0.0 110.342 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.725 HG22 ' HB2' ' A' ' 33' ' ' PRO . 25.0 m -70.13 -24.23 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.11 -0.993 . . . . 0.0 110.304 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.407 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 3.0 t70 -87.5 -6.12 58.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.181 -0.949 . . . . 0.0 110.758 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.685 HD12 ' CD1' ' A' ' 34' ' ' PHE . 20.3 mt -52.19 160.54 0.76 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.043 -1.036 . . . . 0.0 110.282 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.87 150.78 19.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -0.897 . . . . 0.0 109.981 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -56.04 -25.39 44.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.254 -0.904 . . . . 0.0 110.313 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.34 38.34 4.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.122 -0.986 . . . . 0.0 110.709 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.453 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 36.4 t80 -59.34 133.45 56.1 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.043 -1.036 . . . . 0.0 109.793 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 13.8 mtp -109.98 155.79 21.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.367 -0.833 . . . . 0.0 109.5 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 30.6 t -71.78 131.8 85.62 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.15 -0.969 . . . . 0.0 110.213 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -75.41 -2.18 12.24 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.585 1.308 . . . . 0.0 110.513 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -112.91 -32.5 6.37 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.055 -1.028 . . . . 0.0 110.403 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.471 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 1.3 p -133.61 7.78 3.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.075 -1.016 . . . . 0.0 111.178 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 58.75 13.65 2.79 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.175 -0.953 . . . . 0.0 112.935 177.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.9 m -68.37 163.12 55.87 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 120.604 -1.31 . . . . 0.0 110.052 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.405 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 46.6 Cg_endo -72.6 143.59 38.33 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.699 1.368 . . . . 0.0 110.431 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.5 ' HE2' ' CE2' ' A' ' 34' ' ' PHE . 9.8 tttm -49.97 -26.39 4.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.039 -1.038 . . . . 0.0 110.666 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -66.64 -12.07 56.49 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.124 -0.985 . . . . 0.0 110.006 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -86.27 -4.56 59.19 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.169 -0.957 . . . . 0.0 110.174 179.237 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.464 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 44.1 m-85 -84.25 144.44 28.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.945 -1.097 . . . . 0.0 110.44 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.0 ttmm -124.56 119.19 28.37 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.365 -0.834 . . . . 0.0 109.535 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.519 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 3.7 t -50.95 177.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.058 -1.026 . . . . 0.0 110.573 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.1 pt . . . . . 0 C--N 1.297 -1.681 0 O-C-N 121.653 -0.654 . . . . 0.0 110.012 179.721 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.516 ' O ' HG22 ' A' ' 56' ' ' ILE . 6.1 tttp . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.529 ' CE2' ' CD2' ' A' ' 34' ' ' PHE . 11.5 m-85 -112.28 155.27 24.34 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.981 -1.074 . . . . 0.0 110.602 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 8.3 tt0 -122.29 130.74 53.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.462 -0.774 . . . . 0.0 109.827 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 t -73.35 114.67 11.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.096 -1.002 . . . . 0.0 110.373 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.71 -12.68 61.71 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.371 -0.931 . . . . 0.0 109.36 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.488 ' HB2' ' NE2' ' A' ' 52' ' ' GLN . . . -85.03 -41.01 16.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.343 -0.848 . . . . 0.0 111.758 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.438 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 11.4 p -123.53 -28.58 3.89 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.583 -1.323 . . . . 0.0 111.795 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.71 20.06 8.76 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.226 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.804 ' C ' HD12 ' A' ' 16' ' ' ILE . 35.8 t80 -83.0 159.54 22.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.135 -1.215 . . . . 0.0 109.867 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.804 HD12 ' C ' ' A' ' 15' ' ' TYR . 2.9 mp -121.82 120.36 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.91 . . . . 0.0 109.835 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.488 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 61.4 t80 -84.12 138.0 33.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.908 . . . . 0.0 110.376 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.97 110.62 45.88 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.738 -0.601 . . . . 0.0 109.911 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.474 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 38.7 Cg_endo -72.89 -65.06 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.494 1.26 . . . . 0.0 111.088 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.426 ' O ' ' CB ' ' A' ' 30' ' ' PRO . 3.3 tt0 -45.48 -25.44 0.43 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.692 -0.63 . . . . 0.0 111.374 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.54 -41.84 7.57 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.094 -1.004 . . . . 0.0 110.65 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.26 145.96 19.75 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.539 ' HB3' HD12 ' A' ' 28' ' ' ILE . 22.4 t0 -85.09 63.23 7.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.335 -1.097 . . . . 0.0 109.676 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -43.64 -27.64 0.32 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.725 -0.61 . . . . 0.0 111.254 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -71.85 -29.1 64.04 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.154 -0.966 . . . . 0.0 109.924 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.494 ' HB3' HD12 ' A' ' 28' ' ' ILE . . . -96.82 -27.53 14.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.411 -0.805 . . . . 0.0 110.048 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.26 25.86 2.84 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.539 HD12 ' HB3' ' A' ' 23' ' ' ASP . 5.8 mt -114.6 120.27 38.08 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.074 -1.251 . . . . 0.0 110.001 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.426 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 45.4 Cg_endo -70.74 174.01 10.99 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.534 1.281 . . . . 0.0 110.509 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.426 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 47.6 Cg_endo -70.95 -163.28 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.715 1.376 . . . . 0.0 110.112 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 50.3 24.88 7.53 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 91.9 m -126.0 113.32 24.27 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.092 -1.24 . . . . 0.0 110.295 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.777 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.2 Cg_endo -72.1 149.68 52.72 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 O-C-N 123.532 1.28 . . . . 0.0 110.619 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.529 ' CD2' ' CE2' ' A' ' 8' ' ' TYR . 27.3 t80 -52.38 -28.67 20.58 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.371 -0.831 . . . . 0.0 109.957 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.777 HG22 ' HB2' ' A' ' 33' ' ' PRO . 24.8 m -70.23 -15.41 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.285 -0.884 . . . . 0.0 110.557 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -98.32 -6.43 30.91 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.025 -1.047 . . . . 0.0 110.752 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.438 HD21 ' CZ ' ' A' ' 17' ' ' TYR . 27.2 mt -51.25 162.28 0.34 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.956 -1.09 . . . . 0.0 110.461 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.3 m -50.31 154.8 1.14 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.347 -0.846 . . . . 0.0 110.508 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.19 -24.03 66.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.286 -0.884 . . . . 0.0 110.1 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.2 t -127.91 38.41 4.03 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.236 -0.915 . . . . 0.0 110.205 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.457 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 45.7 t80 -54.98 138.03 44.62 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.297 -0.877 . . . . 0.0 110.263 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.3 mmt -113.74 135.82 53.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.291 -0.881 . . . . 0.0 109.74 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 24.4 t -53.79 133.03 56.82 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.249 -0.907 . . . . 0.0 110.585 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -75.06 -3.69 14.29 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.447 1.235 . . . . 0.0 110.506 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -112.17 -35.65 5.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.033 -1.042 . . . . 0.0 110.559 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.438 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 1.5 p -128.57 6.51 5.69 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.087 -1.008 . . . . 0.0 111.01 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 54.46 20.07 2.63 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.209 -0.932 . . . . 0.0 112.714 178.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.0 m -74.27 165.68 51.33 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 120.617 -1.302 . . . . 0.0 109.658 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.51 136.06 30.11 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.638 1.336 . . . . 0.0 110.177 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 41' ' ' PHE . 14.5 tttm -48.32 -26.01 1.83 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.2 -0.938 . . . . 0.0 110.697 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -63.69 -15.07 57.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.167 -0.958 . . . . 0.0 109.822 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.488 ' NE2' ' HB2' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -85.13 -2.97 58.62 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.255 -0.903 . . . . 0.0 110.136 179.381 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 34' ' ' PHE . 11.3 m-85 -82.75 133.16 35.15 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.95 -1.094 . . . . 0.0 110.478 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.91 120.33 38.12 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.197 -0.939 . . . . 0.0 109.527 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 3.0 t -52.0 -178.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.338 -0.851 . . . . 0.0 110.625 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.59 HG23 ' O ' ' A' ' 56' ' ' ILE . 3.0 tt . . . . . 0 C--N 1.3 -1.575 0 O-C-N 121.531 -0.731 . . . . 0.0 109.691 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.69 ' HB3' HD11 ' A' ' 56' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.152 0.501 . . . . 0.0 109.951 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.505 ' CE2' ' HB2' ' A' ' 55' ' ' SER . 22.9 m-85 -117.0 149.1 40.8 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.148 -0.97 . . . . 0.0 110.381 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.466 ' HA ' HD13 ' A' ' 16' ' ' ILE . 1.2 tm-20 -119.16 130.06 55.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 0.0 110.323 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.6 t -73.62 114.72 12.2 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.274 -0.891 . . . . 0.0 110.25 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -70.4 -11.39 60.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.071 -1.018 . . . . 0.0 109.624 178.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.09 -42.29 14.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.397 -0.814 . . . . 0.0 111.579 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.466 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 13.8 p -121.88 -31.04 4.0 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.709 -1.245 . . . . 0.0 111.418 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.65 23.0 6.73 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.427 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 44.6 t80 -82.31 159.25 23.15 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.34 -1.094 . . . . 0.0 109.517 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.466 HD13 ' HA ' ' A' ' 9' ' ' GLU . 41.3 mm -123.77 115.77 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.205 -0.934 . . . . 0.0 110.041 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.535 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 81.1 t80 -81.44 135.81 35.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.3 -0.875 . . . . 0.0 110.321 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -114.94 114.33 43.92 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.529 -0.732 . . . . 0.0 109.603 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.481 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 37.7 Cg_endo -69.44 -67.04 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.531 1.28 . . . . 0.0 111.559 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -43.04 -28.0 0.24 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.739 -0.601 . . . . 0.0 111.225 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.4 tptt -96.8 -27.13 14.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.159 -0.963 . . . . 0.0 110.271 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.62 159.58 30.52 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.55 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 1.0 OUTLIER -85.05 59.86 5.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.339 -1.095 . . . . 0.0 109.81 179.799 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -46.51 -26.51 0.89 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.406 -0.809 . . . . 0.0 110.613 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -76.01 -28.01 57.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 110.061 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.55 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -97.71 -27.45 14.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.304 -0.872 . . . . 0.0 110.192 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.16 22.67 2.58 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.5 HD12 ' HB3' ' A' ' 23' ' ' ASP . 5.0 mt -112.18 130.01 23.72 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 120.975 -1.309 . . . . 0.0 109.595 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.416 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 49.1 Cg_endo -74.38 173.48 14.17 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.483 1.254 . . . . 0.0 110.393 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.416 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 49.9 Cg_endo -71.68 -163.54 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.65 1.342 . . . . 0.0 110.065 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 51.17 32.98 29.68 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.794 -1.323 . . . . 0.0 109.794 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 93.8 m -137.63 122.03 12.1 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.209 -1.171 . . . . 0.0 110.064 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.77 ' HB2' HG22 ' A' ' 35' ' ' VAL . 50.1 Cg_endo -76.32 151.84 34.19 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.547 1.288 . . . . 0.0 110.697 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.535 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 20.7 t80 -52.26 -33.25 40.86 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.305 -0.872 . . . . 0.0 109.84 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.77 HG22 ' HB2' ' A' ' 33' ' ' PRO . 33.3 m -64.69 -15.11 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.921 . . . . 0.0 110.506 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.53 -18.29 33.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.15 -0.968 . . . . 0.0 110.559 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.487 HD11 ' CE1' ' A' ' 17' ' ' TYR . 71.0 mt -51.81 146.45 8.13 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.046 -1.034 . . . . 0.0 110.29 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.93 160.0 0.36 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.194 -0.942 . . . . 0.0 110.519 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -66.83 -13.88 62.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -0.897 . . . . 0.0 110.624 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.6 t -122.11 25.5 9.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.023 -1.048 . . . . 0.0 110.365 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.463 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 25.4 t80 -54.81 135.22 47.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.131 -0.981 . . . . 0.0 109.871 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -109.42 150.66 27.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.369 -0.832 . . . . 0.0 109.58 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 18.1 t -66.38 134.76 94.62 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.113 -0.992 . . . . 0.0 110.347 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.71 -7.85 18.82 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.667 1.351 . . . . 0.0 110.185 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -110.19 -31.92 7.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.172 -0.955 . . . . 0.0 110.844 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.466 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.8 OUTLIER -134.49 7.31 3.57 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.021 -1.049 . . . . 0.0 111.353 -179.681 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 58.49 14.56 3.07 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.098 -1.001 . . . . 0.0 112.837 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.5 m -65.45 165.93 16.32 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 120.619 -1.301 . . . . 0.0 110.087 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.99 141.34 26.56 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.666 1.35 . . . . 0.0 110.152 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.463 ' HB2' ' HB3' ' A' ' 41' ' ' PHE . 8.6 tttm -51.87 -26.21 9.61 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.215 -0.928 . . . . 0.0 110.261 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -68.53 -11.17 59.52 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.185 -0.947 . . . . 0.0 109.89 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.88 -2.35 58.55 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.175 -0.953 . . . . 0.0 110.076 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.412 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 17.9 m-85 -86.25 140.01 30.51 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.999 -1.063 . . . . 0.0 110.226 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.61 124.89 46.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.2 -0.938 . . . . 0.0 109.801 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.527 ' C ' HG23 ' A' ' 56' ' ' ILE . 3.0 t -57.28 178.34 0.07 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.237 -0.914 . . . . 0.0 110.809 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.69 HD11 ' HB3' ' A' ' 7' ' ' LYS . 1.1 pt . . . . . 0 N--CA 1.494 1.747 0 O-C-N 121.828 -0.545 . . . . 0.0 109.832 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.43 ' O ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.52 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 7.8 m-85 -115.77 156.42 26.04 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.075 -1.015 . . . . 0.0 110.566 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.529 ' HA ' HD13 ' A' ' 16' ' ' ILE . 2.5 pp20? -126.43 136.26 52.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.367 -0.833 . . . . 0.0 110.168 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.0 t -78.25 111.84 14.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.945 . . . . 0.0 110.242 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.69 -10.83 59.82 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.204 -0.998 . . . . 0.0 109.426 178.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.68 -43.01 14.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.352 -0.843 . . . . 0.0 111.383 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.46 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 12.7 p -120.5 -31.66 4.26 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.632 -1.292 . . . . 0.0 111.273 -179.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.6 21.5 6.8 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.684 -1.246 . . . . 0.0 110.132 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.525 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 52.2 t80 -83.18 167.38 17.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.109 -1.23 . . . . 0.0 109.907 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.529 HD13 ' HA ' ' A' ' 9' ' ' GLU . 36.5 mm -131.11 117.67 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.137 -0.977 . . . . 0.0 110.334 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.503 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 72.7 t80 -81.04 135.31 35.82 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.436 -0.79 . . . . 0.0 110.422 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -112.38 113.7 50.98 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.612 -0.68 . . . . 0.0 109.761 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.47 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 39.0 Cg_endo -72.26 -68.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.414 1.218 . . . . 0.0 111.144 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -45.16 -26.63 0.5 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.581 -0.699 . . . . 0.0 111.2 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.99 -37.57 11.07 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.079 -1.013 . . . . 0.0 110.49 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.63 152.09 28.84 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.549 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 4.2 t0 -85.11 62.9 7.8 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.4 -1.059 . . . . 0.0 109.674 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.43 -27.37 0.44 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.647 -0.658 . . . . 0.0 111.03 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -77.22 -27.86 53.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.184 -0.947 . . . . 0.0 110.206 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.549 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -95.85 -28.83 14.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.251 -0.906 . . . . 0.0 110.362 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.08 11.55 5.21 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.815 -1.183 . . . . 0.0 110.296 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.422 HD12 ' HB3' ' A' ' 23' ' ' ASP . 4.6 mt -103.08 124.61 37.84 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 120.938 -1.33 . . . . 0.0 110.012 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.423 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 45.3 Cg_endo -71.91 173.74 12.31 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.468 1.246 . . . . 0.0 110.222 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.423 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 48.6 Cg_endo -70.19 -163.77 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.613 1.323 . . . . 0.0 110.252 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 49.94 27.17 9.52 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.4 m -128.12 116.51 20.33 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.333 -1.098 . . . . 0.0 110.279 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.842 ' HB2' HG22 ' A' ' 35' ' ' VAL . 49.0 Cg_endo -73.55 150.33 45.58 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.53 1.279 . . . . 0.0 110.617 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.503 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 12.7 t80 -53.49 -29.53 36.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.413 -0.804 . . . . 0.0 109.979 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.842 HG22 ' HB2' ' A' ' 33' ' ' PRO . 35.3 m -67.22 -13.2 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 110.608 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.6 -4.03 38.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.069 -1.02 . . . . 0.0 110.93 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.458 ' HA ' HD23 ' A' ' 37' ' ' LEU . 28.1 mt -53.13 165.61 0.31 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.872 -1.142 . . . . 0.0 110.14 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.0 m -59.36 162.48 4.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.889 . . . . 0.0 110.279 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.36 -27.42 69.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.311 -0.868 . . . . 0.0 110.2 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.65 46.31 2.5 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.263 -0.898 . . . . 0.0 110.042 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.438 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 23.9 t80 -62.58 140.2 58.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.334 -0.854 . . . . 0.0 110.159 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 36.5 mtt -112.61 151.08 30.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.358 -0.839 . . . . 0.0 109.468 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 29.4 t -65.69 135.46 95.6 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.178 -0.951 . . . . 0.0 110.268 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -75.87 -0.02 9.76 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.503 1.265 . . . . 0.0 110.594 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -119.39 -38.77 2.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.01 -1.056 . . . . 0.0 110.825 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.46 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 1.4 p -123.12 8.16 9.2 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.025 -1.047 . . . . 0.0 111.13 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 27.3 mtt85 54.5 18.84 2.12 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.332 -0.855 . . . . 0.0 112.79 178.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.5 m -72.52 166.3 43.43 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 120.577 -1.327 . . . . 0.0 109.732 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.408 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 45.2 Cg_endo -71.98 139.9 33.84 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.668 1.352 . . . . 0.0 110.387 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.499 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 9.6 tttm -48.98 -26.33 2.46 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.162 -0.961 . . . . 0.0 110.822 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -63.65 -14.9 56.22 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.127 -0.983 . . . . 0.0 109.862 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -83.87 -4.2 58.49 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.157 -0.965 . . . . 0.0 110.151 179.277 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -86.23 131.81 34.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.977 -1.077 . . . . 0.0 110.348 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.41 ' O ' ' HG3' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -117.99 131.74 56.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.272 -0.893 . . . . 0.0 109.544 179.28 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.653 ' O ' HG23 ' A' ' 56' ' ' ILE . 79.7 p -60.82 176.86 0.36 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.156 -0.965 . . . . 0.0 110.893 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.653 HG23 ' O ' ' A' ' 55' ' ' SER . 9.9 pt . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 121.362 0.601 . . . . 0.0 109.699 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.431 ' O ' ' CG1' ' A' ' 56' ' ' ILE . 4.3 mmtt . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.587 ' CE2' ' CD2' ' A' ' 34' ' ' PHE . 7.5 m-85 -112.26 145.11 40.55 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.156 -0.965 . . . . 0.0 110.625 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 3.1 tt0 -115.12 135.74 53.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.404 -0.81 . . . . 0.0 109.995 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.9 t -75.24 113.46 12.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.23 -0.919 . . . . 0.0 110.573 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -11.28 60.79 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.449 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.484 ' HB2' ' NE2' ' A' ' 52' ' ' GLN . . . -85.14 -40.26 16.94 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.312 -0.867 . . . . 0.0 111.484 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.462 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 12.6 p -123.95 -32.51 3.26 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.683 -1.26 . . . . 0.0 111.484 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.55 21.71 6.37 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.851 ' C ' HD12 ' A' ' 16' ' ' ILE . 46.6 t80 -83.56 162.3 20.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -1.123 . . . . 0.0 109.74 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.851 HD12 ' C ' ' A' ' 15' ' ' TYR . 2.1 mp -123.51 116.39 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 0.0 109.939 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.504 ' OH ' HD21 ' A' ' 37' ' ' LEU . 78.3 t80 -82.86 127.87 33.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.164 -0.96 . . . . 0.0 110.15 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -106.4 111.08 64.25 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.698 -0.626 . . . . 0.0 109.614 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.474 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 38.1 Cg_endo -70.28 -63.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.525 1.276 . . . . 0.0 110.806 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -46.8 -26.05 0.88 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.73 -0.606 . . . . 0.0 110.558 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -95.29 -31.16 13.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -0.924 . . . . 0.0 110.041 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.69 153.59 21.68 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.728 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -85.19 60.85 6.5 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.395 -1.062 . . . . 0.0 109.431 179.473 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -46.84 -26.76 1.04 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.536 -0.727 . . . . 0.0 110.682 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -81.14 -22.49 38.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.175 -0.953 . . . . 0.0 110.207 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.728 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -100.08 -27.61 13.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.229 -0.919 . . . . 0.0 110.012 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.51 28.98 1.36 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.573 HD13 ' CD2' ' A' ' 37' ' ' LEU . 5.4 mt -125.14 123.58 25.34 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.013 -1.286 . . . . 0.0 109.707 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.42 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 44.0 Cg_endo -70.0 173.47 11.14 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.525 1.276 . . . . 0.0 110.238 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 47.2 Cg_endo -69.99 -163.72 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.674 1.355 . . . . 0.0 110.233 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 49.04 26.0 5.7 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.6 m -125.34 121.11 24.97 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.272 -1.134 . . . . 0.0 110.257 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.653 ' HB2' HG22 ' A' ' 35' ' ' VAL . 50.3 Cg_endo -76.41 158.16 36.69 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.477 1.251 . . . . 0.0 110.651 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.587 ' CD2' ' CE2' ' A' ' 8' ' ' TYR . 13.6 t80 -61.04 -34.18 74.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.349 -0.844 . . . . 0.0 109.945 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.653 HG22 ' HB2' ' A' ' 33' ' ' PRO . 26.8 m -65.51 -12.93 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.908 . . . . 0.0 110.529 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.57 -9.17 36.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.025 -1.047 . . . . 0.0 110.817 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.573 ' CD2' HD13 ' A' ' 28' ' ' ILE . 49.8 mt -53.85 156.07 3.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.0 -1.063 . . . . 0.0 110.185 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.9 t -52.56 147.78 7.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.168 -0.958 . . . . 0.0 110.255 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.64 -23.14 10.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 110.214 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 72.3 p -123.71 47.5 2.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.908 . . . . 0.0 110.487 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.465 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 27.7 t80 -70.56 145.63 50.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.164 -0.96 . . . . 0.0 109.835 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.411 ' HA ' ' O ' ' A' ' 48' ' ' SER . 28.3 mtm -121.11 138.02 54.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.293 -0.88 . . . . 0.0 109.994 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 27.5 t -54.68 133.81 64.8 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.368 -0.832 . . . . 0.0 110.235 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -76.33 -0.68 10.64 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.485 1.255 . . . . 0.0 110.627 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.72 -42.56 3.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.98 -1.075 . . . . 0.0 110.473 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.462 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 1.7 p -119.75 5.63 10.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.106 -0.996 . . . . 0.0 111.121 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 54.57 24.82 5.7 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.256 -0.902 . . . . 0.0 112.64 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 42' ' ' MET . 5.8 m -79.29 166.02 44.56 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 120.578 -1.327 . . . . 0.0 109.599 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.4 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 43.8 Cg_endo -70.37 140.89 41.4 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.567 1.299 . . . . 0.0 110.75 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.509 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 23.8 tttt -50.58 -24.66 3.4 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.21 -0.931 . . . . 0.0 110.55 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -66.01 -13.41 59.83 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.08 -1.013 . . . . 0.0 109.933 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.484 ' NE2' ' HB2' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -85.05 -4.34 59.12 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.203 -0.936 . . . . 0.0 110.006 179.347 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -85.5 137.31 32.98 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.956 -1.09 . . . . 0.0 110.526 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.8 tttm -123.48 133.51 54.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.625 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.634 ' O ' HG23 ' A' ' 56' ' ' ILE . 68.6 p -62.11 175.56 0.69 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.177 -0.952 . . . . 0.0 110.888 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.634 HG23 ' O ' ' A' ' 55' ' ' SER . 7.4 pt . . . . . 0 N--CA 1.497 1.89 0 CA-C-O 121.334 0.588 . . . . 0.0 110.079 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.405 ' O ' ' CG1' ' A' ' 56' ' ' ILE . 20.1 mttt . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.525 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 9.1 m-85 -112.26 150.09 31.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.115 -0.991 . . . . 0.0 110.432 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 43.7 tt0 -120.35 138.49 53.7 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.337 -0.852 . . . . 0.0 110.564 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.1 t -77.23 111.06 12.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.321 -0.862 . . . . 0.0 110.3 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -68.02 -11.23 58.53 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.36 -0.936 . . . . 0.0 109.568 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.36 -42.06 16.11 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.296 -0.878 . . . . 0.0 111.52 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.453 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 14.5 p -121.86 -34.75 3.31 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.707 -1.246 . . . . 0.0 111.498 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.06 22.08 5.06 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.452 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 29.5 t80 -84.27 158.82 21.1 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.308 -1.113 . . . . 0.0 109.804 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.442 ' N ' ' CD1' ' A' ' 15' ' ' TYR . 29.3 mm -122.5 120.04 59.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.318 -0.864 . . . . 0.0 110.267 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.5 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 80.6 t80 -83.25 130.03 35.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.909 . . . . 0.0 109.97 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -109.95 114.76 55.95 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.583 -0.698 . . . . 0.0 109.484 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.478 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 37.8 Cg_endo -69.95 -68.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.529 1.279 . . . . 0.0 111.225 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -46.27 -25.48 0.63 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.476 -0.765 . . . . 0.0 111.175 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.66 -39.22 11.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.113 -0.992 . . . . 0.0 110.882 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.41 145.68 15.56 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.42 ' HB3' HD12 ' A' ' 28' ' ' ILE . 25.1 t0 -85.09 61.54 6.94 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.345 -1.091 . . . . 0.0 109.937 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.94 -25.92 1.54 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.397 -0.814 . . . . 0.0 110.461 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -75.49 -21.66 57.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.907 . . . . 0.0 110.092 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -105.56 -34.4 7.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.288 -0.883 . . . . 0.0 109.887 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 131.18 34.11 0.43 Allowed Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.892 -1.147 . . . . 0.0 110.361 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.52 HD13 ' CD2' ' A' ' 37' ' ' LEU . 5.2 mt -129.85 121.65 20.05 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 120.807 -1.408 . . . . 0.0 109.988 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.411 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 45.0 Cg_endo -70.13 173.93 10.58 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 O-C-N 123.613 1.323 . . . . 0.0 110.265 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 45.4 Cg_endo -68.59 -163.78 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.616 1.324 . . . . 0.0 110.176 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 47.76 27.79 4.91 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 15.4 m -125.75 113.9 24.81 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.218 -1.166 . . . . 0.0 110.344 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.718 ' HB2' HG22 ' A' ' 35' ' ' VAL . 45.9 Cg_endo -73.31 146.92 41.02 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 123.472 1.248 . . . . 0.0 110.738 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.5 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 22.7 t80 -51.41 -34.02 32.94 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.433 -0.792 . . . . 0.0 110.561 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.718 HG22 ' HB2' ' A' ' 33' ' ' PRO . 30.0 m -65.75 -14.04 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.202 -0.936 . . . . 0.0 110.723 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.416 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 36.0 t0 -98.32 -1.61 41.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.998 -1.063 . . . . 0.0 110.996 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.52 ' CD2' HD13 ' A' ' 28' ' ' ILE . 26.0 mt -54.38 176.37 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.903 -1.123 . . . . 0.0 110.17 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.9 m -69.36 152.98 44.3 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.235 -0.916 . . . . 0.0 110.123 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.65 -23.28 40.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.161 -0.962 . . . . 0.0 110.216 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.4 m -129.28 43.52 3.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.167 -0.958 . . . . 0.0 110.27 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.462 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 20.0 t80 -62.89 132.65 52.83 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.377 -0.827 . . . . 0.0 109.85 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.409 ' HA ' ' O ' ' A' ' 48' ' ' SER . 7.0 mtt -111.33 148.19 33.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.376 -0.827 . . . . 0.0 109.668 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.437 ' HB3' ' N ' ' A' ' 47' ' ' ARG . 10.0 t -57.99 135.23 83.83 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.897 . . . . 0.0 110.422 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -76.12 -0.34 10.21 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 123.628 1.331 . . . . 0.0 110.578 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -122.88 -38.97 2.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.943 -1.098 . . . . 0.0 110.859 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.453 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -121.24 8.03 10.27 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.038 -1.039 . . . . 0.0 111.202 -179.62 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.437 ' N ' ' HB3' ' A' ' 43' ' ' CYS . 2.5 ttt180 58.37 13.84 2.62 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.183 -0.948 . . . . 0.0 112.786 178.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.409 ' O ' ' HA ' ' A' ' 42' ' ' MET . 1.3 m -63.63 156.81 69.9 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 120.594 -1.316 . . . . 0.0 109.714 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.403 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 46.8 Cg_endo -72.77 146.54 43.07 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.665 1.35 . . . . 0.0 110.183 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 41' ' ' PHE . 19.5 tttm -53.74 -27.19 26.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.022 -1.049 . . . . 0.0 110.235 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -67.98 -11.29 58.57 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.176 -0.952 . . . . 0.0 109.827 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -88.65 -2.67 58.72 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.21 -0.931 . . . . 0.0 110.016 179.205 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -89.9 126.06 35.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.012 -1.055 . . . . 0.0 110.348 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.2 tptt -108.8 134.13 51.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.209 -0.932 . . . . 0.0 109.739 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.525 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 80.0 p -63.72 179.46 0.49 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.121 -0.987 . . . . 0.0 110.761 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.491 HG23 ' C ' ' A' ' 55' ' ' SER . 1.1 pt . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.271 0.557 . . . . 0.0 110.157 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.427 ' CB ' HG12 ' A' ' 56' ' ' ILE . 29.2 mttt . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.514 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 13.4 m-85 -122.7 148.04 45.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.037 -1.039 . . . . 0.0 110.628 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 5.1 tm-20 -120.02 128.08 53.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.414 -0.804 . . . . 0.0 109.906 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.4 t -65.31 110.07 2.48 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.161 -0.962 . . . . 0.0 110.059 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.91 -11.92 57.77 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.206 -0.934 . . . . 0.0 109.612 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.445 ' HB2' ' NE2' ' A' ' 52' ' ' GLN . . . -85.01 -40.46 16.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.327 -0.858 . . . . 0.0 111.782 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 11.7 p -123.95 -32.71 3.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.647 -1.283 . . . . 0.0 111.523 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.09 18.9 6.57 Favored Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.713 -1.232 . . . . 0.0 110.256 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.529 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 42.7 t80 -76.28 167.98 20.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -1.175 . . . . 0.0 109.516 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.529 ' N ' ' CD1' ' A' ' 15' ' ' TYR . 35.1 mm -130.82 120.26 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 110.424 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.474 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 51.5 t80 -89.36 142.5 27.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.325 -0.86 . . . . 0.0 109.966 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -123.69 112.49 29.11 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.544 -0.723 . . . . 0.0 109.829 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.523 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 40.4 Cg_endo -72.2 -67.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.516 1.272 . . . . 0.0 111.284 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -44.22 -28.0 0.47 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.794 -0.566 . . . . 0.0 110.922 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.7 mttp -96.15 -40.06 9.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 0.0 110.24 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.29 147.85 22.53 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.481 ' HB3' HD12 ' A' ' 28' ' ' ILE . 2.8 t0 -84.94 61.11 6.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.465 -1.021 . . . . 0.0 109.65 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -45.49 -27.08 0.67 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.444 -0.785 . . . . 0.0 110.955 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -74.69 -27.43 60.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.115 -0.99 . . . . 0.0 109.975 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.462 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -98.48 -22.83 15.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.346 -0.846 . . . . 0.0 109.9 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.12 23.23 3.94 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.481 HD12 ' HB3' ' A' ' 23' ' ' ASP . 9.2 mt -115.26 114.57 43.07 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.117 -1.225 . . . . 0.0 109.907 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.409 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 43.0 Cg_endo -68.91 173.9 9.54 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 O-C-N 123.597 1.314 . . . . 0.0 110.294 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 44.9 Cg_endo -67.89 -164.43 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.57 1.3 . . . . 0.0 110.024 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 48.19 34.02 11.83 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 m -134.48 109.35 11.24 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.121 -1.223 . . . . 0.0 110.52 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.879 ' HB2' HG22 ' A' ' 35' ' ' VAL . 44.6 Cg_endo -71.8 148.72 52.81 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.455 1.24 . . . . 0.0 110.344 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.532 ' CD1' HD12 ' A' ' 37' ' ' LEU . 38.8 t80 -52.92 -24.23 8.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.204 -0.935 . . . . 0.0 109.861 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.879 HG22 ' HB2' ' A' ' 33' ' ' PRO . 32.1 m -72.27 -17.49 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.169 -0.957 . . . . 0.0 110.201 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.68 0.6 47.4 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.183 -0.948 . . . . 0.0 110.708 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.532 HD12 ' CD1' ' A' ' 34' ' ' PHE . 21.8 mt -52.23 167.33 0.13 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.947 -1.095 . . . . 0.0 110.182 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.3 m -56.53 173.31 0.19 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 110.257 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.05 -27.62 65.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.33 -0.856 . . . . 0.0 110.211 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 65.9 p -134.13 45.79 2.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 110.345 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.47 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 27.2 t80 -54.26 130.97 40.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.932 . . . . 0.0 109.932 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -108.34 150.01 27.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.427 -0.796 . . . . 0.0 109.43 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.436 ' HB3' ' N ' ' A' ' 47' ' ' ARG . 12.8 t -63.55 135.82 96.43 Favored Pre-proline 0 C--N 1.3 -1.551 0 O-C-N 121.16 -0.963 . . . . 0.0 110.539 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.76 -1.52 11.47 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.589 1.31 . . . . 0.0 110.382 178.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -118.72 -41.57 2.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.052 -1.03 . . . . 0.0 110.867 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -119.81 2.91 11.11 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.121 -0.987 . . . . 0.0 111.141 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.436 ' N ' ' HB3' ' A' ' 43' ' ' CYS . 1.1 ttt-85 58.28 23.36 10.31 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.146 -0.971 . . . . 0.0 112.515 178.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.3 m -75.01 164.94 58.01 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 120.566 -1.333 . . . . 0.0 109.676 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.06 138.98 29.07 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.632 1.333 . . . . 0.0 110.434 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.536 ' HA ' ' CD1' ' A' ' 53' ' ' PHE . 15.9 tttm -48.93 -29.18 4.46 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.271 -0.893 . . . . 0.0 110.821 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -63.09 -14.54 49.66 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.113 -0.992 . . . . 0.0 109.967 179.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.445 ' NE2' ' HB2' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -87.21 -1.39 57.87 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.086 -1.009 . . . . 0.0 110.169 179.416 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.536 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 32.6 m-85 -88.17 127.84 35.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.906 -1.121 . . . . 0.0 110.425 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.18 128.11 55.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 109.587 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.514 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 89.0 p -54.14 -174.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 110.814 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.625 ' O ' HD12 ' A' ' 56' ' ' ILE . 1.3 pp . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.679 -0.638 . . . . 0.0 109.875 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.427 ' CB ' HG12 ' A' ' 56' ' ' ILE . 29.2 mttt . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.514 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 13.4 m-85 -122.7 148.04 45.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.037 -1.039 . . . . 0.0 110.628 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 5.1 tm-20 -120.02 128.08 53.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.414 -0.804 . . . . 0.0 109.906 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.4 t -65.31 110.07 2.48 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.161 -0.962 . . . . 0.0 110.059 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.91 -11.92 57.77 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.206 -0.934 . . . . 0.0 109.612 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.445 ' HB2' ' NE2' ' A' ' 52' ' ' GLN . . . -85.01 -40.46 16.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.327 -0.858 . . . . 0.0 111.782 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 11.7 p -123.95 -32.71 3.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.647 -1.283 . . . . 0.0 111.523 -179.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.09 18.9 6.57 Favored Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.713 -1.232 . . . . 0.0 110.256 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.529 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 42.7 t80 -76.28 167.98 20.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -1.175 . . . . 0.0 109.516 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.529 ' N ' ' CD1' ' A' ' 15' ' ' TYR . 35.1 mm -130.82 120.26 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 110.424 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.474 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 51.5 t80 -89.36 142.5 27.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.325 -0.86 . . . . 0.0 109.966 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -123.69 112.49 29.11 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.544 -0.723 . . . . 0.0 109.829 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.523 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 40.4 Cg_endo -72.2 -67.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.516 1.272 . . . . 0.0 111.284 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -44.22 -28.0 0.47 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.794 -0.566 . . . . 0.0 110.922 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.7 mttp -96.15 -40.06 9.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 0.0 110.24 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.29 147.85 22.53 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.481 ' HB3' HD12 ' A' ' 28' ' ' ILE . 2.8 t0 -84.94 61.11 6.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.465 -1.021 . . . . 0.0 109.65 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -45.49 -27.08 0.67 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.444 -0.785 . . . . 0.0 110.955 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -74.69 -27.43 60.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.115 -0.99 . . . . 0.0 109.975 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.462 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -98.48 -22.83 15.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.346 -0.846 . . . . 0.0 109.9 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.12 23.23 3.94 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.481 HD12 ' HB3' ' A' ' 23' ' ' ASP . 9.2 mt -115.26 114.57 43.07 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.117 -1.225 . . . . 0.0 109.907 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.409 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 43.0 Cg_endo -68.91 173.9 9.54 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 O-C-N 123.597 1.314 . . . . 0.0 110.294 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 44.9 Cg_endo -67.89 -164.43 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.57 1.3 . . . . 0.0 110.024 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 48.19 34.02 11.83 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 m -134.48 109.35 11.24 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.121 -1.223 . . . . 0.0 110.52 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.879 ' HB2' HG22 ' A' ' 35' ' ' VAL . 44.6 Cg_endo -71.8 148.72 52.81 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.455 1.24 . . . . 0.0 110.344 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.532 ' CD1' HD12 ' A' ' 37' ' ' LEU . 38.8 t80 -52.92 -24.23 8.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.204 -0.935 . . . . 0.0 109.861 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.879 HG22 ' HB2' ' A' ' 33' ' ' PRO . 32.1 m -72.27 -17.49 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.169 -0.957 . . . . 0.0 110.201 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.68 0.6 47.4 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.183 -0.948 . . . . 0.0 110.708 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.532 HD12 ' CD1' ' A' ' 34' ' ' PHE . 21.8 mt -52.23 167.33 0.13 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.947 -1.095 . . . . 0.0 110.182 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.3 m -56.53 173.31 0.19 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 110.257 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.05 -27.62 65.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.33 -0.856 . . . . 0.0 110.211 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 65.9 p -134.13 45.79 2.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 110.345 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.47 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 27.2 t80 -54.26 130.97 40.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.932 . . . . 0.0 109.932 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -108.34 150.01 27.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.427 -0.796 . . . . 0.0 109.43 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.436 ' HB3' ' N ' ' A' ' 47' ' ' ARG . 12.8 t -63.55 135.82 96.43 Favored Pre-proline 0 C--N 1.3 -1.551 0 O-C-N 121.16 -0.963 . . . . 0.0 110.539 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.76 -1.52 11.47 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.589 1.31 . . . . 0.0 110.382 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -118.72 -41.57 2.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.052 -1.03 . . . . 0.0 110.867 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -119.81 2.91 11.11 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.121 -0.987 . . . . 0.0 111.141 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.436 ' N ' ' HB3' ' A' ' 43' ' ' CYS . 1.1 ttt-85 58.28 23.36 10.31 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.146 -0.971 . . . . 0.0 112.515 178.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.3 m -75.01 164.94 58.01 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 120.566 -1.333 . . . . 0.0 109.676 179.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.06 138.98 29.07 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.632 1.333 . . . . 0.0 110.434 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.536 ' HA ' ' CD1' ' A' ' 53' ' ' PHE . 15.9 tttm -48.93 -29.18 4.46 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.271 -0.893 . . . . 0.0 110.821 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -63.09 -14.54 49.66 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.113 -0.992 . . . . 0.0 109.967 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.445 ' NE2' ' HB2' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -87.21 -1.39 57.87 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.086 -1.009 . . . . 0.0 110.169 179.416 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.536 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 32.6 m-85 -88.17 127.84 35.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.906 -1.121 . . . . 0.0 110.425 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.18 128.11 55.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 109.587 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.514 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 89.0 p -54.14 -174.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 110.814 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.625 ' O ' HD12 ' A' ' 56' ' ' ILE . 1.3 pp . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.679 -0.638 . . . . 0.0 109.875 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.4 mtpt . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.544 ' HE2' ' HG ' ' A' ' 55' ' ' SER . 30.2 m-85 -115.78 139.26 50.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.034 -1.041 . . . . 0.0 110.789 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 29.8 tt0 -105.56 132.83 51.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.309 -0.87 . . . . 0.0 110.241 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.7 t -75.56 110.33 9.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 0.0 110.121 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.71 -11.92 56.37 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.203 -0.936 . . . . 0.0 109.866 178.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.425 ' HB2' ' NE2' ' A' ' 52' ' ' GLN . . . -85.03 -41.19 16.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -0.92 . . . . 0.0 111.717 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.47 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 13.8 p -122.85 -34.47 3.19 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.604 -1.31 . . . . 0.0 111.454 -179.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.76 21.72 5.29 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.8 ' C ' HD12 ' A' ' 16' ' ' ILE . 24.5 t80 -84.57 158.19 20.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.365 -1.079 . . . . 0.0 109.706 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.8 HD12 ' C ' ' A' ' 15' ' ' TYR . 3.2 mp -123.97 120.17 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.216 -0.928 . . . . 0.0 110.15 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.503 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 66.5 t80 -83.05 137.56 34.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.312 -0.868 . . . . 0.0 110.025 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.426 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 53.5 mt-10 -116.28 110.87 42.72 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.592 -0.693 . . . . 0.0 109.411 179.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.474 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 37.9 Cg_endo -69.42 -71.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.507 1.267 . . . . 0.0 111.151 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.414 ' O ' ' CB ' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -47.4 -24.73 0.85 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.335 -0.853 . . . . 0.0 111.04 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -94.52 -39.27 10.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.973 -1.079 . . . . 0.0 110.48 -179.881 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.16 137.93 9.29 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -85.07 63.73 8.28 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.392 -1.064 . . . . 0.0 109.679 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.96 -28.35 0.25 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.778 -0.576 . . . . 0.0 111.117 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -67.17 -33.62 75.8 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.202 -0.936 . . . . 0.0 109.795 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.53 ' HB3' HD12 ' A' ' 28' ' ' ILE . . . -95.94 -25.53 15.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.303 -0.873 . . . . 0.0 110.09 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.16 25.31 3.28 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.53 HD12 ' HB3' ' A' ' 26' ' ' ALA . 4.7 mt -112.15 118.74 45.48 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.071 -1.252 . . . . 0.0 110.079 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.433 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 45.4 Cg_endo -71.95 174.49 11.16 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 O-C-N 123.541 1.285 . . . . 0.0 110.219 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.433 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 46.8 Cg_endo -69.27 -164.72 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.582 1.306 . . . . 0.0 109.933 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 47.73 26.19 3.88 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 47.9 m -127.45 111.4 21.07 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.136 -1.214 . . . . 0.0 110.038 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.853 ' HB2' HG22 ' A' ' 35' ' ' VAL . 45.0 Cg_endo -71.76 147.56 50.76 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.604 1.318 . . . . 0.0 110.77 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.513 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 47.3 t80 -54.42 -25.74 26.59 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.542 -0.723 . . . . 0.0 110.275 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.853 HG22 ' HB2' ' A' ' 33' ' ' PRO . 34.2 m -71.06 -13.59 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.272 -0.893 . . . . 0.0 110.647 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.56 -4.5 41.17 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.091 -1.005 . . . . 0.0 110.891 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 37' ' ' LEU . 51.3 mt -51.0 164.53 0.15 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.91 -1.119 . . . . 0.0 110.428 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.03 173.31 1.44 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.324 -0.86 . . . . 0.0 110.244 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -74.17 -19.33 60.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.367 -0.833 . . . . 0.0 110.293 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.9 m -128.79 36.05 4.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.0 110.534 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.484 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 31.5 t80 -56.18 123.3 14.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.144 -0.973 . . . . 0.0 109.464 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 7.3 mtt -106.72 142.4 36.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 0.0 109.682 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.445 ' HB3' ' N ' ' A' ' 47' ' ' ARG . 5.4 t -52.58 136.41 43.36 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.27 -0.894 . . . . 0.0 110.426 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.66 -1.52 11.21 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.574 1.302 . . . . 0.0 110.673 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -123.9 -42.5 2.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.91 -1.119 . . . . 0.0 110.811 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.47 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -114.15 5.11 15.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.065 -1.022 . . . . 0.0 111.122 -179.703 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.445 ' N ' ' HB3' ' A' ' 43' ' ' CYS . 27.3 mtt180 54.43 25.65 6.3 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.171 -0.956 . . . . 0.0 112.408 178.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.417 ' CB ' ' SG ' ' A' ' 46' ' ' CYS . 2.5 t -75.6 157.68 83.98 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 120.702 -1.249 . . . . 0.0 109.779 178.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.16 139.45 35.49 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.675 1.355 . . . . 0.0 110.362 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.529 ' HA ' ' CD1' ' A' ' 53' ' ' PHE . 56.0 tttt -48.49 -28.26 3.22 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.184 -0.947 . . . . 0.0 110.901 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -67.14 -10.85 54.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.1 -1.0 . . . . 0.0 110.096 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.425 ' NE2' ' HB2' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -89.66 -2.38 58.28 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.191 -0.943 . . . . 0.0 110.193 179.335 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.529 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 33.1 m-85 -88.74 125.48 34.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.845 -1.159 . . . . 0.0 110.083 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -97.1 139.57 32.9 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.246 -0.909 . . . . 0.0 109.935 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.544 ' HG ' ' HE2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -80.12 153.99 28.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.426 -0.796 . . . . 0.0 110.187 -179.519 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.677 HG23 ' O ' ' A' ' 56' ' ' ILE . 1.2 tp . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.289 -0.882 . . . . 0.0 110.236 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.447 ' O ' HG22 ' A' ' 56' ' ' ILE . 17.0 mttt . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.158 0.504 . . . . 0.0 109.707 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.516 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 13.3 m-85 -108.34 152.08 25.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.055 -1.028 . . . . 0.0 110.561 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.531 ' HA ' HD13 ' A' ' 16' ' ' ILE . 1.6 tm-20 -119.91 122.99 42.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.442 -0.786 . . . . 0.0 109.814 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.4 t -64.39 111.16 2.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.109 -0.994 . . . . 0.0 110.515 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -67.51 -12.17 59.69 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.229 -0.919 . . . . 0.0 109.501 178.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.415 ' HB2' ' NE2' ' A' ' 52' ' ' GLN . . . -85.04 -39.98 17.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.285 -0.884 . . . . 0.0 111.647 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.449 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 11.9 p -125.07 -29.66 3.3 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.62 -1.3 . . . . 0.0 111.433 -179.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.08 18.93 8.85 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.585 -1.293 . . . . 0.0 110.421 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 48.1 t80 -78.87 167.12 21.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.126 -1.22 . . . . 0.0 109.547 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.531 HD13 ' HA ' ' A' ' 9' ' ' GLU . 35.3 mm -129.06 115.54 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.17 -0.956 . . . . 0.0 110.454 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.517 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 73.1 t80 -82.17 136.31 35.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.436 -0.79 . . . . 0.0 110.378 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 22' ' ' GLY . 5.6 mt-10 -115.84 109.65 45.02 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.599 -0.688 . . . . 0.0 109.468 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.493 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 37.9 Cg_endo -68.77 -70.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.573 1.302 . . . . 0.0 111.467 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -44.75 -27.09 0.46 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.551 -0.718 . . . . 0.0 111.034 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.41 -22.56 15.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.165 -0.959 . . . . 0.0 110.078 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 18' ' ' GLU . . . 79.93 147.22 4.44 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.522 ' HB3' HD12 ' A' ' 28' ' ' ILE . 15.2 t0 -85.04 62.32 7.43 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.356 -1.085 . . . . 0.0 109.69 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.56 -28.8 0.41 Allowed 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 121.465 0.65 . . . . 0.0 110.827 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.85 -32.12 73.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.298 -0.876 . . . . 0.0 110.005 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -99.03 -28.0 13.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.263 -0.898 . . . . 0.0 110.368 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.81 25.13 2.17 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.578 HD11 ' CD1' ' A' ' 41' ' ' PHE . 9.8 mt -110.71 123.98 34.22 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 120.955 -1.32 . . . . 0.0 109.597 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -70.9 170.09 18.77 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.49 1.258 . . . . 0.0 110.588 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -71.85 -163.39 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.694 1.365 . . . . 0.0 110.296 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 49.14 31.52 11.67 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 84.3 m -136.88 116.69 10.65 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.163 -1.198 . . . . 0.0 110.289 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.493 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 47.2 Cg_endo -72.15 148.21 49.76 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 123.582 1.306 . . . . 0.0 110.345 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.517 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 5.5 t80 -51.08 -36.37 39.76 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.238 -0.914 . . . . 0.0 110.018 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.14 -13.79 12.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.408 -0.807 . . . . 0.0 110.748 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -98.58 -0.25 43.53 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.028 -1.045 . . . . 0.0 110.691 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.514 HD21 ' CE1' ' A' ' 17' ' ' TYR . 36.9 mt -55.82 163.59 1.39 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.913 -1.117 . . . . 0.0 110.248 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.9 m -53.73 168.38 0.19 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.323 -0.86 . . . . 0.0 110.367 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.98 -35.18 79.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.275 -0.891 . . . . 0.0 110.29 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.2 t -124.32 51.6 1.57 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.179 -0.95 . . . . 0.0 110.369 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.578 ' CD1' HD11 ' A' ' 28' ' ' ILE . 18.1 t80 -64.76 126.93 29.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.171 -0.956 . . . . 0.0 109.915 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.415 ' HA ' ' O ' ' A' ' 48' ' ' SER . 10.9 mtt -97.95 145.36 26.55 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.23 -0.919 . . . . 0.0 109.588 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 25.1 t -63.01 136.34 96.64 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.214 -0.929 . . . . 0.0 110.375 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -75.93 -3.27 13.63 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.581 1.306 . . . . 0.0 110.571 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -115.23 -37.9 3.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.038 -1.039 . . . . 0.0 110.823 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.449 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 1.6 p -124.72 7.07 8.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.045 -1.035 . . . . 0.0 111.152 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 57.2 17.16 3.4 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.195 -0.941 . . . . 0.0 112.804 178.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' A' ' 42' ' ' MET . 11.6 m -74.7 163.09 70.63 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 120.589 -1.319 . . . . 0.0 109.899 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.23 141.78 36.43 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.666 1.35 . . . . 0.0 110.699 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.519 ' HA ' ' CD1' ' A' ' 53' ' ' PHE . 24.5 tttm -48.34 -27.85 2.81 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.327 -0.858 . . . . 0.0 110.833 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -62.07 -15.29 43.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.075 -1.016 . . . . 0.0 109.971 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.415 ' NE2' ' HB2' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -86.45 -1.93 58.01 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.106 -0.996 . . . . 0.0 110.276 179.457 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.519 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 20.9 m-85 -85.09 134.34 34.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.833 -1.167 . . . . 0.0 110.494 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.99 119.99 35.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.385 -0.822 . . . . 0.0 109.768 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.516 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 3.4 t -52.89 178.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 110.58 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.661 HG23 ' O ' ' A' ' 56' ' ' ILE . 2.7 tt . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.664 -0.647 . . . . 0.0 109.952 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.826 ' O ' HG22 ' A' ' 56' ' ' ILE . 4.0 mttt . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.529 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 6.8 m-85 -109.55 150.23 28.48 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.073 -1.017 . . . . 0.0 110.784 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.682 ' HA ' HD13 ' A' ' 16' ' ' ILE . 17.9 tt0 -119.46 132.57 55.82 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.433 -0.792 . . . . 0.0 109.555 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.9 t -72.91 114.6 11.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.103 -0.998 . . . . 0.0 110.591 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -70.84 -11.66 61.09 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.379 -0.928 . . . . 0.0 109.548 178.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.529 ' HB2' ' NE2' ' A' ' 52' ' ' GLN . . . -85.07 -40.55 16.69 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.312 -0.867 . . . . 0.0 111.759 -179.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.457 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 12.6 p -123.53 -33.65 3.19 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.65 -1.281 . . . . 0.0 111.413 -178.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.23 21.45 5.89 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.129 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.524 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 49.9 t80 -84.45 168.67 15.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.296 -1.12 . . . . 0.0 109.812 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.682 HD13 ' HA ' ' A' ' 9' ' ' GLU . 40.9 mm -131.47 117.54 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.185 -0.947 . . . . 0.0 110.621 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.52 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 61.3 t80 -83.64 128.76 34.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.408 -0.808 . . . . 0.0 110.133 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -106.51 111.9 63.91 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.361 -0.837 . . . . 0.0 109.749 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.495 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 37.9 Cg_endo -69.78 -65.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.489 1.257 . . . . 0.0 111.085 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -45.64 -29.43 1.23 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.648 -0.658 . . . . 0.0 110.865 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.6 mttp -94.82 -38.05 10.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 0.0 110.173 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.29 150.65 26.34 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.533 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 1.5 t0 -85.08 63.86 8.35 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.438 -1.036 . . . . 0.0 109.653 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -46.39 -27.27 1.02 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.525 -0.735 . . . . 0.0 110.796 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -74.77 -23.15 58.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.22 -0.925 . . . . 0.0 109.985 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.533 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -100.99 -31.28 11.19 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.377 -0.827 . . . . 0.0 109.92 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.34 28.29 1.35 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.488 HD13 ' CD2' ' A' ' 37' ' ' LEU . 10.7 mt -118.84 123.7 28.85 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.906 -1.349 . . . . 0.0 109.774 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.406 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 43.3 Cg_endo -69.94 173.41 11.17 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.486 1.256 . . . . 0.0 110.431 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 51.1 Cg_endo -72.39 -164.09 0.17 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.564 1.297 . . . . 0.0 110.216 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 48.5 30.98 8.85 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.6 m -131.01 116.85 16.95 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.118 -1.225 . . . . 0.0 110.362 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.825 ' HB2' HG22 ' A' ' 35' ' ' VAL . 49.1 Cg_endo -74.49 150.31 40.64 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.408 1.215 . . . . 0.0 110.469 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.545 ' CD2' HD12 ' A' ' 37' ' ' LEU . 11.8 t80 -56.94 -23.45 45.38 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.231 -0.918 . . . . 0.0 109.907 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.825 HG22 ' HB2' ' A' ' 33' ' ' PRO . 31.3 m -70.22 -15.61 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.288 -0.883 . . . . 0.0 110.718 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.12 -0.99 35.16 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.174 -0.954 . . . . 0.0 110.893 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.545 HD12 ' CD2' ' A' ' 34' ' ' PHE . 41.0 mt -54.28 161.27 1.39 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.826 -1.171 . . . . 0.0 110.159 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.7 m -52.68 177.67 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.216 -0.928 . . . . 0.0 110.187 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.7 -18.03 49.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.248 -0.907 . . . . 0.0 110.458 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.6 p -133.2 37.4 3.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.105 -0.997 . . . . 0.0 110.541 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.462 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 14.5 t80 -56.61 133.87 54.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.138 -0.976 . . . . 0.0 109.774 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.438 ' HA ' ' O ' ' A' ' 48' ' ' SER . 5.1 mtt -106.99 143.9 34.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 109.854 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 35.9 t -56.64 138.96 76.6 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.879 . . . . 0.0 110.472 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -77.8 2.79 7.52 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.523 1.275 . . . . 0.0 110.873 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -124.61 -38.23 2.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.961 -1.087 . . . . 0.0 110.873 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.457 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 1.6 p -121.59 6.17 10.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.091 -1.006 . . . . 0.0 111.43 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.36 17.73 4.99 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.033 -1.042 . . . . 0.0 112.622 178.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.438 ' O ' ' HA ' ' A' ' 42' ' ' MET . 4.4 m -72.81 163.06 71.13 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 120.56 -1.338 . . . . 0.0 109.628 179.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.38 145.74 54.44 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.667 1.351 . . . . 0.0 110.334 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.502 ' HG2' ' CZ ' ' A' ' 34' ' ' PHE . 31.1 tttt -51.6 -24.74 5.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.3 -0.875 . . . . 0.0 110.255 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -66.12 -13.95 60.99 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.248 -0.907 . . . . 0.0 109.773 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.529 ' NE2' ' HB2' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -85.73 -3.73 58.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.238 -0.914 . . . . 0.0 110.043 179.193 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.45 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 17.1 m-85 -84.77 134.75 34.31 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.039 -1.038 . . . . 0.0 110.437 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.47 130.36 55.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.307 -0.87 . . . . 0.0 109.736 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.529 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 74.7 p -63.7 179.54 0.48 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 111.188 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.826 HG22 ' O ' ' A' ' 7' ' ' LYS . 4.8 tp . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.348 0.594 . . . . 0.0 109.546 179.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.904 ' O ' HG22 ' A' ' 56' ' ' ILE . 1.3 mttt . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.193 0.521 . . . . 0.0 109.961 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.586 ' CE2' ' CD1' ' A' ' 34' ' ' PHE . 8.0 m-85 -113.95 125.54 54.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.131 -0.981 . . . . 0.0 109.931 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 2.1 tm-20 -88.85 128.78 35.67 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.239 -0.913 . . . . 0.0 110.168 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.6 t -72.35 115.16 11.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.195 -0.941 . . . . 0.0 110.242 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -70.37 -12.8 61.83 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.146 -0.971 . . . . 0.0 109.537 178.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.465 ' HB2' ' NE2' ' A' ' 52' ' ' GLN . . . -85.08 -42.75 14.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.324 -0.86 . . . . 0.0 111.657 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.46 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 12.9 p -120.85 -27.29 5.05 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.72 -1.238 . . . . 0.0 111.382 -178.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.72 22.01 9.28 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.447 ' CG ' ' N ' ' A' ' 16' ' ' ILE . 60.7 t80 -81.88 168.35 18.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -1.117 . . . . 0.0 109.545 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.447 ' N ' ' CG ' ' A' ' 15' ' ' TYR . 25.7 mm -127.58 102.65 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.238 -0.914 . . . . 0.0 109.935 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.519 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 76.4 t80 -66.91 134.82 52.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 109.693 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -114.4 110.6 47.47 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.475 -0.766 . . . . 0.0 110.01 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.501 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 39.2 Cg_endo -71.04 -62.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.506 1.266 . . . . 0.0 110.641 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -45.1 -26.45 0.46 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.825 -0.547 . . . . 0.0 111.054 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.5 mtpp -103.16 -29.51 11.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.083 -1.01 . . . . 0.0 110.364 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.75 151.36 21.57 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.736 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 0.3 OUTLIER -85.1 63.42 8.1 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.399 -1.06 . . . . 0.0 109.533 179.754 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.69 -26.6 0.96 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.517 -0.74 . . . . 0.0 110.79 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -78.88 -19.77 51.11 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.189 -0.944 . . . . 0.0 110.254 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.736 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -104.1 -32.36 9.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.259 -0.9 . . . . 0.0 109.965 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 125.09 32.3 0.8 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.3 mt -126.82 123.51 23.75 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.037 -1.272 . . . . 0.0 109.875 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.407 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 46.5 Cg_endo -71.2 173.09 12.76 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.543 1.286 . . . . 0.0 110.596 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 50.2 Cg_endo -72.45 -163.4 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.759 1.399 . . . . 0.0 110.255 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 49.77 26.43 8.05 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.3 m -132.75 117.94 15.37 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.161 -1.2 . . . . 0.0 110.3 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.822 ' HB2' HG22 ' A' ' 35' ' ' VAL . 48.4 Cg_endo -74.38 151.77 43.22 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.492 1.259 . . . . 0.0 110.755 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.586 ' CD1' ' CE2' ' A' ' 8' ' ' TYR . 9.2 t80 -55.47 -24.42 30.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.365 -0.834 . . . . 0.0 110.104 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.822 HG22 ' HB2' ' A' ' 33' ' ' PRO . 26.9 m -71.07 -17.21 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 0.0 110.532 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -100.24 3.54 43.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.051 -1.031 . . . . 0.0 110.859 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' A' ' 37' ' ' LEU . 40.9 mt -54.64 169.67 0.2 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.975 -1.078 . . . . 0.0 110.265 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.25 162.05 12.72 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.184 -0.947 . . . . 0.0 110.253 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.3 -19.36 61.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.274 -0.891 . . . . 0.0 110.339 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -132.76 54.1 1.97 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.219 -0.926 . . . . 0.0 110.136 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.465 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 30.7 t80 -70.19 129.5 39.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.298 -0.876 . . . . 0.0 109.98 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 6.8 mtp -112.0 141.06 46.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.231 -0.918 . . . . 0.0 109.605 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 17.7 t -55.45 133.42 70.61 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 0.0 110.527 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.72 -1.91 11.75 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.615 1.324 . . . . 0.0 110.458 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.84 -35.92 4.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.976 -1.077 . . . . 0.0 110.914 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.46 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.9 OUTLIER -127.15 16.4 7.24 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.989 -1.069 . . . . 0.0 110.943 -179.694 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 56.4 mtt85 45.48 23.56 0.14 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.371 -0.831 . . . . 0.0 112.611 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.417 ' CB ' ' SG ' ' A' ' 46' ' ' CYS . 7.3 t -75.66 156.03 85.02 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 120.61 -1.307 . . . . 0.0 109.872 179.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.44 141.18 50.22 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.604 1.318 . . . . 0.0 110.41 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.517 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 12.5 tttm -49.16 -26.92 3.13 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.33 -0.856 . . . . 0.0 110.789 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.71 -14.56 53.43 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.066 -1.021 . . . . 0.0 109.952 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.465 ' NE2' ' HB2' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -89.2 1.45 55.66 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.227 -0.921 . . . . 0.0 110.271 179.303 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -89.54 148.47 23.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.896 -1.127 . . . . 0.0 111.012 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.5 133.95 47.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.564 -0.71 . . . . 0.0 109.152 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.535 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 75.7 p -70.52 176.81 3.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.989 -1.069 . . . . 0.0 111.301 -179.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.904 HG22 ' O ' ' A' ' 7' ' ' LYS . 1.6 tt . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.361 0.601 . . . . 0.0 109.912 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.734 ' O ' HG22 ' A' ' 56' ' ' ILE . 19.6 mttm . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.503 ' CE2' ' HB2' ' A' ' 55' ' ' SER . 22.3 m-85 -122.64 139.56 53.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -0.906 . . . . 0.0 110.858 -179.385 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.4 OUTLIER -110.13 141.15 43.41 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.361 -0.837 . . . . 0.0 109.836 179.409 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.7 t -81.01 114.1 19.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.068 -1.02 . . . . 0.0 110.37 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.27 -11.51 60.95 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.174 -0.954 . . . . 0.0 109.633 178.874 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.04 -42.22 15.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.369 -0.832 . . . . 0.0 111.759 -179.252 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.449 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 13.6 p -121.42 -34.71 3.4 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.668 -1.27 . . . . 0.0 111.424 -178.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.49 20.48 5.44 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 119.673 -1.251 . . . . 0.0 110.211 179.419 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.864 ' C ' HD12 ' A' ' 16' ' ' ILE . 55.9 t80 -84.58 162.49 19.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.206 -1.173 . . . . 0.0 109.856 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.864 HD12 ' C ' ' A' ' 15' ' ' TYR . 3.3 mp -128.29 115.13 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.125 -0.984 . . . . 0.0 110.018 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.567 ' CE1' HD21 ' A' ' 37' ' ' LEU . 71.2 t80 -77.44 131.18 37.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.316 -0.865 . . . . 0.0 110.187 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -109.5 115.71 55.65 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.427 -0.795 . . . . 0.0 109.415 179.371 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.487 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 38.2 Cg_endo -71.0 -65.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.465 1.245 . . . . 0.0 111.041 -179.484 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' A' ' 30' ' ' PRO . 0.5 OUTLIER -47.86 -24.04 0.9 Allowed 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.552 -0.717 . . . . 0.0 111.023 -179.835 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.2 tttp -99.13 -40.06 8.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.923 -1.11 . . . . 0.0 110.732 -179.724 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.74 147.85 22.72 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -85.11 61.34 6.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.447 -1.031 . . . . 0.0 109.985 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -44.72 -27.31 0.48 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.622 -0.674 . . . . 0.0 111.039 -179.724 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -69.26 -28.33 66.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.118 -0.989 . . . . 0.0 109.88 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -100.88 -28.33 12.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.343 -0.848 . . . . 0.0 109.983 179.661 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.54 28.54 1.43 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 179.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.57 HD13 ' CD2' ' A' ' 37' ' ' LEU . 8.8 mt -116.87 119.82 34.82 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.046 -1.267 . . . . 0.0 109.739 179.647 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.403 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 48.0 Cg_endo -71.81 172.95 13.47 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.496 1.261 . . . . 0.0 110.553 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.425 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 49.1 Cg_endo -70.64 -163.37 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.741 1.39 . . . . 0.0 110.28 179.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 50.22 27.83 12.03 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.849 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 63.3 m -131.71 115.91 15.87 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.198 -1.178 . . . . 0.0 110.341 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.848 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.2 Cg_endo -72.83 148.61 46.4 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.466 1.245 . . . . 0.0 110.586 179.818 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.519 ' CE1' ' HE2' ' A' ' 50' ' ' LYS . 30.1 t80 -53.06 -30.27 34.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.36 -0.838 . . . . 0.0 109.968 179.823 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.848 HG22 ' HB2' ' A' ' 33' ' ' PRO . 33.9 m -66.75 -11.78 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.844 . . . . 0.0 110.716 -179.876 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.401 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 1.5 t70 -103.2 -2.42 27.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.012 -1.055 . . . . 0.0 110.92 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.57 ' CD2' HD13 ' A' ' 28' ' ' ILE . 19.7 mt -52.1 172.81 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.926 -1.109 . . . . 0.0 110.312 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.8 m -64.36 150.9 45.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.219 -0.926 . . . . 0.0 110.23 -179.9 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -57.65 -22.18 44.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 0.0 110.234 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.4 p -129.61 38.51 3.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 0.0 109.911 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.465 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 30.8 t80 -60.46 135.66 57.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 110.345 -179.784 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.432 ' HA ' ' O ' ' A' ' 48' ' ' SER . 0.0 OUTLIER -109.81 149.55 29.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.336 -0.853 . . . . 0.0 109.558 179.214 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 18.1 t -61.1 137.0 94.05 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.104 -0.997 . . . . 0.0 110.52 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.11 -3.37 13.75 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.602 1.317 . . . . 0.0 110.353 179.383 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.97 -39.28 3.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.07 -1.019 . . . . 0.0 110.632 -179.682 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.449 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.9 OUTLIER -124.24 9.17 8.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.164 -0.96 . . . . 0.0 110.954 -179.801 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 54.39 15.98 1.14 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.31 -0.869 . . . . 0.0 112.964 178.147 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.432 ' O ' ' HA ' ' A' ' 42' ' ' MET . 3.4 m -67.25 165.38 28.73 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 120.621 -1.299 . . . . 0.0 109.746 179.293 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.458 ' HB2' ' ND2' ' A' ' 51' ' ' ASN . 43.5 Cg_endo -69.85 144.29 53.08 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.677 1.356 . . . . 0.0 110.492 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.519 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 37.4 tttt -53.57 -32.16 49.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.174 -0.954 . . . . 0.0 110.608 -179.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.458 ' ND2' ' HB2' ' A' ' 49' ' ' PRO . 24.5 p30 -63.29 -14.45 49.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.054 -1.029 . . . . 0.0 109.738 179.258 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -80.62 -7.66 59.35 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.069 -1.019 . . . . 0.0 109.755 178.985 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -82.56 124.62 30.3 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.107 -0.996 . . . . 0.0 109.678 179.375 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.416 ' O ' ' HG3' ' A' ' 9' ' ' GLU . 1.5 tttm -104.03 123.78 47.83 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.142 -0.974 . . . . 0.0 109.545 179.52 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.503 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 2.2 t -52.12 -179.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.103 -0.998 . . . . 0.0 110.241 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.734 HG22 ' O ' ' A' ' 7' ' ' LYS . 4.5 tt . . . . . 0 N--CA 1.493 1.716 0 O-C-N 121.457 -0.777 . . . . 0.0 110.046 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.408 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.206 0.527 . . . . 0.0 110.19 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.726 ' HG2' HG22 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -135.84 103.13 5.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.282 -0.886 . . . . 0.0 110.097 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.457 HG21 HG23 ' A' ' 56' ' ' ILE . 51.2 mt -137.98 166.45 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.148 -0.97 . . . . 0.0 110.328 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.423 ' HA ' ' CG ' ' A' ' 57' ' ' LYS . 0.2 OUTLIER 174.02 -24.88 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.271 -0.893 . . . . 0.0 111.046 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.68 61.44 0.16 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.06 -1.025 . . . . 0.0 110.74 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 48.6 25.52 4.71 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.777 ' O ' HG22 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -76.12 117.36 17.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.096 -1.238 . . . . 0.0 109.723 179.566 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.588 ' CE2' ' CD1' ' A' ' 34' ' ' PHE . 4.3 m-85 -100.4 147.05 26.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.13 -0.981 . . . . 0.0 109.908 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -117.71 128.15 54.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.234 -0.916 . . . . 0.0 110.222 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.9 t -69.86 112.04 6.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 110.178 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -11.54 59.54 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.135 -0.978 . . . . 0.0 109.592 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.19 -39.61 17.63 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.29 -0.881 . . . . 0.0 111.76 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.452 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 12.6 p -125.61 -32.99 2.82 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.672 -1.268 . . . . 0.0 111.752 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.83 21.61 5.97 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.777 ' C ' HD12 ' A' ' 16' ' ' ILE . 54.2 t80 -83.09 156.03 23.53 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.229 -1.16 . . . . 0.0 109.565 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.777 HD12 ' C ' ' A' ' 15' ' ' TYR . 2.7 mp -120.57 109.88 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 110.262 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.523 ' CE1' HD21 ' A' ' 37' ' ' LEU . 64.5 t80 -75.75 126.63 31.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.321 -0.862 . . . . 0.0 109.659 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.431 ' HB3' ' CB ' ' A' ' 21' ' ' LYS . 24.2 mt-10 -102.48 111.21 64.41 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.345 -0.847 . . . . 0.0 109.666 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.48 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 37.7 Cg_endo -68.77 -70.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.487 1.256 . . . . 0.0 110.939 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.403 ' O ' ' CB ' ' A' ' 30' ' ' PRO . 66.4 tt0 -47.45 -26.18 1.29 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.448 -0.783 . . . . 0.0 110.567 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.431 ' CB ' ' HB3' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -93.58 -33.75 13.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.241 -0.912 . . . . 0.0 110.196 179.833 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.91 157.03 32.27 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.471 ' HB3' HD12 ' A' ' 28' ' ' ILE . 8.5 t0 -85.04 61.34 6.81 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.479 -1.013 . . . . 0.0 109.854 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -46.54 -26.67 0.93 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.454 -0.779 . . . . 0.0 110.679 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -80.77 -25.28 38.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.265 -0.897 . . . . 0.0 110.125 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.443 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -97.82 -30.41 12.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.209 -0.932 . . . . 0.0 110.157 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 127.39 4.17 5.92 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.959 -1.115 . . . . 0.0 110.536 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.471 HD12 ' HB3' ' A' ' 23' ' ' ASP . 3.5 mt -98.19 129.04 31.65 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.824 -1.398 . . . . 0.0 110.162 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.417 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 47.0 Cg_endo -74.31 173.14 14.71 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 O-C-N 123.505 1.266 . . . . 0.0 110.557 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 49.9 Cg_endo -70.9 -163.38 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.623 1.328 . . . . 0.0 110.262 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 50.21 40.58 37.39 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 99.7 m -147.28 115.46 4.26 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.183 -1.187 . . . . 0.0 110.253 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.73 ' HB2' HG22 ' A' ' 35' ' ' VAL . 45.4 Cg_endo -71.98 151.55 56.35 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.514 1.27 . . . . 0.0 110.584 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.588 ' CD1' ' CE2' ' A' ' 8' ' ' TYR . 12.6 t80 -54.6 -32.5 58.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.328 -0.858 . . . . 0.0 110.066 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.73 HG22 ' HB2' ' A' ' 33' ' ' PRO . 24.4 m -63.56 -13.47 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.355 -0.841 . . . . 0.0 110.623 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -102.57 4.38 38.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.027 -1.045 . . . . 0.0 111.053 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.523 HD21 ' CE1' ' A' ' 17' ' ' TYR . 22.4 mt -56.61 178.97 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.832 -1.167 . . . . 0.0 110.044 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.8 m -69.18 164.96 21.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.215 -0.928 . . . . 0.0 110.324 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -63.93 -20.79 66.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.207 -0.933 . . . . 0.0 110.218 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.3 m -138.89 54.91 1.73 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.163 -0.961 . . . . 0.0 110.356 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.45 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 18.4 t80 -70.69 140.98 51.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.147 -0.971 . . . . 0.0 109.831 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.429 ' HA ' ' O ' ' A' ' 48' ' ' SER . 1.9 mtt -116.4 143.9 44.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.289 -0.882 . . . . 0.0 109.644 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 11.6 t -60.16 132.84 90.17 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.195 -0.941 . . . . 0.0 110.498 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.92 -9.22 20.79 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.569 1.3 . . . . 0.0 110.314 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -106.15 -40.04 5.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.078 -1.014 . . . . 0.0 110.707 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.452 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 1.3 p -122.72 5.1 9.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.133 -0.98 . . . . 0.0 111.113 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 4.2 mtm105 57.65 18.17 4.53 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.185 -0.947 . . . . 0.0 112.816 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.429 ' O ' ' HA ' ' A' ' 42' ' ' MET . 4.6 m -72.32 163.34 68.19 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 120.66 -1.275 . . . . 0.0 109.704 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -70.52 143.74 48.04 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.639 1.336 . . . . 0.0 110.235 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.511 ' HG2' ' CZ ' ' A' ' 34' ' ' PHE . 19.4 tttt -49.94 -24.63 2.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.208 -0.933 . . . . 0.0 110.549 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -66.17 -14.14 61.36 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.096 -1.002 . . . . 0.0 109.977 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.93 -5.56 59.24 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.141 -0.974 . . . . 0.0 109.999 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.523 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 12.7 m-85 -85.11 149.46 25.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.018 -1.051 . . . . 0.0 110.285 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.66 132.66 26.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.352 -0.842 . . . . 0.0 109.878 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.53 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 5.8 p -61.83 172.62 1.25 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.166 -0.959 . . . . 0.0 110.917 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.777 HG22 ' O ' ' A' ' 7' ' ' LYS . 3.2 tt -159.99 77.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.733 -0.605 . . . . 0.0 109.718 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.423 ' CG ' ' HA ' ' A' ' 4' ' ' ASP . 0.5 OUTLIER -100.71 65.76 1.17 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.299 -0.876 . . . . 0.0 109.975 -179.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.49 153.15 50.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.5 -0.75 . . . . 0.0 110.131 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.726 HG22 ' HG2' ' A' ' 2' ' ' GLU . 98.8 t -125.4 113.2 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.24 -0.913 . . . . 0.0 110.16 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 mp -126.1 120.58 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.158 -0.963 . . . . 0.0 110.29 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -176.2 127.16 0.21 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.34 -0.85 . . . . 0.0 109.913 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -176.85 104.96 0.19 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.404 ' CE1' ' HB3' ' A' ' 64' ' ' ALA . 52.9 p90 -118.76 -27.22 5.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.209 -1.171 . . . . 0.0 110.377 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.404 ' HB3' ' CE1' ' A' ' 63' ' ' PHE . . . -141.97 145.27 34.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 110.322 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -154.36 79.01 1.1 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.302 -0.874 . . . . 0.0 110.146 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.7 m-20 -90.74 53.16 2.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.164 -0.96 . . . . 0.0 110.406 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -157.43 -177.38 6.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.192 -0.942 . . . . 0.0 110.296 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.38 30.29 3.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 110.203 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 26.2 t80 53.58 68.38 0.85 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.191 -0.943 . . . . 0.0 110.255 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 CA-C-O 118.03 -1.428 . . . . 0.0 109.584 179.933 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.424 ' N ' ' OE1' ' A' ' 9' ' ' GLU . 6.4 ttt . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.222 0.534 . . . . 0.0 110.057 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.79 ' O ' HD13 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -61.88 96.38 0.07 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 110.158 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.79 HD13 ' O ' ' A' ' 2' ' ' GLU . 29.8 mm -140.91 165.68 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.248 -0.908 . . . . 0.0 109.649 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.528 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 29.7 t70 -138.48 5.17 2.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.104 -0.997 . . . . 0.0 111.178 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.492 ' H ' HG22 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -90.57 -148.47 0.2 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.956 -1.09 . . . . 0.0 109.858 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.11 30.67 6.9 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.86 ' O ' HG22 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -80.24 130.39 35.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -1.152 . . . . 0.0 109.936 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.564 ' CE2' ' CD2' ' A' ' 34' ' ' PHE . 7.4 m-85 -109.59 141.93 41.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.168 -0.957 . . . . 0.0 109.878 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.508 ' HA ' HD13 ' A' ' 16' ' ' ILE . 4.8 tt0 -106.18 129.88 54.16 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.162 -0.961 . . . . 0.0 110.275 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.9 t -71.42 116.17 11.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 110.339 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.73 -11.47 60.96 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.091 -1.006 . . . . 0.0 109.585 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.686 ' HB2' ' OE1' ' A' ' 52' ' ' GLN . . . -85.15 -41.37 15.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.309 -0.87 . . . . 0.0 111.653 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.472 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 14.3 p -123.12 -32.62 3.43 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.758 -1.214 . . . . 0.0 111.406 -179.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.0 24.0 5.92 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.46 ' CD2' ' N ' ' A' ' 16' ' ' ILE . 40.9 t80 -84.13 168.96 15.33 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.365 -1.079 . . . . 0.0 109.343 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.508 HD13 ' HA ' ' A' ' 9' ' ' GLU . 33.9 mm -129.41 117.59 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.27 -0.894 . . . . 0.0 110.309 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.543 ' CE1' HD21 ' A' ' 37' ' ' LEU . 56.1 t80 -80.54 129.17 34.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.429 -0.794 . . . . 0.0 109.912 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -104.91 110.73 64.87 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.488 -0.758 . . . . 0.0 109.546 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.464 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 37.5 Cg_endo -68.58 -76.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.591 1.311 . . . . 0.0 111.464 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -46.02 -26.58 0.75 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.285 -0.885 . . . . 0.0 111.037 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.5 tttp -87.95 -36.09 17.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 110.522 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.46 145.63 17.81 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.413 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 2.9 t0 -85.11 62.07 7.27 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.3 -1.118 . . . . 0.0 109.876 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.39 -26.5 2.1 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.249 -0.907 . . . . 0.0 110.416 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -74.51 -20.41 59.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.303 -0.873 . . . . 0.0 109.921 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.413 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -106.99 -33.28 7.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.929 . . . . 0.0 109.969 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.94 32.97 0.66 Allowed Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.948 -1.12 . . . . 0.0 110.309 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.1 mt -124.1 130.39 24.4 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 120.876 -1.367 . . . . 0.0 109.753 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.46 173.21 13.57 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 O-C-N 123.601 1.316 . . . . 0.0 110.394 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -72.19 -164.87 0.19 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.629 1.331 . . . . 0.0 110.186 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 49.76 27.87 10.18 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.9 m -127.94 112.08 20.28 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.099 -1.236 . . . . 0.0 110.228 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.75 ' HB2' HG22 ' A' ' 35' ' ' VAL . 44.3 Cg_endo -70.87 153.08 64.0 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.554 1.292 . . . . 0.0 110.478 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.763 ' CD1' HD12 ' A' ' 37' ' ' LEU . 27.5 t80 -55.48 -28.36 54.04 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.234 -0.916 . . . . 0.0 110.106 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.75 HG22 ' HB2' ' A' ' 33' ' ' PRO . 33.8 m -64.79 -20.16 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.207 -0.933 . . . . 0.0 110.077 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -90.54 -11.11 41.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.13 -0.981 . . . . 0.0 110.69 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.763 HD12 ' CD1' ' A' ' 34' ' ' PHE . 25.5 mt -52.54 157.65 1.47 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.974 -1.079 . . . . 0.0 110.322 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.34 139.34 58.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.307 -0.871 . . . . 0.0 109.99 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -51.17 -24.86 4.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.26 -0.9 . . . . 0.0 110.348 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.95 26.19 10.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.87 . . . . 0.0 110.177 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.455 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 18.3 t80 -56.04 131.96 48.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.0 109.844 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.1 mtt -113.3 147.46 37.55 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.265 -0.897 . . . . 0.0 109.545 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 7.9 t -58.72 134.25 86.39 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.0 110.44 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -77.83 1.09 9.21 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.533 1.281 . . . . 0.0 110.29 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -120.97 -34.96 3.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.027 -1.045 . . . . 0.0 110.923 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.472 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.7 OUTLIER -126.16 4.07 7.14 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.937 -1.102 . . . . 0.0 111.345 -179.668 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.78 17.75 10.13 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.085 -1.009 . . . . 0.0 112.142 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.41 ' OG ' ' HB3' ' A' ' 52' ' ' GLN . 5.0 t -70.44 153.39 95.11 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.822 -1.174 . . . . 0.0 109.707 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.16 145.33 43.89 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.587 1.309 . . . . 0.0 110.558 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.455 ' HB2' ' HB3' ' A' ' 41' ' ' PHE . 24.7 tttm -52.37 -32.03 36.6 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.175 -0.953 . . . . 0.0 110.186 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.15 -15.66 47.39 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.122 -0.987 . . . . 0.0 109.745 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.686 ' OE1' ' HB2' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -91.1 3.77 53.92 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.24 -0.912 . . . . 0.0 110.159 179.401 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.403 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 18.8 m-85 -92.84 128.16 38.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.896 -1.127 . . . . 0.0 110.209 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.86 135.73 50.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.301 -0.874 . . . . 0.0 109.737 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.529 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 77.9 p -68.15 -178.44 1.04 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 110.908 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.86 HG22 ' O ' ' A' ' 7' ' ' LYS . 7.2 tp -160.0 88.12 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 121.466 0.65 . . . . 0.0 109.691 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 4' ' ' ASP . 6.0 ptmt -101.66 64.55 0.99 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.136 -0.978 . . . . 0.0 110.533 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -174.62 156.75 2.44 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.172 -0.955 . . . . 0.0 110.487 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.2 m -103.48 178.31 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.268 -0.895 . . . . 0.0 110.275 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.5 mm -112.4 -65.09 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.29 -0.881 . . . . 0.0 110.223 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.83 62.92 6.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.227 -0.921 . . . . 0.0 110.268 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -101.07 110.27 3.85 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -89.83 61.22 5.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -1.144 . . . . 0.0 110.438 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.3 -20.39 40.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 110.142 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.22 -33.49 11.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.295 -0.878 . . . . 0.0 110.291 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -88.16 121.98 31.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.278 -0.889 . . . . 0.0 110.264 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -103.54 62.89 0.78 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.205 -0.934 . . . . 0.0 110.177 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 20.2 tttm -109.86 -42.62 4.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.284 -0.885 . . . . 0.0 110.08 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.62 109.39 9.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -0.915 . . . . 0.0 110.099 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 CA-C-O 117.965 -1.464 . . . . 0.0 109.453 -179.878 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.151 0.5 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.0 65.16 1.34 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.166 -0.959 . . . . 0.0 110.691 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.477 HG22 ' N ' ' A' ' 4' ' ' ASP . 4.2 mp -128.72 169.31 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.187 -0.946 . . . . 0.0 109.478 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.533 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 29.4 t70 -141.42 4.53 1.79 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.003 -1.061 . . . . 0.0 111.62 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.456 ' H ' HG22 ' A' ' 3' ' ' ILE . 16.8 mm-40 -91.38 -146.95 0.21 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.809 -1.182 . . . . 0.0 109.662 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.74 33.58 5.11 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.872 ' O ' HG22 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -80.19 133.65 36.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.334 -1.098 . . . . 0.0 109.879 179.875 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.52 ' CE2' ' HB3' ' A' ' 55' ' ' SER . 8.9 m-85 -118.1 135.88 53.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.153 -0.967 . . . . 0.0 109.635 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.407 ' HA ' HD13 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -101.53 135.76 42.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.048 -1.033 . . . . 0.0 110.55 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.9 t -77.49 113.95 15.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.194 -0.941 . . . . 0.0 110.248 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.01 -10.26 59.45 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.004 -1.06 . . . . 0.0 109.572 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.05 -39.48 17.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.43 -0.794 . . . . 0.0 111.584 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.48 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 13.8 p -125.5 -35.24 2.58 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.652 -1.28 . . . . 0.0 111.531 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.02 22.8 4.81 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.466 ' CG ' ' N ' ' A' ' 16' ' ' ILE . 59.2 t80 -83.66 170.22 14.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.351 -1.088 . . . . 0.0 109.871 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.466 ' N ' ' CG ' ' A' ' 15' ' ' TYR . 37.2 mm -132.24 115.03 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 110.255 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.5 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 68.4 t80 -78.17 135.94 37.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.331 -0.856 . . . . 0.0 110.136 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.415 ' O ' ' N ' ' A' ' 22' ' ' GLY . 5.8 mt-10 -115.28 110.09 45.75 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.516 -0.74 . . . . 0.0 109.461 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.447 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 37.4 Cg_endo -68.99 -72.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.395 0 O-C-N 123.52 1.274 . . . . 0.0 111.237 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -44.81 -27.27 0.49 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.544 -0.722 . . . . 0.0 111.032 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -98.13 -24.02 15.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.207 -0.933 . . . . 0.0 110.147 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 18' ' ' GLU . . . 80.04 153.36 8.49 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.596 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 0.3 OUTLIER -84.93 61.2 6.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.361 -1.081 . . . . 0.0 109.595 179.627 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.45 -27.78 0.78 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.57 -0.706 . . . . 0.0 110.965 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.85 -28.08 60.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.187 -0.946 . . . . 0.0 109.899 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.596 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -96.54 -28.22 14.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.291 -0.88 . . . . 0.0 110.073 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.8 24.63 2.27 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.49 HD11 ' CD1' ' A' ' 41' ' ' PHE . 7.6 mt -113.98 128.86 25.32 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.959 -1.318 . . . . 0.0 109.684 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.33 170.45 19.87 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.598 1.315 . . . . 0.0 110.665 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.01 -163.59 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.674 1.355 . . . . 0.0 110.144 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 48.99 34.38 15.79 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 90.2 m -138.7 115.08 8.79 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.259 -1.142 . . . . 0.0 110.271 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.773 ' HB2' HG22 ' A' ' 35' ' ' VAL . 48.2 Cg_endo -72.08 148.8 51.3 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.568 1.299 . . . . 0.0 110.507 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.508 ' CZ ' ' HG2' ' A' ' 50' ' ' LYS . 19.1 t80 -51.59 -27.85 12.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.42 -0.8 . . . . 0.0 110.272 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.773 HG22 ' HB2' ' A' ' 33' ' ' PRO . 31.1 m -71.0 -19.59 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.936 . . . . 0.0 110.52 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.27 -2.26 55.21 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.186 -0.946 . . . . 0.0 110.924 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.469 HD23 ' HA ' ' A' ' 37' ' ' LEU . 25.2 mt -53.19 -179.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.971 -1.08 . . . . 0.0 110.372 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.15 156.48 38.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.381 -0.825 . . . . 0.0 110.232 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -53.11 -26.31 16.13 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.268 -0.895 . . . . 0.0 110.424 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.32 60.43 1.67 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.143 -0.973 . . . . 0.0 110.42 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.49 ' CD1' HD11 ' A' ' 28' ' ' ILE . 10.0 t80 -71.64 128.49 35.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.164 -0.96 . . . . 0.0 109.685 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.441 ' HA ' ' O ' ' A' ' 48' ' ' SER . 18.1 mmt -103.0 145.83 29.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -0.925 . . . . 0.0 109.795 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 8.3 t -58.36 138.12 85.11 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.403 -0.811 . . . . 0.0 110.67 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.4 ' HB3' ' HB2' ' A' ' 26' ' ' ALA . 53.0 Cg_endo -77.68 -0.57 10.77 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 O-C-N 123.686 1.361 . . . . 0.0 110.394 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -122.41 -34.15 3.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.032 -1.042 . . . . 0.0 111.022 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.48 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.8 OUTLIER -125.03 8.01 7.99 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.933 -1.105 . . . . 0.0 111.298 -179.655 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.69 21.41 4.59 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.122 -0.987 . . . . 0.0 112.432 178.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 42' ' ' MET . 10.9 t -77.23 153.25 82.11 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 120.666 -1.271 . . . . 0.0 109.627 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.26 142.06 49.04 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.584 1.307 . . . . 0.0 110.548 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.508 ' HG2' ' CZ ' ' A' ' 34' ' ' PHE . 4.4 ttpm? -48.4 -29.44 4.01 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.445 -0.784 . . . . 0.0 110.937 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -62.77 -14.79 49.13 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.986 -1.071 . . . . 0.0 109.967 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.09 1.1 56.08 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.125 -0.985 . . . . 0.0 110.03 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.494 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 16.6 m-85 -89.63 137.43 32.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.116 -0.99 . . . . 0.0 110.307 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -115.9 131.63 56.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.285 -0.885 . . . . 0.0 109.64 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.52 ' HB3' ' CE2' ' A' ' 8' ' ' TYR . 79.3 p -63.68 179.67 0.46 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.048 -1.032 . . . . 0.0 111.054 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.872 HG22 ' O ' ' A' ' 7' ' ' LYS . 1.2 tp -157.6 69.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-O 121.405 0.622 . . . . 0.0 109.561 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 4' ' ' ASP . 39.5 mttt -91.12 65.61 5.56 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.438 -0.788 . . . . 0.0 109.717 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 3' ' ' ILE . 0.0 OUTLIER -170.47 148.59 3.15 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.474 -0.766 . . . . 0.0 110.474 -179.72 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.2 t -123.88 122.54 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.249 -0.907 . . . . 0.0 110.217 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.6 tp -125.72 154.07 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.305 -0.872 . . . . 0.0 110.21 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -153.36 23.23 0.54 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.197 -0.939 . . . . 0.0 110.147 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -144.07 103.22 0.3 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.1 128.7 55.21 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.255 -1.144 . . . . 0.0 110.248 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -100.77 -40.32 7.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.209 -0.932 . . . . 0.0 110.219 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 53.46 79.38 0.13 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.905 . . . . 0.0 110.275 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 45.4 p-10 -146.92 46.38 1.17 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.224 -0.923 . . . . 0.0 110.329 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -70.83 -25.78 62.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 0.0 109.955 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.3 mttt 52.06 43.15 30.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.284 -0.885 . . . . 0.0 110.333 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -141.53 64.33 1.41 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.221 -0.924 . . . . 0.0 110.374 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.944 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 ttm . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.313 0.578 . . . . 0.0 110.258 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -84.65 90.29 7.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 0.0 110.231 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.647 HD12 ' HB ' ' A' ' 56' ' ' ILE . 13.1 pt -134.88 126.17 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.229 -0.92 . . . . 0.0 110.204 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.449 ' HB2' HG13 ' A' ' 59' ' ' VAL . 12.6 t0 178.06 -32.02 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.62 -0.675 . . . . 0.0 110.18 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.413 ' O ' ' CG ' ' A' ' 19' ' ' PRO . 25.6 mt-10 -66.66 78.03 0.11 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 110.104 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 55.06 22.46 28.5 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.53 131.7 35.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.211 -1.17 . . . . 0.0 109.468 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.518 ' CE2' ' HB2' ' A' ' 55' ' ' SER . 22.2 m-85 -129.3 150.39 50.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.017 -1.052 . . . . 0.0 110.864 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.586 ' HA ' HD13 ' A' ' 16' ' ' ILE . 13.8 pt-20 -120.56 140.66 51.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.323 -0.861 . . . . 0.0 109.863 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 t -80.05 113.86 18.53 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.176 -0.953 . . . . 0.0 110.434 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.63 -11.71 61.11 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.115 -0.99 . . . . 0.0 109.613 178.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.08 -41.3 15.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 111.726 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.4 p -122.08 -32.85 3.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.726 -1.234 . . . . 0.0 111.551 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.14 21.12 6.03 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.507 ' CD2' ' N ' ' A' ' 16' ' ' ILE . 60.5 t80 -81.6 168.92 17.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.265 -1.138 . . . . 0.0 109.92 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.586 HD13 ' HA ' ' A' ' 9' ' ' GLU . 34.8 mm -135.11 116.25 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.246 -0.908 . . . . 0.0 110.201 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.548 ' CZ ' HD21 ' A' ' 37' ' ' LEU . 63.5 t80 -80.57 132.86 35.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -0.874 . . . . 0.0 110.109 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -113.93 113.86 46.78 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.561 -0.712 . . . . 0.0 109.655 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.493 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 38.5 Cg_endo -71.72 -65.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.474 1.25 . . . . 0.0 110.892 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -45.38 -27.33 0.67 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.715 -0.616 . . . . 0.0 110.776 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.12 -35.57 10.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.282 -0.886 . . . . 0.0 110.0 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.64 149.54 10.69 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.471 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 2.2 t0 -85.14 62.42 7.49 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.457 -1.025 . . . . 0.0 109.725 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -44.91 -27.5 0.54 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.629 -0.669 . . . . 0.0 110.916 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.45 -26.44 60.05 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.315 -0.865 . . . . 0.0 110.26 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.471 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -100.72 -25.68 14.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.223 -0.923 . . . . 0.0 110.335 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.92 19.1 3.39 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.893 -1.146 . . . . 0.0 110.244 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.2 mt -111.19 116.59 51.1 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 120.897 -1.355 . . . . 0.0 109.717 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.35 172.18 13.7 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.503 1.265 . . . . 0.0 110.611 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.54 -164.14 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.724 1.381 . . . . 0.0 110.145 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 47.61 27.33 4.36 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.406 ' O ' ' CB ' ' A' ' 19' ' ' PRO . 89.9 m -128.73 119.53 20.21 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.12 -1.223 . . . . 0.0 110.245 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.655 ' HB2' HG22 ' A' ' 35' ' ' VAL . 48.6 Cg_endo -73.78 159.47 45.29 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 O-C-N 123.525 1.276 . . . . 0.0 110.878 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.507 ' CD1' HD12 ' A' ' 37' ' ' LEU . 44.2 t80 -65.79 -28.93 69.37 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.448 -0.783 . . . . 0.0 110.157 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.655 HG22 ' HB2' ' A' ' 33' ' ' PRO . 23.2 m -69.45 -9.83 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -0.904 . . . . 0.0 110.809 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.67 -1.96 23.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.965 -1.085 . . . . 0.0 110.892 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.548 HD21 ' CZ ' ' A' ' 17' ' ' TYR . 46.9 mt -52.07 162.57 0.45 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.883 -1.136 . . . . 0.0 110.27 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.7 t -49.57 164.86 0.08 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.31 -0.869 . . . . 0.0 110.44 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.46 -26.0 68.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.916 . . . . 0.0 110.233 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.9 p -131.65 52.73 2.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.271 -0.893 . . . . 0.0 110.46 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.478 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 26.9 t80 -63.46 132.17 50.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.216 -0.927 . . . . 0.0 109.785 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -110.17 143.97 39.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.878 . . . . 0.0 109.663 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.461 ' HB3' ' N ' ' A' ' 47' ' ' ARG . 8.7 t -55.49 137.45 69.56 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 110.741 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -77.6 -1.68 11.85 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.58 1.305 . . . . 0.0 110.287 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -120.56 -39.81 2.72 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.146 -0.971 . . . . 0.0 110.533 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.417 ' SG ' ' CB ' ' A' ' 48' ' ' SER . 0.6 OUTLIER -121.82 10.42 10.24 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.087 -1.008 . . . . 0.0 110.836 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.461 ' N ' ' HB3' ' A' ' 43' ' ' CYS . 0.0 OUTLIER 52.95 17.73 0.94 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.29 -0.881 . . . . 0.0 112.655 178.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.417 ' CB ' ' SG ' ' A' ' 46' ' ' CYS . 4.1 t -67.7 156.2 89.6 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.598 -1.313 . . . . 0.0 109.715 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.86 143.48 45.65 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 123.684 1.36 . . . . 0.0 110.486 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.524 ' HA ' ' CD1' ' A' ' 53' ' ' PHE . 22.1 tttm -50.32 -25.26 3.6 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.325 -0.86 . . . . 0.0 110.517 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 -67.24 -11.61 57.92 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.202 -0.936 . . . . 0.0 110.146 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.52 0.7 57.46 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.053 -1.029 . . . . 0.0 110.104 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.524 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 39.6 m-85 -89.99 125.67 35.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.951 -1.093 . . . . 0.0 110.428 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.408 ' O ' ' HG2' ' A' ' 9' ' ' GLU . 12.0 tttt -100.75 131.54 46.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.391 -0.818 . . . . 0.0 109.579 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.667 ' O ' HG23 ' A' ' 56' ' ' ILE . 2.5 t -60.89 179.34 0.18 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.124 -0.985 . . . . 0.0 110.316 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.667 HG23 ' O ' ' A' ' 55' ' ' SER . 7.9 pt -159.99 94.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.782 -0.573 . . . . 0.0 109.509 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -108.69 66.46 0.64 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.369 -0.832 . . . . 0.0 110.193 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.07 66.5 0.92 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.32 -0.863 . . . . 0.0 110.193 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.449 HG13 ' HB2' ' A' ' 4' ' ' ASP . 33.9 m -84.67 158.37 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.373 -0.83 . . . . 0.0 110.364 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 66.7 mt -123.18 80.88 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.345 -0.847 . . . . 0.0 110.104 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.61 161.86 2.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.191 -0.943 . . . . 0.0 110.389 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -134.47 -111.39 1.19 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -149.41 179.1 8.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.174 -1.192 . . . . 0.0 110.332 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -174.19 127.7 0.36 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.261 -0.899 . . . . 0.0 110.37 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -149.73 70.29 1.06 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.262 -0.899 . . . . 0.0 110.038 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -129.93 113.33 14.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 0.0 110.501 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.68 -167.31 1.27 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.279 -0.888 . . . . 0.0 110.038 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.5 mtpt -134.86 112.41 10.66 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.096 -1.003 . . . . 0.0 110.297 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -144.06 77.97 1.57 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 0.0 110.159 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 CA-C-O 117.959 -1.467 . . . . 0.0 109.479 -179.997 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.482 ' O ' HG23 ' A' ' 3' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.303 0.573 . . . . 0.0 110.235 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.923 ' OE2' HG13 ' A' ' 59' ' ' VAL . 0.8 OUTLIER 53.68 71.46 0.5 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.216 -0.927 . . . . 0.0 110.186 -179.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.482 HG23 ' O ' ' A' ' 1' ' ' MET . 25.9 pt -148.38 145.84 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.275 -0.891 . . . . 0.0 110.106 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 21.6 t0 -146.7 10.53 1.07 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.171 -0.955 . . . . 0.0 111.248 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -78.24 61.53 2.74 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.183 -0.948 . . . . 0.0 110.613 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.4 ' O ' ' HG3' ' A' ' 19' ' ' PRO . . . 50.91 23.97 7.77 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.898 ' O ' HG22 ' A' ' 56' ' ' ILE . 6.5 mttt -78.67 132.36 37.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.099 -1.236 . . . . 0.0 109.529 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.524 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 6.6 m-85 -111.93 132.19 54.91 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.055 -1.028 . . . . 0.0 110.354 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 17.3 tt0 -95.23 135.49 36.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.262 -0.899 . . . . 0.0 109.982 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.4 t -76.95 114.45 15.75 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.191 -0.943 . . . . 0.0 110.309 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -69.34 -11.47 60.84 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.192 -0.942 . . . . 0.0 109.722 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.568 ' HB2' ' NE2' ' A' ' 52' ' ' GLN . . . -85.2 -40.79 16.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.906 . . . . 0.0 111.819 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.474 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 14.0 p -124.53 -35.35 2.76 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.738 -1.226 . . . . 0.0 111.802 -178.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 116.94 20.5 4.87 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.616 -1.278 . . . . 0.0 109.988 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.858 ' C ' HD12 ' A' ' 16' ' ' ILE . 73.7 t80 -83.73 169.99 14.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -1.124 . . . . 0.0 109.51 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.858 HD12 ' C ' ' A' ' 15' ' ' TYR . 3.4 mp -132.7 110.23 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.119 -0.988 . . . . 0.0 110.064 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.499 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 73.3 t80 -70.06 140.28 52.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.265 -0.897 . . . . 0.0 110.109 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.444 ' HG2' ' HE2' ' A' ' 7' ' ' LYS . 14.6 mt-10 -115.26 108.21 48.26 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.545 -0.722 . . . . 0.0 109.857 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.441 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 38.0 Cg_endo -68.81 -74.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.379 0 O-C-N 123.427 1.224 . . . . 0.0 111.042 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -46.85 -25.76 0.83 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.4 -0.812 . . . . 0.0 110.914 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.99 -38.2 11.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.13 -0.981 . . . . 0.0 110.44 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.37 148.52 24.1 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.588 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 0.6 OUTLIER -85.09 61.99 7.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.399 -1.06 . . . . 0.0 110.07 179.787 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.18 -26.82 0.84 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.523 -0.735 . . . . 0.0 110.915 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -77.5 -23.0 50.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.173 -0.954 . . . . 0.0 110.333 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.588 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -102.69 -28.67 11.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.204 -0.935 . . . . 0.0 110.143 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.66 30.94 1.19 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.6 mt -122.89 122.39 27.09 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.123 -1.222 . . . . 0.0 109.783 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.401 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 45.5 Cg_endo -70.71 173.06 12.38 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 O-C-N 123.516 1.272 . . . . 0.0 110.529 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.401 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 48.3 Cg_endo -70.84 -163.54 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.788 1.415 . . . . 0.0 110.137 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 49.15 25.69 5.75 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 93.0 m -127.39 114.74 21.36 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.102 -1.234 . . . . 0.0 110.04 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.839 ' HB2' HG22 ' A' ' 35' ' ' VAL . 48.8 Cg_endo -73.72 149.88 43.91 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.501 1.263 . . . . 0.0 110.78 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.645 ' CD1' HD12 ' A' ' 37' ' ' LEU . 55.0 t80 -53.9 -26.88 27.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.361 -0.837 . . . . 0.0 110.151 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.839 HG22 ' HB2' ' A' ' 33' ' ' PRO . 35.4 m -69.09 -16.11 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.172 -0.955 . . . . 0.0 110.632 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.19 -2.48 49.62 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.045 -1.034 . . . . 0.0 110.927 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.645 HD12 ' CD1' ' A' ' 34' ' ' PHE . 58.4 mt -59.0 158.56 8.31 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.919 -1.113 . . . . 0.0 110.155 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.0 t -54.55 166.84 0.4 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.302 -0.874 . . . . 0.0 110.227 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -72.3 -11.68 60.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.206 -0.934 . . . . 0.0 110.635 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 54.3 p -137.37 34.02 2.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.966 -1.084 . . . . 0.0 110.322 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.482 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 22.9 t80 -54.25 144.23 20.79 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.257 -0.902 . . . . 0.0 109.59 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.07 138.31 51.7 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.2 -0.938 . . . . 0.0 110.32 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 39.2 t -57.33 131.8 81.15 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.453 -0.779 . . . . 0.0 110.182 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.61 -3.26 13.6 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.489 1.257 . . . . 0.0 110.673 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -111.12 -30.19 7.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.004 -1.06 . . . . 0.0 110.686 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.474 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 1.5 p -135.17 7.94 3.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.995 -1.065 . . . . 0.0 111.313 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.3 16.32 3.06 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.207 -0.933 . . . . 0.0 112.897 178.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.4 p -72.66 156.93 89.65 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 120.626 -1.296 . . . . 0.0 109.884 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.4 ' HG2' ' OD1' ' A' ' 51' ' ' ASN . 43.0 Cg_endo -69.0 140.67 46.16 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.551 1.29 . . . . 0.0 110.306 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.51 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 41.0 tttt -47.29 -30.42 3.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.31 -0.869 . . . . 0.0 111.481 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.4 ' OD1' ' HG2' ' A' ' 49' ' ' PRO . 29.6 p30 -63.18 -14.03 44.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.888 -1.133 . . . . 0.0 110.048 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.568 ' NE2' ' HB2' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -85.97 -2.83 58.66 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.101 -0.999 . . . . 0.0 110.146 179.313 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -81.95 168.04 18.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.958 -1.089 . . . . 0.0 110.21 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 9' ' ' GLU . 0.7 OUTLIER -147.28 132.79 18.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.376 -0.827 . . . . 0.0 109.471 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.524 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 64.5 p -65.52 174.82 2.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.973 -1.08 . . . . 0.0 110.91 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.898 HG22 ' O ' ' A' ' 7' ' ' LYS . 0.6 OUTLIER -160.03 81.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 121.418 0.628 . . . . 0.0 110.207 179.61 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 4' ' ' ASP . 13.5 mtpt -93.75 62.03 3.17 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -0.908 . . . . 0.0 109.785 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.5 mttp -122.12 124.62 44.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -0.907 . . . . 0.0 110.423 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.923 HG13 ' OE2' ' A' ' 2' ' ' GLU . 58.9 t -126.4 65.54 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 109.957 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.648 HG23 ' O ' ' A' ' 60' ' ' ILE . 7.1 tt -132.26 114.04 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.271 -0.893 . . . . 0.0 110.181 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.513 ' HB3' ' HG3' ' A' ' 2' ' ' GLU . . . -176.8 -56.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.188 -0.945 . . . . 0.0 110.044 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 152.28 -125.62 1.86 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -116.32 143.45 45.52 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.317 -1.108 . . . . 0.0 110.324 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -120.15 -35.76 3.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.339 -0.851 . . . . 0.0 109.957 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -63.6 -29.67 70.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.242 -0.911 . . . . 0.0 110.214 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -57.03 167.82 0.77 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.27 -0.894 . . . . 0.0 110.323 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -149.53 107.44 3.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.3 -0.875 . . . . 0.0 109.981 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.2 mtmt 55.32 173.75 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.188 -0.945 . . . . 0.0 110.125 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -147.09 -72.9 0.22 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 110.085 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 CA-C-O 117.968 -1.462 . . . . 0.0 109.463 179.996 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mtp . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.296 0.57 . . . . 0.0 110.018 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -155.85 121.95 5.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.407 -0.808 . . . . 0.0 109.888 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.759 HG21 HG13 ' A' ' 56' ' ' ILE . 3.3 mp -125.48 172.06 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 0.0 110.18 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.499 ' N ' HG22 ' A' ' 3' ' ' ILE . 1.1 t70 -176.35 -30.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.242 -0.911 . . . . 0.0 110.967 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -78.59 -142.04 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.042 -1.037 . . . . 0.0 109.525 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.51 27.97 9.85 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.479 -1.343 . . . . 0.0 109.795 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.424 ' O ' ' CG1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -74.78 119.38 18.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.006 -1.291 . . . . 0.0 109.281 179.38 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.54 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 4.2 m-85 -104.41 166.68 10.24 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.113 -0.992 . . . . 0.0 110.565 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.473 ' HB2' HD13 ' A' ' 56' ' ' ILE . 28.1 tt0 -131.12 134.33 46.47 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.344 -0.847 . . . . 0.0 110.279 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.9 t -74.85 112.42 11.04 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.204 -0.935 . . . . 0.0 109.991 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.61 -10.84 59.84 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.28 -0.968 . . . . 0.0 109.65 178.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.07 -39.93 17.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 111.767 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.452 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 13.0 p -124.54 -36.54 2.61 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.713 -1.242 . . . . 0.0 111.521 -178.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.27 21.16 4.15 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.852 ' C ' HD12 ' A' ' 16' ' ' ILE . 37.5 t80 -81.19 160.62 24.29 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.206 -1.173 . . . . 0.0 109.756 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.852 HD12 ' C ' ' A' ' 15' ' ' TYR . 2.8 mp -127.04 120.93 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.169 -0.957 . . . . 0.0 110.185 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.547 ' CE1' HD21 ' A' ' 37' ' ' LEU . 58.5 t80 -86.7 138.17 31.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.22 -0.925 . . . . 0.0 110.194 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -116.15 112.95 41.7 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.565 -0.709 . . . . 0.0 109.857 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.423 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 38.1 Cg_endo -72.02 -66.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.58 1.305 . . . . 0.0 111.026 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.402 ' O ' ' CB ' ' A' ' 30' ' ' PRO . 1.4 tt0 -45.26 -27.04 0.58 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.698 -0.626 . . . . 0.0 110.97 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.1 tptt -99.86 -30.65 11.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 110.332 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.62 148.38 8.35 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.445 ' HB3' HD12 ' A' ' 28' ' ' ILE . 2.0 t70 -85.03 63.16 7.95 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.451 -1.029 . . . . 0.0 109.599 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -45.34 -29.29 1.01 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.606 -0.684 . . . . 0.0 110.899 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -68.69 -26.46 65.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.314 -0.866 . . . . 0.0 109.89 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -100.67 -28.89 12.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.335 -0.853 . . . . 0.0 109.995 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.05 15.71 3.76 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.955 -1.117 . . . . 0.0 110.462 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.722 HD13 ' CD2' ' A' ' 37' ' ' LEU . 11.9 mt -105.64 121.68 45.19 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.776 -1.426 . . . . 0.0 109.78 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -70.86 171.82 14.92 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.504 1.265 . . . . 0.0 110.691 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.402 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 49.6 Cg_endo -71.42 -163.83 0.14 Allowed 'Trans proline' 0 C--N 1.314 -1.285 0 O-C-N 123.771 1.406 . . . . 0.0 110.201 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 47.98 33.43 10.11 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 85.0 m -137.27 121.63 12.24 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.194 -1.18 . . . . 0.0 110.191 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.763 ' HB2' HG22 ' A' ' 35' ' ' VAL . 48.1 Cg_endo -73.07 155.16 52.61 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.505 1.266 . . . . 0.0 110.745 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.671 ' CD2' HD12 ' A' ' 37' ' ' LEU . 24.5 t80 -58.04 -30.06 65.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.32 -0.862 . . . . 0.0 109.809 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.763 HG22 ' HB2' ' A' ' 33' ' ' PRO . 22.4 m -63.66 -14.84 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.321 -0.862 . . . . 0.0 110.691 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.64 0.94 45.77 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.053 -1.03 . . . . 0.0 111.001 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.722 ' CD2' HD13 ' A' ' 28' ' ' ILE . 21.3 mt -53.64 169.58 0.14 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.888 -1.133 . . . . 0.0 110.209 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.5 t -61.08 153.65 24.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.218 -0.927 . . . . 0.0 110.392 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -54.13 -39.3 66.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.262 -0.899 . . . . 0.0 110.445 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 96.7 p -120.04 43.85 2.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 110.489 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.444 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 40.7 t80 -63.26 137.01 58.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.202 -0.936 . . . . 0.0 109.971 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 45.2 mmm -111.47 164.43 12.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.206 -0.934 . . . . 0.0 109.575 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.3 t -76.63 133.27 70.7 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.291 -0.881 . . . . 0.0 110.3 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -75.09 -1.96 11.92 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.525 1.276 . . . . 0.0 110.287 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.96 -33.62 4.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.961 -1.087 . . . . 0.0 110.712 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.452 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.8 OUTLIER -129.38 7.12 5.34 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.995 -1.066 . . . . 0.0 111.188 -179.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.66 17.6 4.16 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.102 -0.999 . . . . 0.0 112.566 178.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.42 ' CB ' ' SG ' ' A' ' 46' ' ' CYS . 6.6 t -72.44 155.94 90.78 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 120.675 -1.266 . . . . 0.0 109.846 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.96 140.54 50.52 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.615 1.324 . . . . 0.0 110.377 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.464 ' HG2' ' CZ ' ' A' ' 34' ' ' PHE . 21.6 tttt -50.23 -25.41 3.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.238 -0.913 . . . . 0.0 110.735 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -66.6 -12.91 60.13 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.056 -1.028 . . . . 0.0 109.963 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.79 -2.88 58.91 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.07 -1.019 . . . . 0.0 110.08 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.495 ' HB2' ' CZ ' ' A' ' 34' ' ' PHE . 23.9 m-85 -86.41 134.33 33.71 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.956 -1.09 . . . . 0.0 110.072 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.68 139.11 52.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.203 -0.935 . . . . 0.0 109.612 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.646 ' O ' HG23 ' A' ' 56' ' ' ILE . 35.5 p -63.83 176.91 0.83 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.935 . . . . 0.0 111.034 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.759 HG13 HG21 ' A' ' 3' ' ' ILE . 8.1 pt -158.78 89.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 121.261 0.553 . . . . 0.0 109.639 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.9 mtpt -105.59 67.48 0.76 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.362 -0.836 . . . . 0.0 110.033 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -155.87 144.19 20.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.391 -0.818 . . . . 0.0 110.009 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.0 m -133.17 149.25 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.354 -0.841 . . . . 0.0 110.237 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.592 HG23 ' O ' ' A' ' 60' ' ' ILE . 5.2 tt -152.33 71.67 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 110.112 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -157.24 78.84 0.89 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.341 -0.849 . . . . 0.0 110.108 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 162.36 -99.2 0.17 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -147.36 -158.41 0.91 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.113 -1.228 . . . . 0.0 110.357 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.48 58.93 5.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.242 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -129.48 -165.51 1.53 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.125 -0.984 . . . . 0.0 110.051 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -170.65 -38.9 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.155 -0.966 . . . . 0.0 110.441 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.12 -164.07 1.17 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.188 -0.945 . . . . 0.0 110.212 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.5 mttp -113.79 -29.16 7.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.233 -0.917 . . . . 0.0 110.314 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -122.14 68.28 0.93 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.253 -0.904 . . . . 0.0 109.975 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.919 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.4 mtm . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.319 0.581 . . . . 0.0 110.053 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.403 ' C ' HG23 ' A' ' 3' ' ' ILE . 19.5 tt0 54.19 94.03 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.365 -0.834 . . . . 0.0 110.347 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.403 HG23 ' C ' ' A' ' 2' ' ' GLU . 2.9 pt -151.49 140.94 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.349 -0.844 . . . . 0.0 110.167 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.4 ' HB3' ' O ' ' A' ' 3' ' ' ILE . 9.7 p-10 179.56 112.77 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.365 -0.835 . . . . 0.0 109.65 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -158.61 26.27 0.23 Allowed 'General case' 0 C--N 1.29 -2.016 0 CA-C-O 121.245 0.545 . . . . 0.0 110.183 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 95.77 23.73 17.44 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.842 ' O ' HG22 ' A' ' 56' ' ' ILE . 20.6 mtmt -83.88 134.98 34.66 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.303 -1.116 . . . . 0.0 109.611 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.537 ' CE2' ' CD2' ' A' ' 34' ' ' PHE . 14.9 m-85 -125.76 135.58 52.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.131 -0.981 . . . . 0.0 110.688 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 44.8 tt0 -103.91 138.99 39.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.384 -0.822 . . . . 0.0 110.063 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.7 t -79.66 112.53 17.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.191 -0.943 . . . . 0.0 110.331 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.97 -11.18 60.49 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.147 -0.97 . . . . 0.0 109.658 178.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.412 ' HB2' ' NE2' ' A' ' 52' ' ' GLN . . . -85.03 -41.07 16.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.298 -0.876 . . . . 0.0 111.598 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.462 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 14.2 p -123.12 -35.51 2.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.699 -1.25 . . . . 0.0 111.428 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 116.65 20.62 4.94 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 119.677 -1.249 . . . . 0.0 110.071 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.786 ' C ' HD12 ' A' ' 16' ' ' ILE . 67.4 t80 -84.84 169.11 14.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.108 -1.231 . . . . 0.0 109.828 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.786 HD12 ' C ' ' A' ' 15' ' ' TYR . 3.3 mp -133.39 115.2 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.218 -0.926 . . . . 0.0 110.154 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.49 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 58.3 t80 -75.47 136.63 40.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.913 . . . . 0.0 110.086 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.403 ' HB3' ' HB2' ' A' ' 21' ' ' LYS . 88.8 mt-10 -113.5 112.3 48.81 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.549 -0.72 . . . . 0.0 109.632 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.463 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 38.0 Cg_endo -70.06 -74.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.456 1.24 . . . . 0.0 111.554 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.411 ' O ' ' CB ' ' A' ' 30' ' ' PRO . 3.6 mm-40 -43.38 -27.3 0.25 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.525 -0.734 . . . . 0.0 111.398 -179.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.403 ' HB2' ' HB3' ' A' ' 18' ' ' GLU . 2.0 mmmt -93.65 -36.03 12.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.079 -1.013 . . . . 0.0 110.501 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.33 145.17 14.14 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.472 ' HB3' HD12 ' A' ' 28' ' ' ILE . 10.0 t0 -85.08 62.93 7.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.378 -1.072 . . . . 0.0 109.707 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -44.57 -27.17 0.44 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.595 -0.691 . . . . 0.0 111.251 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -74.6 -26.71 60.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.028 -1.045 . . . . 0.0 110.074 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -98.71 -27.93 13.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.219 -0.925 . . . . 0.0 109.983 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.05 30.72 1.42 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.477 HD11 ' CD1' ' A' ' 41' ' ' PHE . 11.4 mt -121.63 119.24 29.28 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.12 -1.224 . . . . 0.0 109.904 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.402 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 43.1 Cg_endo -69.26 173.13 10.97 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.459 1.242 . . . . 0.0 110.359 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.411 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 47.1 Cg_endo -70.05 -163.85 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.68 1.358 . . . . 0.0 110.224 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 48.49 39.91 23.11 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.7 m -142.26 115.56 6.45 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.176 -1.191 . . . . 0.0 110.446 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.767 ' HB2' HG22 ' A' ' 35' ' ' VAL . 46.1 Cg_endo -74.18 153.29 46.05 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.474 1.25 . . . . 0.0 110.51 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.586 ' CD1' HD12 ' A' ' 37' ' ' LEU . 43.3 t80 -61.74 -28.15 69.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.34 -0.85 . . . . 0.0 110.236 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.767 HG22 ' HB2' ' A' ' 33' ' ' PRO . 35.6 m -67.96 -9.73 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -0.933 . . . . 0.0 110.875 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.403 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -110.13 0.25 18.21 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.96 -1.087 . . . . 0.0 110.989 -179.744 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.586 HD12 ' CD1' ' A' ' 34' ' ' PHE . 28.2 mt -51.02 164.09 0.17 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.997 -1.064 . . . . 0.0 110.285 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.4 m -50.18 157.59 0.65 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.189 -0.944 . . . . 0.0 110.446 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.18 -15.48 46.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.0 110.398 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.2 51.74 1.58 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.071 -1.018 . . . . 0.0 110.43 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.477 ' CD1' HD11 ' A' ' 28' ' ' ILE . 32.1 t80 -68.96 142.84 54.58 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.213 -0.929 . . . . 0.0 110.022 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.429 ' HA ' ' O ' ' A' ' 48' ' ' SER . 7.7 mtt -120.11 150.67 40.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.327 -0.858 . . . . 0.0 109.57 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.442 ' HB3' ' N ' ' A' ' 47' ' ' ARG . 7.3 t -58.13 135.92 84.37 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.223 -0.923 . . . . 0.0 110.26 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.78 -2.89 12.86 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.596 1.314 . . . . 0.0 110.437 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -121.66 -50.42 2.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.91 -1.119 . . . . 0.0 110.918 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.462 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -105.38 5.54 31.84 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.03 -1.044 . . . . 0.0 111.304 -179.345 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.442 ' N ' ' HB3' ' A' ' 43' ' ' CYS . 12.3 ttm-85 56.92 20.48 5.34 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.061 -1.024 . . . . 0.0 112.272 178.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.429 ' O ' ' HA ' ' A' ' 42' ' ' MET . 2.8 t -70.41 155.95 92.64 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 120.798 -1.188 . . . . 0.0 109.676 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.91 142.56 43.15 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.588 1.31 . . . . 0.0 110.266 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.514 ' HE2' ' CE2' ' A' ' 34' ' ' PHE . 22.4 tttt -51.77 -25.27 7.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.157 -0.964 . . . . 0.0 110.329 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.5 t30 -68.2 -11.95 60.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.136 -0.977 . . . . 0.0 109.826 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.412 ' NE2' ' HB2' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -91.83 1.36 57.22 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.162 -0.961 . . . . 0.0 110.077 179.352 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.499 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 34.6 m-85 -90.78 129.09 36.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.018 -1.051 . . . . 0.0 110.628 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.93 134.31 49.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.368 -0.832 . . . . 0.0 109.603 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.509 ' HB3' ' CE2' ' A' ' 8' ' ' TYR . 86.4 p -64.25 -179.94 0.5 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.074 -1.016 . . . . 0.0 110.984 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.842 HG22 ' O ' ' A' ' 7' ' ' LYS . 9.7 tt -160.12 91.96 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.787 -0.57 . . . . 0.0 110.267 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.2 74.88 1.48 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.029 -1.044 . . . . 0.0 110.44 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.9 142.32 28.11 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.272 -0.892 . . . . 0.0 110.196 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 59' ' ' VAL . 9.2 p -146.41 135.92 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.228 -0.92 . . . . 0.0 110.175 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.431 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 5.8 tp -135.45 146.77 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 110.146 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 60' ' ' ILE . . . 55.64 -164.06 0.14 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.159 -0.963 . . . . 0.0 110.25 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.8 92.6 2.22 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -141.09 -177.31 5.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.228 -1.16 . . . . 0.0 110.147 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -153.38 40.36 0.52 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.178 -0.951 . . . . 0.0 110.318 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.62 132.38 45.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.317 -0.865 . . . . 0.0 110.034 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -114.46 49.91 0.99 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.256 -0.903 . . . . 0.0 110.403 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -77.42 168.29 20.25 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.12 -0.987 . . . . 0.0 110.043 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.35 -70.43 0.67 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.246 -0.909 . . . . 0.0 110.192 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -87.85 101.02 13.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.3 -0.875 . . . . 0.0 110.345 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 179.945 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 ttm . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.231 0.538 . . . . 0.0 110.265 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.7 160.53 17.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.187 -0.946 . . . . 0.0 110.339 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.556 HG21 HG23 ' A' ' 56' ' ' ILE . 4.2 mp -136.91 167.56 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.3 -0.875 . . . . 0.0 110.23 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.431 ' N ' HG22 ' A' ' 3' ' ' ILE . 0.2 OUTLIER 171.77 -26.57 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.225 -0.922 . . . . 0.0 110.88 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.401 ' HB3' ' HE2' ' A' ' 7' ' ' LYS . 0.5 OUTLIER -71.02 64.01 0.33 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.176 -0.953 . . . . 0.0 111.032 -179.188 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 49.23 24.26 4.78 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.826 ' O ' HG22 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -78.35 112.39 15.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.913 -1.345 . . . . 0.0 109.263 179.375 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.575 ' CE2' ' CD1' ' A' ' 34' ' ' PHE . 4.4 m-85 -95.47 133.93 38.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 110.555 -179.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.628 ' HA ' HD13 ' A' ' 16' ' ' ILE . 11.0 tt0 -101.54 132.06 47.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.42 -0.8 . . . . 0.0 110.281 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.1 t -74.39 119.45 18.61 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.2 -0.938 . . . . 0.0 110.169 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.3 -11.69 60.34 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.087 -1.008 . . . . 0.0 109.654 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.425 ' HB2' ' NE2' ' A' ' 52' ' ' GLN . . . -85.07 -37.85 19.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.241 -0.912 . . . . 0.0 111.699 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.468 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 13.7 p -126.63 -34.56 2.42 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.717 -1.24 . . . . 0.0 111.645 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.74 22.4 5.39 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.449 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 55.9 t80 -84.41 159.2 20.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.373 -1.074 . . . . 0.0 109.762 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.628 HD13 ' HA ' ' A' ' 9' ' ' GLU . 39.4 mm -123.6 111.0 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 0.0 110.655 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.43 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 53.1 t80 -75.75 130.65 38.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.41 -0.806 . . . . 0.0 110.175 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -108.38 113.25 60.49 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.434 -0.791 . . . . 0.0 109.406 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.49 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 38.3 Cg_endo -71.95 -64.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.495 1.261 . . . . 0.0 110.963 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -45.35 -26.82 0.58 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.702 -0.624 . . . . 0.0 111.12 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -97.07 -30.36 13.09 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.04 -1.037 . . . . 0.0 110.236 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.66 153.51 23.63 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.734 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -85.12 61.9 7.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.39 -1.064 . . . . 0.0 109.795 179.657 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.71 -28.51 0.63 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.513 -0.742 . . . . 0.0 110.953 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.8 -24.76 44.37 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.226 -0.921 . . . . 0.0 110.42 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.734 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -97.69 -27.48 14.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.154 -0.966 . . . . 0.0 110.213 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 119.48 27.57 2.14 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.44 HD13 ' CD2' ' A' ' 37' ' ' LEU . 6.5 mt -120.13 126.07 27.01 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.097 -1.237 . . . . 0.0 109.975 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.409 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 43.9 Cg_endo -71.3 173.28 12.55 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.54 1.284 . . . . 0.0 110.289 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 49.1 Cg_endo -70.76 -163.73 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.683 1.36 . . . . 0.0 110.088 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 47.71 26.79 4.2 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 91.8 m -124.22 111.34 28.52 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.138 -1.213 . . . . 0.0 110.292 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.712 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.3 Cg_endo -73.11 148.99 45.51 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.492 1.259 . . . . 0.0 110.614 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.575 ' CD1' ' CE2' ' A' ' 8' ' ' TYR . 12.7 t80 -52.46 -30.88 32.03 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.308 -0.87 . . . . 0.0 110.506 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.712 HG22 ' HB2' ' A' ' 33' ' ' PRO . 26.6 m -65.27 -17.49 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.23 -0.919 . . . . 0.0 110.841 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -99.73 -0.01 40.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.072 -1.017 . . . . 0.0 110.887 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.495 ' HA ' HD23 ' A' ' 37' ' ' LEU . 15.5 mt -53.66 170.68 0.11 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.853 -1.155 . . . . 0.0 110.248 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.8 m -57.82 166.2 1.51 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.207 -0.933 . . . . 0.0 110.412 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.44 -22.28 66.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.301 -0.874 . . . . 0.0 110.245 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.7 m -139.0 53.05 1.76 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.267 -0.896 . . . . 0.0 110.075 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.44 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 11.3 t80 -65.3 141.16 58.7 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.365 -0.834 . . . . 0.0 110.184 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.418 ' HA ' ' O ' ' A' ' 48' ' ' SER . 8.9 mtt -114.33 147.97 38.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.354 -0.841 . . . . 0.0 109.348 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.401 ' HB2' ' OG ' ' A' ' 48' ' ' SER . 23.9 t -60.48 138.36 92.45 Favored Pre-proline 0 C--N 1.3 -1.552 0 O-C-N 121.278 -0.889 . . . . 0.0 110.582 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -78.79 3.14 7.59 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.643 1.338 . . . . 0.0 110.661 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -124.57 -35.83 2.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.913 -1.117 . . . . 0.0 110.782 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.468 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 1.2 p -124.66 4.62 8.21 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.989 -1.069 . . . . 0.0 111.334 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.44 18.87 7.24 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.163 -0.961 . . . . 0.0 112.478 178.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 42' ' ' MET . 26.3 p -71.51 162.0 75.36 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 120.573 -1.329 . . . . 0.0 109.507 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.406 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 43.5 Cg_endo -70.4 144.86 51.81 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.596 1.314 . . . . 0.0 110.625 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.501 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 3.8 tttm -51.48 -31.23 22.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.219 -0.925 . . . . 0.0 110.496 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -65.25 -13.11 57.56 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.05 -1.032 . . . . 0.0 109.783 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.425 ' NE2' ' HB2' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -84.79 -5.22 59.32 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.12 -0.988 . . . . 0.0 109.762 178.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.429 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 21.5 m-85 -84.25 152.78 23.98 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.255 -0.903 . . . . 0.0 109.582 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.7 ttpp -142.57 131.55 23.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.175 -0.953 . . . . 0.0 110.034 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.52 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 9.1 p -59.88 172.42 0.75 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.158 -0.964 . . . . 0.0 110.444 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.826 HG22 ' O ' ' A' ' 7' ' ' LYS . 2.6 tt -159.97 84.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 CA-C-O 121.572 0.701 . . . . 0.0 109.898 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.0 68.01 0.66 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.234 -0.916 . . . . 0.0 110.285 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.6 mttp -144.56 127.02 15.93 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.27 -0.894 . . . . 0.0 110.355 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.9 m -71.5 151.08 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.159 -0.963 . . . . 0.0 110.045 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.6 pt -130.62 58.15 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.194 -0.941 . . . . 0.0 110.393 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.24 -23.56 8.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.173 -0.954 . . . . 0.0 110.205 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 178.76 -108.12 0.24 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.435 ' CZ ' ' HG3' ' A' ' 65' ' ' GLU . 45.8 p90 -156.77 34.89 0.3 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.313 -1.11 . . . . 0.0 110.281 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 52.57 78.09 0.14 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.221 -0.924 . . . . 0.0 110.312 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.435 ' HG3' ' CZ ' ' A' ' 63' ' ' PHE . 3.9 mt-10 -52.22 147.57 7.54 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.231 -0.918 . . . . 0.0 110.256 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -119.94 39.9 3.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.283 -0.886 . . . . 0.0 110.166 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -125.45 -168.1 1.79 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.175 -0.953 . . . . 0.0 110.283 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.42 102.51 12.16 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.312 -0.868 . . . . 0.0 110.294 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -167.13 81.64 0.22 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.244 -0.91 . . . . 0.0 110.156 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 CA-C-O 117.986 -1.452 . . . . 0.0 109.552 -179.868 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.189 0.518 . . . . 0.0 110.301 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 52.71 69.77 0.65 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.186 -0.946 . . . . 0.0 110.246 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.403 ' O ' ' HB3' ' A' ' 4' ' ' ASP . 20.4 pt -134.18 136.61 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.23 -0.919 . . . . 0.0 110.314 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.403 ' HB3' ' O ' ' A' ' 3' ' ' ILE . 9.4 p-10 179.92 112.44 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 121.815 0.817 . . . . 0.0 109.424 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -168.03 46.38 0.05 OUTLIER 'General case' 0 C--N 1.29 -1.983 0 CA-C-O 121.32 0.581 . . . . 0.0 109.953 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 65.38 16.21 62.43 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -84.61 144.64 28.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.123 -1.222 . . . . 0.0 109.828 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.519 ' CE2' ' HB2' ' A' ' 55' ' ' SER . 27.1 m-85 -130.31 143.66 50.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.029 -1.044 . . . . 0.0 110.473 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.638 ' HA ' HD13 ' A' ' 16' ' ' ILE . 2.8 tm-20 -111.78 134.54 53.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.383 -0.823 . . . . 0.0 109.8 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.2 t -77.61 113.64 15.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.227 -0.921 . . . . 0.0 110.446 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -70.44 -11.23 60.78 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.182 -0.949 . . . . 0.0 109.556 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.99 -40.42 16.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.894 . . . . 0.0 111.579 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.471 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 12.5 p -124.18 -32.07 3.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.728 -1.232 . . . . 0.0 111.553 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.13 22.03 6.38 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.516 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 56.7 t80 -83.18 169.02 16.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.282 -1.128 . . . . 0.0 109.871 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.638 HD13 ' HA ' ' A' ' 9' ' ' GLU . 40.9 mm -134.06 115.32 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.058 -1.026 . . . . 0.0 110.68 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.503 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 69.5 t80 -78.88 136.8 37.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.335 -0.853 . . . . 0.0 109.898 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -117.75 112.61 38.59 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.482 -0.761 . . . . 0.0 109.801 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.491 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 37.7 Cg_endo -69.82 -63.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.442 1.233 . . . . 0.0 110.558 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -47.46 -25.47 1.08 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.691 -0.631 . . . . 0.0 110.635 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.56 -42.24 7.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 0.0 110.675 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.55 153.31 29.59 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.489 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 0.9 OUTLIER -85.12 60.44 6.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.369 -1.077 . . . . 0.0 109.975 179.762 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.99 -25.81 0.88 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.443 -0.786 . . . . 0.0 110.948 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.83 -20.95 41.3 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.179 -0.951 . . . . 0.0 110.318 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.489 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -104.39 -29.82 10.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.119 -0.988 . . . . 0.0 110.295 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 124.52 34.07 0.73 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.435 ' HB ' ' CB ' ' A' ' 23' ' ' ASP . 4.6 mt -128.73 125.65 23.09 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.162 -1.199 . . . . 0.0 109.712 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.86 173.26 14.3 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.468 1.246 . . . . 0.0 110.575 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.66 -163.79 0.13 Allowed 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.77 1.405 . . . . 0.0 109.913 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 48.72 25.72 5.01 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.5 m -125.84 115.68 24.43 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.295 -1.121 . . . . 0.0 109.979 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.725 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.6 Cg_endo -72.64 149.71 49.5 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.448 1.236 . . . . 0.0 110.894 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.685 ' CD1' HD12 ' A' ' 37' ' ' LEU . 60.4 t80 -54.97 -25.88 32.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.425 -0.797 . . . . 0.0 110.342 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.725 HG22 ' HB2' ' A' ' 33' ' ' PRO . 25.0 m -70.13 -24.23 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.11 -0.993 . . . . 0.0 110.304 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.407 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 3.0 t70 -87.5 -6.12 58.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.181 -0.949 . . . . 0.0 110.758 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.685 HD12 ' CD1' ' A' ' 34' ' ' PHE . 20.3 mt -52.19 160.54 0.76 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.043 -1.036 . . . . 0.0 110.282 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.87 150.78 19.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -0.897 . . . . 0.0 109.981 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -56.04 -25.39 44.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.254 -0.904 . . . . 0.0 110.313 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.34 38.34 4.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.122 -0.986 . . . . 0.0 110.709 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.453 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 36.4 t80 -59.34 133.45 56.1 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.043 -1.036 . . . . 0.0 109.793 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 13.8 mtp -109.98 155.79 21.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.367 -0.833 . . . . 0.0 109.5 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 30.6 t -71.78 131.8 85.62 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.15 -0.969 . . . . 0.0 110.213 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -75.41 -2.18 12.24 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.585 1.308 . . . . 0.0 110.513 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -112.91 -32.5 6.37 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.055 -1.028 . . . . 0.0 110.403 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.471 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 1.3 p -133.61 7.78 3.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.075 -1.016 . . . . 0.0 111.178 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 58.75 13.65 2.79 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.175 -0.953 . . . . 0.0 112.935 177.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.9 m -68.37 163.12 55.87 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 120.604 -1.31 . . . . 0.0 110.052 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.405 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 46.6 Cg_endo -72.6 143.59 38.33 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.699 1.368 . . . . 0.0 110.431 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.5 ' HE2' ' CE2' ' A' ' 34' ' ' PHE . 9.8 tttm -49.97 -26.39 4.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.039 -1.038 . . . . 0.0 110.666 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -66.64 -12.07 56.49 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.124 -0.985 . . . . 0.0 110.006 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -86.27 -4.56 59.19 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.169 -0.957 . . . . 0.0 110.174 179.237 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.464 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 44.1 m-85 -84.25 144.44 28.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.945 -1.097 . . . . 0.0 110.44 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.0 ttmm -124.56 119.19 28.37 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.365 -0.834 . . . . 0.0 109.535 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.519 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 3.7 t -50.95 177.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.058 -1.026 . . . . 0.0 110.573 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.1 pt -141.98 58.05 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.653 -0.654 . . . . 0.0 110.012 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.8 tttt -93.74 61.68 3.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.348 -0.845 . . . . 0.0 109.905 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.08 115.22 29.72 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.325 -0.859 . . . . 0.0 110.611 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.8 m -135.72 153.49 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.332 -0.855 . . . . 0.0 110.011 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.5 mm -123.18 155.22 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.937 . . . . 0.0 110.079 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -147.59 81.92 1.52 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.18 -0.95 . . . . 0.0 110.169 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -131.94 51.02 0.87 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -86.0 105.88 16.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -1.15 . . . . 0.0 110.297 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -144.89 -167.82 2.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.372 -0.83 . . . . 0.0 110.024 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -132.47 -163.59 1.36 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.191 -0.943 . . . . 0.0 110.275 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -126.02 136.12 52.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.304 -0.873 . . . . 0.0 110.203 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -89.48 159.72 17.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.177 -0.952 . . . . 0.0 110.008 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.1 mttm 52.89 -170.33 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.141 -0.975 . . . . 0.0 110.038 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -138.42 146.79 42.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.922 . . . . 0.0 110.185 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 CA-C-O 117.981 -1.455 . . . . 0.0 109.556 179.946 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 ptt? . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.215 0.531 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 51.8 74.23 0.27 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.233 -0.917 . . . . 0.0 110.114 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.595 HG21 HG23 ' A' ' 56' ' ' ILE . 44.9 mt -123.32 171.87 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.245 -0.91 . . . . 0.0 110.077 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.492 ' N ' HG22 ' A' ' 3' ' ' ILE . 0.2 OUTLIER 178.91 -22.2 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.1 -1.0 . . . . 0.0 111.937 -179.576 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -79.13 -141.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.764 -1.21 . . . . 0.0 110.26 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.45 31.63 5.67 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.516 ' O ' HG22 ' A' ' 56' ' ' ILE . 6.1 tttp -80.39 124.87 29.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.02 -1.283 . . . . 0.0 109.28 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.529 ' CE2' ' CD2' ' A' ' 34' ' ' PHE . 11.5 m-85 -112.28 155.27 24.34 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.981 -1.074 . . . . 0.0 110.602 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 8.3 tt0 -122.29 130.74 53.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.462 -0.774 . . . . 0.0 109.827 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 t -73.35 114.67 11.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.096 -1.002 . . . . 0.0 110.373 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.71 -12.68 61.71 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.371 -0.931 . . . . 0.0 109.36 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.488 ' HB2' ' NE2' ' A' ' 52' ' ' GLN . . . -85.03 -41.01 16.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.343 -0.848 . . . . 0.0 111.758 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.438 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 11.4 p -123.53 -28.58 3.89 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.583 -1.323 . . . . 0.0 111.795 -178.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.71 20.06 8.76 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 119.703 -1.237 . . . . 0.0 110.226 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.804 ' C ' HD12 ' A' ' 16' ' ' ILE . 35.8 t80 -83.0 159.54 22.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.135 -1.215 . . . . 0.0 109.867 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.804 HD12 ' C ' ' A' ' 15' ' ' TYR . 2.9 mp -121.82 120.36 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.91 . . . . 0.0 109.835 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.488 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 61.4 t80 -84.12 138.0 33.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.908 . . . . 0.0 110.376 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.97 110.62 45.88 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.738 -0.601 . . . . 0.0 109.911 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.474 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 38.7 Cg_endo -72.89 -65.06 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.494 1.26 . . . . 0.0 111.088 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.426 ' O ' ' CB ' ' A' ' 30' ' ' PRO . 3.3 tt0 -45.48 -25.44 0.43 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.692 -0.63 . . . . 0.0 111.374 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.54 -41.84 7.57 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.094 -1.004 . . . . 0.0 110.65 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.26 145.96 19.75 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.539 ' HB3' HD12 ' A' ' 28' ' ' ILE . 22.4 t0 -85.09 63.23 7.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.335 -1.097 . . . . 0.0 109.676 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -43.64 -27.64 0.32 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.725 -0.61 . . . . 0.0 111.254 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -71.85 -29.1 64.04 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.154 -0.966 . . . . 0.0 109.924 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.494 ' HB3' HD12 ' A' ' 28' ' ' ILE . . . -96.82 -27.53 14.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.411 -0.805 . . . . 0.0 110.048 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.26 25.86 2.84 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.539 HD12 ' HB3' ' A' ' 23' ' ' ASP . 5.8 mt -114.6 120.27 38.08 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.074 -1.251 . . . . 0.0 110.001 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.426 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 45.4 Cg_endo -70.74 174.01 10.99 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.534 1.281 . . . . 0.0 110.509 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.426 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 47.6 Cg_endo -70.95 -163.28 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.715 1.376 . . . . 0.0 110.112 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 50.3 24.88 7.53 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 91.9 m -126.0 113.32 24.27 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.092 -1.24 . . . . 0.0 110.295 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.777 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.2 Cg_endo -72.1 149.68 52.72 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 O-C-N 123.532 1.28 . . . . 0.0 110.619 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.529 ' CD2' ' CE2' ' A' ' 8' ' ' TYR . 27.3 t80 -52.38 -28.67 20.58 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.371 -0.831 . . . . 0.0 109.957 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.777 HG22 ' HB2' ' A' ' 33' ' ' PRO . 24.8 m -70.23 -15.41 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.285 -0.884 . . . . 0.0 110.557 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -98.32 -6.43 30.91 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.025 -1.047 . . . . 0.0 110.752 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.438 HD21 ' CZ ' ' A' ' 17' ' ' TYR . 27.2 mt -51.25 162.28 0.34 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.956 -1.09 . . . . 0.0 110.461 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.3 m -50.31 154.8 1.14 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.347 -0.846 . . . . 0.0 110.508 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.19 -24.03 66.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.286 -0.884 . . . . 0.0 110.1 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.2 t -127.91 38.41 4.03 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.236 -0.915 . . . . 0.0 110.205 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.457 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 45.7 t80 -54.98 138.03 44.62 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.297 -0.877 . . . . 0.0 110.263 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.3 mmt -113.74 135.82 53.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.291 -0.881 . . . . 0.0 109.74 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 24.4 t -53.79 133.03 56.82 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.249 -0.907 . . . . 0.0 110.585 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -75.06 -3.69 14.29 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.447 1.235 . . . . 0.0 110.506 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -112.17 -35.65 5.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.033 -1.042 . . . . 0.0 110.559 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.438 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 1.5 p -128.57 6.51 5.69 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.087 -1.008 . . . . 0.0 111.01 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 54.46 20.07 2.63 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.209 -0.932 . . . . 0.0 112.714 178.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.0 m -74.27 165.68 51.33 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 120.617 -1.302 . . . . 0.0 109.658 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.51 136.06 30.11 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.638 1.336 . . . . 0.0 110.177 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 41' ' ' PHE . 14.5 tttm -48.32 -26.01 1.83 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.2 -0.938 . . . . 0.0 110.697 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -63.69 -15.07 57.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.167 -0.958 . . . . 0.0 109.822 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.488 ' NE2' ' HB2' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -85.13 -2.97 58.62 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.255 -0.903 . . . . 0.0 110.136 179.381 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 34' ' ' PHE . 11.3 m-85 -82.75 133.16 35.15 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.95 -1.094 . . . . 0.0 110.478 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.91 120.33 38.12 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.197 -0.939 . . . . 0.0 109.527 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 3.0 t -52.0 -178.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.338 -0.851 . . . . 0.0 110.625 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.595 HG23 HG21 ' A' ' 3' ' ' ILE . 3.0 tt -158.26 91.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.531 -0.731 . . . . 0.0 109.691 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 4' ' ' ASP . 5.1 mttt -105.73 67.86 0.77 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.4 -0.813 . . . . 0.0 110.124 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -127.08 141.8 51.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.324 -0.86 . . . . 0.0 110.338 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.451 HG23 ' OD1' ' A' ' 4' ' ' ASP . 88.6 t -127.53 140.67 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 110.155 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.644 HG23 ' O ' ' A' ' 60' ' ' ILE . 2.1 tp -150.93 110.95 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.908 . . . . 0.0 110.151 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -142.28 66.16 1.34 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.19 -0.944 . . . . 0.0 110.147 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.74 93.57 0.74 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -125.01 28.17 6.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.137 -1.214 . . . . 0.0 110.18 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -106.08 -76.92 0.6 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.245 -0.909 . . . . 0.0 110.194 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -109.17 -75.27 0.63 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.93 . . . . 0.0 110.42 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -165.61 -59.15 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.19 -0.944 . . . . 0.0 110.277 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -75.22 137.61 41.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.224 -0.923 . . . . 0.0 110.24 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.13 -56.35 23.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.238 -0.914 . . . . 0.0 110.134 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -58.37 -173.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.294 -0.879 . . . . 0.0 110.19 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 CA-C-O 117.975 -1.458 . . . . 0.0 109.559 -179.879 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 mtt . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.226 0.536 . . . . 0.0 110.173 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.15 113.53 18.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.318 -0.864 . . . . 0.0 110.129 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.546 HD12 HD13 ' A' ' 56' ' ' ILE . 12.8 pt -147.36 122.13 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.153 -0.967 . . . . 0.0 110.613 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.419 ' OD1' ' CB ' ' A' ' 57' ' ' LYS . 39.5 t0 -159.54 13.3 0.14 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.391 -0.818 . . . . 0.0 111.36 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.16 68.81 4.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.048 -1.033 . . . . 0.0 110.575 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 50.46 28.13 13.82 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.69 ' HB3' HD11 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -84.25 130.17 34.83 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.143 -1.21 . . . . 0.0 109.951 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.505 ' CE2' ' HB2' ' A' ' 55' ' ' SER . 22.9 m-85 -117.0 149.1 40.8 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.148 -0.97 . . . . 0.0 110.381 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.466 ' HA ' HD13 ' A' ' 16' ' ' ILE . 1.2 tm-20 -119.16 130.06 55.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 0.0 110.323 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.6 t -73.62 114.72 12.2 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.274 -0.891 . . . . 0.0 110.25 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -70.4 -11.39 60.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.071 -1.018 . . . . 0.0 109.624 178.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.09 -42.29 14.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.397 -0.814 . . . . 0.0 111.579 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.466 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 13.8 p -121.88 -31.04 4.0 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.709 -1.245 . . . . 0.0 111.418 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.65 23.0 6.73 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.427 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 44.6 t80 -82.31 159.25 23.15 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.34 -1.094 . . . . 0.0 109.517 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.466 HD13 ' HA ' ' A' ' 9' ' ' GLU . 41.3 mm -123.77 115.77 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.205 -0.934 . . . . 0.0 110.041 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.535 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 81.1 t80 -81.44 135.81 35.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.3 -0.875 . . . . 0.0 110.321 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -114.94 114.33 43.92 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.529 -0.732 . . . . 0.0 109.603 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.481 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 37.7 Cg_endo -69.44 -67.04 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.531 1.28 . . . . 0.0 111.559 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -43.04 -28.0 0.24 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.739 -0.601 . . . . 0.0 111.225 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.4 tptt -96.8 -27.13 14.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.159 -0.963 . . . . 0.0 110.271 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.62 159.58 30.52 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.55 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 1.0 OUTLIER -85.05 59.86 5.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.339 -1.095 . . . . 0.0 109.81 179.799 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -46.51 -26.51 0.89 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.406 -0.809 . . . . 0.0 110.613 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -76.01 -28.01 57.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 110.061 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.55 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -97.71 -27.45 14.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.304 -0.872 . . . . 0.0 110.192 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.16 22.67 2.58 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.5 HD12 ' HB3' ' A' ' 23' ' ' ASP . 5.0 mt -112.18 130.01 23.72 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 120.975 -1.309 . . . . 0.0 109.595 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.416 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 49.1 Cg_endo -74.38 173.48 14.17 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.483 1.254 . . . . 0.0 110.393 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.416 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 49.9 Cg_endo -71.68 -163.54 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.65 1.342 . . . . 0.0 110.065 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 51.17 32.98 29.68 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.794 -1.323 . . . . 0.0 109.794 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 93.8 m -137.63 122.03 12.1 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.209 -1.171 . . . . 0.0 110.064 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.77 ' HB2' HG22 ' A' ' 35' ' ' VAL . 50.1 Cg_endo -76.32 151.84 34.19 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.547 1.288 . . . . 0.0 110.697 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.535 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 20.7 t80 -52.26 -33.25 40.86 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.305 -0.872 . . . . 0.0 109.84 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.77 HG22 ' HB2' ' A' ' 33' ' ' PRO . 33.3 m -64.69 -15.11 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.921 . . . . 0.0 110.506 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.53 -18.29 33.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.15 -0.968 . . . . 0.0 110.559 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.487 HD11 ' CE1' ' A' ' 17' ' ' TYR . 71.0 mt -51.81 146.45 8.13 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.046 -1.034 . . . . 0.0 110.29 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.93 160.0 0.36 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.194 -0.942 . . . . 0.0 110.519 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -66.83 -13.88 62.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -0.897 . . . . 0.0 110.624 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 30.6 t -122.11 25.5 9.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.023 -1.048 . . . . 0.0 110.365 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.463 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 25.4 t80 -54.81 135.22 47.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.131 -0.981 . . . . 0.0 109.871 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -109.42 150.66 27.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.369 -0.832 . . . . 0.0 109.58 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 18.1 t -66.38 134.76 94.62 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.113 -0.992 . . . . 0.0 110.347 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.71 -7.85 18.82 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.667 1.351 . . . . 0.0 110.185 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -110.19 -31.92 7.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.172 -0.955 . . . . 0.0 110.844 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.466 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.8 OUTLIER -134.49 7.31 3.57 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.021 -1.049 . . . . 0.0 111.353 -179.681 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 58.49 14.56 3.07 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.098 -1.001 . . . . 0.0 112.837 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.5 m -65.45 165.93 16.32 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 120.619 -1.301 . . . . 0.0 110.087 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.99 141.34 26.56 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.666 1.35 . . . . 0.0 110.152 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.463 ' HB2' ' HB3' ' A' ' 41' ' ' PHE . 8.6 tttm -51.87 -26.21 9.61 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.215 -0.928 . . . . 0.0 110.261 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -68.53 -11.17 59.52 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.185 -0.947 . . . . 0.0 109.89 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.88 -2.35 58.55 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.175 -0.953 . . . . 0.0 110.076 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.412 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 17.9 m-85 -86.25 140.01 30.51 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.999 -1.063 . . . . 0.0 110.226 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.61 124.89 46.37 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.2 -0.938 . . . . 0.0 109.801 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.527 ' C ' HG23 ' A' ' 56' ' ' ILE . 3.0 t -57.28 178.34 0.07 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.237 -0.914 . . . . 0.0 110.809 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.69 HD11 ' HB3' ' A' ' 7' ' ' LYS . 1.1 pt -155.35 84.52 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.828 -0.545 . . . . 0.0 109.832 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.419 ' CB ' ' OD1' ' A' ' 4' ' ' ASP . 0.2 OUTLIER -99.17 63.86 1.34 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.172 -0.955 . . . . 0.0 110.142 -179.882 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.477 ' C ' HG13 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -95.55 138.86 32.63 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.298 -0.877 . . . . 0.0 110.092 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.477 HG13 ' C ' ' A' ' 58' ' ' LYS . 29.6 m -148.9 135.52 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 110.249 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.449 ' N ' HD12 ' A' ' 60' ' ' ILE . 4.7 mp -129.04 -43.71 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.242 -0.911 . . . . 0.0 110.288 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -144.61 123.38 12.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -0.898 . . . . 0.0 110.241 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -151.71 -114.61 0.62 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -97.49 -50.95 4.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -1.143 . . . . 0.0 110.2 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -129.09 109.52 11.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.178 -0.952 . . . . 0.0 110.259 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -72.64 -158.37 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.22 -0.925 . . . . 0.0 110.211 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -165.14 74.0 0.22 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 110.049 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -60.57 114.71 3.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.152 -0.968 . . . . 0.0 110.246 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.5 tptt -140.99 -45.17 0.39 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.894 . . . . 0.0 110.084 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -174.8 152.05 1.51 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.312 -0.867 . . . . 0.0 110.202 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 CA-C-O 117.959 -1.467 . . . . 0.0 109.513 -179.975 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.0 ttp . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.241 0.544 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -142.52 91.4 2.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.203 -0.936 . . . . 0.0 110.3 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.845 HD12 ' HB ' ' A' ' 56' ' ' ILE . 8.2 pt -140.85 134.14 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.265 -0.897 . . . . 0.0 109.754 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' A' ' 6' ' ' GLY . 0.7 OUTLIER 179.91 -30.26 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.205 -0.934 . . . . 0.0 110.96 -179.398 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -67.49 71.2 0.12 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.354 -0.841 . . . . 0.0 110.36 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 4' ' ' ASP . . . 51.33 23.66 9.08 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.43 ' O ' HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -79.37 125.33 29.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.124 -1.221 . . . . 0.0 109.223 179.213 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.52 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 7.8 m-85 -115.77 156.42 26.04 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.075 -1.015 . . . . 0.0 110.566 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.529 ' HA ' HD13 ' A' ' 16' ' ' ILE . 2.5 pp20? -126.43 136.26 52.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.367 -0.833 . . . . 0.0 110.168 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.0 t -78.25 111.84 14.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.945 . . . . 0.0 110.242 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.69 -10.83 59.82 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.204 -0.998 . . . . 0.0 109.426 178.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.68 -43.01 14.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.352 -0.843 . . . . 0.0 111.383 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.46 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 12.7 p -120.5 -31.66 4.26 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.632 -1.292 . . . . 0.0 111.273 -179.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.6 21.5 6.8 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.684 -1.246 . . . . 0.0 110.132 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.525 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 52.2 t80 -83.18 167.38 17.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.109 -1.23 . . . . 0.0 109.907 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.529 HD13 ' HA ' ' A' ' 9' ' ' GLU . 36.5 mm -131.11 117.67 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.137 -0.977 . . . . 0.0 110.334 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.503 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 72.7 t80 -81.04 135.31 35.82 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.436 -0.79 . . . . 0.0 110.422 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -112.38 113.7 50.98 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.612 -0.68 . . . . 0.0 109.761 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.47 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 39.0 Cg_endo -72.26 -68.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.414 1.218 . . . . 0.0 111.144 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -45.16 -26.63 0.5 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.581 -0.699 . . . . 0.0 111.2 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.99 -37.57 11.07 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.079 -1.013 . . . . 0.0 110.49 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.63 152.09 28.84 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.549 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 4.2 t0 -85.11 62.9 7.8 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.4 -1.059 . . . . 0.0 109.674 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.43 -27.37 0.44 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.647 -0.658 . . . . 0.0 111.03 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -77.22 -27.86 53.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.184 -0.947 . . . . 0.0 110.206 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.549 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -95.85 -28.83 14.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.251 -0.906 . . . . 0.0 110.362 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.08 11.55 5.21 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.815 -1.183 . . . . 0.0 110.296 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.422 HD12 ' HB3' ' A' ' 23' ' ' ASP . 4.6 mt -103.08 124.61 37.84 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 120.938 -1.33 . . . . 0.0 110.012 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.423 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 45.3 Cg_endo -71.91 173.74 12.31 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.468 1.246 . . . . 0.0 110.222 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.423 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 48.6 Cg_endo -70.19 -163.77 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.613 1.323 . . . . 0.0 110.252 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 49.94 27.17 9.52 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.4 m -128.12 116.51 20.33 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.333 -1.098 . . . . 0.0 110.279 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.842 ' HB2' HG22 ' A' ' 35' ' ' VAL . 49.0 Cg_endo -73.55 150.33 45.58 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.53 1.279 . . . . 0.0 110.617 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.503 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 12.7 t80 -53.49 -29.53 36.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.413 -0.804 . . . . 0.0 109.979 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.842 HG22 ' HB2' ' A' ' 33' ' ' PRO . 35.3 m -67.22 -13.2 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 110.608 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.6 -4.03 38.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.069 -1.02 . . . . 0.0 110.93 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.458 ' HA ' HD23 ' A' ' 37' ' ' LEU . 28.1 mt -53.13 165.61 0.31 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.872 -1.142 . . . . 0.0 110.14 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.0 m -59.36 162.48 4.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.889 . . . . 0.0 110.279 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.36 -27.42 69.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.311 -0.868 . . . . 0.0 110.2 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.65 46.31 2.5 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.263 -0.898 . . . . 0.0 110.042 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.438 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 23.9 t80 -62.58 140.2 58.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.334 -0.854 . . . . 0.0 110.159 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 36.5 mtt -112.61 151.08 30.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.358 -0.839 . . . . 0.0 109.468 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 29.4 t -65.69 135.46 95.6 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.178 -0.951 . . . . 0.0 110.268 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -75.87 -0.02 9.76 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.503 1.265 . . . . 0.0 110.594 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -119.39 -38.77 2.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.01 -1.056 . . . . 0.0 110.825 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.46 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 1.4 p -123.12 8.16 9.2 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.025 -1.047 . . . . 0.0 111.13 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 27.3 mtt85 54.5 18.84 2.12 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.332 -0.855 . . . . 0.0 112.79 178.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.5 m -72.52 166.3 43.43 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 120.577 -1.327 . . . . 0.0 109.732 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.408 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 45.2 Cg_endo -71.98 139.9 33.84 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.668 1.352 . . . . 0.0 110.387 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.499 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 9.6 tttm -48.98 -26.33 2.46 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.162 -0.961 . . . . 0.0 110.822 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -63.65 -14.9 56.22 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.127 -0.983 . . . . 0.0 109.862 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -83.87 -4.2 58.49 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.157 -0.965 . . . . 0.0 110.151 179.277 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -86.23 131.81 34.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.977 -1.077 . . . . 0.0 110.348 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.41 ' O ' ' HG3' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -117.99 131.74 56.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.272 -0.893 . . . . 0.0 109.544 179.28 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.653 ' O ' HG23 ' A' ' 56' ' ' ILE . 79.7 p -60.82 176.86 0.36 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.156 -0.965 . . . . 0.0 110.893 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.845 ' HB ' HD12 ' A' ' 3' ' ' ILE . 9.9 pt -159.48 92.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-O 121.362 0.601 . . . . 0.0 109.699 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 0.4 OUTLIER -114.27 70.96 0.74 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.357 -0.84 . . . . 0.0 110.296 -179.582 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.7 ttpt -128.23 75.46 1.62 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 110.197 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 66.8 t -83.34 120.41 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 110.262 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.508 HG23 ' O ' ' A' ' 60' ' ' ILE . 0.7 OUTLIER -157.63 69.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.31 -0.869 . . . . 0.0 110.242 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.01 170.1 13.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.92 . . . . 0.0 110.197 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 143.63 -23.26 2.17 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -75.93 179.21 5.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.253 -1.145 . . . . 0.0 110.292 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -128.4 155.49 44.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 110.157 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -92.63 148.19 22.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.229 -0.919 . . . . 0.0 110.166 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -102.58 -64.57 1.06 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.258 -0.901 . . . . 0.0 110.45 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -139.75 -51.36 0.51 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.213 -0.929 . . . . 0.0 110.418 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.88 147.94 8.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.166 -0.959 . . . . 0.0 110.273 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -57.88 96.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.309 -0.869 . . . . 0.0 110.24 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.995 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mtp . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.188 0.518 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.2 146.85 36.77 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.168 -0.957 . . . . 0.0 110.156 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 1.083 HD12 HD12 ' A' ' 56' ' ' ILE . 13.3 pt -146.58 131.47 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.32 -0.863 . . . . 0.0 110.091 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.45 ' CB ' ' HA ' ' A' ' 57' ' ' LYS . 33.1 t0 -177.87 -25.73 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.32 -0.862 . . . . 0.0 111.442 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -64.87 75.8 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.002 -1.061 . . . . 0.0 110.287 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 4' ' ' ASP . . . 56.29 20.65 29.97 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.431 ' O ' ' CG1' ' A' ' 56' ' ' ILE . 4.3 mmtt -80.12 116.56 20.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.158 -1.201 . . . . 0.0 109.501 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.587 ' CE2' ' CD2' ' A' ' 34' ' ' PHE . 7.5 m-85 -112.26 145.11 40.55 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.156 -0.965 . . . . 0.0 110.625 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 3.1 tt0 -115.12 135.74 53.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.404 -0.81 . . . . 0.0 109.995 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.9 t -75.24 113.46 12.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.23 -0.919 . . . . 0.0 110.573 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -11.28 60.79 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.449 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.484 ' HB2' ' NE2' ' A' ' 52' ' ' GLN . . . -85.14 -40.26 16.94 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.312 -0.867 . . . . 0.0 111.484 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.462 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 12.6 p -123.95 -32.51 3.26 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.683 -1.26 . . . . 0.0 111.484 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.55 21.71 6.37 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.851 ' C ' HD12 ' A' ' 16' ' ' ILE . 46.6 t80 -83.56 162.3 20.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.291 -1.123 . . . . 0.0 109.74 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.851 HD12 ' C ' ' A' ' 15' ' ' TYR . 2.1 mp -123.51 116.39 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.244 -0.91 . . . . 0.0 109.939 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.504 ' OH ' HD21 ' A' ' 37' ' ' LEU . 78.3 t80 -82.86 127.87 33.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.164 -0.96 . . . . 0.0 110.15 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -106.4 111.08 64.25 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.698 -0.626 . . . . 0.0 109.614 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.474 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 38.1 Cg_endo -70.28 -63.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.525 1.276 . . . . 0.0 110.806 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -46.8 -26.05 0.88 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.73 -0.606 . . . . 0.0 110.558 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -95.29 -31.16 13.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -0.924 . . . . 0.0 110.041 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.69 153.59 21.68 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.728 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 0.4 OUTLIER -85.19 60.85 6.5 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.395 -1.062 . . . . 0.0 109.431 179.473 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -46.84 -26.76 1.04 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.536 -0.727 . . . . 0.0 110.682 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -81.14 -22.49 38.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.175 -0.953 . . . . 0.0 110.207 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.728 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -100.08 -27.61 13.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.229 -0.919 . . . . 0.0 110.012 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.51 28.98 1.36 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.573 HD13 ' CD2' ' A' ' 37' ' ' LEU . 5.4 mt -125.14 123.58 25.34 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.013 -1.286 . . . . 0.0 109.707 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.42 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 44.0 Cg_endo -70.0 173.47 11.14 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.525 1.276 . . . . 0.0 110.238 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 47.2 Cg_endo -69.99 -163.72 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.674 1.355 . . . . 0.0 110.233 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 49.04 26.0 5.7 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 88.6 m -125.34 121.11 24.97 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.272 -1.134 . . . . 0.0 110.257 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.653 ' HB2' HG22 ' A' ' 35' ' ' VAL . 50.3 Cg_endo -76.41 158.16 36.69 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.477 1.251 . . . . 0.0 110.651 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.587 ' CD2' ' CE2' ' A' ' 8' ' ' TYR . 13.6 t80 -61.04 -34.18 74.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.349 -0.844 . . . . 0.0 109.945 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.653 HG22 ' HB2' ' A' ' 33' ' ' PRO . 26.8 m -65.51 -12.93 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.908 . . . . 0.0 110.529 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.57 -9.17 36.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.025 -1.047 . . . . 0.0 110.817 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.573 ' CD2' HD13 ' A' ' 28' ' ' ILE . 49.8 mt -53.85 156.07 3.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.0 -1.063 . . . . 0.0 110.185 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.9 t -52.56 147.78 7.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.168 -0.958 . . . . 0.0 110.255 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.64 -23.14 10.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 110.214 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 72.3 p -123.71 47.5 2.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.908 . . . . 0.0 110.487 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.465 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 27.7 t80 -70.56 145.63 50.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.164 -0.96 . . . . 0.0 109.835 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.411 ' HA ' ' O ' ' A' ' 48' ' ' SER . 28.3 mtm -121.11 138.02 54.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.293 -0.88 . . . . 0.0 109.994 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 27.5 t -54.68 133.81 64.8 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.368 -0.832 . . . . 0.0 110.235 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -76.33 -0.68 10.64 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.485 1.255 . . . . 0.0 110.627 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.72 -42.56 3.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.98 -1.075 . . . . 0.0 110.473 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.462 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 1.7 p -119.75 5.63 10.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.106 -0.996 . . . . 0.0 111.121 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 54.57 24.82 5.7 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.256 -0.902 . . . . 0.0 112.64 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 42' ' ' MET . 5.8 m -79.29 166.02 44.56 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 120.578 -1.327 . . . . 0.0 109.599 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.4 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 43.8 Cg_endo -70.37 140.89 41.4 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.567 1.299 . . . . 0.0 110.75 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.509 ' HE2' ' CZ ' ' A' ' 34' ' ' PHE . 23.8 tttt -50.58 -24.66 3.4 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.21 -0.931 . . . . 0.0 110.55 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -66.01 -13.41 59.83 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.08 -1.013 . . . . 0.0 109.933 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.484 ' NE2' ' HB2' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -85.05 -4.34 59.12 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.203 -0.936 . . . . 0.0 110.006 179.347 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -85.5 137.31 32.98 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.956 -1.09 . . . . 0.0 110.526 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.8 tttm -123.48 133.51 54.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.625 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.634 ' O ' HG23 ' A' ' 56' ' ' ILE . 68.6 p -62.11 175.56 0.69 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.177 -0.952 . . . . 0.0 110.888 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.083 HD12 HD12 ' A' ' 3' ' ' ILE . 7.4 pt -159.42 90.81 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 CA-C-O 121.334 0.588 . . . . 0.0 110.079 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.45 ' HA ' ' CB ' ' A' ' 4' ' ' ASP . 0.0 OUTLIER -101.64 65.49 1.03 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.935 -1.103 . . . . 0.0 109.837 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.81 147.56 40.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.392 -0.818 . . . . 0.0 110.211 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.408 ' O ' HG12 ' A' ' 59' ' ' VAL . 86.5 t -116.18 81.01 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.273 -0.892 . . . . 0.0 110.171 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 51.4 mm -85.05 73.33 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.328 -0.857 . . . . 0.0 110.284 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.86 83.4 6.6 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.126 -0.984 . . . . 0.0 110.246 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -139.58 36.0 1.89 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.6 t80 52.23 54.29 11.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.284 -1.127 . . . . 0.0 110.335 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.03 65.32 8.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.321 -0.862 . . . . 0.0 110.084 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.16 158.83 15.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.302 -0.873 . . . . 0.0 110.487 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -80.95 95.47 6.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.415 -0.803 . . . . 0.0 110.102 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -120.57 -175.81 3.1 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.206 -0.934 . . . . 0.0 110.277 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.3 mmtt -82.32 75.33 9.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.281 -0.887 . . . . 0.0 109.989 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -64.86 97.98 0.25 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.217 -0.927 . . . . 0.0 110.175 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.339 0 CA-C-O 118.026 -1.43 . . . . 0.0 109.572 179.948 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.404 ' O ' HG22 ' A' ' 60' ' ' ILE . 93.7 mtp . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.285 0.564 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.474 ' C ' HG23 ' A' ' 3' ' ' ILE . 32.3 mt-10 -131.8 80.83 1.94 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.301 -0.874 . . . . 0.0 110.018 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.474 HG23 ' C ' ' A' ' 2' ' ' GLU . 22.1 pt -151.43 144.49 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.27 -0.894 . . . . 0.0 110.452 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' A' ' 3' ' ' ILE . 8.1 p-10 178.83 112.75 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 121.756 0.788 . . . . 0.0 109.41 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -171.95 54.22 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.316 0.579 . . . . 0.0 110.023 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 63.39 17.7 59.98 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.405 ' O ' ' CG1' ' A' ' 56' ' ' ILE . 20.1 mttt -84.26 119.91 25.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.137 -1.213 . . . . 0.0 109.676 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.525 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 9.1 m-85 -112.26 150.09 31.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.115 -0.991 . . . . 0.0 110.432 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 43.7 tt0 -120.35 138.49 53.7 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.337 -0.852 . . . . 0.0 110.564 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.1 t -77.23 111.06 12.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.321 -0.862 . . . . 0.0 110.3 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -68.02 -11.23 58.53 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.36 -0.936 . . . . 0.0 109.568 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.36 -42.06 16.11 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.296 -0.878 . . . . 0.0 111.52 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.453 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 14.5 p -121.86 -34.75 3.31 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.707 -1.246 . . . . 0.0 111.498 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.06 22.08 5.06 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.452 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 29.5 t80 -84.27 158.82 21.1 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.308 -1.113 . . . . 0.0 109.804 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.442 ' N ' ' CD1' ' A' ' 15' ' ' TYR . 29.3 mm -122.5 120.04 59.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.318 -0.864 . . . . 0.0 110.267 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.5 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 80.6 t80 -83.25 130.03 35.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.909 . . . . 0.0 109.97 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -109.95 114.76 55.95 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.583 -0.698 . . . . 0.0 109.484 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.478 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 37.8 Cg_endo -69.95 -68.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.529 1.279 . . . . 0.0 111.225 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -46.27 -25.48 0.63 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.476 -0.765 . . . . 0.0 111.175 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.66 -39.22 11.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.113 -0.992 . . . . 0.0 110.882 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.41 145.68 15.56 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.42 ' HB3' HD12 ' A' ' 28' ' ' ILE . 25.1 t0 -85.09 61.54 6.94 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.345 -1.091 . . . . 0.0 109.937 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.94 -25.92 1.54 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.397 -0.814 . . . . 0.0 110.461 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -75.49 -21.66 57.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.907 . . . . 0.0 110.092 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -105.56 -34.4 7.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.288 -0.883 . . . . 0.0 109.887 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 131.18 34.11 0.43 Allowed Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.892 -1.147 . . . . 0.0 110.361 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.52 HD13 ' CD2' ' A' ' 37' ' ' LEU . 5.2 mt -129.85 121.65 20.05 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 120.807 -1.408 . . . . 0.0 109.988 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.411 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 45.0 Cg_endo -70.13 173.93 10.58 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 O-C-N 123.613 1.323 . . . . 0.0 110.265 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 45.4 Cg_endo -68.59 -163.78 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.616 1.324 . . . . 0.0 110.176 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 47.76 27.79 4.91 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 15.4 m -125.75 113.9 24.81 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.218 -1.166 . . . . 0.0 110.344 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.718 ' HB2' HG22 ' A' ' 35' ' ' VAL . 45.9 Cg_endo -73.31 146.92 41.02 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 123.472 1.248 . . . . 0.0 110.738 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.5 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 22.7 t80 -51.41 -34.02 32.94 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.433 -0.792 . . . . 0.0 110.561 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.718 HG22 ' HB2' ' A' ' 33' ' ' PRO . 30.0 m -65.75 -14.04 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.202 -0.936 . . . . 0.0 110.723 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.416 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 36.0 t0 -98.32 -1.61 41.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.998 -1.063 . . . . 0.0 110.996 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.52 ' CD2' HD13 ' A' ' 28' ' ' ILE . 26.0 mt -54.38 176.37 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.903 -1.123 . . . . 0.0 110.17 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.9 m -69.36 152.98 44.3 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.235 -0.916 . . . . 0.0 110.123 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.65 -23.28 40.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.161 -0.962 . . . . 0.0 110.216 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.4 m -129.28 43.52 3.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.167 -0.958 . . . . 0.0 110.27 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.462 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 20.0 t80 -62.89 132.65 52.83 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.377 -0.827 . . . . 0.0 109.85 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.409 ' HA ' ' O ' ' A' ' 48' ' ' SER . 7.0 mtt -111.33 148.19 33.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.376 -0.827 . . . . 0.0 109.668 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.437 ' HB3' ' N ' ' A' ' 47' ' ' ARG . 10.0 t -57.99 135.23 83.83 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.897 . . . . 0.0 110.422 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -76.12 -0.34 10.21 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 123.628 1.331 . . . . 0.0 110.578 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -122.88 -38.97 2.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.943 -1.098 . . . . 0.0 110.859 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.453 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -121.24 8.03 10.27 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.038 -1.039 . . . . 0.0 111.202 -179.62 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.437 ' N ' ' HB3' ' A' ' 43' ' ' CYS . 2.5 ttt180 58.37 13.84 2.62 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.183 -0.948 . . . . 0.0 112.786 178.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.409 ' O ' ' HA ' ' A' ' 42' ' ' MET . 1.3 m -63.63 156.81 69.9 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 120.594 -1.316 . . . . 0.0 109.714 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.403 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 46.8 Cg_endo -72.77 146.54 43.07 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.665 1.35 . . . . 0.0 110.183 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 41' ' ' PHE . 19.5 tttm -53.74 -27.19 26.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.022 -1.049 . . . . 0.0 110.235 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -67.98 -11.29 58.57 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.176 -0.952 . . . . 0.0 109.827 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -88.65 -2.67 58.72 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.21 -0.931 . . . . 0.0 110.016 179.205 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -89.9 126.06 35.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.012 -1.055 . . . . 0.0 110.348 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.2 tptt -108.8 134.13 51.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.209 -0.932 . . . . 0.0 109.739 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.525 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 80.0 p -63.72 179.46 0.49 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.121 -0.987 . . . . 0.0 110.761 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.491 HG23 ' C ' ' A' ' 55' ' ' SER . 1.1 pt -151.48 76.49 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-O 121.271 0.557 . . . . 0.0 110.157 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -100.01 62.73 1.15 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.306 -0.871 . . . . 0.0 110.144 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.5 mttp -82.2 123.28 28.87 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.276 -0.89 . . . . 0.0 110.372 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 40.0 t -140.81 121.1 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.247 -0.908 . . . . 0.0 110.262 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.404 HG22 ' O ' ' A' ' 1' ' ' MET . 0.4 OUTLIER -145.43 139.0 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.215 -0.928 . . . . 0.0 110.318 179.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.41 90.87 0.25 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.282 -0.886 . . . . 0.0 110.005 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -110.73 -62.94 0.5 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.25 151.15 28.14 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.302 -1.117 . . . . 0.0 110.317 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -173.47 142.16 0.95 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.319 -0.863 . . . . 0.0 110.22 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -134.72 129.72 35.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.223 -0.923 . . . . 0.0 110.223 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -147.91 48.86 1.07 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.314 -0.866 . . . . 0.0 110.04 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -152.69 40.5 0.58 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.282 -0.886 . . . . 0.0 110.064 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.88 -42.58 99.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.352 -0.842 . . . . 0.0 110.335 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -80.81 135.25 35.92 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.217 -0.927 . . . . 0.0 110.225 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.991 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtt . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.252 0.549 . . . . 0.0 110.126 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -115.31 77.5 1.08 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -0.905 . . . . 0.0 110.375 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.425 ' O ' ' HB3' ' A' ' 4' ' ' ASP . 45.0 mt -135.31 166.31 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.214 -0.929 . . . . 0.0 109.951 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.425 ' HB3' ' O ' ' A' ' 3' ' ' ILE . 8.2 p-10 176.54 113.26 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.718 0.77 . . . . 0.0 109.825 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -159.46 -148.89 0.19 Allowed 'General case' 0 C--N 1.291 -1.962 0 O-C-N 121.795 -0.566 . . . . 0.0 109.669 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.68 19.23 55.45 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.427 ' CB ' HG12 ' A' ' 56' ' ' ILE . 29.2 mttt -82.47 136.73 34.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.071 -1.252 . . . . 0.0 109.656 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.514 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 13.4 m-85 -122.7 148.04 45.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.037 -1.039 . . . . 0.0 110.628 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 5.1 tm-20 -120.02 128.08 53.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.414 -0.804 . . . . 0.0 109.906 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.4 t -65.31 110.07 2.48 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.161 -0.962 . . . . 0.0 110.059 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.91 -11.92 57.77 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.206 -0.934 . . . . 0.0 109.612 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.445 ' HB2' ' NE2' ' A' ' 52' ' ' GLN . . . -85.01 -40.46 16.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.327 -0.858 . . . . 0.0 111.782 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 11.7 p -123.95 -32.71 3.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.647 -1.283 . . . . 0.0 111.523 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.09 18.9 6.57 Favored Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.713 -1.232 . . . . 0.0 110.256 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.529 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 42.7 t80 -76.28 167.98 20.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -1.175 . . . . 0.0 109.516 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.529 ' N ' ' CD1' ' A' ' 15' ' ' TYR . 35.1 mm -130.82 120.26 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 110.424 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.474 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 51.5 t80 -89.36 142.5 27.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.325 -0.86 . . . . 0.0 109.966 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -123.69 112.49 29.11 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.544 -0.723 . . . . 0.0 109.829 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.523 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 40.4 Cg_endo -72.2 -67.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.516 1.272 . . . . 0.0 111.284 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -44.22 -28.0 0.47 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.794 -0.566 . . . . 0.0 110.922 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.7 mttp -96.15 -40.06 9.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 0.0 110.24 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.29 147.85 22.53 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.481 ' HB3' HD12 ' A' ' 28' ' ' ILE . 2.8 t0 -84.94 61.11 6.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.465 -1.021 . . . . 0.0 109.65 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -45.49 -27.08 0.67 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.444 -0.785 . . . . 0.0 110.955 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -74.69 -27.43 60.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.115 -0.99 . . . . 0.0 109.975 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.462 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -98.48 -22.83 15.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.346 -0.846 . . . . 0.0 109.9 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.12 23.23 3.94 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.481 HD12 ' HB3' ' A' ' 23' ' ' ASP . 9.2 mt -115.26 114.57 43.07 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.117 -1.225 . . . . 0.0 109.907 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.409 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 43.0 Cg_endo -68.91 173.9 9.54 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 O-C-N 123.597 1.314 . . . . 0.0 110.294 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 44.9 Cg_endo -67.89 -164.43 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.57 1.3 . . . . 0.0 110.024 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 48.19 34.02 11.83 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 m -134.48 109.35 11.24 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.121 -1.223 . . . . 0.0 110.52 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.879 ' HB2' HG22 ' A' ' 35' ' ' VAL . 44.6 Cg_endo -71.8 148.72 52.81 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.455 1.24 . . . . 0.0 110.344 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.532 ' CD1' HD12 ' A' ' 37' ' ' LEU . 38.8 t80 -52.92 -24.23 8.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.204 -0.935 . . . . 0.0 109.861 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.879 HG22 ' HB2' ' A' ' 33' ' ' PRO . 32.1 m -72.27 -17.49 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.169 -0.957 . . . . 0.0 110.201 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.68 0.6 47.4 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.183 -0.948 . . . . 0.0 110.708 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.532 HD12 ' CD1' ' A' ' 34' ' ' PHE . 21.8 mt -52.23 167.33 0.13 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.947 -1.095 . . . . 0.0 110.182 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.3 m -56.53 173.31 0.19 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 110.257 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.05 -27.62 65.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.33 -0.856 . . . . 0.0 110.211 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 65.9 p -134.13 45.79 2.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 110.345 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.47 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 27.2 t80 -54.26 130.97 40.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.932 . . . . 0.0 109.932 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -108.34 150.01 27.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.427 -0.796 . . . . 0.0 109.43 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.436 ' HB3' ' N ' ' A' ' 47' ' ' ARG . 12.8 t -63.55 135.82 96.43 Favored Pre-proline 0 C--N 1.3 -1.551 0 O-C-N 121.16 -0.963 . . . . 0.0 110.539 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.76 -1.52 11.47 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.589 1.31 . . . . 0.0 110.382 178.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -118.72 -41.57 2.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.052 -1.03 . . . . 0.0 110.867 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -119.81 2.91 11.11 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.121 -0.987 . . . . 0.0 111.141 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.436 ' N ' ' HB3' ' A' ' 43' ' ' CYS . 1.1 ttt-85 58.28 23.36 10.31 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.146 -0.971 . . . . 0.0 112.515 178.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.3 m -75.01 164.94 58.01 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 120.566 -1.333 . . . . 0.0 109.676 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.06 138.98 29.07 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.632 1.333 . . . . 0.0 110.434 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.536 ' HA ' ' CD1' ' A' ' 53' ' ' PHE . 15.9 tttm -48.93 -29.18 4.46 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.271 -0.893 . . . . 0.0 110.821 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -63.09 -14.54 49.66 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.113 -0.992 . . . . 0.0 109.967 179.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.445 ' NE2' ' HB2' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -87.21 -1.39 57.87 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.086 -1.009 . . . . 0.0 110.169 179.416 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.536 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 32.6 m-85 -88.17 127.84 35.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.906 -1.121 . . . . 0.0 110.425 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.18 128.11 55.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 109.587 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.514 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 89.0 p -54.14 -174.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 110.814 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.625 ' O ' HD12 ' A' ' 56' ' ' ILE . 1.3 pp -132.38 78.38 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.679 -0.638 . . . . 0.0 109.875 179.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.54 70.86 0.74 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.458 -0.776 . . . . 0.0 110.041 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -106.37 122.03 45.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.322 -0.862 . . . . 0.0 110.338 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.623 ' C ' HD12 ' A' ' 60' ' ' ILE . 85.3 t -131.88 97.62 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.326 -0.859 . . . . 0.0 109.952 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.689 ' N ' HD12 ' A' ' 60' ' ' ILE . 4.9 mp -129.46 97.69 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.208 -0.933 . . . . 0.0 110.385 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 50.47 -149.41 0.28 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.331 -0.856 . . . . 0.0 110.504 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.2 -53.23 1.36 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 51.99 91.08 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -1.13 . . . . 0.0 110.285 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -97.59 -166.21 1.36 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.192 -0.942 . . . . 0.0 110.105 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -114.28 121.97 45.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.192 -0.942 . . . . 0.0 110.313 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -139.11 83.62 1.96 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 110.104 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 53.84 60.23 3.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.219 -0.926 . . . . 0.0 110.009 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.8 ttpt -113.55 -48.95 2.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.373 -0.829 . . . . 0.0 110.237 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -81.05 -40.85 23.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.228 -0.92 . . . . 0.0 110.246 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.943 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtt . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.252 0.549 . . . . 0.0 110.126 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -115.31 77.5 1.08 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -0.905 . . . . 0.0 110.375 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.425 ' O ' ' HB3' ' A' ' 4' ' ' ASP . 45.0 mt -135.31 166.31 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.214 -0.929 . . . . 0.0 109.951 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.425 ' HB3' ' O ' ' A' ' 3' ' ' ILE . 8.2 p-10 176.54 113.26 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.718 0.77 . . . . 0.0 109.825 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -159.46 -148.89 0.19 Allowed 'General case' 0 C--N 1.291 -1.962 0 O-C-N 121.795 -0.566 . . . . 0.0 109.669 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.68 19.23 55.45 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.427 ' CB ' HG12 ' A' ' 56' ' ' ILE . 29.2 mttt -82.47 136.73 34.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.071 -1.252 . . . . 0.0 109.656 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.514 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 13.4 m-85 -122.7 148.04 45.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.037 -1.039 . . . . 0.0 110.628 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 5.1 tm-20 -120.02 128.08 53.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.414 -0.804 . . . . 0.0 109.906 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.4 t -65.31 110.07 2.48 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.161 -0.962 . . . . 0.0 110.059 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.91 -11.92 57.77 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.206 -0.934 . . . . 0.0 109.612 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.445 ' HB2' ' NE2' ' A' ' 52' ' ' GLN . . . -85.01 -40.46 16.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.327 -0.858 . . . . 0.0 111.782 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 11.7 p -123.95 -32.71 3.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.647 -1.283 . . . . 0.0 111.523 -179.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.09 18.9 6.57 Favored Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.713 -1.232 . . . . 0.0 110.256 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.529 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 42.7 t80 -76.28 167.98 20.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -1.175 . . . . 0.0 109.516 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.529 ' N ' ' CD1' ' A' ' 15' ' ' TYR . 35.1 mm -130.82 120.26 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 110.424 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.474 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 51.5 t80 -89.36 142.5 27.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.325 -0.86 . . . . 0.0 109.966 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -123.69 112.49 29.11 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.544 -0.723 . . . . 0.0 109.829 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.523 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 40.4 Cg_endo -72.2 -67.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.516 1.272 . . . . 0.0 111.284 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -44.22 -28.0 0.47 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.794 -0.566 . . . . 0.0 110.922 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.7 mttp -96.15 -40.06 9.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 0.0 110.24 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.29 147.85 22.53 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.481 ' HB3' HD12 ' A' ' 28' ' ' ILE . 2.8 t0 -84.94 61.11 6.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.465 -1.021 . . . . 0.0 109.65 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -45.49 -27.08 0.67 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.444 -0.785 . . . . 0.0 110.955 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -74.69 -27.43 60.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.115 -0.99 . . . . 0.0 109.975 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.462 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -98.48 -22.83 15.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.346 -0.846 . . . . 0.0 109.9 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.12 23.23 3.94 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.481 HD12 ' HB3' ' A' ' 23' ' ' ASP . 9.2 mt -115.26 114.57 43.07 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.117 -1.225 . . . . 0.0 109.907 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.409 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 43.0 Cg_endo -68.91 173.9 9.54 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 O-C-N 123.597 1.314 . . . . 0.0 110.294 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 44.9 Cg_endo -67.89 -164.43 0.1 OUTLIER 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.57 1.3 . . . . 0.0 110.024 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 48.19 34.02 11.83 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 m -134.48 109.35 11.24 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.121 -1.223 . . . . 0.0 110.52 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.879 ' HB2' HG22 ' A' ' 35' ' ' VAL . 44.6 Cg_endo -71.8 148.72 52.81 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.455 1.24 . . . . 0.0 110.344 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.532 ' CD1' HD12 ' A' ' 37' ' ' LEU . 38.8 t80 -52.92 -24.23 8.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.204 -0.935 . . . . 0.0 109.861 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.879 HG22 ' HB2' ' A' ' 33' ' ' PRO . 32.1 m -72.27 -17.49 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.169 -0.957 . . . . 0.0 110.201 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.68 0.6 47.4 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.183 -0.948 . . . . 0.0 110.708 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.532 HD12 ' CD1' ' A' ' 34' ' ' PHE . 21.8 mt -52.23 167.33 0.13 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.947 -1.095 . . . . 0.0 110.182 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.3 m -56.53 173.31 0.19 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 110.257 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.05 -27.62 65.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.33 -0.856 . . . . 0.0 110.211 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 65.9 p -134.13 45.79 2.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 110.345 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.47 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 27.2 t80 -54.26 130.97 40.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.932 . . . . 0.0 109.932 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -108.34 150.01 27.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.427 -0.796 . . . . 0.0 109.43 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.436 ' HB3' ' N ' ' A' ' 47' ' ' ARG . 12.8 t -63.55 135.82 96.43 Favored Pre-proline 0 C--N 1.3 -1.551 0 O-C-N 121.16 -0.963 . . . . 0.0 110.539 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.76 -1.52 11.47 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.589 1.31 . . . . 0.0 110.382 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -118.72 -41.57 2.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.052 -1.03 . . . . 0.0 110.867 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -119.81 2.91 11.11 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.121 -0.987 . . . . 0.0 111.141 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.436 ' N ' ' HB3' ' A' ' 43' ' ' CYS . 1.1 ttt-85 58.28 23.36 10.31 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.146 -0.971 . . . . 0.0 112.515 178.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.3 m -75.01 164.94 58.01 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 120.566 -1.333 . . . . 0.0 109.676 179.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.06 138.98 29.07 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.632 1.333 . . . . 0.0 110.434 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.536 ' HA ' ' CD1' ' A' ' 53' ' ' PHE . 15.9 tttm -48.93 -29.18 4.46 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.271 -0.893 . . . . 0.0 110.821 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -63.09 -14.54 49.66 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.113 -0.992 . . . . 0.0 109.967 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.445 ' NE2' ' HB2' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -87.21 -1.39 57.87 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.086 -1.009 . . . . 0.0 110.169 179.416 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.536 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 32.6 m-85 -88.17 127.84 35.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.906 -1.121 . . . . 0.0 110.425 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.18 128.11 55.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.319 -0.863 . . . . 0.0 109.587 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.514 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 89.0 p -54.14 -174.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 110.814 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.625 ' O ' HD12 ' A' ' 56' ' ' ILE . 1.3 pp -132.38 78.38 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.679 -0.638 . . . . 0.0 109.875 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.54 70.86 0.74 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.458 -0.776 . . . . 0.0 110.041 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -106.37 122.03 45.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.322 -0.862 . . . . 0.0 110.338 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.623 ' C ' HD12 ' A' ' 60' ' ' ILE . 85.3 t -131.88 97.62 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.326 -0.859 . . . . 0.0 109.952 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.689 ' N ' HD12 ' A' ' 60' ' ' ILE . 4.9 mp -129.46 97.69 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.208 -0.933 . . . . 0.0 110.385 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 50.47 -149.41 0.28 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.331 -0.856 . . . . 0.0 110.504 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 97.2 -53.23 1.36 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 51.99 91.08 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -1.13 . . . . 0.0 110.285 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -97.59 -166.21 1.36 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.192 -0.942 . . . . 0.0 110.105 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -114.28 121.97 45.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.192 -0.942 . . . . 0.0 110.313 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -139.11 83.62 1.96 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 110.104 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 53.84 60.23 3.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.219 -0.926 . . . . 0.0 110.009 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.8 ttpt -113.55 -48.95 2.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.373 -0.829 . . . . 0.0 110.237 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -81.05 -40.85 23.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.228 -0.92 . . . . 0.0 110.246 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.943 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.58 ' O ' HG23 ' A' ' 3' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.271 0.558 . . . . 0.0 110.253 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 52.64 65.02 1.64 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.228 -0.92 . . . . 0.0 110.197 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.58 HG23 ' O ' ' A' ' 1' ' ' MET . 27.7 pt -142.05 156.42 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.155 -0.965 . . . . 0.0 110.469 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 3' ' ' ILE . 6.0 p-10 179.22 112.19 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.831 0.824 . . . . 0.0 109.535 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -167.6 29.52 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.942 0 O-C-N 121.761 -0.587 . . . . 0.0 110.07 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.403 ' HA3' ' HG3' ' A' ' 19' ' ' PRO . . . 75.15 22.05 77.02 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.4 mtpt -84.85 130.1 34.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.171 -1.194 . . . . 0.0 109.599 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.544 ' HE2' ' HG ' ' A' ' 55' ' ' SER . 30.2 m-85 -115.78 139.26 50.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.034 -1.041 . . . . 0.0 110.789 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 29.8 tt0 -105.56 132.83 51.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.309 -0.87 . . . . 0.0 110.241 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.7 t -75.56 110.33 9.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 0.0 110.121 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.71 -11.92 56.37 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.203 -0.936 . . . . 0.0 109.866 178.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.425 ' HB2' ' NE2' ' A' ' 52' ' ' GLN . . . -85.03 -41.19 16.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -0.92 . . . . 0.0 111.717 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.47 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 13.8 p -122.85 -34.47 3.19 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.604 -1.31 . . . . 0.0 111.454 -179.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.76 21.72 5.29 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.8 ' C ' HD12 ' A' ' 16' ' ' ILE . 24.5 t80 -84.57 158.19 20.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.365 -1.079 . . . . 0.0 109.706 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.8 HD12 ' C ' ' A' ' 15' ' ' TYR . 3.2 mp -123.97 120.17 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.216 -0.928 . . . . 0.0 110.15 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.503 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 66.5 t80 -83.05 137.56 34.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.312 -0.868 . . . . 0.0 110.025 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.426 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 53.5 mt-10 -116.28 110.87 42.72 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.592 -0.693 . . . . 0.0 109.411 179.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.474 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 37.9 Cg_endo -69.42 -71.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.507 1.267 . . . . 0.0 111.151 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.414 ' O ' ' CB ' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -47.4 -24.73 0.85 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.335 -0.853 . . . . 0.0 111.04 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -94.52 -39.27 10.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.973 -1.079 . . . . 0.0 110.48 -179.881 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.16 137.93 9.29 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -85.07 63.73 8.28 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.392 -1.064 . . . . 0.0 109.679 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.96 -28.35 0.25 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.778 -0.576 . . . . 0.0 111.117 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -67.17 -33.62 75.8 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.202 -0.936 . . . . 0.0 109.795 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.53 ' HB3' HD12 ' A' ' 28' ' ' ILE . . . -95.94 -25.53 15.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.303 -0.873 . . . . 0.0 110.09 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 117.16 25.31 3.28 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.53 HD12 ' HB3' ' A' ' 26' ' ' ALA . 4.7 mt -112.15 118.74 45.48 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.071 -1.252 . . . . 0.0 110.079 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.433 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 45.4 Cg_endo -71.95 174.49 11.16 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 O-C-N 123.541 1.285 . . . . 0.0 110.219 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.433 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 46.8 Cg_endo -69.27 -164.72 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.582 1.306 . . . . 0.0 109.933 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 47.73 26.19 3.88 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 47.9 m -127.45 111.4 21.07 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.136 -1.214 . . . . 0.0 110.038 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.853 ' HB2' HG22 ' A' ' 35' ' ' VAL . 45.0 Cg_endo -71.76 147.56 50.76 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.604 1.318 . . . . 0.0 110.77 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.513 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 47.3 t80 -54.42 -25.74 26.59 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.542 -0.723 . . . . 0.0 110.275 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.853 HG22 ' HB2' ' A' ' 33' ' ' PRO . 34.2 m -71.06 -13.59 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.272 -0.893 . . . . 0.0 110.647 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.56 -4.5 41.17 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.091 -1.005 . . . . 0.0 110.891 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 37' ' ' LEU . 51.3 mt -51.0 164.53 0.15 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.91 -1.119 . . . . 0.0 110.428 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.03 173.31 1.44 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.324 -0.86 . . . . 0.0 110.244 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -74.17 -19.33 60.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.367 -0.833 . . . . 0.0 110.293 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.9 m -128.79 36.05 4.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.0 110.534 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.484 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 31.5 t80 -56.18 123.3 14.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.144 -0.973 . . . . 0.0 109.464 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 7.3 mtt -106.72 142.4 36.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 0.0 109.682 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.445 ' HB3' ' N ' ' A' ' 47' ' ' ARG . 5.4 t -52.58 136.41 43.36 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.27 -0.894 . . . . 0.0 110.426 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.66 -1.52 11.21 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.574 1.302 . . . . 0.0 110.673 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -123.9 -42.5 2.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.91 -1.119 . . . . 0.0 110.811 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.47 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -114.15 5.11 15.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.065 -1.022 . . . . 0.0 111.122 -179.703 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.445 ' N ' ' HB3' ' A' ' 43' ' ' CYS . 27.3 mtt180 54.43 25.65 6.3 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.171 -0.956 . . . . 0.0 112.408 178.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.417 ' CB ' ' SG ' ' A' ' 46' ' ' CYS . 2.5 t -75.6 157.68 83.98 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 120.702 -1.249 . . . . 0.0 109.779 178.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.16 139.45 35.49 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.675 1.355 . . . . 0.0 110.362 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.529 ' HA ' ' CD1' ' A' ' 53' ' ' PHE . 56.0 tttt -48.49 -28.26 3.22 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.184 -0.947 . . . . 0.0 110.901 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -67.14 -10.85 54.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.1 -1.0 . . . . 0.0 110.096 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.425 ' NE2' ' HB2' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -89.66 -2.38 58.28 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.191 -0.943 . . . . 0.0 110.193 179.335 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.529 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 33.1 m-85 -88.74 125.48 34.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.845 -1.159 . . . . 0.0 110.083 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -97.1 139.57 32.9 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.246 -0.909 . . . . 0.0 109.935 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.544 ' HG ' ' HE2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -80.12 153.99 28.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.426 -0.796 . . . . 0.0 110.187 -179.519 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.677 HG23 ' O ' ' A' ' 56' ' ' ILE . 1.2 tp -146.83 80.33 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.289 -0.882 . . . . 0.0 110.236 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.87 74.84 1.52 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.253 -0.904 . . . . 0.0 110.131 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.3 mppt? -130.75 174.25 10.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.18 -0.95 . . . . 0.0 110.156 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.0 m -144.49 160.4 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.206 -0.934 . . . . 0.0 110.185 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 59.2 mt -112.19 116.93 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.245 -0.909 . . . . 0.0 109.912 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -114.47 -160.31 0.73 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.246 -0.909 . . . . 0.0 110.447 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -104.88 -99.29 2.58 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -164.36 159.8 20.12 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.29 -1.124 . . . . 0.0 110.451 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -140.82 53.07 1.6 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.249 -0.907 . . . . 0.0 109.888 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -108.47 46.63 0.95 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 110.407 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' A' ' 66' ' ' ASN . 17.1 p-10 -55.04 152.68 7.35 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.184 -0.947 . . . . 0.0 110.053 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -164.19 29.82 0.07 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.918 . . . . 0.0 110.203 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.83 47.31 1.34 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.93 . . . . 0.0 110.324 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -102.83 -171.51 1.96 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.13 -0.982 . . . . 0.0 110.29 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 179.971 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 ttt . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.159 0.504 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.57 ' HG3' HG23 ' A' ' 59' ' ' VAL . 35.5 tt0 -138.88 76.95 1.6 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.273 -0.892 . . . . 0.0 110.352 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.809 HG21 HG23 ' A' ' 56' ' ' ILE . 3.3 mp -111.44 171.77 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.272 -0.892 . . . . 0.0 109.836 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.509 ' N ' HG22 ' A' ' 3' ' ' ILE . 0.7 OUTLIER -177.56 -29.96 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.055 -1.028 . . . . 0.0 111.385 -179.71 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -78.85 -141.39 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.008 -1.057 . . . . 0.0 109.758 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.14 34.35 4.32 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.447 ' O ' HG22 ' A' ' 56' ' ' ILE . 17.0 mttt -81.56 122.63 27.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.109 -1.23 . . . . 0.0 109.707 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.516 ' CZ ' ' HB2' ' A' ' 55' ' ' SER . 13.3 m-85 -108.34 152.08 25.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.055 -1.028 . . . . 0.0 110.561 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.531 ' HA ' HD13 ' A' ' 16' ' ' ILE . 1.6 tm-20 -119.91 122.99 42.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.442 -0.786 . . . . 0.0 109.814 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.4 t -64.39 111.16 2.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.109 -0.994 . . . . 0.0 110.515 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -67.51 -12.17 59.69 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.229 -0.919 . . . . 0.0 109.501 178.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.415 ' HB2' ' NE2' ' A' ' 52' ' ' GLN . . . -85.04 -39.98 17.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.285 -0.884 . . . . 0.0 111.647 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.449 ' CB ' ' HB3' ' A' ' 46' ' ' CYS . 11.9 p -125.07 -29.66 3.3 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.62 -1.3 . . . . 0.0 111.433 -179.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.08 18.93 8.85 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.585 -1.293 . . . . 0.0 110.421 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.52 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 48.1 t80 -78.87 167.12 21.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.126 -1.22 . . . . 0.0 109.547 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.531 HD13 ' HA ' ' A' ' 9' ' ' GLU . 35.3 mm -129.06 115.54 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.17 -0.956 . . . . 0.0 110.454 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.517 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 73.1 t80 -82.17 136.31 35.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.436 -0.79 . . . . 0.0 110.378 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 22' ' ' GLY . 5.6 mt-10 -115.84 109.65 45.02 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.599 -0.688 . . . . 0.0 109.468 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.493 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 37.9 Cg_endo -68.77 -70.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.573 1.302 . . . . 0.0 111.467 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -44.75 -27.09 0.46 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.551 -0.718 . . . . 0.0 111.034 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.41 -22.56 15.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.165 -0.959 . . . . 0.0 110.078 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 18' ' ' GLU . . . 79.93 147.22 4.44 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.522 ' HB3' HD12 ' A' ' 28' ' ' ILE . 15.2 t0 -85.04 62.32 7.43 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.356 -1.085 . . . . 0.0 109.69 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.56 -28.8 0.41 Allowed 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 121.465 0.65 . . . . 0.0 110.827 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -65.85 -32.12 73.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.298 -0.876 . . . . 0.0 110.005 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -99.03 -28.0 13.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.263 -0.898 . . . . 0.0 110.368 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.81 25.13 2.17 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.578 HD11 ' CD1' ' A' ' 41' ' ' PHE . 9.8 mt -110.71 123.98 34.22 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 120.955 -1.32 . . . . 0.0 109.597 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -70.9 170.09 18.77 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.49 1.258 . . . . 0.0 110.588 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -71.85 -163.39 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.694 1.365 . . . . 0.0 110.296 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 49.14 31.52 11.67 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 84.3 m -136.88 116.69 10.65 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.163 -1.198 . . . . 0.0 110.289 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.493 ' HA ' ' HB3' ' A' ' 19' ' ' PRO . 47.2 Cg_endo -72.15 148.21 49.76 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 123.582 1.306 . . . . 0.0 110.345 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.517 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 5.5 t80 -51.08 -36.37 39.76 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.238 -0.914 . . . . 0.0 110.018 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.14 -13.79 12.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.408 -0.807 . . . . 0.0 110.748 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -98.58 -0.25 43.53 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.028 -1.045 . . . . 0.0 110.691 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.514 HD21 ' CE1' ' A' ' 17' ' ' TYR . 36.9 mt -55.82 163.59 1.39 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.913 -1.117 . . . . 0.0 110.248 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.9 m -53.73 168.38 0.19 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.323 -0.86 . . . . 0.0 110.367 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.98 -35.18 79.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.275 -0.891 . . . . 0.0 110.29 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.2 t -124.32 51.6 1.57 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.179 -0.95 . . . . 0.0 110.369 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.578 ' CD1' HD11 ' A' ' 28' ' ' ILE . 18.1 t80 -64.76 126.93 29.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.171 -0.956 . . . . 0.0 109.915 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.415 ' HA ' ' O ' ' A' ' 48' ' ' SER . 10.9 mtt -97.95 145.36 26.55 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.23 -0.919 . . . . 0.0 109.588 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 25.1 t -63.01 136.34 96.64 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.214 -0.929 . . . . 0.0 110.375 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -75.93 -3.27 13.63 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.581 1.306 . . . . 0.0 110.571 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -115.23 -37.9 3.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.038 -1.039 . . . . 0.0 110.823 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.449 ' HB3' ' CB ' ' A' ' 13' ' ' CYS . 1.6 p -124.72 7.07 8.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.045 -1.035 . . . . 0.0 111.152 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 57.2 17.16 3.4 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.195 -0.941 . . . . 0.0 112.804 178.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' A' ' 42' ' ' MET . 11.6 m -74.7 163.09 70.63 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 120.589 -1.319 . . . . 0.0 109.899 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.23 141.78 36.43 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.666 1.35 . . . . 0.0 110.699 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.519 ' HA ' ' CD1' ' A' ' 53' ' ' PHE . 24.5 tttm -48.34 -27.85 2.81 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.327 -0.858 . . . . 0.0 110.833 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -62.07 -15.29 43.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.075 -1.016 . . . . 0.0 109.971 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.415 ' NE2' ' HB2' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -86.45 -1.93 58.01 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.106 -0.996 . . . . 0.0 110.276 179.457 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.519 ' CD1' ' HA ' ' A' ' 50' ' ' LYS . 20.9 m-85 -85.09 134.34 34.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.833 -1.167 . . . . 0.0 110.494 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.99 119.99 35.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.385 -0.822 . . . . 0.0 109.768 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.516 ' HB2' ' CZ ' ' A' ' 8' ' ' TYR . 3.4 t -52.89 178.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 110.58 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.809 HG23 HG21 ' A' ' 3' ' ' ILE . 2.7 tt -160.11 91.67 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.664 -0.647 . . . . 0.0 109.952 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 4' ' ' ASP . 0.0 OUTLIER -99.13 63.0 1.3 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.213 -0.929 . . . . 0.0 110.198 -179.788 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.3 mmtt -121.92 139.01 54.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -0.894 . . . . 0.0 110.256 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.57 HG23 ' HG3' ' A' ' 2' ' ' GLU . 13.9 p -135.31 154.0 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -0.906 . . . . 0.0 109.99 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -142.23 144.28 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.104 -0.998 . . . . 0.0 110.473 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -101.04 -162.12 0.91 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.302 -0.874 . . . . 0.0 110.073 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.62 -158.91 25.29 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -74.03 156.43 37.5 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.267 -1.137 . . . . 0.0 110.407 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -122.25 67.42 0.93 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.217 -0.927 . . . . 0.0 110.05 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -98.29 44.22 1.04 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.244 -0.91 . . . . 0.0 110.41 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -169.19 33.75 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.256 -0.903 . . . . 0.0 110.261 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 56.4 168.34 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.356 -0.84 . . . . 0.0 110.513 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.8 143.93 45.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 110.047 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.94 121.88 45.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.222 -0.924 . . . . 0.0 110.27 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 CA-C-O 117.966 -1.464 . . . . 0.0 109.549 -179.989 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 mtm . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.215 0.531 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.401 ' CG ' ' O ' ' A' ' 2' ' ' GLU . 3.3 pm0 -173.94 76.7 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 110.308 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 4' ' ' ASP . 61.5 mt -134.63 169.49 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.231 -0.918 . . . . 0.0 109.845 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.484 ' N ' HG22 ' A' ' 3' ' ' ILE . 7.4 t70 171.58 -21.26 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.471 0 O-C-N 121.639 -0.663 . . . . 0.0 110.692 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -67.89 65.27 0.09 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.012 -1.055 . . . . 0.0 110.714 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 4' ' ' ASP . . . 51.51 22.84 8.4 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.826 ' O ' HG22 ' A' ' 56' ' ' ILE . 4.0 mttt -81.57 120.88 25.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.99 -1.3 . . . . 0.0 109.371 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.529 ' CZ ' ' HB3' ' A' ' 55' ' ' SER . 6.8 m-85 -109.55 150.23 28.48 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.073 -1.017 . . . . 0.0 110.784 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.682 ' HA ' HD13 ' A' ' 16' ' ' ILE . 17.9 tt0 -119.46 132.57 55.82 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.433 -0.792 . . . . 0.0 109.555 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.9 t -72.91 114.6 11.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.103 -0.998 . . . . 0.0 110.591 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -70.84 -11.66 61.09 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.379 -0.928 . . . . 0.0 109.548 178.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.529 ' HB2' ' NE2' ' A' ' 52' ' ' GLN . . . -85.07 -40.55 16.69 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.312 -0.867 . . . . 0.0 111.759 -179.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.457 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 12.6 p -123.53 -33.65 3.19 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.65 -1.281 . . . . 0.0 111.413 -178.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 113.23 21.45 5.89 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.129 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.524 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 49.9 t80 -84.45 168.67 15.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.296 -1.12 . . . . 0.0 109.812 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.682 HD13 ' HA ' ' A' ' 9' ' ' GLU . 40.9 mm -131.47 117.54 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.185 -0.947 . . . . 0.0 110.621 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.52 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 61.3 t80 -83.64 128.76 34.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.408 -0.808 . . . . 0.0 110.133 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -106.51 111.9 63.91 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.361 -0.837 . . . . 0.0 109.749 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.495 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 37.9 Cg_endo -69.78 -65.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.489 1.257 . . . . 0.0 111.085 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -45.64 -29.43 1.23 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.648 -0.658 . . . . 0.0 110.865 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.6 mttp -94.82 -38.05 10.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 0.0 110.173 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.29 150.65 26.34 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.533 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 1.5 t0 -85.08 63.86 8.35 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.438 -1.036 . . . . 0.0 109.653 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -46.39 -27.27 1.02 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.525 -0.735 . . . . 0.0 110.796 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -74.77 -23.15 58.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.22 -0.925 . . . . 0.0 109.985 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.533 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -100.99 -31.28 11.19 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.377 -0.827 . . . . 0.0 109.92 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.34 28.29 1.35 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.488 HD13 ' CD2' ' A' ' 37' ' ' LEU . 10.7 mt -118.84 123.7 28.85 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.906 -1.349 . . . . 0.0 109.774 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.406 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 43.3 Cg_endo -69.94 173.41 11.17 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.486 1.256 . . . . 0.0 110.431 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 51.1 Cg_endo -72.39 -164.09 0.17 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.564 1.297 . . . . 0.0 110.216 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 48.5 30.98 8.85 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.6 m -131.01 116.85 16.95 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.118 -1.225 . . . . 0.0 110.362 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.825 ' HB2' HG22 ' A' ' 35' ' ' VAL . 49.1 Cg_endo -74.49 150.31 40.64 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.408 1.215 . . . . 0.0 110.469 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.545 ' CD2' HD12 ' A' ' 37' ' ' LEU . 11.8 t80 -56.94 -23.45 45.38 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.231 -0.918 . . . . 0.0 109.907 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.825 HG22 ' HB2' ' A' ' 33' ' ' PRO . 31.3 m -70.22 -15.61 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.288 -0.883 . . . . 0.0 110.718 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.12 -0.99 35.16 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.174 -0.954 . . . . 0.0 110.893 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.545 HD12 ' CD2' ' A' ' 34' ' ' PHE . 41.0 mt -54.28 161.27 1.39 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.826 -1.171 . . . . 0.0 110.159 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.7 m -52.68 177.67 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.216 -0.928 . . . . 0.0 110.187 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.7 -18.03 49.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.248 -0.907 . . . . 0.0 110.458 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.6 p -133.2 37.4 3.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.105 -0.997 . . . . 0.0 110.541 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.462 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 14.5 t80 -56.61 133.87 54.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.138 -0.976 . . . . 0.0 109.774 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.438 ' HA ' ' O ' ' A' ' 48' ' ' SER . 5.1 mtt -106.99 143.9 34.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 109.854 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 35.9 t -56.64 138.96 76.6 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.879 . . . . 0.0 110.472 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -77.8 2.79 7.52 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.523 1.275 . . . . 0.0 110.873 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -124.61 -38.23 2.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.961 -1.087 . . . . 0.0 110.873 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.457 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 1.6 p -121.59 6.17 10.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.091 -1.006 . . . . 0.0 111.43 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.36 17.73 4.99 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.033 -1.042 . . . . 0.0 112.622 178.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.438 ' O ' ' HA ' ' A' ' 42' ' ' MET . 4.4 m -72.81 163.06 71.13 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 120.56 -1.338 . . . . 0.0 109.628 179.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.38 145.74 54.44 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.667 1.351 . . . . 0.0 110.334 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.502 ' HG2' ' CZ ' ' A' ' 34' ' ' PHE . 31.1 tttt -51.6 -24.74 5.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.3 -0.875 . . . . 0.0 110.255 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -66.12 -13.95 60.99 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.248 -0.907 . . . . 0.0 109.773 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.529 ' NE2' ' HB2' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -85.73 -3.73 58.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.238 -0.914 . . . . 0.0 110.043 179.193 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.45 ' CB ' ' CE2' ' A' ' 34' ' ' PHE . 17.1 m-85 -84.77 134.75 34.31 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.039 -1.038 . . . . 0.0 110.437 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.47 130.36 55.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.307 -0.87 . . . . 0.0 109.736 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.529 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 74.7 p -63.7 179.54 0.48 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 111.188 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.826 HG22 ' O ' ' A' ' 7' ' ' LYS . 4.8 tp -159.98 91.81 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.348 0.594 . . . . 0.0 109.546 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 1.2 pttt -115.2 71.76 0.77 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.166 -0.959 . . . . 0.0 110.531 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.61 64.77 0.84 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.466 -0.771 . . . . 0.0 109.849 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.3 t -65.79 151.85 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.894 . . . . 0.0 110.218 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.4 tt -128.78 142.87 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.308 -0.87 . . . . 0.0 110.089 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 53.51 -158.87 0.15 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.316 -0.865 . . . . 0.0 110.225 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 61.05 31.29 76.11 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -109.57 -68.68 0.91 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.255 -1.144 . . . . 0.0 110.286 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -132.7 175.73 9.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.288 -0.882 . . . . 0.0 110.182 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -128.29 105.74 8.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.197 -0.94 . . . . 0.0 110.374 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 19.3 m-20 -78.45 -72.99 0.35 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.193 -0.942 . . . . 0.0 109.97 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -120.41 -79.78 0.61 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.304 -0.872 . . . . 0.0 109.717 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -121.26 77.28 1.3 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.324 -0.86 . . . . 0.0 109.826 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -161.58 125.53 3.3 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.39 -0.819 . . . . 0.0 109.997 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 CA-C-O 117.998 -1.446 . . . . 0.0 109.583 179.939 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.285 0.565 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -114.35 58.81 0.69 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.178 -0.951 . . . . 0.0 110.199 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.8 mt -134.02 162.64 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 109.875 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 32.5 t70 -157.8 10.81 0.19 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.383 -0.823 . . . . 0.0 111.708 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -81.42 53.54 2.1 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.011 -1.056 . . . . 0.0 110.362 -179.812 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 51.52 25.19 13.05 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.904 ' O ' HG22 ' A' ' 56' ' ' ILE . 1.3 mttt -79.25 135.81 36.88 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.375 -1.074 . . . . 0.0 109.961 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.586 ' CE2' ' CD1' ' A' ' 34' ' ' PHE . 8.0 m-85 -113.95 125.54 54.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.131 -0.981 . . . . 0.0 109.931 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 2.1 tm-20 -88.85 128.78 35.67 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.239 -0.913 . . . . 0.0 110.168 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.6 t -72.35 115.16 11.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.195 -0.941 . . . . 0.0 110.242 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -70.37 -12.8 61.83 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.146 -0.971 . . . . 0.0 109.537 178.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.465 ' HB2' ' NE2' ' A' ' 52' ' ' GLN . . . -85.08 -42.75 14.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.324 -0.86 . . . . 0.0 111.657 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.46 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 12.9 p -120.85 -27.29 5.05 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.72 -1.238 . . . . 0.0 111.382 -178.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.72 22.01 9.28 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.447 ' CG ' ' N ' ' A' ' 16' ' ' ILE . 60.7 t80 -81.88 168.35 18.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -1.117 . . . . 0.0 109.545 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.447 ' N ' ' CG ' ' A' ' 15' ' ' TYR . 25.7 mm -127.58 102.65 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.238 -0.914 . . . . 0.0 109.935 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.519 ' CD2' ' HB2' ' A' ' 34' ' ' PHE . 76.4 t80 -66.91 134.82 52.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 109.693 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -114.4 110.6 47.47 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.475 -0.766 . . . . 0.0 110.01 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.501 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 39.2 Cg_endo -71.04 -62.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.506 1.266 . . . . 0.0 110.641 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -45.1 -26.45 0.46 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.825 -0.547 . . . . 0.0 111.054 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.5 mtpp -103.16 -29.51 11.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.083 -1.01 . . . . 0.0 110.364 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.75 151.36 21.57 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.736 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 0.3 OUTLIER -85.1 63.42 8.1 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.399 -1.06 . . . . 0.0 109.533 179.754 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.69 -26.6 0.96 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.517 -0.74 . . . . 0.0 110.79 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -78.88 -19.77 51.11 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.189 -0.944 . . . . 0.0 110.254 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.736 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -104.1 -32.36 9.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.259 -0.9 . . . . 0.0 109.965 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 125.09 32.3 0.8 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.3 mt -126.82 123.51 23.75 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.037 -1.272 . . . . 0.0 109.875 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.407 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 46.5 Cg_endo -71.2 173.09 12.76 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.543 1.286 . . . . 0.0 110.596 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 29' ' ' PRO . 50.2 Cg_endo -72.45 -163.4 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.759 1.399 . . . . 0.0 110.255 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 49.77 26.43 8.05 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 56.3 m -132.75 117.94 15.37 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.161 -1.2 . . . . 0.0 110.3 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.822 ' HB2' HG22 ' A' ' 35' ' ' VAL . 48.4 Cg_endo -74.38 151.77 43.22 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.492 1.259 . . . . 0.0 110.755 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.586 ' CD1' ' CE2' ' A' ' 8' ' ' TYR . 9.2 t80 -55.47 -24.42 30.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.365 -0.834 . . . . 0.0 110.104 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.822 HG22 ' HB2' ' A' ' 33' ' ' PRO . 26.9 m -71.07 -17.21 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 0.0 110.532 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -100.24 3.54 43.64 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.051 -1.031 . . . . 0.0 110.859 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' A' ' 37' ' ' LEU . 40.9 mt -54.64 169.67 0.2 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.975 -1.078 . . . . 0.0 110.265 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.25 162.05 12.72 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.184 -0.947 . . . . 0.0 110.253 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.3 -19.36 61.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.274 -0.891 . . . . 0.0 110.339 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -132.76 54.1 1.97 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.219 -0.926 . . . . 0.0 110.136 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.465 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 30.7 t80 -70.19 129.5 39.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.298 -0.876 . . . . 0.0 109.98 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 6.8 mtp -112.0 141.06 46.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.231 -0.918 . . . . 0.0 109.605 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 17.7 t -55.45 133.42 70.61 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 0.0 110.527 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.72 -1.91 11.75 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.615 1.324 . . . . 0.0 110.458 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.84 -35.92 4.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.976 -1.077 . . . . 0.0 110.914 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.46 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.9 OUTLIER -127.15 16.4 7.24 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.989 -1.069 . . . . 0.0 110.943 -179.694 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 56.4 mtt85 45.48 23.56 0.14 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.371 -0.831 . . . . 0.0 112.611 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.417 ' CB ' ' SG ' ' A' ' 46' ' ' CYS . 7.3 t -75.66 156.03 85.02 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 120.61 -1.307 . . . . 0.0 109.872 179.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.44 141.18 50.22 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.604 1.318 . . . . 0.0 110.41 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.517 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 12.5 tttm -49.16 -26.92 3.13 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.33 -0.856 . . . . 0.0 110.789 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.71 -14.56 53.43 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.066 -1.021 . . . . 0.0 109.952 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.465 ' NE2' ' HB2' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -89.2 1.45 55.66 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.227 -0.921 . . . . 0.0 110.271 179.303 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -89.54 148.47 23.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.896 -1.127 . . . . 0.0 111.012 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.5 133.95 47.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.564 -0.71 . . . . 0.0 109.152 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.535 ' HB3' ' CZ ' ' A' ' 8' ' ' TYR . 75.7 p -70.52 176.81 3.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.989 -1.069 . . . . 0.0 111.301 -179.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.904 HG22 ' O ' ' A' ' 7' ' ' LYS . 1.6 tt -155.95 67.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-O 121.361 0.601 . . . . 0.0 109.912 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 4' ' ' ASP . 0.3 OUTLIER -80.6 57.89 3.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.889 . . . . 0.0 110.155 -179.878 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -130.0 104.7 7.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.437 -0.79 . . . . 0.0 110.26 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.665 HG13 ' O ' ' A' ' 59' ' ' VAL . 9.3 p -130.24 106.2 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.166 -0.958 . . . . 0.0 110.156 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 55.6 mt -95.07 57.86 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.105 -0.997 . . . . 0.0 110.149 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -148.94 93.02 2.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -0.919 . . . . 0.0 110.422 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -151.29 -138.29 2.79 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -85.09 139.25 31.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.188 -1.184 . . . . 0.0 110.119 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.31 129.38 35.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.226 -0.921 . . . . 0.0 110.22 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -156.47 50.85 0.51 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.286 -0.884 . . . . 0.0 110.106 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -97.48 -36.51 10.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.237 -0.915 . . . . 0.0 110.081 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -149.63 95.94 2.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.316 -0.865 . . . . 0.0 110.132 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.75 156.29 36.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.886 . . . . 0.0 110.428 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -97.21 101.06 12.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.284 -0.885 . . . . 0.0 110.199 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 179.968 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.241 0.543 . . . . 0.0 110.253 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -173.52 66.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.364 -0.835 . . . . 0.0 109.898 179.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.762 HD11 ' CD ' ' A' ' 7' ' ' LYS . 6.5 tt -159.25 169.11 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.383 -0.823 . . . . 0.0 110.145 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.454 ' N ' ' CG1' ' A' ' 3' ' ' ILE . 4.5 p-10 178.46 112.02 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.81 0.814 . . . . 0.0 109.526 179.408 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.47 65.7 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.933 0 CA-C-O 121.286 0.565 . . . . 0.0 110.122 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 56.0 20.72 28.25 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.762 ' CD ' HD11 ' A' ' 3' ' ' ILE . 19.6 mttm -87.35 131.17 34.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.071 -1.253 . . . . 0.0 109.64 179.608 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.503 ' CE2' ' HB2' ' A' ' 55' ' ' SER . 22.3 m-85 -122.64 139.56 53.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -0.906 . . . . 0.0 110.858 -179.385 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.4 OUTLIER -110.13 141.15 43.41 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.361 -0.837 . . . . 0.0 109.836 179.409 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.7 t -81.01 114.1 19.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.068 -1.02 . . . . 0.0 110.37 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.27 -11.51 60.95 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.174 -0.954 . . . . 0.0 109.633 178.874 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.04 -42.22 15.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.369 -0.832 . . . . 0.0 111.759 -179.252 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.449 ' HB3' ' CB ' ' A' ' 46' ' ' CYS . 13.6 p -121.42 -34.71 3.4 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.668 -1.27 . . . . 0.0 111.424 -178.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 115.49 20.48 5.44 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 119.673 -1.251 . . . . 0.0 110.211 179.419 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.864 ' C ' HD12 ' A' ' 16' ' ' ILE . 55.9 t80 -84.58 162.49 19.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.206 -1.173 . . . . 0.0 109.856 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.864 HD12 ' C ' ' A' ' 15' ' ' TYR . 3.3 mp -128.29 115.13 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.125 -0.984 . . . . 0.0 110.018 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.567 ' CE1' HD21 ' A' ' 37' ' ' LEU . 71.2 t80 -77.44 131.18 37.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.316 -0.865 . . . . 0.0 110.187 179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -109.5 115.71 55.65 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.427 -0.795 . . . . 0.0 109.415 179.371 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.487 ' HB3' ' HA ' ' A' ' 33' ' ' PRO . 38.2 Cg_endo -71.0 -65.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.465 1.245 . . . . 0.0 111.041 -179.484 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' A' ' 30' ' ' PRO . 0.5 OUTLIER -47.86 -24.04 0.9 Allowed 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.552 -0.717 . . . . 0.0 111.023 -179.835 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.2 tttp -99.13 -40.06 8.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.923 -1.11 . . . . 0.0 110.732 -179.724 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.74 147.85 22.72 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -85.11 61.34 6.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.447 -1.031 . . . . 0.0 109.985 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -44.72 -27.31 0.48 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.622 -0.674 . . . . 0.0 111.039 -179.724 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -69.26 -28.33 66.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.118 -0.989 . . . . 0.0 109.88 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -100.88 -28.33 12.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.343 -0.848 . . . . 0.0 109.983 179.661 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.54 28.54 1.43 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 179.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.57 HD13 ' CD2' ' A' ' 37' ' ' LEU . 8.8 mt -116.87 119.82 34.82 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.046 -1.267 . . . . 0.0 109.739 179.647 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.403 ' HB2' ' HD2' ' A' ' 30' ' ' PRO . 48.0 Cg_endo -71.81 172.95 13.47 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.496 1.261 . . . . 0.0 110.553 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.425 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 49.1 Cg_endo -70.64 -163.37 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.741 1.39 . . . . 0.0 110.28 179.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 50.22 27.83 12.03 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.849 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 63.3 m -131.71 115.91 15.87 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.198 -1.178 . . . . 0.0 110.341 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.848 ' HB2' HG22 ' A' ' 35' ' ' VAL . 47.2 Cg_endo -72.83 148.61 46.4 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.466 1.245 . . . . 0.0 110.586 179.818 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.519 ' CE1' ' HE2' ' A' ' 50' ' ' LYS . 30.1 t80 -53.06 -30.27 34.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.36 -0.838 . . . . 0.0 109.968 179.823 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.848 HG22 ' HB2' ' A' ' 33' ' ' PRO . 33.9 m -66.75 -11.78 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.844 . . . . 0.0 110.716 -179.876 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.401 ' HB2' ' HG2' ' A' ' 33' ' ' PRO . 1.5 t70 -103.2 -2.42 27.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.012 -1.055 . . . . 0.0 110.92 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.57 ' CD2' HD13 ' A' ' 28' ' ' ILE . 19.7 mt -52.1 172.81 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.926 -1.109 . . . . 0.0 110.312 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.8 m -64.36 150.9 45.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.219 -0.926 . . . . 0.0 110.23 -179.9 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -57.65 -22.18 44.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 0.0 110.234 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.4 p -129.61 38.51 3.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 0.0 109.911 179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.465 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 30.8 t80 -60.46 135.66 57.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 110.345 -179.784 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.432 ' HA ' ' O ' ' A' ' 48' ' ' SER . 0.0 OUTLIER -109.81 149.55 29.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.336 -0.853 . . . . 0.0 109.558 179.214 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 18.1 t -61.1 137.0 94.05 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.104 -0.997 . . . . 0.0 110.52 -179.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.11 -3.37 13.75 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.602 1.317 . . . . 0.0 110.353 179.383 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -116.97 -39.28 3.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.07 -1.019 . . . . 0.0 110.632 -179.682 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.449 ' CB ' ' HB3' ' A' ' 13' ' ' CYS . 0.9 OUTLIER -124.24 9.17 8.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.164 -0.96 . . . . 0.0 110.954 -179.801 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 54.39 15.98 1.14 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.31 -0.869 . . . . 0.0 112.964 178.147 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.432 ' O ' ' HA ' ' A' ' 42' ' ' MET . 3.4 m -67.25 165.38 28.73 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 120.621 -1.299 . . . . 0.0 109.746 179.293 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.458 ' HB2' ' ND2' ' A' ' 51' ' ' ASN . 43.5 Cg_endo -69.85 144.29 53.08 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.677 1.356 . . . . 0.0 110.492 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.519 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 37.4 tttt -53.57 -32.16 49.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.174 -0.954 . . . . 0.0 110.608 -179.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.458 ' ND2' ' HB2' ' A' ' 49' ' ' PRO . 24.5 p30 -63.29 -14.45 49.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.054 -1.029 . . . . 0.0 109.738 179.258 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -80.62 -7.66 59.35 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.069 -1.019 . . . . 0.0 109.755 178.985 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -82.56 124.62 30.3 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.107 -0.996 . . . . 0.0 109.678 179.375 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.416 ' O ' ' HG3' ' A' ' 9' ' ' GLU . 1.5 tttm -104.03 123.78 47.83 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.142 -0.974 . . . . 0.0 109.545 179.52 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.503 ' HB2' ' CE2' ' A' ' 8' ' ' TYR . 2.2 t -52.12 -179.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.103 -0.998 . . . . 0.0 110.241 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.734 HG22 ' O ' ' A' ' 7' ' ' LYS . 4.5 tt -158.53 67.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.457 -0.777 . . . . 0.0 110.046 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.441 ' HA ' ' HB3' ' A' ' 4' ' ' ASP . 0.0 OUTLIER -102.58 61.39 0.82 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.416 -0.802 . . . . 0.0 110.194 -179.975 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -106.13 125.16 50.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -0.899 . . . . 0.0 110.093 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.6 p -135.84 148.25 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.286 -0.884 . . . . 0.0 110.123 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.419 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 0.5 OUTLIER -135.99 49.39 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.202 -0.936 . . . . 0.0 110.264 -179.956 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -128.92 21.73 5.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.202 -0.936 . . . . 0.0 110.282 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 162.49 130.73 1.14 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -116.43 138.45 51.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.259 -1.142 . . . . 0.0 110.314 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -121.99 20.31 10.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.219 -0.926 . . . . 0.0 110.23 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -136.78 17.27 3.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.139 -0.975 . . . . 0.0 110.48 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -160.49 -44.41 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.138 -0.976 . . . . 0.0 110.149 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.49 -173.32 2.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.277 -0.89 . . . . 0.0 110.113 179.837 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -168.18 -177.96 3.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 110.19 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -119.75 111.6 18.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.232 -0.918 . . . . 0.0 110.144 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 CA-C-O 118.006 -1.441 . . . . 0.0 109.547 179.994 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_